Text

Rev 2 to PP&L SSES Odcm
	ML17164A589
Person / Time
Site:	Susquehanna
Issue date:	01/20/1995
From:	Shank K; PENNSYLVANIA POWER & LIGHT CO.
To:	;
Shared Package
ML17164A588	List: ML17164A587; ML17164A589; PLA-4268, Forwards Monthly Operating Repts for Jan 1995 for SSES Units 1 & 2.Rev 2 to PP&L SSES ODCM Also Encl;
References
	PROC-950120, NUDOCS 9502210309
	Download: ML17164A589 (172)
	v • d • e

PENNSYLVANIA POWER 5 LIGHT COMPANY-"=.".

SUSGUEHANNA STEAM ELECTRIC. STN'ZON...,-.."

OFFSITE DOSE CALCULATION MAtwtUAL ":::"

jl Revision 2

wA

> ~

~

a i

Prepared By Date Reviewed By Supervisor-Environmen al Services Nuc ear Date

/ /

Reviewed By S

Db Date i i5'pproved By Nanager-Nuclear Technology Date Itmlmmlll II<SIIIIIIE 9'5022l0309 950215 PDR ADOCK 05000387 R

PDR

SUNSLRY OF ODCN CHANGES Changes other than those of a minor, editorial nature are suttittarized below.

Section 10.3 (Evaluation and Honitoring Criteria for Effluent Pathways) has been expanded to show specific plant systems evaluated in the categories NOT AN EFFLUENT PATHNY (listed in new Table 8), and INSIGNIFICANT EFFLUENT PATfNAY (listed in new Table 9).

References for the bases for these evaluations are included for each system in the Table.

Unless otherwise listed, most of the. systems were evaluated in PPEL Calculation EC-ENVR-1008, which.was performed in response to NRC Open Item 91-10-01-07.

This revision to the ODCH is submitted in response to NRC Open Item 91-10-01-0&.

2.

3.

Equations 7, 8,'7 and 18 are revised to show the Gamma Shielding Factor (S,).

This factor has always been used in GASPAR calculations (NRC code referenced in the ODCM) for whole body and skin dose from noble gas effluent:

the equations are revised to be consistent with the application of the GASPAR code.

The Gaaea Shielding Factor

(

0.7 for the Maximally-Exposed member of the Public) is taken from Reg.

Guide 1.109 Table E-15.

Sections 8.1 and 8.3 have been revised to reflect the current state of liquid and solid radwaste processing, respectively.

Figures 1,

3 and 4 have also been updated to show changes to'iquid and solid radwaste processing

systems, including vendor interfaces,'ased on information from Effluents Management.

Rev.

2

TABLE OF CONTENTS APPROVAL REVISION 85K MAIS

~EF

1.0 INTRODUCTION

2.1 WATERBORNE EFFLUENT MONITORS..............

2.2 AIRBORNE EFFLUENT MONITORS..............--

3.0 WATERBORNE EFFLUENT CONCENTRATION HEASUREMENTS 7.0 TOTAL DOSE..........

8.0 OPERABILITY OF WASTE TREATHENT SYSTEMS........

8.1 LIQUID WASTE TREATMENT....................

8.2 GASEOUS WASTE TREATHENT...................

8.3 SOLID WASTE TREATMENT....................

4.0 AIRBORNE EFFLUENT DOSE RATES.................

4.1 NOBLE GASES...............................

4.2 RADIONUCLIDES OTHER THAN NOBLE GASES...."

5.0 INDIVIDUALDOSE DUE TO WATERBORNE EFFLUENT....

5.1 FISH PATHWAY LIQUID EFFLUENT DOSE CALCULATION HETHODOLOGY...................

5.2 POTABLE WATER PATHWAY EFFLUENT DOSE CALCULATION METHODOLOGY...................

5.3 SHORELINE EXPOSURE PATHWAY................

5.4 PROJECTED DOSE FROM LIQUID EFFLUENT.......

6.0 INDIVIDUALDOSE DUE TO AIRBORNE EFFLUENT......

6.1 NOBLE GASES.................-....--.--.---

6.2 RADIONUCLIDES OTHER THAN NOBLE GASES......

0 0

~ ~ ~ ~

~

~ ~ ~

~ ~ ~ ~ ~ ~

~

2 3

4 4

5 6

7 8

9 10Il 12 13 14 15 15 16 17 18 19 20 21 22 23 24 24 25 26 27 27 28 29 30 31 32 32 33 34 35 36 37 10/29/93 2/5/92 11/9/93 2/5/92 2/5/92 12/11/89 2/5/92 12/11/89 12/11/89 2/5/92 12/11/89 12/11/89 ll/21/92 2/5/92 2/5/92 2/5/92 1/16/95 1/16/95 2/11/92 2/5/92 12/Il/89 12/1/92 10/29/93 3/11/94 2/21/92 3/11/94 2/21/92 2/21/92 12/11/89 2/21/92 12/11/89 12/11/89 2/Zl/92 12/11/89 12/11/89 ll/25/92 2/21/92 2(21/92 2/21/92 1/20/95 1/20/95 2/21/92 2/21/92 12/11/89 12/4/92 3/11/94 1 l(9/93 11/9/93 ll/9(93

'/18/94 11/9/93 10/29/93 10/29/93 10/29/93 10/29/93 1/16/95 10/29/93 10/29/93 1/16/95 1/16/95 1/16/95 1/16/95 1/16/95 1/16/95 3/ll(94 3/ll/94 3(ll/94 3/ll/94 3/ll(94 3/ll/94 3/11/94 3/11/94 3/11/94 1/20/95 3/11/94 3/ll/94 1/20/95 1/20/95 1/20/95 1/20/95 1/20/95 1/20/95 2/18/94 3/ll/94 OAT Vev.

2

APPROVAL ZM~~T 9.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM. 42 9.1 DEFIt)ITIONS................................

42 9.2 MONITORING PROGRAM......................'.;.

42 9.3 CENSUS PROGRAM............................

43 9.4 INTERLABORATORY COMPARISON PROGRAM........

44 45 1/16/95 1/16/95

'/16/95 1/16/95 1/16/95 1/16/95 REVISION

~OAT

~ 1/20/95 1/20/95 1/20/95 1/20/95 1/20/95 1/20/95 DOSE CALCULATIONS 10.2 ASSIGNMENT'F RELEASES TO THE REACTOR UNITS 10.3 EVALUATION AND MONITORING CRITERIA FOR EFFLUENT PATHWAYS 10.4 FLOW FROM THE SGTS VENT WHEN THE SYSTEM IS NOT IN USE 10.5 ODCM SETPOINTS ARE UPPER LIHIT VALUES 10.6 DEFINITION OF "APPROPRIATE TREATHENT" FOR LIQUID WASTES 10.7 MONITOR LINE-lOSS CORRECTIONS 10.8 SELECTION OF DATA FOR DETERHINATION OF DOSE RATE COMPLIANCE 10.9 LOW-LEVEL RADIOACTIVITY IN THE SEWAGE TREATMENT PLANT 11.0 ODCH REVIEW AND REVISION CONTROL.............

53 53 54 55 55 57 57 58 60 10.0 DOSE ASSESSMENT POLICY STATEHENTS............

53 10.1 SELECTION OF ANALYSIS RESULTS FOR 53 1/16/95 1/16/95 1/)6/95 1/16/95 1/16/95 1(16(95 1/20/95 1/20/95 1/20/95 1/20/95 1/20/95 1/20/95 1/16/95 1/20/95 1/16/95 1/20/95 1/16/95 1/20/95 1/16/95 1/20/95 1/16/95 1(20/95 APPENDIX A - SAMPLE CALCULATIONS OF ODCH PARAMETERS........

I APPENDIX B - REPORTING REQUIREHENTS...............

A-1 A-2 A-3 A-4 A-5 A-6 A-7 A-8 A-9 A-10 A-11 A-12 A-13 8-1 8-2 8-3 8-4 2/5/92 2/5/92 12/ll/89 2/5/92 10/29/93 10/29/93 10/29/93 10/29/93 2/5/92 2/5/92 10/29/93 10/29/93 10/29/93 12/11/89 10/29/93 12/11/89 12/11/89 2/21/92 2/21/92 12/ll/89 2/21/92 3/ll/94 3/ll/94 3/ll/94 3/ll/94 2/21/92 2/21/92 3/ll/94 3/11/94 3/il/94 12/)1/89 3/ll/94 12/ll/89 12/11/89 I

OAT Rev.

2

APPROVAL REVISION ELK ~YE'0E APPENDIX C - SITE SPECIFIC INFORMATION USED BY GASPAR CODE...............:..

C-1 12/11/89 12/11/89 APPENDIX D - SITE SPECIFIC INFORMATION USED BY LADTAP CODE..................

D-1 10/10/94 10/14/94 Rev.

1

APPROVN.

MSK REVISION M53.-

2 Radiological Effluent Objectives and Standards..

3 Dose Factors for Noble Gases............'.......

18 Sample Annual Average Relative Concentrations and Deposition Rates...:.;......................

19 11/9/93 2/5/92 3/11/94 2/21/92 11(9/93 3(11(94'ose Factors for Inhalation, Ingestion and Ground Exposure Pathways:

Radionuclides Other Than Noble Gases................................

20 12/1/92 5-la Dose Factors for Fish Pathway, Haximum Hypothetical Adult (2pp).......................5-'a(1,2) 10/10/94 5-lb Dose Factors for Fish Pathway, Haximum Hypothetical Teen (2pp)........................5-1b(1,2) 10/10/94 5-lc Dose Factors for Fish Pathway, Haximum Hypothetical Child (2pp).......................5-1c(1,2) 10/10/94 5-2a Dose Factors for Potable Water Pathway, Haximum Hypothetical Adult (2pp).......................5-2a(1,2) 10/29/93 5-2b Dose Factors for Potable Mater Pathway, Haximum Hypothetical Teen (2pp)........................5-2b(1,2) 10/29/93 12/4/92

'0/14/94 10/14/94 10/1 3/ll/94.

3/11/94 5-2c 5-2d 5-3 5-4 5-5 Dose Factors for Potable Water Pathway, Haximum Hypothetical Child (2pp).......................5-2c(1,2)

Dose Factors for Potable Mater Pathway, Haximum Hypothetical Infant (2pp)......................5-2d(1,2)

Radioactive Decay Constants.....................5-3 Dilution Factors and Transit Times for SSES Effluents to Danville, PA......................5-4(1,2)

Dose Factors for Shore Exposure Pathway, All Age Groups (2pp)...................................5-5(1,2) 10/29/93 10/29/93 10/29/93 10/29/93 10/29/93 3/ll/94 3/11/94, 3/11/94 3/11/94 3/11/94 5-6a Composite Dose Factors:

Maximum Hypothetical Adult (2pp}....................................5-6a(1,2) 10/10/94 5-6b Composite Dose Factors:

Haximum Hypothetical Teen (2pp)'.....................................5-6b(1,2) 10/10/94 10/14/94 10/14 OAT Rev.

1 iv

TABL APPROVAL REVISION 5-6d Mater Ingestion 'Dose Factors:

Hypothetical Infant (2pp)....

6 Operational Radiological'nvi Monitoring Program...........

Maximum

.--...--.-........5-6d(1,2) 2/18/94 ronmental

~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 48 49 50 1/16/95 1/16/95 1/16/95 5-6c Composite Dose Factors:

Maximum Hypothetical Child (2pp)....................................5-6c(1,2) 2/18/94 3/11/94 3/11/94 1/20/95 1/20/95 1/20/95 8

9 Systems Classified as Not an Effluent Pathway...

61 Systems Classified as Insignificant Effluent Pathway.........................................

62 7

Detection Capabilities for Environmental Sample Analysis.................................

51.

52 1/16/95 1/16/95 1/16/95 1/16/95 1/20/95 1/20/95 1/20/95 1/20/95 B-1 Radiological Environmental Monitoring Program Annual Summary.......................,..........

B-3 B-2 Reporting Levels for Nonroutine Operating Reports.........................................

'B-4 12/11/89 12/11/89 12/11/89 3/11/94 D-1 Dilution Factors and Transit Times for SSES Effluents to Danville, PA.......................

D-l 11/9/93 3/ll/94

LIST OF FI6URES APPROVAL REVISION 85K MSK MHK Figure 1

Figure 2

Figure 3

Liquid Radwaste System Flow Diagram..........................

Offgas and Recombiner System Flow Diagram..................,........

Solid Waste Management System Flow Diagram.........................-

Figure 5

Environmental Monitoring Locations Mithin One Nile of SSES...............

Figure 4

SSES Dry Contaminated Maste Processing............................

38

'/16/95 1/20/95 39 1/16/95 1/20/95 40 1/16/95 1/20/95 41 1/16/95 1/20/95 46 1/16/95 1/20/95 Figure 6

Environmental Monitoring Locations Greater than One Hile from SSES.......

47 1/16/95 1/20/95 DAT Rev.

2 vi

The purpose of this manual is to provide the parameters and methodology to be used in calculating offsite doses and effluent monitor setpoints for the Susquehanna Steam Electric Station, Units 1 and 2.

Included are methods for determining maximum individual, whole-body, and organ doses due to waterborne and airborne effluents to ensure compliance with the dose limitations in the Technical Specifications.

methods are included for performing dose calculations to ensure compliance with the waterborne and airborne treatment system operability sections of the Technical Specifications.

This manual includes the methods used for determining quarterly individual doses-for inclusion in Annual Effluent and Maste Disposal Reports.

The dose models consider two release modes:

airborne and waterborne.

All airborne effluents are treated as ground-level releases.

Dose to each of the seven organs listed in Regulatory Guide 1.109 (bone, liver, total body, thyroid, kidney, lung, and GI-LLI) are computed based on the individual nuclide composition of the effluent.

The largest of the doses are compared to 10 CFR 50, Appendix I design objectives.

Liquid effluents discharged into a river undergo mixing prior to consumption as either potable water or through the fish pathway.

For releases to the Susquehanna River, river model dilution factors are used-Doses to'he seven critical organs are determined from individual nuclide contributions and are compared to the 10 CFR 50 Appendix I design objectives.

Compliance with the 10 CFR 20 maximum permissible concentrations is done on a batch-by-batch basis prior to discharge.

This manual discusses the methodology to be used in determining effluent monitor alarm/trip setpoints to be used, to ensure compliance with the instantaneous release rate limits in the Technical Specifications.

Hethods are described for determining the annual cumulative dose to a real individual from liquid effluents, gaseous effluents, and direct raPiation for critical organs to ensure compliance with 40 CFR 190 limits.

The calculational methodology for doses are based on models and

. data that make it unlikely to substantially underestimate the actual

exPosure of an individual through any of the appropriate pathways.

The Radiological Environmental Honitoring Program is described. in Section 9.0 of the manual, which includes the annual land use census survey and interlaboratory comparison program.

It is the responsibility of the Superintendent of Plant-Susquehanna to ensure that this manual is used in performance of the surveillince.

requirements and for compliance with the limiting conditions of.

operations stated in the Technical Specifications.

It is the responsibility of the Hanager-Nuclear Technology to ensure adequacy and correctness of calculational approaches.

.ABLE I RADIOLOGICAL EFFLUENT OBJEC IVES 5 STAND DS 10 CFR 50 40 CFR 190 APPENDIX I STANDARDS*

DESIGN OBJECTIVES (BOTH REACTOR (PER REACTOR UNIT)

UNITS COMBINED) 10CFR 20 STANDARDS**

(BOTH REACTOR UNITS COMBINED)

WATERBORNE EFFLUENTS Dose to Total Body From all Pathways Dose to any Organ From all Pathways AIRBORNE NOBLE GAS EFFLUENTS Dose Rate to Total Body Dose Rate to Skin Gamma Dose in Air Beta Dose in Air Dose to Total Body of an Individual Dose to Skin of an Individual-AIRBORNE RADIOIOOINES AND PARTICULATES Dose Rate to any Organ Dose to any Organ From all Pathways-TOTAL'RANIUM FUEL CYCLE Dose to Mhole Body From all Fuel Cycle Operations Dose to Thyroid From all Fuel Cycle Operations Dose to any Other Organ From all Fuel Cycle Operations 3 mrem/year

'0 mrem/year 10 mrad/year 20 mrad/year 5 mrem/year 15 mrem/year 15 mrem/year 25 mrem/year 75 mrem/year 25 mrem/year 500 mrem/year 3000 mrem/year 1500 mrem/year

As currently reflected in Technical Specification 3.11.4.

- Technical Specification limits set to ensure compliance with 10 CFR 20 limits

2.0

~SETPO NTS 2.1 M

RBORN F tj NT MONI S

S CAT 0 3.3.

- THE RADIOACTIVE LIQUID EFFLUENT NNITORING INSTRUMENTATIQN SHQMN IN TABLE 3.3.7.10-1 SHALL BE OPERABLE MITH THEIR ALARM/TRIP SETPOINTS SET TO ENSURE THAT THE LIMITS OF SPECIFICATION 3.11.1.1 ARE NOT EXCEEDED-.

THE ALARM/TRIP SETPOINTS OF THESE CHANNELS SHALL BE DETERMINED IN ACCORDANCE MITH THE METHODOLOGY AND PARAMETERS DESCRIBED IN THE OFFSITE DOSE CALCULATION MANUAL (ODCM).

A gross radioactivity monitor providing automatic termination of liquid effluent releases is present on the liquid radwaste effluent line.

Flow rate measurement devices are also present on the liquid radwaste effluent line and the discharge line (cooling tower blowdown).

Precautions, limitations, and setpoints applicable to the operation of the Susquehanna Steam Electric Station liquid effluent monitors are provided in the applicable plant procedures.

Setpoint values are to be calculated to ensure that alarm and trip actions occur upon approaching the MPC limits of 10 CFR 20, Appendix 8, Table II, Column 2 at the release point to the unrestricted area.

The calculated alarm and trip action setpoints for the liquid effluent monitor and each flow measurement device must satisfy the following equation:

where:

F+ f C - the liquid effluent concentration limit implementing 10 CFR 20 for unrestricted areas (uCi/ml).

c - the setpoint (uCi/ml) of the radioactive liquid effluent monitor measuring the radioactivity concentration in the effluent line prior to dilution and subsequent release.

the radwaste discharge flow.setpoint, in volume per unit time, in the same units as F.

F =

the dilution (cooling tower blowdown) water flow setpoint as measured prior to injection of the radwaste, in volume per unit time Radioactive liquid effluents from the SSKS are only discharged as batch releases and are discharged through the liquid radwaste effluent line.

The radioactive liquid waste stream is diluted.in the plant discharge (cooling tower blowdown) line prior to entering the Susquehanna River.

The limiting batch release concentration (c}

corresponding to the liquid radwaste effluent line monitor setpoint is calculated from the above expression.

The MPC value used for the liquid effluent concentra'tion limit (C} in the above expression for the liquid radwaste effluent line monitor setpoint is 1 x 1Q uCi/ml or the actual MPC for identified mixtures.

Therefore, the expression for determining the setpoint on the liquid radwaste effluent line monitor becomes:

c < (1 x 10 j(uC1/ml) f (Eq. 2)

In order to prevent spurious isolations by the LRH effluent radiation monitor, the setpoint concentration, (c) can be defined as.

c X(A) where (A) is the actual tank concentration and X p l The setpoint dilution factor must then be some factor, Y (where Y P X), times the minimum dilution factor.

f m

MPC where j + f the minimum dilution factor.

f m

E+<

- XE f

HPC where f + f the outpoint dilution factor f

The requirements of Equation (2) are then met as follows:

Y(A)

HPC F+ fi f

I

Since, by definition, Y > X and Y(A) > X(A), then:

c X(A) <HPC

+ f f

The setpoint concentration (c) can be converted to a setpoint count rate by use of the monitor calibration factor.

(Eq-3)

Setpoint (cpm)

+ Background (cpm)

Cal. Factor (uCi/ml per cpm)

The setpoint for the dilution water flow (cooling tower blowdown) is 5000 gpm from both cooling tower basins.

The setpoint for the LRM discharge flow can then be determined from:

F+ f ee

~YQ f

NPC (Eq. 4)

Sample calculations for determining the release concentration limits and setpoints are given in Section A.lel of Appendix A.

The Service Mater System provides screened water from the cooling tower basin for cooling plant systems and equipment.

The Residual Heat Removal (RHR) Service Mater System provides water from the

~ ~vrv

~ngineered Safeguard Service Mater (ESSM) spray pond to the exchangers.

In post-accident conditions, RHR Service Mater can supply water for vessel and containment flooding.

The Service Water and RHR Service Mater Systems are not normal pathways for liquid effluents.

Radiation monitors are in place on these systems to provide indication of leaks across heat exchangers into the service water.

The high radiation setpoints for these monitors axe set at 2E-5 uCi/cc cesium-137 equivalent. 'onsidering the radionuclides predominant in SSES liquid effluents, e.g.,

Co-58, Co-60, Fe-59, Mn-54 and Cr-51, use of a setpoint based on the Cs-137 HPC's conservative based on the following parameters:

1) photon abundance (85%)

2) magnitude of applicable HPC (2E-5 uCi/cc}-

Because Service Mater I RHR Service Mater are not normal release pathways for liquid effluents, no credit should be taken for possible dilution scenarios.

All service water should be maintained below 2E-5 uCi/cc Cs-137 equivalent.

In order to minimize the chance of a change in the background of a monitor masking a significant trend in monitored activity, the alarm setpofnts for the Service Mater and RHR Service Mater monitor s are determined as follows:

a.

When moni tor background>> (2E-5)/Cal. Factor:

Hl RAD Setpoint

0.5 Background

+ (2E-5)/Cal. Factor DOWNSCALE or LOM RAD Setpoint

~ 0.5 Background b.

Mhen monitor background>(2E-5)/Cal.

Factor:

HI RAD Setpoint Background + 0.5 (2E-5)/Cal. Factor

'OOMNSCALE or LOM RAD Setpoint

~ Background - 0.5 (2E-5)/Cal. Factor Where:

Setpoint Alarm threshold value to be entered into monitor (cps for Service Water, cpm for RHR Service Mater).

Background

Monitor background at most recent background determination (cps for Service Water, cpm for RHR Service Water).

(ZE-5)

Cs-137 Maximum Permissible Concentration (uCi/ml).

Cal.

Factor Monitor response factor per unit Cs-137 concentration determined during most recent

calibration (uCi/ml per cps for Service Water, uCi/ml per cpm for RHR Service Mater).

The ALERT RAD setpoints for the RHR Service Mater monitors are f

maintained at 80K of the applicable HI RAD setpoint (cpm).

2.2 ORNE FF U

HON ORS SPECIFICATION 3.3.7.11 - THE RADIOACTIVE GASEOUS EFFLUENT HONITORING INSTRUMENTATION CHANNELS SHOWN IN TABLE 3.3.7.11-1 SHALL BE OPERABLE

'ITH THEIR ALARM/TRIP SETPQINTS SET TO ENSURE THAT THE LIHITS OF SPECIFICATION 3.11.2.1 ARE NOT EXCEEDED.

THE ALARH/TRIP SETPOINTS OF THESE CHANNELS SHALL BE DETERMINED IN ACCORDANCE WITH THE METHODOLOGY AND PARAHETERS IN THE ODCH.

Noble gas activity monitors, iodine samplers and monitors, and particulate samplers and monitors are present on the reactor building ventilation system (Units 1 and 2), the turbine building ventilation system (Units 1 and 2),

and the standby gas treatment system exhaust vents.

Effluent system flow rate and sampler flow rate are measured on all of the systems allowing the vent monitor microprocessor to calculate release rates based on measured flow rates.

Precautions, limitations, and setpoints applicable to the operation of the SSES airborne effluent monitors are provided in the applicable plant procedures.

Setpoints are conservatively established for each effluent monitor so that the instantaneous dose rates corresponding to annual dose limits in 10 CFR 20.105 for unrestricted areas will not be exceeded.

The general methodology for establishing plant ventilation airborne effluent monitor setpoints is based upon vent release rates derived from site-specific meteorological dispersion conditions, vent flow

rates, and measured or expected radionuclide mixtures in the gaseous effluents.

The vent release rate can then be converted to vent concentrations for input as setpoints for the'applicable detectors.

Since the vent monitors are programmed to calculate concentrations

, of iodine-131 and particulate being released based on the rate of

'ccumulation of activity on the filters, setpoints can be established for the iodine and particulate channels.

The following method fs'sed for calculating vent monftor high radiation alarm setpoints:

An isotop~c mixture is selected for the detector in question, if applicable.

Noble gas and partfculate detector setpoints are based on actual isotopic mixtures obtained from vent sample analysis or h

the FSAR/FES expected release mixtures ff actual samples do not contain sufficient detectable activity to accurately estimate the mixtures.

The assumed isotopic mixtures are periodically reviewed to verify that they remain representatfve of plant effluents.

2.

The selected noble gas or particulate mixture is used in the GASPAR program run to calculate the associated doses.

The total source term (total curfes used for the calculatfon) does not matter as long as the proper nucl fdes are present fn the relative proportions indicated in sample analysis data or FSAR/FES tables.

For the iodine-131 setpoint, any release total for I-131 can be entered.

The highest calculated annual average relative 10

concentrations (X/gs) at the site boundary are used for these GASpAR

'\\

calculations.

3.

The following ratio concept is used to calculate a release rate limit for the assumed mixture (or I-131)'.

Calculated Dose mrem ota GASPAR Source erm Dose Rate Limit mrem/ r m tsng e ease te'r The limiting release rate of the assumed mixture (or I-131) can therefore be calculated:

Limiting Release (Ci/yr)

Total GASPAR Source Term Ci Dose Rate Limit mrem/ r a cu ate

ose, mrem For the noble gas setpoint, the. calculated. whole body and skin dose rates via the plume pathway are subject to the 10 CFR 20-derived limits of 500 and 3000 mrem/yr, respectively.

The whole-body dose rate limit is usually most restrictive.

For particulates and for iodine-131, the maximum calculated organ dose rate via the inhalation pathway is subject to the limit of 1S00 mrem/yr.

4.

The limiting release rates are converted to limiting vent concentrations using high limit vent flow rates.

Limiting Vent Concentration, uCi/cc imitino Release Rate C

6uiC (Eq. 6)

(5.26E5 min/yr)

(Vent Flow Rate, cc/min)

Sample calculations of waterborne and airborne effluent monitor setpoints are presented in Section A.1.2 of Appendix A.

Vent flow rates and sample flow rates are monitored and recorded for each of the five SSES release points.

The measured flow rates are used to calculate vent concentrations and release rates.

Flow channel setpoints are set at approximately lOX and 90K of the calibrated sensor ranges to provide indication of possibly abnormal flow rates.

SPECIF CATION 3.

6 - THE CONCENTRATION OF HYDROGEN OR OXYGEN IN THE. HAIN CONDENSER OFFGAS TREATMENT SYSTEM SHALL BE LIMITED TO LESS THAN OR EQUAL TO 4X BY VOLUME.

Hydrogen recombiners are used at SSES to maintain the relative concentration of components of potentially explosive gas mixtures outside the explosive envelope.

The main condenser offgas treatment system explosive gas monitoring system (offgas hydrogen analyzers) have setpoints to alarm at 1X and 2X hydrogen.

'SPEC FICATION 3.

7 - The radioactivity rate of the'noble gases Kr-85m, Kr-87, Kr-88, Xe-133, Xe-135 and Xe-138 measured at the motive steam jet condenser discharge shall be limited to less than or equal to 330 millicuries/second.

The main condenser offgas pre-treatment monitor provides indication of offgas activity prior to input to the holdup system.

Alarm setpoints are based on the Tech.

Spec. 3.11.2.7 noble gas release rate limit of 330 millicuries/second or less at the motive steam jet condenser discharge.

12

'0 W

U C

S C

3

- - THE CONCENTRATION OF RADIOACTIVE MATERIAL RELEASED IN LIQUID EFFLUENTS TO UNRESTRICTED AREAS (SEE FIGURE 5-1.3-1)

SHALL BE LIMITED TO THE CONCENTRATIONS SPECIFIED IN 10 CFR PART 20, APPENDIX B, TABLE II, COLUMN 2 FOR RADIONUGLIDES OTHER THAN DISSOLVED OR ENTRAINED NOBLE GASES.

FOR DISSOLVED OR ENTRAINED NOBLE GASES, THE CONCENTRATION SHALL BE LIMITED TO THE CONCENTRATIONS SPECIFIED IN TABLE 3.11.1.1-1.

Liquid batch releases are controlled individually and each batch release is authorized based upon sample analysis and the existing dilution flow in the discharge line.

The methods for sampling and analysis of each batch prior to release are given in the applicable plant procedures.

A release rate limit is calculated for each batch based upon analysis, dilution flow and all procedural, conditions being met before it is authorized for release.

Table 3.11.1-1 mentioned in Specification 3.11.1.1 contains the following "Maximum Permissible Concentrations of Dissolved or Entrained Noble Gases Released From the Site to Unrestricted Areas in Liquid Waste":

~Nu 1 ide Kr-85m Kr-85 Kr-87 Kr-88 Ar-41 Xe-131m Xe-133m Xe-133, Xe-135m Xe-135 PC u

m 2E-4 5E-4 4E-5 9E-5 7E-5 7E-4 5E-4 6E-4 2E-4 2E-4 I

These values were computed using Equation 20 of ICRP2 (1959), adjusted for infinite cloud submersion in water, with R equal to 0.01 rem/week, ko t'V Cr.T=

13

the density of water equal to 1.0 gm/caP, and Pw/Pt equal to 1.0, where Pw/Pt is stopping power of water. relative to tissue, and R is the dose rate limit for total body exposure.

The HPC value for other liquid effluents is the actual HPC for identified mixtures, or 1E-7 uGi/ml for unidentified mixtures.

The liquid radwaste effluent stream entering the discharge line is monitored and will automatically be terminated if the pre-selected monitor setpoint is exceeded as described in Section 2.1.

Additional monthly and quarterly analyses shall be performed in accordance with Table 4.11-1 of the SSES Technica1 Specifications.

A DAT 14

4.0 ORN FF U NT 50SE RA S

SP FICATION 3..1.

THE DOSE RATE DUE TO RADIOACTIVE HATERIALS RELEASED IN GASEOUS EFFLUENTS FROM THE SITE (SEE FIGURE 5.1.3-1)

SHALL.

'E LIMITED TO THE FOLLOMING:

a.

FOR NOBLE GASES:

LESS THAN OR EQUAL TO 500 HREH/YR TO THE TOTAL BODY AND LESS THAN OR EQUAL TO 3000 HREH/YR "TO THE SKIN, AND b.

FOR IODINE-131, FOR TRITIUH, AND FOR ALL RADIONUCLIDES IN PARTICULATE FORH MITH HALF-LIVES GREATER THAN 8 DAYS:

LESS THAN OR EQUAL TO 1500 KAREN/YR TO ANY ORGAN (INHALATIONPAT%AY ONLY)..

4.1

~NQB AE S

Noble gas activity monitor setpoints are established at release rates which permit some margin for corrective action to be taken before exceeding offsite'dose rates corresponding to the 10 CFR 20 annual dose limits as described in Section 2.2.

The methods for sampling and analysis of continuous ventilation releases are given in the applicable plant procedures.

The dose rate in unrestricted areas due to radioactive materials released in airborne effluents may be determined by the following equation for whole body dose:

D Z

(K (X/Q) (Q')(S )

1 and by the following equation for skin dose:

s Z [Li + ((1 11 (Hi)(S<))] (X/Q ~ (Q 1

(Eq.

7)

(Eq. 8)

DAT

~

f-Rev.

2 15

where:

Ki V

the whole-body dose factor due to gaaaa emissions for each idenfified noble gas radionuclide. (i) (mrem/yr per uCi/m ) from Table. 2.

v the rel ease rate of radi onucl ide (i) from vent (v)

(uCi/sec).

(X/g) the highest calculated annual average relative concentration for any area at or beyond the site boundary in an upestricted area from vent release point (v) (sec/m ) such as.from Table 3.

'wb Li the annual whole-body dose (mrem/yr).

the skin dose factor due to the beta emissions for each iden)ified noble gas radionuclide (i) (mrem/yr per uCi/m ) from Table 2.

the air dose factor due to gaaea emissions for each ident)fied noble gas radionuclide (i) (mrad/yr per uCi/m ) from Table 2 (conversion constant of 1.1 converts air dose-mrad to skin dose-mrem).

the annual skin dose (mrem/yr).

the gamma shielding factor (0.7 for maximally exposed individual)

Sample calculations for determining whole body and skin doses from noble gas radionuclides released from the SSES are given in Section A.2. 1 of Appendix A.

4.2 RADIONUC ID S OTH R THAN NO GA S

The methods for sampling and analysis of continuous ventilation releases for radioiodines and radioactive particulates are given in the applicable plant procedures.

Additional monthly and quarterly analyses shall be performed in accordance with Table 4.11.2.1.2-1 of the SSES Technical Specifications.

The dose rate in unrestricted

'reas due to inhalation of radioactive materials released in 0

Rev.

2

,16

'I airborne effluents may be determined by the following equation for any organ:

0 Z(Rj)(Wv)(qjv)

(Eq. 9) where:

Ri the dose rate parameter based on inhalation pathway for radionuclides other than noble ga~es for the inhalation pathway (mrem/yr per uCi/m ) from Table 4.

the highest annual average dispersion parameter for estimating the dose to the3critical receptor; relative concentration (X/g) (sec/m

) for the inhalation

pathway, such as from Table 3.

jv the rel ease rate of radionucl ide (i) from vent (v)

'uCi/sec).

the annual organ dose (mrem/yr).

Sample calculations for determining doses to critical organs from radionuclides other than noble gases released from the SSES are given in Section A.2.2 of Appendix A.

II 2

17

NABLE 2 bOSE FACTORS FOR NOBLE GASES' c

Kr-83m kr-85m Kr-85 Kr-BT Kr-88 Kr-&9 Kr-90 Xe-13 1m Xe-133m Xe-133 0

Xe-135m Xe-135 Xe-137 Xe-138 Ar-41 Hhole Body Dose Factor K

e c

7.5&E-02 1.17E+03 1.61E+01 5.92E+03 1.4TE+04 1.66E+04 1.5&E+04 9.15E+01 2.51E+OR 2.94E+02 3.12E+03 1.81E+03 1.42E+03 8.83E+03 8.84E+03 Sk1n Dose Factor L) 1.4&E+03 1.34E+03 9.73E+D3 2.37E+03

.1.01B04 7.29E<03 4.7&EIOR 9.94E+02 3.0&BOR 7.11BDR 1.&6E+03 1.22E+04

4. 13B03 2.&9E+03 Gamma Air Dose Factor H

1.93E+01 1.23E+03 1.72E>0) 6.17E+03 1.52E+D4 1.73E+04 143E+04 1.5&E+D2 3.27E+DR 3.53E+02, 3.36E+03 1.92E+03 1.51E+03 9.21B03 9.30E+03 Beta A)r Dose Factor N

C 2.&BE+02 1.97E+03 1.95E+03 1.03E+D4 2.93E+03 1.06E+04 7.83E~03 1.11B03 1.48E+03 1.05E<03 7.39E>02 2.46E+03 1.27E+04 4.75E<03 3.2&E+03

'jhe listed dose factors are for radionucIides that may be detected

$n airborne effluents and der)ved from Table B-1

$ n Reg. Gu)de'.109.

7.56E-O2

~ 7.56 x 10

TABLE 3 SAMPLE ANNUAL AVERAGE RELATIVE CONCENTRATIONS AND DEPOSITION RATES DOWNWIND

~SECTO I

RELATIVE RELATIVE SITE CONCENTRATIONS

'ONCENTRATIONS BOUNDARY UNDECAYED/UNDEP ETED DECAYED, DEPL ED QQLE~S sec c

RELATIVE DEPOSITION RATES

~D WE NE ENE E

ESE SE SSE S

SSW SW.

WSW W

WNM NW NlQ N

.78

.61

.53

.51

.34

.41

.83 1.03 1.02

.62

.65

.59

.59 4.7E-6 4;9E-.6 3.3E-6 1.8E-6 2.1E-6 2.8E-6 5.6E-6 8.0E-6 1.2E-5 6.4E-6 1.3E-5 5.7E-6 7.0E-6 6.6E-6 6.1E-6 6.3E-6 3.9E-6 4.5E-6 3.1E-6 1.4E-6 1.8E-6 2.5E-6 4.7E-6 6.6E-6 1.0E-5 5.7E-6 1.1E-5 5.2E-6 6.2E-G 5.4E-6 5.8E-6 5.7E-6 1.4E-8 2.8E-8 2.7E-8 1.2E-8 1.4E-8 2.3E-B 4.0E-8 3.6E-8 4.1E-8 1.5E-B 1.9E-8 1.1E-8 1.6E-B 1.7E-8 1.8E-8

2. 1E-.8 a From SSES 1992 Heteorological Summary, Haliburton NUS Corporation, 5/93.

Site Boundary distances are approximate, and current as of 5/93.

19

TABLE 4 DOSE FACTORS FOR INHALATION, INGESTION AND GROUND EXPOSURE PATHMAYS:

RADIONUCLIDES OTHER THAN NOBLE GASES(1)

(2)

(1)Reference letter R. K. Barclay to File R9-5:

Technical Documentation of Lotus 1-2-3 00CMTAB and TGTHSTR files:

Gaseous Dose Factor Calculation using NUREG-0133/Reg.

Guide 1.109 Hethodology, PLI 69605, 11/8/91.

(2)Reference letter R. K. Barclay to file Rg-5:

Technical Documentation:

ODCNTAB.MK1 Revision 1 Correction of Tritium'in Vegetation Pathway Dose Calculations Factor Algorithms, PLI 72980, I)/24/92.

20

O.D.C.M.

MAXIMUM PAlHWAY 00SE FACTORS:

RAOIONUCLIDES OTHER THAN NOBLE GASES*

I'OPE:

H-3 k'ATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G. I.

SKIN GDAT lQLK COM NILK ADULT TEEN CHILD INFANT ADULT.

TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT EGTBLE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST.

TEEN CHILD INFANT O.DOE+00 O.OOE+00 O.DOE+00 0.DOE+00 0.00E+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 1.3&E+03 O.OOE+00 1.&OE+03 O.DOE+00 2.&4E+03 O.DOE+00 4.31E+03 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.00E+QD 0.DOE+00 Q.DOE+00 0.00E+00 0.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.ODE+00 0.DOE+00 1.3&E+03 1.38E+Q3 1.3&E+03 1.38E+Q3 1.3&E+03 1.&DE+03 I.SOE+03 1.80E+03 I.&DE+03 1.&DE+03 2.84E+03 2.84E+03 2.84E+03 2.84E+03 2.84E+03 4.31E+03 4.3IE+03 4.31E+03 4.31E+03 4.31E+03 0.00E+00 1.82E+03 O.DOE+00 2. l&E+03 0.00E+00 3.42E+D3 0.00E+00 0.00E+00 0.00E+00 4.17Et03 0.00E+00 5.03E+03 0.00E+00 7.&6E+03 O.DOE+00 6.43E+03 1.&2E+03 1.&ZE+03 I.S2E+03 1..82E+03 1.82E+03 2.1&E+03 2.1&E+03 2.1&E+03 2.18E+03 2.1&E+03 3.42E+03 3.42E+03 3.42E+03 3.42E+03 3.42E+03 0.00E+00 0.DOE+00 O.DOE+00 O.OOE+OD O.DOE+00 4.1?E+03 4.17E+03 4.1?E+03 4.17E+03 4.17E+03 5.03E+03 5.03E+Q3 5.03E+Q3 5.Q3E+03 5.03E+03 7.&6E+03 7.86E+03 7.86E+03 7.86E+03 7.86E+03 6.43E+03 6.43E+03 6.43E+03 6.43E+03 6.43E+03 O.OOE+00 6.77E+02 6.7?E+02 6.77E+02 6.77E+02 6.77E+02 6.7?E+02 O.DOE+00 &.&2E+02 &.82E+02 8.82E+02 8.82E+02 8.82E+02 8.82E+02 O.DOE+00 1.39F+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 O.DOE+00 2.11E+03 2.11E+03 Z.IIE+D3 2.11E+03 2.11E+03 2.11E+03 D.OOE+QO 2.&9E+02 2.89E+02 2.89E+02 2.89E+02 2.89E+02 2.&9E+02 O.DOE+00 1.72E+02 1.72E+02 1.?ZE&2 1.?2E+02 1.?2E+02 1-72E+02 0.00E+00 2.0&E+02 2.0&E+02 2.0&E+02 2.08E+02 2.08E+02 2.0&E+02 0.00E+00 0.00E+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.QDE+QD N/A N/A N/A H/A N/A H/A NgA N/A N/A N/A N/A H/A N/A H/A H/A N/A-N/A N/A N%A 1NHAL.

ADULT TEEN CHILD INFANT 0.00E+00 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 0.DOE+00 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 O.DOE+00 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 0.00E+00 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 H/A N/A N/A N/A

&ON LEV R

.OY UNG "Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

""*MAXEMUMVALUES GROUND:

GROUND:

GOAT COM T.B./ORG.

SKIN MILK:

MILK:

0.00E+00 0.00E+00 4.3lf+03 2.11E+03 FOR PATHMAYS"~*

MEAT:

VEGTBLE:

2.&9E+02 3.42E+03 TOTAL INGEST:

7.&6E+03 INHAL.

1.2?E+03 PAGE:

4-1

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

I'bufOPE: C-14 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G'- I-SKIN GROUND ADULT TEEN CHILD INFANT Q.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0-QOE+00 0.00E+00 0.00E+00 O.OOE+00 Q.QQF+QQ O.OOE+00 0.00E+00 O.QQE+00 Q.QOE+00 O.QOE+QO O.OOE+00 O.QOE+00 Q.QOE+QQ Q.OOE+00 O.OOE+QO Q.QOE+00 O.QOE+00 0.00E+00 Q.QOE+00 O.OOE+00. Q.QOE+00 GOAT HILK ADULT TEEN CHILD INFANT 1.69E+0& 3.39E+07 3.39E+07 3.39E+07 3.12E+08 6.24E+07 6.24E+07 6.24E+07 7.6&E+08 1.54E+08 1.54E+08 1.54E+08 1.50E+09 3.21E+08 3.21f+08 3.21E+08 3.39E+07 3.39E+07 6.24E+07 6.24E+07 1.54E&8 1.54E+08 3.21E+08 3.21E+08 3.39E+07 6.24f+07 1.54E+08 3.21E+08 N/A H/A N/A H/A COW MILK HEAT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 1.35E+08 2.71E+07 2.71E+07 2.71E+07 2.71E+07 2.71E+07 2.50E+08 4.99E+07 4;99E+07 4.99E+07 4.99E+07 4.99E+07 6.14E+08 1.23E+08 1.23E+08 1.23E+08 1.23E+08 1.23E+08 1.20E+09 2.57E+08 2.57E+08 2.57E+08 2.57E+08 2.57E+08 1.36E+08 2.72E+07 2.72E+07 2.72E+07 2.72E+07 2.72E+07 1.15E+08 2.30E+07 2.30E+07 2.30E+07 2.30E+07 2.30E+07 2.16E+08 4.33E+07 4.33E+07 4.33E+07 4.33E+07 4.33E+07 0.00E+00 0.00E+00 0.00E+00 O.QOE+00 O.QOE+00 0.00E+00 2.06E+08 4.13E+07 4.13E+07 4.13E+07 4.13E+07 4.13E+07 3.49E+08 6.98E+07 6.9&E+07 6.98E+07 6.9&E+07 6.9&E+07

&.53E+08 1.7IE+08 1.71E+08 1.7IE+08 l.71E+08 1.TIE+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Q.QOE+00 2.7IE+07 4.99E+07 1.23E+08 2.57E+08 2.72E+07 2.30E+07 4.33E+07 0;OOE+00 4.13E+07 6.98E+07 1.71E+08 O.OOE+00 N/A H/A N/A H/A N/A H/A N/A N/A H/A N/A N/A N/A TOTAL ADULT NGEST TEEN CHILD INFANT 6.47E+08 1.29E+08 1.29E+08 1.29E+08 1.29E+08 1.29E+08 1.03E+09 2.05E+08 2.05E+08 2.05E+08 2.05E+08 2.05E+08 2.45E+09 4.90E+08 4.90E+08 4.90E+08 4.90E+08 4.90E+08 2.71E+09 5.7&E+08 5.7&E+08 5.78E+08 5.7&E+08 5.7&E+08 1.29E+08 2;05E+08 4.90E+08 5.7&E+08 N/A NgA NP, H/A XNHAL.

ADULT TEEN CHILD INFANT 1.82E+04 3.41E+03 3.41E+03 3.41E+03 3.4IE+03 3.4IE+03 2.60E+04 4.&7E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 2.65E+04 5.31E+03 5.31E+03 5.3IE+03 5.31E+03 5.31E+03 3.41E+03 4.87E+03 6.73E+03 5.3IE+03 H/A H/A H/A N/A BON LIV R

.BODY THYROID KIDNEY LUNG G. L.

SK Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

<<*MAXIMUMVALUES FOR PA HWAYS***

GROUND:

GOAT COW TOTAL T.B./ORG.. SKIN MILK:

MILK:

MEAT:

VEGTBLE:

.INGEST:

IHHAL.

Q.OOE+00 0.00E+00 1.50E+09 1.20E+09 2.16E+08 8.53E+08 2.7IF+09 3.59E+04 PAGE:

O.D.C.H.

HAXINUH PATHWAY DOSE FACTORS-RADIONUCLIDES OTHER THAN NOBLE GASES*

- a~JTOPE:

P-32 PATHWAY AGE GROUP BONE LIVER, T.BQOY

'HYROID KIDNEY LUNG G.I.

SKIN.

ADULT D.DOE+00 0;DOE+00 O.DOE+00 O.DOE+00 TEEN O.DOE+00 O.DOE+DO O.DOE+DO O.DOE+00 CHILD

.O.DOE+00 Q.QQE+QQ O.QQE+Qo O.DOE+00 INFANT D.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 Q.DOE+00 O.DOE+00 0.DOE+00 Q.OQE+QD O.DOE+00 Q.ODE+00 0.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+QO O.DOE+00 0.DOE+00 GOAT NILK ADULT 9.28E+09 5.77E+08 3.59E+08 D.DOE+00 TEEN 1.7IE+10 1.06E+09 6.64E+08 O.DOE+DO CHILD 4.22E+10 1.98E+09 1.63E+09 O.DOE+00 INFANT 7.25E+10 5.12E+09 3.37E+09 O.DOE+00 O.DOE+00 O.DOE+DO O.DOE+DO O.DOE+DO O.DOE+00,,0.DOE+00 O.DOE+00 0.DOE+00 1.04E+09 1.44E+09 1.17E+09 1.18E+09 N/A N/A N/A N/A COW NLK ADULT TEEN CHILD INFANT 4.36E+09 2.71E+08 1.69E+08 0.DOE+00 O.DOE+00 O.DOE+DO 8.05E+09 4.99E+08 3.12E+08 O.DOE+00 D.DOE+00 D.DOE+00 1.99E+10 9.29E+0& 7.65E+08 O.DOE+00 D.DOE+DO O.QQE+QQ 4.09E+10 2.41E+09 1.59E+09 O.DOE+00 O.DOE+00 O.DOE+DO 4.91E+08 6.77E+08 5.49E+08 5.54E+08 N/A N/A N/A N/A ADULT TEEN CHILD INFANT

'LE ADULT TEEN CHILD INFANT 1.55E+09 9.63E+07 5.99E+07 O.DOE+00 1.31E+09 8.11E+07 5.07E+07 O.DOE+00 2.47E+09 1.15E+QB 9.51E+07 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 7.09E+08 4.41E+07 2.74E+07 O.DOE+00 9.5TE+08 5.93E+D7 3.71E+07 O.OOE+OD 2.16E+09 1.QlE+Q& 8.34E+07 O.DOE+00 O.DOE+00 O.DOE+DO O.OOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0;DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.ODE+q0 O.DOE+00 D.DOE+00 D.DOE+00 O.DOE+00 D.DOE+DO O.DOE+00 O.DOE+00 O.DOE+00 O.ODE+QQ 1.74E+08 1.10E+08 6.82E+QT O.DOE+00 7.98E+07 8.05E+07 5.98E+07 O.DOE+00 N/A N/A N/A N/A N/A N/A N/A N/A TOTAL ADULT INGEST TEEN CHILL)

INFANT 1.59E+10 9.89E+08 6.15E+08 Q.DOE+00 O.DOE+00 O.DOE+00 2 74E+10 1.70E+09 1.06E+09 0.DOE+00 O.DOE+DO Q.DOE+00 6 ATE+10 3.12E+Q9 2.57E+09 0.DOE+00 Q.DOE+DO O.DOE+00 1.13E+11 7.53E+09 4.96E+09 0.DOE+00 0.DOE+00 O.ODE+OQ 1.79E+09 2.31E+09 1.84E+09 1.73E+09 N/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT 1.32E+06 7.71E+04 5.01E+04 O.DOE+00 O.DOE+00 O.DOE+00 1.89E+06 1.10E+05 7.16E+04 O.QQE+OD O.DOE+00 O.ODE+QQ 2.60E+06 1.14E+05 9.88E+04 0.00E+00 O.DOE+DO Q.OQF+QO 2.03E+06 1.12E+05 7.74E+04 O.DOE+00 0.DOE+00 O.DOE+00 8.64E+04 9.28E+04 4.22E+04 1.61E+O4 N/A N/A N/A N/A BONE LIVER T.BODY THYROID, KIDN Y LUNG G.l.

SKIN Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

" tQXINUH VALUES fOR PA WAYS~

GROUND:

GOAT COW TOTAL T.B./ORG.

SKIN HILK:

HILK:

HEAT:

VEGTBLE:

INGEST:

INHAL.

O.DOE+00 Q.DOE+00 7.25E+IQ 4.09E+IO 2.47E+09 2.16E+09 1.13E+ll 2.60E+06 fV D.~T" PAGE:

4-3

D.D.C-M. MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

ISOTOPE:

Cr-51 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN ADULT TEEN CHILD INFANT 4.61E+06 4.61E+06 4.61E+06 4.61E+06 4;61E+06 4.61E+06 4.61E+06 5.45E+06 4.61E+06 4.61E+06 4.61E+06 4.6IE+06 4.61E+06 '4.61E+06 4.61E+06 5.45E+06 4.61E+06 4.61E+06 4.61E+D6 4.61E+06 4.61E+06 4.61E+06 4.61E+06 5.45B06 4.6IE+06 4.61E+06 4.61E+06 4..61E+06 4.6lE+06 4.61E+06 4.61E+06 5.45E+06 GOAT 'DULT MILK TEEN CHILD INFANT O.OOE+OO O.OOE+00 1.61E+03 9.64E+02 3.55E+02 2.14E+03 4.06E+05 D.DOE+00 O.DOE+00 2.82E+03 1.56E+03 6.17E+02 4.02E+03 4.?3E+05 O.DOE+00 0.DOE+00 5.74E+03 3;19E+03 8.71E+02 5.82E+03 3.05E+05 O.DOE+00 0.00E+OD 9.10E+03 5.94E+03 1.30E+03 1 )6E+04 2.65E+D5 N/A N/A N/4 N/A HEAT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 0.DOE+00 O.DOE+DO 7.99E+03 4.77E+D3 1.76E+03 1.06E+04 2.01E+06 O.DOE+00 0.DOE+00 1.39E+04 7.75E+03 3.06E+03 1.99E+04 2.34E+06 D.DOE+00 0.DOE+00 2.84E+04 1.58E+04 4.32E+03 2.88E+04 1.51E+06 O.DOE+00 O.OOE+00 4.51E+04 2.94E+04 6.43E+03 5.72E+04 1.31E+06 O.OOE+OO O.OOE+OO 2.50E+O3 1.49E+O3 5.50E+02 3.31E+03 6.28E+05 D.OOE+00 D.DOE+00 2.DOE+03 1.11E+03 4.38E+02 2.85E+03 3.36E+05 O.DOE+00 O.DOE+00 3.11E+03 1.73E+03 4.72E+02 3.16E+03 1-65E+05 O.DOE+00 0.00E+00 0.00E+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 N/A H/A N/A H/A H/A N/A N/A N/A V'LE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST TEEN CHILD INFANT 0.DOE+00 0.00E+00 3.35E+04 2.DIE+04 7.39E+03 4.45E+04 8.44E+06 0.DOE+00 0.DOE+00 5.02E+04 2.79E+04 1.10E+04 7.17E+04 8.44E+06 O.DOE+00 O.OOEt00 9.96E+04 5.53E+04 1.51E+04 1.01E+05 5.28E+06 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.OOF+00 O.DOE+00 0.00E+00 0.00E+OQ 4.56E+04 2.?3E+04 1.DIE+04 6.06E+04 1.15E+07 0 DOE+00 0.DOE+00 6.90E+04 3.83E+04 1.51E+04 9.85E+04 1.16E+07 O.DOE+00 O.OOE+00 1.3?E+05

?.60E+04 2.08E+04 1.39E+05 7.26E+06 0.00E+00 O.DOE+00 5.42E+04 3.53E+04 7.72E+03 6.88E+04 1.58E+06 H/A N/A N/A N/A N/A H/A N/A N/A

.INHAL.

ADULT TEEN CHILD INFANT O.DOE+00 O.OOE+00 I.DOE+02 5.95E+01 2.28E+01 O.DOE+00 O.DOE+00 1.35E+02 7.50E+Dl 3.07E+Ol O.OOE+OO O.OOE+OO 1.54E+O2 8.55E+Ol 2.43E+Ol O.DOE+00 O.DOE+00 8.95E+Ol 5.75E+01 1.32E+Dl l.44E+04 3.32E+03 2.10E+04 3.DOE+03 1.70E+04 1.08E+03 1.28E+04 3.57E+D2 H/A N/A N/A N/A BONE LIV R ODY LUNG G.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN

'4.6IE+06 5.45E+06

<<<<HA NUN VAL S

OR PA HWAYS*<<<<

GOAT COW NILK:

MILK:

NEAT:

VEGTB LE:

4.73E+05 2.34E+06 6.28E+05 8.44E+06 TOTAL INGEST:

INHAL.

1.16E+07 2.10E+04 PAGE:

O.D.C.M. HAXIHUH PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

~

x~uTOPE:

Hn-54 PATHWAY AGE GROUP BONE LIVER

, T.BODY THYROID KIDNEY LUNG G.I.

SKIN GROUND ADULT TEEH CHILD INFANT 1.37E+09 1.37E+09 1.37E+09'.37E+09 1.37E+09 1:37E+09 1.37E+09 1.61E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.61E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.61E+09 1.37E+09 1.37F+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09.1.61E+09 GOAT ADULT MILK

'EEN CHILD

'NFANT O.OOE+00 6.14E+QS 1.17E+05 O.OOE+00 1.83E+05 0.00E+00 1.02E+06 2.03E+05 O.OOE+00 3.05E+05 O.OOE+00 1.53E+06 4.07E+QS O.OOE+00 4.29E+05 O.OOE+00 2.84E+06 6.45E+05 O.OOE+00 6.30E+05 0.00E+00 1.88E+06 O.OOE+00 2.10E+06 O.OOE+00 1.28E+06 0.00E+00 1.04E+06 H/A N/A N/A N/A'OW MILK

~BLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT O.OOE+00 3.92E+06 7.49E+05 0.00E+00 1.17E+06 O.OOE+00 O.OOE+00 6.54E+06 1.30E+06 O.OOE+00 1.95E+06 O.OOE+00 0.00E+00 9.78E+06 2.61E+06 O.OOE+00 2.74E+06 O.OOE+00 0.00E+00 1.82E+07 4.12E+06 0.00E+00 4.03E+06 0.00E+00 0.00E+00 4.79E+06 9.14E+05 O.OOE+00 1.43E+06 0.00E+00 O.OOE+00 3.65E+06 7.25E+05 O.OOE+00 1;09E+06 O.OOE+00 O.OOE+00 4.18E+06 1.1IE+06 0.00E+00 1.17E+06 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 2.80E+08 5.35E+07 O.OOE+00 8.34E+07 O.OOE+00 O.OOE+00 4.27E+08 8.46E+07 0.00E+00 1.27E+08 0.00E+00 O.OOE+00 6.34E+08 1.69E+08 O.OOE+00 1.78E+08 0.00E+00 0.00E+00 0;OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.20E+07 1.34E+07 8.2IE+06 6.68E+06 1.47E+07 7.49E+06 3.51E+06 O.OOE+00 8.58E+08 8.75E+08 5.32E+08 O.OOE+00 H/A N/A N/A H/A N/A N/A N/A N/A N/A N/A

'H/A H/A TOTAL ADULT JSUM TEEN CHILD INFANT O.OOE+00 2.90E+08 5.53E+07 O.OOE+00 8.62E+07 O.OOE+00 O.OOE+00 4.38E+08 8.69E+07 O.OOE+00 1.31E+08 0.00E+00 O.OOE+00 6.49E+08 1.73E+08 0.00E+00 1.82E+08 O.OOE+00 O.OOE+00 2.10E+07 4.77E+06 O.OOE+00 4.66E+06 O.OOE+00 8.87E+08 8.98E+08 5.45E+08 7.73E+06 N/A N/A N/A H/A INHAL.

ADULT TEEN CHILD INFANT O.OOE+00 3.96E+04 6.3OE+03 O.OOE+00 9.84E+03 1.40E+06 O.OOE+00 5.11E+04 8.40E+03 0.00E+00 1.27E+04 1.98E+06 O.OOE+00 4.29E+04 9.51E+03 O.OOE+00 1.00E+04 l.58E+06 O.OOE+00 2.53E+04 4.98E+03 O.OOE+00 4.98E+03 1.00E+06 7.74E+04 6.68E+04 2.29E+04 7.06E+03 H/A H/A N/A N/A BONE LIVER T.BODY HYROIO K DNEY LUNG G.l.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG; SKIN

~I.37E+09 1.61E+09

<<<<<<MAXIMUM VALU S GOAT COW HILK MILK:

2.84E+06 1.8ZE+07 OR PATHWAYS<<**

TOTAL HEAT:

VEGTBLE:

INGEST:

1.47E+07 8.75E+08 8.98E+08 INNL.

1.98E+06 PAGE:

4-5

O.D.C.N. NXIHUN PATHWAY DOSE FACTORS:

RADIONUCLIGES OTHER THAN NOBLE GASES" lvdTOPE: Fe-55 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID

. KIDNEY LUNG G.I.

SKIN GROUND ADULT TEEN CHILD INFANT Q.DOE+00 Q.QQE+QQ Q.DOE+00 Q.DOE+00 Q.DOE+00

'O.DOE+00 Q.DOE+00 O.QOE+QO O.DOE+00 Q.DOE+00 Q.DOE+00 Q.DOE+00 Q.DOE+00 Q.DOE+00 O.DOE+00 Q.QQE+00 Q.ooE+Qo o.oQE+Qo o.ooE+00 O.OQE+00 O.DOE+00 O.DOE+00 D.QQE+QQ Q.DOE+00 O.'OOE+QQ Q.'QQE+QO O.OOE+OO O.OOE+QO O.OOE+QO O.QOE+OO O.OOE+OO O.OOE+QO GOAT HILK ADULT TEEN CHILD INFANT COW ADULT MILK TEEN CHILD INFANT 2.06E+05 3.65E+05 9.17E+QS

&.52E+07 1.25E+07 2.22E+07 5.56E+02 6.73E+07 1.42E+05 3.32E+04 O.DOE+00 O.DOE+00 7.94E+04 2.59E+05 6.Q4E+04 Q.DOE+00 Q.DOE+00 1.64E+05 4.86E+05 1.51E+05 Q.OQE+OO O.DOE+00 2.75E+05 7.16E+05 1.91E+05 Q.DOE+00 O.oof+00 3.50E+05 8.64E+06 2.01E+06 Q.DOE+00 'Q.DOE+00 4.82E+06 1.57E+07 3.67E+06 O.DOE+00 Q.DOE+DO 9.97E+DS 2.95E+07 9.14E+06 D.DOE+00'Q.DOE+00 l.67E+07 4.34E+07 1.16E+07 D.OOE+QD O.DOE+00 2.12E+07

&.16E+04 1.12E+05 9.01E+04 9.09E+04 4.95E+06 6.80E+06 5.47E+06 5.52E+06 N/A N/A H/A H/A H/A N/A H/A N/A.

,V.~" BLE TOTAL XNMM ZHHAL.

ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 1.6)E+08 1.))E+D& 2.60E+07 Q.DOE+00 Q.QOE+OD 6.22E+07 1.3)E+08 9.29E+07 2.17E+07 Q.DOE+00 Q.DOE+00 5.89E+07 2.5)E+08 1.33E+Q8 4.13E+07 Q.DOE+00 Q.DOE+00 7.54E+07 D.DOE+00 0.DOE+00 Q.DOE+00 Q.DOE+00 O.DOE+00 Q.DOE+00

).89E+08 1.31E+08 3.05E+07 O.DOE+00 Q.DOE+DO 7.30E+07 3.08E+08 2.18E+08 5.09E+07 O.DOE+00 O.DOE+00 1.3&E+08 7.67E+08 4.07E+08 1.26E+08 O.DOE+00 O.DOE+00 2.30E+08 O.OQE+QQ O.QQE+QQ D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 3.63E+08 2.5)E+Q& 5.&SE+07 Q.QOE+OQ O.DOE+00 1.4QE+08 4 6)E+08 3.27E+08 7.62E+07 Q.DOE+00 Q.DOE+00 2.07E+0&

1.07E+09 5.70E+08 1.77E+08 Q.QOE+OQ O.QQE+00 3.22E+08 1.52E+08 4.42E+07 1.18E+07 Q.QQE+QQ Q.DOE+00 2.16E+07 2.46E+04 1.70E+Q4 3.94E+03 Q.DOE+00 Q.DOE+00 7.21E+04 3.34E+04 2.3&E+Q4 S.S4E+03 Q.DOE+00 D.DOE+00 1.24E+05 4.74E+04 2.52E+04 7.77E+03 Q.QQE+OO Q.QQE+QQ 1.11E+05 1.97E+Q4 1.17E+04 3.33E+03 Q.DOE+00 O.DOE+00 8.69E+04 6.39E+07 4.02E+07 2.47E+07 O.DOE+00 7.50E+07 9.44E+07 7.53E+07 D.DOE+00 1.44E+0&

1.41E+08 1.06E+08 5.61E+06 6.03E+D3 6.39E+D3 2.87E+D3 1.09E+03 N/A N/A H/A H/A N/A H/A N/A H/A H/A H/A N/A H/A N/A H/A N/A N/A BONE LIVER

.BODY HYRO K

NEY LUNG G.

S IN Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

"".<<NAXINUN VALUES OR PA A S~~

GROUND:

GOAT COW T.B./ORG.

SKIN HILK:

HILK:

HEAT:

VEGTBLE:

Q.QQE+OQ O.DOE+00 8.52E+07 6.73E+07 2.51E+08 7.67E+08 TOTAL INGEST:

IHHAL.

1.07E+09 1.24E+Q5 V

DAT PAGE:

4-6

LIVER G.I.

D.D.C.M. MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

~

ISOTOPE:

Mn-56 PATHWAY AGE GROUP BONE T.BODY THYROID KIDNEY LUNG SKIN GROUND.

ADULT O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00

.0.00E+00 TEEN 0.00E+00 0;00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.DOE+00 CHILD O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 INFANT 0.00E+00 0.0OE+OO O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 GOAT MILK ADULT 0.00E+00 7.17E-O4 1.27E-04 O.OOE+00 9.11E-04 O.OOE+00 TEEN O.OOE+OO 1.27E-O3 2.26E-04 O.OOE+00 1.61E-03 O.OOE+00 CHILD 0.00E+00 2.22E-03 5.01E-04 O.OOE+00 2.6&E-03 O.OOE+00 INFANT 0.00E+00 5.43E-03 9.36E-04 O.OOE+00 4.67E-03 O.OOE+00 8.37E-02 3s21E-Ol 4.93E-01 N/A H/A H/A'.29E-02 N/A CDM MILK MEAT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 0.00E+00 1.05E-03 1.86E-04 O.OOE+00 1.33E-03'O.OOE+00 O.OOE+00 1.85E-03 3.30E-04 O.OOE+00 2.3SE-03 O.OOE+00 O.OOE+00 3.23E-03 7.30E-04 O.OOE+00 3.91E-03 O.OOE+00 O.OOE+OO 7.92E-03 1.37E-03 0.00E+00 6.&IE-03 O.OOE+00 O.OOE+OO 5.00E-54 8.86E-55 O.OOE+00 6.34E-54 O.oof+00 O.OOE+00 4.06E-54 7.21E-55 O.OOE+00 5.14E-54 O.OOE+00 O.OOE+00 5.41E-54 1.22E-54 0.00E+00 6.54E-54 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 3.34E-02 1.22E-01 4.69E-01 7.19E-01 1.59E-52 2.67E-52 7.84E-52 O.OOE+00 H/A H/A H/A H/A N/A H/A N/A N/A

'LE ADULT TEEN CHILD INFANT TOTAL ADULT JMBEST.

TEEN CHILD INFANT 0.00E+OO 5.2SE+00 9.3IE-Ol O.OOE+00 6.66E+00 O.OOE+00 O.OOE+00 4.73E+00 8.42E-01 O.OOE+00 5.99E+00 O.OOE+00 0.00E+00 6.19E+00 1.40E+00 O.OOE+00 7.49E+OO O.OOE+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 5.25E+OO 9.31E-01 0.00E+00 6.66E+00 Q.OOE+00 O.OOE+00 4.73E+OO &.42E-Ol O.OOE+00 5.99E+00 O.OOE+00 O.OOE+00 6.20E+OO 1.40E+00 0.00E+00 7.50E+00 0.00E+00 0.00E+00 1.34E-02 2.30E-03 0.00E+00 1.15E-02 0.00E+00 1.67E+02 3.11E+02 8.97E+02 O.OOE+00 1.6&E+02 3.12E+02 8.98E+02 1.21E+00 N/A N/A N/A H/A H/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT O.OOE+00 1.24E+OO 1.&3E-Ol O.OOE+00 1.30E+00 9.44E+03 0.00E+00 1.70E+00 2.52E-01 O.OOE+00 1.79E+00 1.52E+04 O.OOE+OO 1.66E+OO 3.12E-Ol O.OOE+OO 1.67E+OO 1.31E+04 O.OOE+00 1.54E+00 2.21E-01 0.00E+00 1.10E+00 1.25E+04 2.02E+04 5.74E+04 1.23E+05 7.17E+04 H/A H/A N/A H/A BONE LIVER

. BODY H ROI ONE LUNG G.

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

~*MAXIMUMVALUES FOR PA HWAYS~~*

GROUND:

GOAT COW TOTAL T.B./ORG.

SKIN MILK:

MILK:

MEAT:

VEGTBLE:

INGEST:

O.OOE+00 O.OOE+00 4.93E-01 7.19E-01 7.84E-52 &.97E+02 8.9&E+02 INHAL.

1.23E+05 PAGE:

4-7

O.D.C.H.

MAXIMUM PATHWAY DOSE FACTORS:

RADIDNUCLIDES OTHER THAN NOBLE GASES*

ISOTOPE:

Co-58 PATHWAY AGE GROUP BONE LIYER T.BODY THYROID KIDNEY

. G.I.

GROUND GOAT NLK COW NILK HEAT BLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADUI T TEEN CHILD INFANT ADULT TEEN'HILD INFANT ADULT TEEN CHILD INFANT INHAL.

ADULT TEEN CHILD INFANT TOTAL ADULT INGEST TEEN CHILD INFANT 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3.75E+OS 3.75E+08 0.DOE+00 3.DOE+05 O.DOE+00 5.05E+05 O.DOE+00 7.71E+05 O.DOE+00 1.54E+06 Q.DOE+00 1.70E+06 O.DOE+00 2.86E+06 O.DOE+00 4.37E+06 Q.DOE+00 8.74E+06 O.QOE+00 7.7&E+06 O.DOE+DO 6.0QE+06 O.DOE+00 7.DIE+06 O.DOE+00 O.DOE+00 0.DOE+00 2.61E+07 O.DOE+00 3.96E+07 0.DOE+00 5.99E+07 Q.DOE+00 O.DOE+00 3.75E+08 3-75E+08 3.75E+08 3.75E+Q8 3.75E+08 3.75E+08 3.75E+OS 3.75E+08 3.75E+08 3.75E+08 3.75E+08

.3.75E+08 3 75E+08 3.'75E+08 3.75E+08 3.75E+08 3.75E+OS 3.75E+08 3.75E+08 3.75E+08 6.72E+05 O.DOE+DO O.DOE+00 O.DOE+00 6.07E+06 1.16E+06'O.DOE+00 O.DOE+00 O.DOE+DO 6.96E+06 2.36E+06 O.DOE+DO O.DOE+00 O,DOE+00 4.50E+06 3.85E+06 O.DOE+00 O.DOE+00 Q.DOE+00 3.84E+06 3.81E+06 O.DDE+00 O.DOE+00 O.ODE+00 3.44E+07 6.59E+06 D.DOE+CD O.DOE+00 O.ODE+00 3.94E+07 1.34E+D7 O.DOE+00 O.DOE+00 O.DOE+DO 2.55E+07 2.18E+OT D.OQF+00 O.DOE+00 O.ODE+OD 2.18E+07 1.74E+OT Q.QOE+QQ O.DOE+00 O.DOE+00 1.58E+08 1.3&E+QT Q.DOE+DO O.DOE+00 O.QOE+OD 8.27E+07 2.14E+0?

Q.DOE+00 O.DOE+00 Q.DOE+00 4.09E+07 Q.DOE+00 Q.QOE+QO O.DOE+00 O.DOE+00 O.DOE+00 5.86E+OT O.DOE+00 O.DOE+00 O.OOE+QO 5.29E+Q&

9.14E+07 Q.DOE+00 O.DOE+00 O.DOE+DO 5.47E+08 1.83E+08 O.DOE+00 O.DOE+00 O.DOE+00 3.49E+08 O.OOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 3.59E+07 8.05E+07 Q.DOE+00 O.DOE+00 O.DOE+00 7.28E+08 D.DOE+00 4.90E+07 1.13E+08 O.DOE+00 O.DOE+00 O.DOE+00 6.76E+08 Q.DOE+DO 7.20E+DT 2.2DE+08 Q.DOE+DO O.DOE+DO O.DOE+DO 4.20E+08 O.DOE+00, 1.03E+07 2.56E+DT D.DOE+00 O.DOE+00 O.DOE+00 2.56E+07 O.OOE+00 1.58E+03 2.DTE+03 D.ODE+OD O.DOE+00 9.28E+05 1.06E+05 Q.DOE+DO 2.07E+03 2.78E+03 D.OOE+OD O.DOE+00 1.34E+06 9.52E+04 Q.OOE+QD 1.77E+03 3.16E+03 Q.DOE+00 O.DOE+00 1.11E+D6 3.44E+04 Q.OOE+OO 1.22E+03 1.82E+03 O.QQE+QO O.DOE+DO 7.77E+05 1.11E+04 4.39E+08 4.39E+0&

4.39E+08 4.39E+08 N/A N/A N/A N/A N/A N/A N/A N/A N/A NfA NfA N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A BONE LI R

.BODY HYROID KIDN Y LUNG G.

SK

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

<<*MAXIMUMVALUES FOR PA MAYS~~

GROUND:

GOAT COM TOTAL T.B./ORG. 'KIN MILK:

HILK:

HEAT:

VEGTBLE:

INGEST:

'3.75E+08 4.39E+08 6.96E+06 3.94E+OT 1.58E+08 5.47E+08 7.28E+08 INHAL.

1.34E+06 8

DAT=

PAGE:

4-8

O.D.C.M. HAXINUN PATHWAY 00SE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

.~OTOPE:

Fe-59 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN GROUND ADULT 2.TOE+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 3.17E+08 TEEN 2.70E+08 2.70E+OS 2.70E+08 2.70E+08 2.70E+08 2.7OE+08 2.70E+08 3.17E+08 CHILD

. 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 3.17E+08 INFANT 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+OS 2.TOE+08 3.17E&8 GOAT MILK ADULT TEEN CHILD INFANT 1.92E+05 4.52E+05 1.73E+05 0.00E+00 O.OQE+00 1.26E+05 1.51E+06 3.35E+05 7.83E+05 3.02E+05 O.OQE+00 O.OQE+00 2.47E+05 1.85E+06 7.78E+05 1.26E+06 6.27E+05 O.OOE+00 O.OQE+00 3.65E+05 1.31E+06 1.12E+08 2.54E+06 9.99E+05 Q.OOE+00 O.QQE+00 7.49E+05 1.21E+06 N/A N/A N/A, N/A COW HILK ADULT TEEN CHILD INFANT 9.41E+06 2.21E+Q7 8.47E+06 1.64E+07 3.83E+07 1.48E+Q7 3.81E+07 6.16E+07 3.07E+07 7.11E+07 1.24E+OS 4.89E+07 O.QOE+00 'O.OOE+00 6.18E+06 O.QQE+00 O.OOE+00 1.21E+07 0.00E+00'.OQE+00 1.79E+Q7 O.OOE+OO O.QQE+00 3.67E+07 7.37E+07 9.06E+07 6.41E+07 5.93E+07 N/A N/A N/A N/A

'TBLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT TOTAL ADULT

~ INGEST.

TEEN CHILD INFANT 1.03E+08 2.42E+08 9.27E+07 0.00E+00 0.00E+00 6.76E+07 8.06E+08 8.23E+07 1.92E+08 7.41E+07 O.OOE+00 0;OQE+00 6.0SE+07 4-54E+08 1.4&E+08 2.36E+08 1.18E+08 O.OOE+00 O.OQE+00 6.84E+07 2.46E+08 O.OQE+00 O.OOE+00 Q.OOE+00 O.OOE+00 O.QOE+00 O.OQE+00 O.OOE+00 1.0ZE+08 2.39E+OS 9.17E+07 O.OOE+00 O.OOE+00 6.68E+07 7.97E+08 1.58E+08 3.6SE+08 1.42E+OS O.OOE+00 0.00E+00 1.16E+08 8.71E+08 3.60E+08 5.82E+08 2.9OE+OS O.OOE+00 O.QOE+00 1.69E+08 6.06E+08 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 2.14E+08 5.04E+08 1.93E+08 O.OQE+00 Q.QQE+00 1.41E+08 1.6&E+09 2 57E+08 5.99E+08 2.31E+08 O.OQE+00 O.OQE+00 1.89E+QB 1.42E+09 5.45E+08 8.81E+08 4.39E+08 O.OOE+00 0.00E+00 2.55E+08 9.18E+08 1.83E+08 1.27E+08 4.99E+07 O.OOE+00 O.OOE+00 3.74E+07 6.05E+07 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT 1.18E+04 2.7SE+04 1.06E+04 O.OOE+00 O.QQE+00 1.02E+06 1.88E+05 1.59E+04 3.7OE+O4 1.43E+04 O.OOE+00 O.OOE+00 1.53E+06 1.78E+05 2.07E+04 3.34E+04 1.67E+04 O.OOE+00 0.00E+00 1.27E+06 7.07E+04 1.36E+04 2.35E+04 9.48E+03 O.OOE+00 O.OOE+00 1.01E+06 2.48E+04 N/A N/A N/A N/A BONE LIVER

.BODY HYROI K DNEY LUNG G.I.

SKIN

~Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

~*HAXIHUHVALUES OR PATHWAYS~

GROUND:

GOAT COW TOTAL T.B./ORG.

SKIN HILK:

H ILK:

HEAT:

VEGTBLE:

INGEST:

2.7OE+08 3.17E+08 1.12E+OS 1.24E+OS 8.06E+08 8.71E+08 1.68E+09 INHAL.

1.53E+06 PAGE:

4-9

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

ISOTOPE:

Co-60 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

GROUND GOAT MILK COW MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 2.13E+10 2.13E+10 2.13E+10 2.13E+10 O.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 2.13E+10 2.13E+10 2.)3Ee)0 2,.13E+10 2.13E+10 2.13E+10 2.13E+10 2.)3Ee)0 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.)3E+10 2.13E+10 2.13E+10 2.13E+10 2.)3E+)0 2.)3E+)0 1;25E+06 2.76E+06 0.DOE+00 0.60Ee00 0.00E+00 2.35E+07 2.)RE+06 4.78E+D6 O.DOE+00 O.DOE+00 O.DOE+00 2.77E+07 3.30E+06 9.72E+06 D.DOE+00 O.DOE+00 O.DOE+00 ).83E+07 6.73E+06 1.'59E+07 O.ODE+OD O.DOE+00 O.DOE+00 1.60E+07 8.29E+06

).83E+07 O.DOE+00 O.DOE+DO O.DOE+00 1.56E+08 1.4)E+07 3.1?E+D?

O.DOE+00 O.DOE+00 O.OOE+00 ).83E+08 2.18E+07 6.44E+07 O.DOE+00 O.DOE+DO O.DOE+00 1.2)E+08 4.46E+07 1.05E+08 O.DOE+DO O.DOE+CD O.DOE+00 ).06f+08 2.51Ee10 2.51E+10 2.51E+10 2.5)Ee)0 H/A N/A N/4 N/A H/A H/A N/A N/A MEAT ADULT TEEN CHILD INFANT O.OOE+OD 4.19E+07 9.23E+07 O.ODE+OO O.DOE+00 0.00E+00 ?.86E+08 O.DOE+00 3.25E+07 7.32E+07 O.ODE+OD O.ODE+DD O.DOE+00 4.23E+08 O.DOE+00 3.S6E+07 1.14E+08 O.DOE+00 O.DOE+DO O.DOE+00 2.14E+08 O.DOE+DO O.OOEe00 O.DOE+DO O.DOE+00 O.DOE+00 O.ODE+OD O.DOE+00 TOTAL ADULT BREST TEEN CHILD INFANT O.DOE+00 2.03E+DS 4.47E+08 O.DOE+DO D.DOE+CD O.DOE+00 3.8)E+09 0 DOE+00 2.84E+08 6.39E+08 O.DOE+00 O.OOE+OD O.DOE+00 3.69E+09 D.DOE+00 4.26E+08

).26E+09 O.DOE+00 O.DOE+DO D.DOE+00 2.36E+09 O.DOE+DO 5.13E+07 1.21E+08 O.OOE+OD O.ODE+OD O.DOE+00 ).22E+08 INHAL.

ADULT TEEN CHILD INFANT O.ODE+OD 1.15E+04 1.48E+04 O.DOE+DO O.DOE+00 5.97E+06 2.85E+05 O.OOE+OD 1.5)E+04

).98E+04 D.ODE+OD O.ODE+OO 8.72E+06 2.59E+05 O.ODE+OD 1.3)E+04 2.26E+04 D.DOE+00 O.OOE+OD 7.07E+06 9.62E+04 O.DOE+00 8.02E+03

).)BE+04 O.DOE+00 O.OOE+OD 4.51E+06 3.)9E+04 TBLE ADULT O.OOE+OD 1.5)E+08 3.34E+08 O.DOE+00 O.DOE+00 O.OOE+OD 2.84E+09 TEEN 0.DOE+00 2.35E+DS 5.29E+08 O.DDE+OD O.DOE+00 O.DOE+00 3.06E+09 CHILD O.DOE+CD 3.62E+08 1.07E+09 O.DOE+00 O.DOE+00 O.DOE+00 2.0)E+09 INFANT 0.DOE+00 D.ODE+OD O.DDE+OD O.DOE+CD 0.DOE+00 O.DOE+00 O.DOE+00 N/A H/A N/A N/A H/A N/A N/A N/A N/A N/A N/A N/A H/A H/A H/A H/A BONE LIV R

.BODY HYROID

. KIDN LUNG G. I.

S N

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

>><<<<MAXIMUM VAL S

0 PA HWAYS>>>>>>

GROUND:

GOAT COW TOTAL T.B./ORG.

SKIN MILK:

MILK:

MEAT:

VEGTBLE:

INGEST:

INHAL.

2.13E+10 2.5)E+10 2.77E+07 1.83E+08 7.86Ee08 3.06E+09 3.81E+09 8.72E+06 PAGE:

4-10

O.D.C.H.

MAXIMUM PATHMAY DOSE FACTORS:

RAOIONUCLIDES OTHER THAN NOBLE NSES*

~

".~QTOPE: Hi-63 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G-I.

SKIN GOAT MILK ADULT TEEN CHILD INFANT GROUND ADULT TEEN CHILD INFANT O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 'O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0-OOE+00 O.OOE+00 O.OOE+00 5.19E+08 3.59E+07 1.74E+07 0.00E+00 O.OOE+00 9.11E+08 6.43E+07 3.09E+07 O.OOE+00 O.OOE+00 2.28E+09 1.22E+08 7.77E+07 O.OOE+00 O.OOE+00 2.24E+10 1.66E+08 9.34E+07 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.QOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 7.50E+06 N/A 1.02E+07 N/A

&.24E+06 N/A 8.2&E+06 N/A COM MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 3.45E+09 2.39E+08 1.1(E+08 0.00E+00 O.OOE+00 0.00E+00 5.00E+07 6.07E+09 4.29E+08 2.06E+OS 0;OOE+00 O.OOE+00 O.OOE+00 6.82E+07 1.52E+10 8.15E+08 5.1&E+08 0.00E+00 0.00E+00 0.00E+00 5.49E+07 1.79E+10 1.11E+09 6.22E+08 O.OOE+00 O.OOE+00 O.OOE+00 5.52E+07 1.06E+10 7.38E+08 3.57E+08 O.OOE+00 0.00E+00 0.00E+00 1.54E+OS 8.56E+09 6.05F+08 2.90E+08 O.OOE+00 O.OOE+00 O.OOE+00 9.63E+07 1.64E+10 8.79E+08 5.59E+08 O.OOE+00 O.OOE+00 O.OOE+00 5.92E+07 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 N/A N/A N/A N/A N/A

. N/A N/A N/A

'TBLE ADULT TEEN CHILD INFANT TOTAL ADULT JNGEST.

TEEN CHII.D INFANT 9.43E+09 6.54E+08 3.16E+08 O.OOE+00 O.DOE+00 O.OOE+00 1.36E+08 1.52E+10 1.07E+09 5.15E+08 O.OOE+OO O.OOE+00 O.OOE+00 1.71E+08 3-79E+10 2.03E+09 1.29E+09 0.00E+00 O.OOE+00 O.OOE+00 1.37E+08 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 2.4OE+10 1.67E+09 8.07E+08 O.OOE+00 O.OOE+00 O.OOE+00 3.48E+08 3.07E+10 2.17E+09 1.04E+09.0.00E+OO O.OOE+00 O.OOE+00 3.46E+08 7.USE+10 3.84E+09 2.44E+09 O.OOE+00 O.OOE+00 O.OOE+00 2.59E+08 4.04E+10 1.2&E+09 7.16E+0& O.OOE+OO 0.00E+00 0.00E+00 6.34E+07 N/A N/A N/A N/A N/A N/A N/A N/A IHHAL.

ADULT TEEN CHILD INFANT 4.32E+05 3.14E+04 1.45E+04 O.OOE+00 O.OOE+00 1.7&E+05 1.34E+04 5.8OE+05 4.34E+04 1.98E+04 O.OOE+00 O.OOE+00 3.07E+05 1.42E+04 8.21E+05 4.63E+04 2.80E+04 0.00E+00 0.00E+00 2.75E+05 6.33E+03 3.39E+05 2.04E+04 1.16E+04 O.OOE+00 O.OOE+00 2.09E+05 2.42E+03 N/A N/A N/A N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.l.

SK N Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.. SKIN 0.00E+00 0.00E+00

~**HAXIHUHVALU S GOAT COW MILK:

NILK:

2.24E+10 1.79E+10 FOR PA HWAYS*~

TOTAL HEAT:

VEGTBLE:

INGEST:

IHHAL.

1.64E+10 3.79E+10 7.18E+10 8.21E+05 A r IJIL I PAGE:

O.D.C.M.

HAXIMUM PATHWAY DOSE FACTORS:

RAOIONUCl.IDES OTHER THAN NOBLE GASES*

ISOTOPE:

2n-65 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID. KIDNEY LUNG G.I.

SKIN GROUND ADULT TEEN CHILD INFANT GOAT ADULT MILK 'EEN CHILD INFANT ADULT TEEN CHILD INFANT 7.40E+08 7.40E+08 7.40E+08 7.40E+08 9.87E+07 1.51E+08 2.97E+08 3.33E+09 6.24E+08 9.58E+08 1.88E+09 2.53E+09 7.40E+08 7.40E+08. 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7;40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7..40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 3.14E+08 1.42E+08 O.OOE+QO 2.10E+0& O.OOE+00 1.98E+08 5.26E+08 2.45F+Q& O.OOE+00 3.37E+08 O.OOE+00 2.23E+08 7.92E+08 4.93E+08 O.OOE+00 4.99E+QB O.OOE+00 1.39E+08 1.37E+09 6.31E+08 O.OOE+00 6.64E+08 O.OOE+00'1.16E+09 1.99E+09 8.97E+08. O.OOE+00 1.33E+09 Q.OOE+00 1.25E+09 3.33E+09 1.55E+09 O.OOE+00 2.13E+09 O.OOE+00 1.4)E+09 5.01E+09 3.12E+09 O.OOE+00 3.16E+09 O.OOE+00 8.80E+08 8.66E+09 3.99E+09 O.OOE+00 4.20E+09 O.OOE+00 7.31E+09 8-50E+08

&.50E+08 8.50E+08 8.50E+08 N/A N/A N/A N/A N/A N/A N/A N/A HEAT ADULT TEEN CHILD INFANT

'.&2E+08 5.79E+08 2.62E+08 O.OQE+00 3.87E+OB O.OOE+00 3.65E+08 1.28E+08 4.44E+08 2.07E+Q8 Q.OOE+00 2.84E+08 O.OOE+00 1.88E+08 1.92E+08 5.1)E+08 3.18E+08 O.QOE+00 3.22E+08 Q.OOE+00 8.98E+07 O.QQE+QQ 0.'OQE+00 Q.OOE+00 O.OQE+QQ 0.00E+00 O.OOE+00 O.OOE+00 N/A N/A N/A N/A

) P ABLE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST TEEN CHILD INFANT INHAL.

ADULT TEEN CHILD INFANT 2.83E+08 9.0)E+08 4.07E+08 0.00E+00 6.03E+08 O.OOE+00 5.68E+08 3.97E+08 1.38E+09 6.43E+08 O.OOE+00 8.83E+08 O.OOE+00 5.84E+08 7.73E+08 2.06E+09 1.28E+09 Q.QOE+00 1.30E+09 O.QOE+OQ 3.62E+08 Q.QQE+00 Q.OQE+00 O.QOE+00 O.QOE+00 Q.QQE+00 O.QOE+00 O.OOE+00 1.19E+09 3.78E+09 1.71E+09 O.OOE+00 2.53E+09 Q.OOE+00 2.38E+09 1.63E+09 5.68E+09 2.65E+09 Q.QQE+00 3.63E+09 Q.OOE+00 2.40E+09 3.14E+09 8.37E+09 5.21E+09 Q.OOE+00 5.28E+09 O.OOE+OQ 1.4?E+09 5.85E+09 1.00E+l0 4.63E+09 0.00E+00 4.86E+09 Q.QOE+00 8.47E+09 3.24E+04 1.03E+05 4.66E+04 O.QOE+00 6.90E+04 8.64E+05 5.34E+04 3.86E+04 1.34E+05 6.24E+04 O.QQE+QO 8.64E+04 1.24E+06 4.66E+04 4.25E+04 1.13E+05 7.03E+04 O.QOE+00 7.14E+04 9.95E+05 1.63E+04 1.93E+04 6.26E+04 3.11E+04 Q.QOE+QQ 3.25E+04 6.47E+05 5.14E+04 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A BONE Ll ER ODY H

RO K DNEY LUNG G.l.

S N

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

<<*MAXIMUMVALUES OR PA HWAYS~"

GROUND:

GOAT COW T.B./ORG.

SKIN

~

MILK:

MEAT:

VEGTBLE:

7.40E+08 8.5QE+08 3.33E+09 8.66E+Q9 5.79E+08 2.06E+09 TOTAL INGEST:

INHAL.

1.00E+10 1.24E+06 PAGE:

4-12

O.D.C.H.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

i~OTOPE:

Rb-86 PATHWAY AGE GROUP BONE L'IVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN GROUND ADULT TEEN CHILD INFANT 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06

&.89E+06 1.02E+07 8.89E+06 8.89E+06

&.89E+06 8.89E+06 8.&9E+06 8.89E+06 8.89E+06 1.02E+07 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 1.02E+07 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06. 8.89E+06 8.89E+06 1..02E+07 GOAT MILK COW MILK MEAT T8LE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT O.QOE+00 1.42E+08 6.63E+07 O.QQE+OQ O.OQE+OQ O.OQE+00 O.QQE+00 2.59E+08 1.22E+08 Q.QQE+00 O.OOE+00 O.OOE+00 O.QOE+QQ 4.81f+08 2.96E+08 O.QOE+00 O.OOE+00 O.OOE+00 0.00E+00 1.22E+Q9 6.03E+08 Q.QOE+00 O.OOE+00 O.OOE+00 Q.QQE+QQ 6.78E+08 3.16E+08 O.QQE+00 O.OOE+00 0-OOE+00 Q.QQE+00 1.24E+09 5.&QE+08 Q.QQE+qo O.OOE+00 O.OOE+00 O.OQE+00 2.29E+09 1.4IE+09 O.OQE+00 O.OOE+00 O.OOE+00 Q.QQE+00 5.8IE+09 2.87E+09 O.QOE+00 O.OOE+00 O.OOE+00 0.00E+00 1.65E+08 7.67E+07 Q.OQE+00 0-OOE+00.0.00E+00 Q.QQE+00 1.37E+08 6.45E+07 O.QQE+00 O.OOE+00 O.QQE+00 0.00E+00 1.95E+08 1.20E+08 O.QOE+00 O.QOE+OQ O.OOE+00 Q.QOE+00 0.00E+00 O.OOE+00 O.QOE+00 0.00E+00 O.OQE+00 Q.QQE+00 1.32E+08 6.17E+07 O.QQE+00 Q.OOE+00 O.OOE+00 Q.QQE+QQ 1.93E+08 9.07E+07 0.00E+00 O.OOE+00 Q.OOE+OO Q.QQE+00 3.40E+08 2.09E+08 O.QQE+00 O.OOE+00 Q.QOE+00 Q.OOE+00 Q.OOE+00 Q.QQE+QO O.QQEtQQ Q.OQE+00 Q.QOE+00 Z.&QE+Q7 3.84E+07 3.09E+07 3.12E+07 1.34E+08 1.&3f+08 1.47E+08 1.49E+08 3.25E+07

'2.03E+07 1.25E+07 O.OOE+00 2.6IE+07 2.86E+07 2.19E+07 Q.QQE+QQ N/A H/A H/A N/A H/A N/A H/A N/A N/A N/A N/A H/A N/A N/A N/A N/A

. TOTAL ADULT INGEST TEEN CHILD INFANT Q.QOE+QQ 1.12E+09 5.20E+08 Q.OQE+00 O.OQE+00 O.OOE+00 Q.QOE+00 1.83f+09 8.57E+08 O.OQE+00 0.00E+00 0.00E+00 Q.QQE+OQ 3.31E+09 2.03E+09 O.QQE+00 O.OOE+00 O.QOE+00 Q.QQE+QQ 7.03E+09 3.48E+09 O.QQE+QQ Q.OOE+00 O.OQE+00 2.20E+08 2.70E+08 2.13E+08 1.80E+08 N/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT Q.QQE+OQ 1.35E+05 5.90E+04 Q.QOE+OQ O.OOE+00 O.OOE+00 Q.QQE+QQ 1.90E+05 8.4QE+Qa Q.QQE+OQ 0.00E+OQ O.OQE+00 Q.QQE+QQ 1.9BE+05 1.14E+05 Q.QQE+QQ Q.OOE+00 Q.OOE+00 Q.QQE+OQ 1.90E+05 8.82E+04 Q.QQE+OQ O.OOE+00 O.OOE+00 1.66E+04 1.77E+04 7.99E+03 3.04E+03 N/A N/A N/A N/A BONE LIVER

.BODY HYRQIO Kl HEY LUNG G.l.

SK N

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND'ROUND:

T.B./ORG.,

SKIN

&.89E+Q6 1.02E+07

~ MAXIMUM VALUES GOAT COW MILK:

NILK:

1.22E+Qg 5.&IE+09 OR PATHWAYS~~

TOTAL HEAT:

VEGTBLE:

INGEST:

1.95E+08 3.40E+08 7.03E+09 IHHAL.

1.98E+05 PAGE:

4-13

D.D.C.M. MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES>>

ISOTOPE: Sr-89 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN GROUND GOAT MILK CDM MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD

. INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT INHAL.

ADULT TEEN CHILD INFANT

'BLE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST.

TEEN CHILD INFANT 2.14E+04 2.14E+04 2.14E+04 2.14E+04 1.54E+09 2.84E+09 7.04E+09 6.37E+09 2.14f+04 2.)4E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.'14E+04 2.14E+04 2.)4E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 O.OOE+00 4.43E+07 O.OOE+00 O.OOE+00 O.OOE+00 2.47E+08 O.OOE+00 8.14E+07 O.OOE+00 O.OOE+00 O.OOE+00 3.39E+08 O.OOE+OO 2.0)E+08 O.OOE+00 O.OOE+00 O.OOE+00 2.72E+08 O.OOE+00 3.84E+08 O.OOE+00 O.OOE+00 0.DOE+00 2.75E+08 4.76E+08 O.OOE+00 1.37E+07 O.OOE+00 O.OOE+00 O.OOE+00 7.64E+07 8.7&E+08 O.OOE+00 2.5)E+07 O.OOE+00 O.OOE+00

'O.OOE+00 1.05E+08 2.17E+09 O.OOE+00 6.20E+07 0.00E+00 0.00E+00 O.OOE+00 8.41E+07 4.13E+09 O.OOE+00 1.18E+08 O.oof+00 O.OOE+00 0.00E+00 &.49E+07

1. 20E+08

1. 01E+08 1.92E+08 O.OOE+00 O.OOE+00 3.44E+06 O.OOE+00 O.OOE+00 O.OOE+00 1.92E+07 0.00E+OO 2.90E+06 O.OOE+00 O.OOE+00 O.OOE+00 1.2)E+07 O.OOE+00 5.4&E+06 O.OOE+00 O.OOE+00 O.OOE+00 7.42E+06 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 8.19E+09 O.OOE+00 2.35E+08 O.OOE+00 O.OOE+00 0.'OOE+00 1.3)E+09 1.35E+10 O.OOE+00 3.86E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.60E+09 3.29E+10 0.00E+00 9.39E+08 0.00E+00 O.OOE+00 O.OOE+00 1.27E+09 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1.03E+10 O.OOE+OO 2.96E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.66E+09

).73E+10 O.OOE+00 4.95E+08 O.OOE+00 O.OOE+00 O.OOE+00 2.06E+09 4.23E+10 O.OOE+OO 1.21E+09 O.OOE+00 O.OOE+00 O.OOE+00 1.64E+09 I.O5E+)O O.OOE+OO 5.OZE+O& O.OOE+OO O.OOE+OO O.OOE+OO 3.6OE+O&

3.04E+05 0.00E+00 8.72E+03 O.OOE+00 0.00E+00 1.40E+06 3.50E+05 4.34E+05 O.OOE+00 1.25E+04 O.OOE+00 O.OOE+00 2.42E+06 3.71E+05 5.99E+05 O.OOE+00 1.72E+04 O.OOE+00 O.OOE+00 2.16E+06 1.67E+05 3.9&E+05 O.OOE+00 1.14E+04 O.OOE+00 O.OOE+00 2.03E+06 6.40E+04 2.49E+94 2.49E+04 2.49E+04 2.49E+04 N/A N/A N/A

~ N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 80NE LIVER ODY HYROID IDNEY LUNG G.

SKI

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yrjuCi/sec

>>>>>>MAXIMUM VALU S GROUND:

GROUND:

GOAT CO14 T.B./ORG., SKIN,. HILK:,

MILK:

2.14E+04 2.49E+04 7.04E+09 4.13E+09 OR PA HAYS>>>>*

TOTAL HEAT,:

VEGTBLE:. INGEST:

INHAL.

1.92E+08 3.29E+10 4.23E+10 2.4ZE+06 PAGE:

4-14

LIVER THYROID KIDNEY O.D.C.H.

HAXIHUN PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE., GASES*

ISOTOPE: Sr-90 PATHMAY AGE GROUP BONE T.BODY LUNG G.I.

SKIN

'ROUND ADULT TEEN CHILD INFANT D.DOE+00 Q.DOE+00

'O.DOE+00 O.OOE+OD 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.OQE+OQ O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DDE+00 O.DOE+00 O.DOE+00 D.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 D.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 Q.DOE+DO D.DOE+00 GOAT ADULT BILK TEEN CHILD INFANT 6.30E+10 0.DOE+00'1.55E+10 Q.DOE+00 O.DOE+00 8.9)E+10 O.DOE+00 2.20E+10 O.DOE+00 O.DOE+00 1.5)E+11 Q.DOE+00 3.82E+10 O.DOE+00 O.DOE+00

?.&DE+10 O.DQE+00 4.17E+10 O.DOE+00 O.DOE+00 O.DOE+00 1.82E+09 O.DOE+00 2.50E+09 O.DOE+00 2.03E+09 O.DOE+00 2.05E+09 H/A N/A H/A N/A COW HILK ADULT TEEN CHILD JHFAHT 2.40E+10 O.DOE+00 5.88E+09 O.DOE+00 O.DOE+00 3.39E+10 Q.DOE+00 8.37E+09 O.DOE+DO.O.DOE+00 5.72E+10 Q.DOE+00 1.45E+1Q Q.DOE+00 O.DOE+00 6.23E+10 O.DOE+00 1.59E+10 O.DOE+00 O.DOE+00 0.DOE+00 6.93E+08 O.ODE+DD 9.51E+DB

0. DOE+00 "7.7)E+08 O.DOE+DO 7.78E+08 H/A N/A N/A

'EAT ADULT TEEN CHILD INFANT 7.DOE+09 D.QQE+QO 1.72E+09 D.DOE+00 O.DOE+DO O.DOE+00 4.53E+09 0.DOE+00 1.12E+09 Q.DOE+00 O.DOE+00 O.DOE+00 5.85E+09 D.DOE+00 1.4&E+09 0.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+DO 2.02E+08 1.27E+08 7.8&E+07 O.DOE+00 N/A N/A N/A N/A BLE ADULT TEEN CHILD INFANT 5.4&E+ll Q.QQE+OQ 1.34f+11 O.DOE+00 O.DOE+00 O.DOE+00

?.1DE+11 Q.DQE+QQ 1.75E+11 D.DOE+00 O.DOE+00 O.DOE+00 1.19E+12 O.QQE+OQ 3.02E+ll O.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+DO O.QQE+OQ Q.DOE+00 0.00f+00 O.DOE+00 0.00f+00 1.5&E+10 1.99E+10 1.61E+10 O.DOE+00 N/A N/A N/A N/A TOTAL INGEST.

INHAL.

ADULT TEEN CHILD INFANT ADULT TffN CHILD INFANT 6.4ZE+ll Q.QQE+OQ 1.5&f+ll D.DOE+00 O.DOE+00 O.ODE+DQ 8.37E+ll O.OQE+OQ 2.07E+ll O.DOE+00 O.DOE+00 Q.OOE+OQ 1.4)E+12 Q.DOE+00 3.56E+Il O.DOE+00 O.DOE+00 O.DOE+00 1.4QE+ll O.QQE+OQ 5.76f+10 O.OOE+00'.DOE+00 O.OOE+QQ 9.92E+07 Q.QQE+00 6.)Of+06 O.DOE+00 O.DOE+00 9.60E+06 1.QBE+Q& O.QQE+OQ 6.6&E+06 0.00f+OQ O.DOE+00 ).65E+07 1.01f+DB O.QDE+QQ 6.44E+Q6 0.DOE+00 Q.DOE+DO 1.48E+07 4.09E+07 O.QQE+QO 2.59E+06 O.DOE+00 D.DOE+00 1.12E+07 1.85E+10 2.35E+10 1.89E+10 2.82E+09 7.22E+05 7.65E+05 3.43E+05 1.3)E+05 N/A N/A N/A N/A N/A N/A H/A N/A BONE LIVER T.BODY HYROID KIDNEY LUNG G.l.

SKIN Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

~NXINUN VALUES FOR PA HWAYS~*

GROUND:

GOAT CQW T.B./ORG.

SKIN HILK:

MILK:

HEAT:

VEGTBLE:

Q.OQE+00 O.QQE+OQ 1.51E+11 6.23f+)Q 7.00f+09 1.19E+12 TOTAL INGEST:

1. 41E+12 INHAL.

1.08E+08 PAGE:

4-15

O.O.C.M.

MAXIMUM PATHMAY DOSE FACTORS:

RAOIONUCLIOES OTHER THAN NOBLE GASES*

"r~dTOPE:

Y-90 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN GROUND GOAT HILK CON HILK HEAT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT Y~".TBLE ADULT TEEN CHILD INFANT 3.83E+00 O.DOE+00 1.03E-O)

O.DOE+00 O.QOE+00 D.DOE+00 4.06E+04 7.03E+00 D.DOE+00 1.89E-O)

O.DOE+00 O.DOE+00 0-DOE+00 5.80E+04 1.74E+Ol O.OOE+OO 4.66E-O)

O.OaE+OO a.OOE+OO O.aOE+OO 4.95E+O4 3.07E+02 O.DOE+00 9.86E-O)

O.DOE+00 D.DOE+00 0 DOE+00 5.08E+04 1-79E+01 O.DOE+00 4-79E-01 O.DOE+00 O.DOE+Do O.QOE+00 1.89E+05 3.28E+01 D.DOE+00 8.84E-D)

O.DOE+00 D.DOE+00 O.DOE+00 2.71E+05 8.12E+01 O.DOE+00 2.17E+Do D.DOE+00 D.DOE+00 O.DOE+Do 2.31E+05 1.72E+02 O.DOE+00 4.60E+00 O.DOE+00 D.DOE+00 O.DOE+00 2.37E+05 3.55E+Ol O.DOE+00 9.52E-O1 O.DOE+00 D.DOE+00 O.DOE+00 3.76E+05 2.99E+Ol O.DOE+00 8.04E-O)

O.DOE+00 O.DOE+00 O.DOE+00 2.46E+05 5.65E+01 0.DOE+00 1.5)E+00 O.DOE+00 O.DOE+00 D.DOE+00 1.6)E+05 0.DOE+00 O.DOE+00 0.DOE+00 D.ODE+00 0.00E+ao O.DOE+00 O.DOE+DO 4.39E+03 O.DOE+00 1.)BE+02 D.DOE+00 D.DOE+Do O.DOE+00 4.65E+07

4. 1OE+03 O.DOE+00 1.10E+02 O.DOE+00 D.DOE+Do D.DOE+00 3.38E+07 7.61E+03 0.DOE+00 2.04E+02 O.DOE+00 D.DOE+00 D.DOE+00 2.17E+07 D.ODE+OO O.OOEe00 O.DOE+00 O.DOE+DO O.DOE+00 D.DOE+00 D.DOE+DO N/A H/A H/A H/A N/A H/A N/A H/A H/A N/A H/A H/A H/A H/A H/A N/A D.DOE+DO O.DOE+DO O.DOE+DO O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+DO O.DOE+Do D.DOE+Do D.OOF+OD O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.ODE+00 O.DOE+DO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.DOE+DO D.DOE+00 O.OOOO O.aOE+OO D.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 0-DOE+00 0 DOE+Do O.DOE+Do TOTAL ADULT

&GEST TEEN

, CHILD INFANT 4.44E+03 O.DOE+00 1.19E+02 O.DOE+00 O.DOE+00 O.DOE+00 4.7)E+07 4.)7E+03 O.OOE+OO 1.12E+O2 O.OOE+OO O.OOE+OO O.aOE+OO 3.44E+O7 7.77E+03 0.DOE+00 2.08E+02 0.DOE+00 0.DOE+00 O.DOE+00 2.2)E+07 4.78E+02 0.DOE+00 5.59E+00 O.DOE+00 O.DOE+00 O.DOE+00 2.88E+05 H/A H/A N/A H/A INHAL.

ADULT TEEH CHILD INFANT 2.09E+D3 0.00E+00 5.6)E+Ol O.DOE+00 0-DOE+00 1.70E+05 5.06E+05 2.98E+03 0.DOE+00 8.00E+Dl O.DOE+00 D.DOE+00 2.93E+05 5.59E+05 4.1)E+03 O.DOE+00 l.l)E+02 O.DOE+00 O.DOE+00 2.62E+05 2.68E+05 3.29E+03 O.DOE+00 8.82E+Ol O.DOE+00 O.DOE+00 2.69E+05 1.04E+05 N/A N/A H/A H/A BONE LIV R OOY G.

S H

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec MAXIMUM VALU S OR PA MAYS~

GROUND:

GOAT COW TOTAL T. B-/ORG.. SKIN MILK:

MILK:

MEAT:

VEGTBLE:

INGEST:

'HHAL.

O.DOE+DO O.OOE+00 5.8OE+04 2.7lE+05 3.76E+05 4.65E+07 4.71E+07 5.59E+05 V

PAGE:

4-16 DAT

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES>>

lbvlOPE: Sr-91 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN tmUNO

~GOAT iMILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 0.00E+00 O.OOE+00 O.OOE+Oa O.OOE+00 0;OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.aaE+00 O.aOE+aa O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00.O.OOE+00 2.73E+04 O.OOE+00 1.10E+03 0.00E+00 O.OOE+00 O.OOE+00 1.30E+05 N/A 5.02E+04 O.OOE+00 2.00E+03 O.OOE+ao O.OOE+00 0.00E+00 2.28E+05 N/A 1.23E+05 0.00E+00 4.65E+03 O.OOE+00 O.OOE+00 0.00E+00 2.72E+05 N/A 1.22E+05 O.OOE+00 9.29E+03 O.OOE+00 0 OOE+00 O.OOE+00 3.04E+05 N/A'OW MILK

&LE ADULT TEEN CHILD INFANT

. ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 7.29E+03 0.00E+00 2.94E+02 O.OOE+00 O.OOE+00 O.OOE+00 3.47E+04 1.34E+04 O.OOE+00 5.32E+02 O.OOE+OO O.OOE+OO O.OOE+00 6.07E+04 3.28E+04 O.OOE+00 1.24E+03 0.00E+00 O.OOE+00 O.OOE+00 7.25E+04 6.84E+04 a'.aOE+aO 2.48E+O3 O.OOE+aa a.aOE+aO O.OaE+aO 8.1aE+O4 5.01E-11 O.OOE+00 2.02E-I2 O.OOE+00 O.OQE+00 O.OOE+00 2.38E-IO 4.21E-ll 0.00E+OO 1.68E-I2 0.00E+00 O.OOE+00 O.OOE+00 1.91E-IO 7.90E-II 0.00E+00 2.98E-12 0.00E+00 O.OOE+00 0.00E+00 1.74E-10 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 1.01E+05 O.OOE+00 4.06E+03 O.OOE+00 O.OOE+00 O.OOE+00 4.79E+05 9.39E+04 O.OOE+00 3.74E+03 0.00E+00 0-OOE+00 0-OOE+00 4.26E+05 l.73E+05 O.OOE+00 6.53E+03 O.OOE+00 O.OOE+00 O.OOE+00 3.82E+05 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 N/A N/A.

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A TOTAL ADULT ZHBEST TEEN CHILD INFANT 1.35E+05 O.OOE+00 5.46E+03 O.OOE+00 O.OOE+00 0.00E+00 6.44E+05 1.58E+05 0.00E+00 6.27E+03 O.OOE+00 0.00E+00 0.00E+00 7.14E+05 3.29E+05 0.00E+00 1.24E+04 O.OOE+00 0.00E+00 0.00E+00 7.26E+05 1.91E+05 O.OOE+00 l. 18E+04 O.OOE+00 O.OOE+00 O.OOE+00 3.85E+05 N/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT.

6.19E+01 O.OOE+00 2.50E+00 O.OOE+00 O.OOE+00 3.65E+04 1.91E+05 8.80E+Ol-O.OOE+00 3.51E+00 O.OOE+00 O.OOE+00 6.07E+04 2.59E+05 1.21E+02 O.OOE+00 4.59E+00 O.OOE+00 O.OOE+00 5.33E+04 1.74E+05 9.56E+Ol O.OOE+00 3.46E+00 O.OOE+00 O.OOE+00 5.26E+04 7.34E+04 N/A N/A N/A N/A BONE LIVER T.BOOY THYROID KIDNEY LUNG G.l.

SKIN Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

"*MAXIMUMVALUES FOR PATHWAYS>>>>>>

GROUND:

GOAT COW TOTAL T.B./ORG.'. SKIN M!LK:

MILK:

MEAT:

VEGTBLE:

INGEST:

'.OOE+00 0.00E+00 3.04E+05 8.10E+04 2.38E-IO 4.79E+05 7.26E+05 INHAL.

2.59E+05 PAGE:

4-17

0 D.C.M. HAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES>>

ISOTOPE:

Y-91 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID. KIDNEY LUNG G.I.

SKIN GROUND ADULT TEEN CHILD INFANT 1.06E+06 l.06E+06 1.06E+06 1.06E+06 1.06E+06

'1.06E+06 1.06E+06 1.20E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.20@46 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.20E+06 1.06E+D6 1.06E+D6 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.20E+06 GOAT tGLK CGM NILK NEAT 3LE ADULT TEEN CHILD INFANT ADULT TEEN CHILD JNFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 5.32E+02 0.DOE+00 1.42E+Ol D.DOE+00 Q.DOE+00 O.DOE+00 2.93E+05 9.79E+02 Q.DOE+00 2.62E+01 0.DOE+00 O.DOE+00 O.DOE+00 4.01E+05 2.42E+03 Q.QQE+QQ 6.47E+Ol Q.QQE+QQ O.DOE+DO O.DOE+00 3.22E+05 3.78E+04 Q.DOE+00 1.21E+02 Q.DOE+00 Q.DOE+00 0.DOE+00 3.25E+05 2.94E+03'Q.DOE+00 7.85E+01 O.DOE+00 Q.QDE+OD O.DOE+DD 1.62E+06 5.40E+03 Q.QQE+00 1.45E+02 Q.QQE+QQ D.DOE+00 Q.DOE+00 2.22E+06 1.34E+04 Q.DOE+00 3.57E+02 O.DOE+00 O.DOE+00 O.DOE+00 1.78E+06 2.51E+04 0.00E+00 6.68E+02 Q.DOE+00 Q.DOE+00 Q.DOE+00 1.80E+06 4.65E+05 0.00E+00 1.24E+04 Q.DOE+00 O.DOE+00 Q.DOE+00 2.56E+08 3.91E+05 Q.DOE+00 1.05E+04 Q.DOE+00 Q.DOE+00 O.DOE+00 1.60E+08 7.39E+05 Q.DOE+00 1.98E+04 Q.DOE+00 O.QDE+00 O.DOE+00 9.85E+07 Q.DOE+QQ Q.QQE+QQ D.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 4.27E+06 Q.DOE+00 1.14E+05 0.DOE+00 Q.DOE+00 0.DOE+00 2.35E+09 7.05E+06 Q.DOE+00 1.89E+05 Q.DOE+00 D.DDE+00 O.DOE+DO 2 89E+09 1.72E+07 0.00E+00 4.60E+05 Q.QQE+QQ D.DOE+00 Q.OQE+QO 2.29E+Q9 O.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 TOTAL ADULT INGEST TEEN CHILD INFANT 4.74E+06 Q.DOE+00 1.27E+05 Q.DOE+00 Q.DOE+00 O.DOE+DO 2.61E+09 7.45E+06 0.00E+00 2.DOE+05 O.DOE+00 0.DOE+00 0.DOE+00 3.05E+09 1.79E+07 O.OQE+00 4.80E+05 O.DOE+00 D.DOE+00 O.DOE+00 2.39E+09 6.29E+04 Q.DOE+00 7.88E+02 Q.DOE+00 Q.DOE+DO Q.DOE+00 2.12E+06 INHAL.

ADULT 4.62E+05 Q.QQE+QD 1.24E+04 Q.DOE+00 D.DOE+00 1.70E+06 3.85E+05 TEEN 6.61E+05 Q.QQE+QQ 1.77E+04 D.DOE+00 Q.DOE+00 2.94E+06 4.09E+05 CHILD 9.14E+O5 Q.QQE+QQ 2.44E+04 Q.DQE+QQ Q.DOE+DO 2.63E+06 1.84E+05 INFANT 5.88E+05 Q.QQE+00 1.57E+04 0.00E+QQ 0.DOE+00 2.45E+06 7.03E+Q4 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

'/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A BONE LIVER T.BODY HYROID KIDN Y LUNG G.I.

"Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GRQUNO:

T.B./ORG.

1.06E+06

"*"HAXIHUHVALUES GOAT COW HILK:

HILK:

OR PA HWAYS**>>

HEAT:

VEGTBLE:

TOTAL INGEST:

GROUND:

SKIN INHAL.

1.20E+06 4.01E+05 2.22E+06 2.56E+08 2.89E+09 3.05E+09 2.94E+06 p

PAGE:

4-18

~

O D-C-H.

MAXIMUM PATHWAY DOSE FACTORS-'ADIOHUCLIDES OTHER THAN NOBLE GASES*

ISOTOPE:

Nb-95 PATHWAY AGE GROUP BONE LIVER' T.BODY THYROID KIDNEY LUNG G.I.

SKIN ADULT TEEN CHILD INFANT 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35f+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08'1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.59E+08 1.35E+08 1.59EAB 1.35E+08 1.59E+08 1.35E+08 1.59E+08 GOAT HHK ADULT TEEN CHILD INFANT 4.78E+03 8.15E+03 1.84E+04 2.86E+05 2.66E+03 1.43E+03 O.OOE+00 2.63E+03 O.OOE+QO 1.61E+07 4.52E+03 2.49E+03 O.OOE+00 4.38E+03 O.OOE+00 1.93E+07 7.17E+03 5.12E+03 0.00E+00 6.73E+03 0.00E+00 1;33E+07 1.42E+04 8.1BE+03 0.00E+00 1.01E+04 O.OOE+00 1.19E+07 N/A N/A N/A N/A ADULT TEEN CHILD INFANT 2.44E+04 4.17E+04 9.-41E+04 1.7GE+05 1.36E+04 7.31E+03 O.OOE+00 1.34E+04 O.OOE+00 2.31E+04 1.27E+04 0.00E+00 2.24E+04 O.OOE+00 3.67E+04 2.62E+04 O.OOE+00 3.44E+04 O.OOE+00 7.24E+04 4.18E+04 0.00E+00 5.19E+04 O.OOE+00 8.25E+07 9.89E+07 6.78E+07 6;11E+07 N/A N/A N/A N/A "3LE TOTAL iNGEST.

ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT

'T'IEN CHILD INFANT 8.48E+05 4.72E+05 2.54E+05 0.00E+00 4.66E+05 O.OOE+00 6.62E+05 3.67E+05 2.02E+05 0.00E+00 3.56E+05 0.00E+00 1.14E+06 4.45E+05 3.1BE+05 0.00E+00 4.18E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 1.10E+05 6.11E+04 3.28E+04 0.00E+00 6.04E+04 0.00E+00 1.64E+05 9.10E+04 5.01E+04 0.00E+00 8.82E+04 0;OOE+00 3.63E+05 1.41E+05 1.01E+05 0.00E+00 1.33E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 9.87E+05 5.49E+05 2.95E+05 0.00E+00 5.43E+05 O.OOE+00 8.76E+05 4-86E+05 2.68E+05 0.00E+00 4.71E+05 0.00E+00 1.62E+06 6.30E+05 4.50E+05 0.00E+00 5.92E+05 0.00E+00 4.62E+05 8.65E+04 5.00E+04 0.00E+00 6.20E+04 0.00E+00 2.86E+09 1.57E+09 8.23E+08 0.00E+00 3.71E+08 3.89E+08 2.6IE+08 0.00E+00 3.33E+09 2.08E+09 1.17E+09 7.30E+07 N/A N/A N/A N/A N/A N/A N/A N/A N/A

. N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT 1.41E+04 7.82E+03 4.21E+03 0.00E+00 7.74E+03 5.05E+05 1.86E+04 1.03E+04 5.66E+03 0.00E+00 1.00E+04 7.51E+05 2.35E+04 9.18E+03 6.55E+03 0.00E+00 8.62E+03 6.14E+05 1.57E+04 6.43E+03 3.78E+03 0.00E+00 4.72E+03 4.79E+05 1.04E+05 9.68E+04 3.70E+04 1.27E+04 N/A N/A N/A N/A BONE LIVER T.BODY HYROIO K OHEY LUNG G.I.

SKIN I

Airborne pathways and tritium ingestion:

~ units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN 1.35E+08 1.59E+08

~"HAXIHUNVALUES FOR PATHWAYS~~~

GOAT COW TOTAL HILK-NILK-'EAT:

VEGTBLE:

INGEST:

INHAL.

1.93E+07 9.89E+07 2.86E+09 3.89E+08 3.33E+09 7.5IE+05 A tV PAGE:

4-19

O.D.C-M.

MAXIMUM'PATHWAYDOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES>>

ISOTOPE: 2r-95 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG

. G.I.

COW MILK MEAT

~BLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT GROUND ADULT TEEN CHILD "

INFANT GOAT

~

ADULT MILK TEEN CHILD INFANT 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+QS 2.42E+QS 2.42E+08 2.42E+08 5.92E+Ol 1.90E+Ol 1.03E+02 3.26E+01 2.40E+02 5.28E+01 3.56E+03 1.04E+02 2.42E+08 2.42E+OS 2.42E+08 2.42E+OS 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.'42E+OS 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 1.28E+Ol O.OOE+OO 2.98E+Ol O.OOE+OO 6.OlE+04 2.25E+01 O.OOE+00 4.80E+Ol O.DOE+00 7.53E+04 4.70E+Ol O.OOE+00 7.56E+01 O.DOE+00 5.51E+04 7.38E+01 O.OOE+00 1.12E+02

'O.DOE+00 5.18E+04 3.31F+02 1.06E+02 7.18E+01 O.OOE+00 1.67E+02 0.00E+00 3.36E+05 5.79E+02 1.83E+02 1.'26E+02 O.OOE+00 2.68E+02 O.OOE+00 4.21E+05 1.34E+03 2.95E+02 2.63E+02 O.OOE+00 4.23E+02 O.DOE+00 3.08E+05 2.39E+03 5.82E+02 4.12E+02 O.QOE+00 6.27E+02 O.DOE+00 2.90E+05 7.&3E+05 2.51E+05 1.70E+05 O.QOE+00 3.94E+05 O.DOE+00 7.96E+08 6.27E+05 1.98E+05 1.36E+05 O.QQE+00 2.91E+05 O.DOE+00 4.57E+08 1.11E+06 2.45E+05 2.1&E+05 O.QQE+00 3.50E+05 O.OOE+00 2.55E+08 0.00E+00 O.OOE+00 Q.QQE+00 O.QQE+00 O.QOE+00 O.DOE+00 O.OOE+00 9.90E+05 3.17E+05 2.15E+05 Q.OOE+00 4.98E+Q5 Q.OOE+00 1.01E+09 1.56E+06 4.91E+05 3.3SE+05 0.00E+00 7.22E+05 O.OOE+QQ 1.13E+Q9 3.57E+06 7.85E+05 6.99E+05 Q.OOE+00 1.12E+06 O.OOE+Oo 8.19E+08 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Q.QOE+00 O.DOE+00 O.OOE+00 2 8IE+08 2.81E+08 2.81E+08 2.81E+08 H/A N/A N/A N/A N/A N/A N/A N/A H/A N/A N/A N/A N/A N/A N/A N/A TDTAL INGEST.

ADULT TEEN CHILD INFANT 1.77E+06 5.69E+05 3.85E+05 0.00E+00 8.92E+05 O.DOE+00 ).BOE+09 2.IBE+06 6.89E+05 4.74E+05 O.OOE+00 1.01E+06 0.DOE+00 1.59E+09 4.69E+06 1.03E+06 9.17E+05 O.OOE+00 1.47E+06 O.OQE+00 1.07E+09 5.94E+03 6.86E+02 4.86E+02 O.OOE+00 7.39E+02 O.DOE+00 3.41E+05 N/A N/A N/A N/A INHAL.

ADULT 1.07E+05 3.44E+04 2.33E+04 O.OOE+00 5.42E+04 1.77E+06 1.50E+05 TEEN 1.46E+05 4.58E+04 3.15E+04 O.OOE+00 6.74E+04 2.69E+06 1.49E+05 CHILD 1.90E+05 4.1SE+O4 3.7OE+O4 O.OOE+OO 5.96E+04 2.23E+06 6. 1)E+O4 INFANT 1.15E+05 2.79E+04 2.03E+04 O.OOE+00 3.1)E+04 1.75E+06 2. 17E+04

- H/A H/A N/A N/A BONE LIVER

. BODY HYRO KIDN Y LUNG G.I.

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

'SKIN

'2.42E+08 2.81E+08 I

>>HAXIMUH VALUES FOR PATHWAYS*>>*

GOAT COW TOTAL MILK:

MILK:

HEAT:

VEGTBLE:

INGEST:

INHAL.

7.53E+04 4-2)E+05

?.96E+OB 1.13E+09 1.80E+09 2.69E+06 4-20

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE, GASES*

ISOTOPE:

Mo-99 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN

'ROUND ADULT TEEN CHILD INFANT D.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 D.DOE+00 D.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 D.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.ODE+OO O.ODE+00 O.OOE+OO O.DOE+DO D.OOE+OO O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+DO O.DOE+00 GOAT HILK CDW MILK HEAT BLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 0.DOE+00 1.34E+06'.55E+05 O.DOE+00 3.03E+06 O.DOE+00 O.DOE+00 2.42E+06.4.61E+05 O.DOE+00 5.53E+06 0.DOE+00 O.DOE+00 4.39E+06 1.09E+06 O.DOE+00 9.38E+06 O.DOE+00 O.DOE+00 1.12E+07 2.19E+06 O.DOE+00 1.68E+07 O.oaf+DO O.DOE+00 6.24E+06 1.19E+06 O.DOE+00 1.41E+07 O.DOE+00 0.DOE+00 1.13E+07 2.15E+06 O.DOE+00

.2.58E+07 O.DOE+00 O.DOE+Do 2.05E+07 5.07f+06 O.DOE+00 4.38E+07 O.DOE+00 O.DOE+00 5.24E+07 1.02E+07 O.DOE+DO 7.83E+07 O.DOE+00 O.DOE+00 3.30E+04 6.27E+03 O.DOE+Do 7.46E+04 O.DOE+00 O.DOE+00 2.73E+04 5.20E+03 O.DOE+00 6.'24E+04 O.DOE+00 0.DOE+00 3.79E+04 9.38E+03 O.DOE+00 8.10E+04 D.DOE+DO O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 2.03E+06 3.86E+05 O.DOE+00 4.60E+06 O.DOE+00 O.OOE+OO 1.86E+06 3.55E+Os O.OOE+OO 4.27E+06 O.OOE+OO O.DOE+00 2.54E+06 6.30E+05 O.OOF+Da 5.43E+06 O.DOE+00 a.aoE+oa a.'aoE+oo o.ooE+oo o.ooE+oo o.ooE+oo O.ooE+oo 3-IOE+06 4.33E+06 3.63E+06 3.70E+D6 1.45E+07 2.02E+07 1.70E+07 1.73E+07 7.64E+04 4.88E+04 3.14E+04 D.DOE+00 4.71E+06 3.34E+06 2.10E+06 O.DOE+00 H/A N/A N/A H/A H/A H/A N/A H/A N/A N/A N/A N/A N/A H/A N/A N/A TOTAL ADULT XHBEST TEEN CHILD INFANT a.DOE+00 9.64E+06 1.83E+06 0.00E+00 2.18E+07 O.DOE+00 D.DOE+Do 1.56E+07 2.97E+06 O.DOE+00 3.56E+07 O.DOE+00 O.OOE+00 2.75E+07 6.80E+06 O.DOE+00 5.87E+07 O.DOE+00 O.DOE+00 6.37E+Q7 1.24E+07 O.DOE+00 9.51E+07 0.DOE+00 2.24E+07 2.79E+07 2.27E+07

2. 1OE+07 N/A N/A N/A N/A MHAL.

ADULT TEEN CHILD INFANT O.DOE+DO 1.21E+02 2.30E+Ol O.DOE+00 2.91E+02 9.12E+04 O.OOE+Oa 1.69E+02 3.22E+Ol O.OOE+aa 4.11E+02 1.54E+05 O.DOE+00 1.72E+02 4.26E+Ol O.DOE+Do 3.92E+02 1.35E+05 O.OOE+Oa 1.65E+02 3.23E+Ol Q.aaf+aa 2.65E+02 1.35E+05 2.48E+05 2.69E+05 1.27E+05 4.87E+04 N/A H/A H/A N/A BONE LIVER

.BODY HYROID KIDNEY LUNG G.l.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN O.OOE+aa O.OOE+Oa

"*~MAXIMUMVALU S FOR PA HWAYS*"*

GOAT COW TOTAL MILK:

MILK:

MEAT:

VEGTBLE:

INGEST:

IHHAL.

1.68E+a7 7.83E+07 8.10E+04 5.43E+06 9.51E+07 2.69E+05 Ar V

$1 PAGE:

4-21

O.D.C.M. NXIMUM PATHWAY DOSE FACTORS-'ADIONUCLIDES OTHER THAN NOBLE GASES

~OTOPE:

Tc-99m PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN GROUND

.ADULT TEEN CHILD INFANT O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 0.DOE+00 O.DOE+00 O.OOE+QO O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+DO O.DOE+00 O.DOE+00 D.DOE+00 O.OOE+QD Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+00 Q.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+DO 0.DOE+00 GOAT HILK COW MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 1.79E-Ql 5.Q?E-01

&.46E+00 0.DOE+00 7,70E+00 2.48E-01 3.DOE+02 3.11E-Q1 &.68E-Ql 1.12E+Ol 0.DOE+00 1.29E+01 4.82E-01 5.70E+02 7.13E-O1 1.40E+00 2.32E+Ql

.D.DOE+00 2.03E+Ol ?.10E<<Ol 7.96E+02 1.24E+Dl 3.06E+00 3.94F+01 O.DOE+00 3.29E+Ql 1.60E+00 8.89E+02 8.37E-01 2.36E+00 3.01E+01 Q.DOE+00 3.59E+01 1.16E+00 1.40E+03 1.45E+00 4.0SE+00 5.25E+Ol O.DOE+00 6.03E+Ol 2.25E+00 2.66E+03 3.33E+DD 6.53E+00 1.08E+02 O.DOE+00 9.49E+01 3.31E+DD 3.71E+03 6.92E+00 1.43E+01 1.84E+02 O.DOE+00 1.54E+02 7.47E+DD 4.15E+D3 N/A N/A N/A N/A H/A N/A N/A N/A HEAT

, V<GTBLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT INHAL.

ADULT TEEN CHILD INFANT TOTAL ADULT INGEST TEEN

~CHILD INFANT l.47E-ZI 4.14E-21 5.28E-20 O.DOE+DO 6.29E-ZO 2.03E-21 2.45E-18 l.16E-21 3.25E-21 4.21E-20 O.DOE+DO 4.84E-20 1.8OE-21 2.13E-18 2.04E-21 4.01E-Zl 6.64E-20 O.DOE+DO 5.8ZE-ZO 2.03E-21 2.28E-18 D.DOE+00 O.DOE+DO O.DOE+DO O.ODE+DD D.DOE+DO O.DOE+DO O.DOE+00 1.02E+00 2.89E+00 3.68E+Dl Q.DOE+00 4.39E+01

).42E+00 1.71E+03 9.03E-Ol 2.52E+DD 3.26E+Dl D.DOE+DO 3.75E+Ol 1.4DE+00 1.65E+03 1.55E+00 3.05E+00 5.05E+Ol O.DOE+00 4.43E+01 1.55E+00 1.73E+03 O.DOE+00 D.DOE+00 D.DOE+DO O.ODE+DD D.DOE+00 O.OOE+OD O.ODE+OD 2.04E+DD 5.76E+00 7.34E+Dl D.DOE+DO 8.75E+Ol 2.82E+00 3.41E+03 2.67E+DD 7.43E+00 9.63E+01 O.DOE+00 1.11E+02 4.13E+00 4.88E+03 3.6DE+00 1.10E+Dl 1.82E+02 D.DOE+DO 1.59E+02 5.57E+00 6.25E+03 1.93E+Dl 1.73E+01 2.23E+02 O.DOE+00 1.87E+02 9.07E+00 5.04E+03 l.03E-D3 2.91E-03 3.70E-02 O.DOE+00 4.42E-02 7.64E+02 4.16E+03 1.38E-03 3.86E-03 4.99E-02 0.00E+OD 5.76E-02 1.15E+03 6.13E+03 1.78E-03 3.48E-03 5.77E-02 O.ODE+OD 5.07E-02 9.5IE+02 4;81E+03 1.4DE-03 2.88E-03 3.72E-OZ 0.00E+OD 3.11E-02 8.11E+02 2.03E+03 N/A H/A N/A N/A N/A N/A N/A N/A N/A N/A N/A H/A H/A H/A H/A H/A BONE LIV R

.BODY THYROID

'KIDNEY LUNG G.I.

SK Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are= mrem-m2/yr/uCi/sec

""*MAXIMUMVALUES OR PA HWAYS~~

GROUND:

GOAT COW T.B./ORG.

SKIN MILK:

MILK:

HEAT:

VEGTBLE:

D.DOE+00 D.DOE+00 8.89E+02 4.15E+03 2.45E-18 1.73E+03 TOTAL INGEST:

INHAL.

6.25E+03 6. 13E+03 zrrV PAGE:

4-22

THYROID KIDNEY O.O.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIOES OTHER THAN NOBLE GASES*

'L ~POPE:

Ru-106 PATHWAY AGE GROUP BONE LIVER T.BODY LUNG G.I.

SKIN GROUND GOAT MILK COW MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD

. INFANT ADULT TEEN CHILD INFANT 4.18E+08 4.18E+08 4.18E+08 4.18E+OS 1.50E+03 2.76E+03 6.79E+03 1.17E+05 9.65E+03 1.77E+04 4.37E+04 9.00E+04 5.01E+OS 5.01E+0&

5.01BOS 5.01E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4;18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+OS 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.1SE+08 4.18E+OS 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+OS 4.18E+08 4.18E+08 0.00E+00 1.90E+02 0.00E+00 2.90E+03 0.00E+00 9.71E+04 0.00E+00 3:48E+02 O.OOE+00 5.32E+03 0.00E+00 1.32E+05 O.OOE+00 8.47E+02 O.OOE+00 9.17E+03 O.OOE+00 1.06E+05 O.OOE+00 1.75E+03 O.OOE+00 1.65E+04 O.OOE+00 1.06E+05

O.OOE+00 1.22E+03 O.OOE+00 1.86E+04 O.OOE+00 6.24E+05 O.OOE+00 2.24E+03 O.OOE+00 3.42E+04 O.OOE+00 8.51E+05 O.OOE+00 5.45E+03 O.OOE+00 5.90E+04 O.OOE+00 6.80E+05 O.OOE+00 1.12E+04, O.OOE+00 1.06E+05 O.OOE+00 6.83E+05 N/A N/A N/A N/A N/A N/A N/A N/A NEAT ADULT TEEN CHILD INFANT 1.48E+09 O.OOE+00 1.S7E+08 0.00E+00 2.85E+09 0.00E+00 9.56E+10 1.24E+09 0.00E+00 1.57E+08 0.00E+00 2.40E+09 0.00E+00 5.97E+10 2.34E+09 0.00E+00 2.92E+08 0.00E+00 3.16E+09 0.00E+00 3.64E+10 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A AN/A N/A N/A

~

BLE TOTAL ADULT INGEST.

TEEN CHILD INFANT 1.65E+09 O.OOE+00 2.09E+08 O.OOE+00 3.19E+09 O.OOE+00 1.07E+ll 1.53E+09 O.OOE+00 1.93E+08 O.OOE+00 2.96E+09 O.OOE+00 7.36E+10 3.05E+09 O.OOE+00 3.81E+08 O.OOE+00 4.12E+09 O.OOE+00 4.75E+10 2.07E+05 O.OOE+00 1.30E+04 O.OOE+00 1.23E+05 O.OOE+00 7.90E+05 ADULT 1.73E+08 O.OOE+00 2.19E+07 O.OOE+00 3.34E+08 O.OOE+00 1.12E+10 TEEN 2.91E+08 0.00E+00 3.67E+07 0.00E+00 5.61E+08 O'.OOE+00 1.40E+10 CHILD 7.11E+08 0.00E+00 8.88E+07 O.OOE+00 9.61E+08 O.OOE+00 1.11E+10 INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A N/A

'N/A N/A N/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT 6.91E+04 O.OOE+00 8.72E+03 O.OOE+00 1.34E+05 9.36E+06 9.12E+05 9.84E+04 O.OOE+00 1.24E+04 O.OOE+00 1.90E+05 1.61E+07 9.60E+05 1.36E+05 O.OOE+00 1.69E+04 O.OOE+00 1.84E+05 1.43E+07 4.29E+05 8.68E+04 0.00E+00 1.09E+04 0.00E+00 1.07E+05

1. 16E+07 1.64E+05 N/A H/A H/A N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.l.

SKIN Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

.SKIN

.4.18E+08 5.01E+08

*NXIMUMVALUES FOR PATHWAYS*~~

GOAT COW MILK:

MlLK:

MEAT:

VEGTBLE:

l.32E+05 8.51E+05 9.56E+10 1.40E+10 TOTAL INGEST:

1.07E+11 IHHAL.

1.61E+07 PAGE:

4-23

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES>>

ISOTOPE: Ag-1 lorn PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN GROUND ADULT 3.4QE+Q9 3.40E+Q9 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.97E+Q9 TEEN 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.97E+09 CHILD 3.40E+09 3.4OE+09 3.40E+09 3.40E+09 3.40E+09 3.40E+Q9 3.40E+09 3.97E+09 INFANT 3.40E+09 3.4OE+09 3.40E+Q9 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.97E+09 GOAT HILK COW MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 4.19E+06 3.&BE+06 2.30E+06 6.93E+06 6.56E+06 3.99E+Q6 1.50E+07 1.02E+07 8.12E+06 2.32E+08 2.03E+07 1.34E+07 2.65E+07 2.46E+07 1.46E+07 4.39E+07 4.15E+07 2.53E+07 9.52E+07 6.43E+07 5.14E+07 1.76E+08 1.2&E+OS 8.50E+07 0.00E+00 7.63E+06 Q.OOE+00 1.25E+07 O.OQE+00 1.89E+07 O.OQE+00 2.90E+07 O.OOE+00 4.83E+07 O.OQE+QQ 7.92E+07 O.OQE+00 1.20EtQS O.OOE+00 1.84E+08 O.OQE+00 1.5SE+Q9 O.OOE+00 1.84E+09 O.OOE+00 1.21E+09 O.QOE+00 1.05E+09 O.OOE+00 1.00E+10 O.OOE+00 1.1?E+10 O.OQE+00 7.65E+09 O.OOE+00 6.66E+09 H/A N/A H/A N/A H/A H/A N/A N/A ADULT TEEN CHILD INFANT BLE ADULT TEEN CHILD INFANT TOTAL AD1JLT INGEST.

TEEN CHILD INFANT 3.42E+06 3.17E+06 1.&BE+06 O.OOE+00 6.23E+06 Q.OOE+00 1.29E+09 2.59E+06 2.45E+06 1.49E+06 O.OOE+00 4.68E+06 O.OOE+00 6.89E+08 4.30E+06 2.90E+06 2.32E+06 O.OOE+00 5.41E+06 O.OOE+00 3.45E+08 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 9.41E+06 8.70E+06 5.17E+06 O.OOE+00 1.71E+07 O.OOE+00 3.55E+09 1.42E+07 1.34E+07 8.1&E+06 O.OOE+00 2.56E+07 0.00E+00 3.?&E+Q9 3.06E+07 2.06E+07 1.65E+07 O.OOE+00 3.85E+07 O.OOE+00 2.46E+09 o.ooE+oo o.ooE+oo o.ooE+oo o.ooE+oo o.ooE+oo o.ooE+oo o.ooE+oo 4.36E+07 4.03E+07 2.39E+07 O.OOE+00 7.92f+07 O.OOE+00 1.64E+10 6.76E+07 6.4OE+07 3.89E+07 O.OOE+00 1.22E+08 O.OOE+00 1.&OE+10 1.45E+08 9.80E+07 7.83E+07 O.OOE+OO 1.83E+08 O.OOE+00 1.17E+10 4.07E+08 1.49E+08 9.84E+07 O.OOE+00 2.13E+08 Q.OOE+00 7.71E+09 H/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT 1.0&E+04 1.00E+04 5.94E+03 O.OOE+00 1.97E+04 4.63E+06 3.02E+05 1.3&E+04 1.31E+04 7.99E+03 O.OOE+00 2.5QE+04 6.75E+06 2.73E+05 1.69E+04 1.14E+04 9.14E+03 O.OOE+00 2.12E+04 5.4&E+06 1.00E+05 9.9&E+03 7.22E+03 5.00E+03 O.OOE+00 1.09E+04 3.67E+06 3.30E+04 N/A N/A N/A N/A BONE LIVER

.BOQY HY 0 K ON Y

LUNG G.I.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN 3.40E+09 3.9?E+09

>>*"MAXIMUMVALUES GOAT COW MILK:

MILK:

1.84E+09 l. l?E+10 FOR PA HWAYS>>*>>

MEAT:

VEGTBLE'.29E+093.78E+09 TOTAL INGEST:

INHAL.

1.80E+10 6.75E+06 PAGE:

4-24

O.D-C-M.

MAXIMUM PATHWAY 00SE FACTORS:

RADIONUCLIDES OTHER THAN NOSLE GASES*

I

.~OTOPE:

I-131 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG SKIN GOAT MILK ADULT TEEN CHILD INFANT GROUND ADULT TEEH CHILD INFANT 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 -1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.6OE+08 2.29f+08 1.31E+08 7.50E+10.3.92E+08 0.00E+00 2.90E+08 4.06E+08 2. 18E+08 1.19E+11 6.99E+08 O.OOE+00 7.04E+08 7.08E+08 4.02E+08 2.34E+11 l. 16E+09 O.OOE+00 1.22E+09 1.73E+09 7.61E+08 5.69E+11 Z.OZE+09 O.OOE+00 1.70E+07 1.70E+07 1.70E+07 1.70E+07 6.04E+07 8.04E+07 6.30E+07 6.18E+07 2.07E+07'.07E+07 2.07E+07 2.07E+07 H/A H/A N/A H/A COW MILK MEAT

'GTBLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 2.86E+07 4.10E+07 2.35E+07 1.34E+10 7.02E+07 O.OOE+00 2.88E+07 4.03E+07 2.16E+07 1.18E+10 6.93E+07.0.00E+00 5.54E+07 5.57E+07 3.17E+07 1.84E+10 9.15E+07 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1.08E+07 7.96E+06 4.96E+06 O.OOE+00 7.46E+07 1.07E+08 6.12E+07 3.50E+10 I;83E+08 O.OOE+00 2.82E+07 1.35E+08 1.90E+08 1.02E+08 5.53E+10 3.26E+08 O.OOE+00 3.75E+07 3.29E+08 3.30E+08 1.88E+08 1.09E+II 5.42E+08 O.OOE+00 2.94E+07 6.86E+08 8.08E+08 3.55E+08 2.65E+l1 9.44E+08 Q.OOE+00 2.88E+07 3.54E+06 5.07E+06 2.90E+06 1.66E+09 8.68E+06 O.OOE+00 1.34E+06 2.94E+06 4.12E+06 2.21E+06 1.20E+09 7.09E+06 O.OOE+00 8.15E+05 5.46E+06 5.49E+06 3. 12E+06 1.81E+09 9.01E+06 O.OOE+00 4.89E+05 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A N/A N/A N/A H/A N/A N/A H/A H/A N/A H/A H/A TOTAL ADULT INGEST.

TEEN CHILD INFANT 2.67E+08 3.82E+08 2.19E+08 1.25E+11 6.54E+08 O.OOE+00 1.01E+08 4.57E+08 6.40E+08 3.44E+08 1.87E+ll 1. 10E+09 O.OOE+00 1.27E+08 1.09E+09 1.10E+09 6.25E+08 3.64E+11 1.81E+09 O.OOE+00 9,79E+07 1.91E+09 2.54E+09 1.12E+09 8.34E+ll 2.97E+09 O.OOE+00 9.06E+07 N/A

'/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT 2.52E+04 3.58E+04 2.05E+04 l. 19E+07 6.13E+04 O.OOE+00 6.28E+03 3.54E+04 4.91E+04 2.64E+04 1.46E+07 8.40E+04 O.OOE+00 6.49E+03 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88f+04 O.OOE+00 2.84E+03 3.79E+04 4.44F+04" 1.96E+04 1.4QE+07 5.18E+04 O.OOE+00 1.06E+03 N/A N/A N/A N/A BONE LIVER T. BODY HYROID KIDNEY LUNG G.l.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

tlAXlNUNVALUES FOR PATHWAYS*

GROUND:

GOAT COW TOTAL T.B./ORG.

SKIN MILK:

MILK:

MEAT:

VEGTBLE'NGEST'.70E+07 2-07E+07 5.69E+11 2.65E+1 1

1.81E+09 1.84E+10 8.34E+11 INHAL.

1. 62E+07 HPc'v9'AGE:

4-25

O.D.C.N.

NAXINUN PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

I>OTOPE:

I-132 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G. I.

SKIN GROUND GOAT HILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD

. INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.QOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Q.OOE+00 O.OOE+00 0-QOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Q.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Q.QOE+00 Q.OQE+00 O.OQE+00 O.QOE+00 O.OOE+00 O.OOE+00 O.OOE+00 8.87E-02 2.37E-OI 8.30E-02 8.30E+00 3.78E-OI O.OOE+00 4.46E-02 1.57E-Ql a.l2E-QI l.'48E-Ol 1.39E+Ol 6.4&E-OI O.OOE+00 1.79E-QI 3.72E-Ql 6.84E-OI 3.14E-Ol 3.17E+01 1.05E+00 Q.OOE+00 8.05E-OI 6.44E-Ql l.57E+00 5.58E-Ol 7.35E+Ql 1.75E+00 O.OOE+00 1.27E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A N/A N/A N/A COM HILK ADULT TEEN CHILD INFANT 4.14E-Q2 1.11E-QI 7.34E-02 1.92E-QI

1. 74E-Ol 3.19E-QI 3.60E-QI 7.31E-QI 3.87E-02 3.87E+00 1.76E-OI O.OOE+00 2.08E-Q2 6.89E-02 6.47E+00 3.03E-OI O.OQE+00 8.37E-02 1.47E-QI 1.48E+Ql 4.88E-OI O.OOE+00 3.75E-OI 2.60E-QI 3.43E+Ol 8.16E-QI O.QOE+00 5.93E-OI N/A N/A N/A N/A HEAT ADULT TEEN CHILD INFANT VIABLE ADULT TEEN CHILD INFANT 2.30E-59 6.14E-59 2.15E-59 2.15E-57 9.79E-59 O.OOE+00 I. ISE-59 1.87E-59 4.&&E-59 1.75E-59 1.64E-57 7.69E-59 O.OOE+00 2.13E-59 3.37E-59 6.20E-59 2.85E-59 2.&SE-57 9.49E-59 O.OOE+00 7.30E-59 O.OOE+00 O.OOE+00 O.QOE+00 O.OOE+00 O.QQE+00 O.OOE+00 O.OOE+00 1.90E+Ol 5.08E+Ql 1.7&E+01 1.7&E+03 8.10E+Ol O.OOE+00 9.55E+00 1.71E+Ql 4.4&E+Ol 1.61E+Ql 1.51E+03 7.06E+01 O.QOE+00 1.95E+Ol 3.04E+01 5.59E+Ol 2.57E+01 2.59E+03 8.56E+01 Q.QOE+00 6.5&E+Ol 0:OOE+QO O.OOE+00 Q.QOE+00 O.OOE+OQ O.OOE+00 O.OOE+00 O.QOE+00 N/A N/A N/A N/A N/A.

N/A N/A N/A TOTAL ADULT

'INGEST.

TEEN CHILD INFANT 1. 91E+Q1 1.74E+Ql 3.10E+Ol 1.0QE+QQ 5.12E+Ql 1.79E+Ol 4.54E+Ol 1.63E+Ql

5. 69f+QI 2. 62E+O1 2.30E+00 8.19E-OI 1.79E+03 8.15E+Ql O.OOE+00 9.61E+00 1.53E+03 7.16E+01 Q.QOE+00 1.9&E+Ol 2.64E+03 8.71E+01 O.QQE+00 6.70E+Ol 1.QSE+02 2.57E+00 O.QOE+00 1.86E+00 N/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT

1. 16E+03 1.58E+03 1.8&E+03 1.26E+03

l. 16E+03 3.26E+03 1.59E+03 4.3&E+03 2.12E+03 4.07E+Q3 1.69E+Q3 3.54E+03

1. 14E+05 5.18E+03 O.OOE+00 4.06E+02 1.51E+05 6.92E+03 O.OOE+00 1.27E+03 1.94E+05 6.25E+03 Q.QQE+00 3.20E+03 1.69E+Q5 3.95E+03 O.QQE+00 1.90E+03 N/A N/A N/A N/A BONE LIVER T.BODY HYROID KIDN Y LUNG G. I.

SKIN "Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN O.OOE+00 O.OOE+00

"" MAXIMUM VALUES FOR PA HWAYS>>>>>>

GOAT COM MILK:

MILK:

NEAT:

VEGTBLE:

7.35E+01 3.43E+Ql 2.8&E-57 2.59E+03 TOTAL

.INGEST:

2.64E+03 INHAL.

1.94E+05 4-26

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

t iiOTOPE: Te-132 PATHWAY AGE GROUP BONE LIVER" T.BODY THYROID KIDNEY LUNG G.I.

SKIN GOAT MILK ADULT TEEN CHILD INFANT GROUND ADULT TEEN CHILD INFANT 0;OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00

'0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1.30E+05 8.39E+04 7.88E+04 9.27E+04 2.32E+05 1.47E+05 1.38E+05 1.55E+05 5.53E+05 2.45E+05 2.96E+05 3.5?E+05 9.50E+06 5.64E+05 5.2?E+05 8.33E+05 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 8.08E+05 1.41E+06 2.27E+06 3.53E+06 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 3.9?E+06 4.65E+06 2.47E+06 2.09E+06 N/A N/A N/A N/A 0.00E+00 O.OOE+OO 0.00E+OO O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOF+00 0.00E+00 COW MILK AOULT TEEN CHILD INFANT 6.05E+05 3.91E+05 3.67E+05 4.32E+05 3.77E+06 O.OOE+00 1.08f+06 6.85E+05 6.45E+05 7.22E+05 6.5?E+06 O.OQE+00 2.5SE+06 1.14E+06 1.38E+06 1.66E+06 1.06E+07 O.OOE+00 5.32E+06 2.63E+06 2.46E+06 3.89E+06 1.65E+07 O.OOE+00 1.85E+07 2.1?E+07 1.15E+07 9.74E+06 N/A N/A N/A N/A ABLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 4.68E+05 3.03E+05 2.84E+05 3.34E+05 2.92E+06 Q.OOE+00 3.83E+05 2.43E+05 2.28E+05 2.56E+05 2;33E+06 O.OOE+00 6.99E+05 3.09E+05 3.74E+05 4.51E+05 2.87F+06 O.OOE+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+OO 1.43E+07 7.6SE+06 3.11E+06 0.00E+00 1.42E+06 9.18E+05 8.62E+05 1.01E+06 8.84E+06 O.OOE+00 4.34E+07 1.29E+06 8.17E+05 7;69E+05 8.61E+05 7.83E+06 0.00E+00 2.59E+07 2.31E+06 1.02E+06 1.24E+06 1.49E+06 9.49E+06 Q.OOE+00 1.03E+07 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A N/A N/A N/A N/A N/A N/A N/A INHAL.

AOULT TEEN CHILD INFANT TOTAL AOULT INGEST TEEN CHILD IHFANT 2.62E+06 2.99E+06

6. 15E+06 1-48E+07 2.60E+02 3.60E+02 4.81E+02 3-72E+02 8.02E+07 5.99E+07 2.74E+07 1.1SE+07 2.15E+02 1.62E+02 1.90E+02 1.46E+03 2.88E+05 2.90E+02 2.19E+02 2.46E+02 1.95E+03 4.49E+05 2.72E+02 2.63E+02 3.17E+02 1.77E+03 3.77E+05 2.37E+02 1.76E+02 2.79E+02 1.03E+03 3.4OE+05 5.10E+05 4.63E+05 1.3BE+05 4.41E+04 1.70E+06 1.59E+06 1.87E+06 1.63E+07 O.OOE+00 1.89E+06 1.78E+06 1.99E+06 1.81E+07 O.OQE+00 2.72E+06 3.29E+06 3.96E+06 2.53E+07 O.OOE+00 3.2OE+06 2.98E+06 4.72E+06 2.00E+07 0.00E+00 N/A N/A N/A N/A N/A N/A N/A N/A BONE LIVER T.BODY HYROID KIDNEY LUNG G.I.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

- ~MAXIMUMVALUES GROUND'ROUND:

GOAT COW T.B./ORG.

SKIN MILK:

MILK:

O.OOE+00 O.OOE+00 9.50E+06 2.17E+07 OR PA HWAYS"~

TOTAL MEAT:

VEGTBLE:

INGEST:

IHHAL.

1.43E+07 4.34E+07 8.02E+07 5.10E+05 PAGE:

4-27

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES>>

~ISOTOPE:

I-133 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID lUDNEY LUNG G.,I.

SKIN GROUND ADULT TEEN CHILD INFANT 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00,0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 GOAT MILK ADULT TEEN CHILD INFANT 2.09E+06 3.64f+06 1.11E+06 5.34E+08 6.34E+06 0;OOE+00 3.2?E+06 3.82E+06 6.48E+06 1.98E+06 9.04E+08 1.14E+07 O.OOE+00-4.90E+06 9.28E+06 1.15E+07 4.34E+06 2.13E+09 1.91E+0?

O.OOE+00 4.62E+06 1.63E+07 2.85E+07 8.35E+06 5.19E+09 3.35E+07 0.00E+00 4.83E+06 N/A N/A N/A N/A CDW MILK ADULT 9.75E+05 1.70f+06 5. 17E+05 2.49E+08 2.96E+06 O.OOE+00 1.52E+06 TEEN 1.78E+06 3.02E+06 9.21E+05 4.22E+08 5.30E+06 O.OOE+00 2.29E+06 CHILD 4.33E+06 5.35E+06 2.02E+06 9.94E+08 8.92E+06 O.OOE+00 2. 16E+06 INFANT

9. 14E+06 1.33E+07 3.90E+06 2.42E+09 1.56E+07 O.OOE+00 2.25E+06 N/A N/A N/A N/A

"""TBLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 1.20E-Ol 2.09E-01 6.38E-02 3.08E+01 1.01E-Ol 1.71E-Ol 5.21E-OZ 2.38E+01 1.87E-Ol'.31E-Ol 8.75E-02 4.30E+01 O.OOE+00,0.00E+00 O.OOE+00 O.OOE+00 6.88E+05 1.20E+06 3.65E+05 1.76E+08 6.39E+05 1.08E+06 3.31E+05 1.51E+08

1. 17E+06 1.44E+06 5.45E+05,2.68E+08 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 3.65E-Ol O.OOE+00 1.88E-Ol 3.00E-01 O.OOE+00 1.29E-01 3.86E-Ol O.OOE+00 9.32E-O2 O.OOE+00 O.OOE+00 O.OOE+00 2.09E+06 O.OOE+00 1.08E+06 1.90E+06 O.OOE+OO 8.20E+05 2.40E+06 O.OOE+00 5.81E+05 O.OOE+00 O.OOE+00 O.OOE+00 N/A N/A N/A N/A N/A N/A N/A N/A TOTAL'DULT INGEST TEEN CHILD INFANT 3.75E+06 6.53E+06 1.99E+06 9.59E+08 1.14E+07 O.OOE+00 5.87E+06 6.24E+06 1.06E+07 3.23E+06 1.48E+09 1.86E+07 O.OOE+00 8.01E+06 1.48E+Q7 1.83E+07 6.91E+06,3.39E+09 3.04E+07 O.OOE+00 7.36E+06 2.55E+07 4.18E+07 1.22E+07 7.61E+09 4.92E+07 O.OOE+00 7.08E+06 N/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT 8.64E+03 1.48E+04 4.5ZE+03 2. 15E+06 2.58E+04 O.OOE+00 8.88E+03 1.22E+04 Z.QSE+04 6.22E+03 2.92E+06 3.59E+04 O.OOE+00 1.03E+04 1.66E+04 2.03E+04 7-;70E+03 3.85E+06 3.38E+04 O.OOE+00 5.48E+03 1.32E+04 1.9ZE+04 5.6OE+03 3.56E+06, 2.24E+04 O.OOE+00 2. 16E+03 N/A N/A N/A N/A BONE LIVER

.BODY HYRO ID

'KIDNEY LUNG G.I.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-mZ/yr/uCi/sec GROUND GROUND:

T.B./ORG.

SKIN O.OOE+00 O.OOE+00

- >>MAXIMUMVALUES FOR PA HWAYS>>>>>>

GOAT COW TOTAL MILK:

MILK:

MEAT:

VEGTB LE:

INGEST:

INHAL.

5,19E+09 2.42E+09 4.30E+01 2.68E+08 7.61E+09 3.85E+06 PAGE:

4-28

O.D.C.N.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

fOPE:

1-134 rATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN

'ROUND GOAT MILK COM HILK GTBLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT a.aaE+OO O.aOE+Oa O.OOE+Oa a.OOE+00 O.aaE+aa Q.OQE+aa O.aaE+00 O.QQE+GO O.QOE+00 O.QOE+00 0.00E+00 0.00E+00 O.OOE+00 Q.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.0'OE+00 Q.QOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+OD 0.00E+00 O.OQE+OO O.OOE+OO O.QOE+00 1.09E-12 2.96E-12 1.06E-12 5.13E-ll 4.71E-12 O.OOE+00 2.58E-15 1.94E-12 5.13E-12 1.84E-I2 8.55E-11 8.09E-12 0.00E+00 6.76E-14 4.58E-12 8.51E-12 3.92E-12 1.96E-10 1.30E-11 O.OQE+00 5.64E-12 7.92E-12 1.95E-ll 6.92E-12. 4.54E-10 2.18E-11 Q.OOE+00 2.01E-ll 5.08E-13 1.38f-'12 4.94E-13 2.39E-ll 2.20E-12 O.OOE+00 1.20E-15 9.03E-13 2.39E-12 8.60E-13 3.99E-ll 3.77E-12 O.OOE+00 3.15E-14 2.14E-12 3.97E-12 1.83E-12 9.13E-11 6.07E-12 Q.QOE+00 2.63E-12 4.43E-12 9.08E-12 3.23E-12 2.12E-10 1.02E-11 0.00E+00 9.39E-12 0.00E+00 Q.OOE+00 O.OOE+OO O.OOE+Oa a.OOE+aO a.aOE+OO a.OOE+OO O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.QOE+00 O.OQE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+OO O.OOE+00 3.19E-05 8.65E-05 3.10E-05 1.50E-03 1.38E-04 0.00E+00 7.54E-OB 2.88E-OS 7.63E-OS 2.74E-OS 1.27E-03 1.20E-04 Q.OOE+00 1.01E-06 5.12E-OS 9.50E-05 4.37E-OS 2.19E-03 1.45E-04 O.QOE+00 6.30E-OS 0.00E+00 0.00E+00 0.00E+QO 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.QOE+00 O.OOE+00 N/A N/A N/A N/A N/A N/A N/A H/A N/A N/A

'/A N/A N/A N/A N/A N/A TOTAL ADULT INGEST.

TEEN CHILD INFANT 3.19E-OS 8.65E-05 2.88E-05 7.63E-OS

5. 12E-05 9.50E-05 1 24E-11 2.85E-11 3.10E-05 2.74E-OS 4.37E-05 1.02E-11 1.50E-03 1.38E-04 0.00E+00 7.54E-08

1. 27E-03 1. 20E-04 O.OOE+00 1. 01E-06 2.19E-03 1.45E-04 0.00E+00 "6 30E-05 6.66E-10 3.19f-ll O.OOE+00 2.95E-ll N/A N/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT 6.44E+02 1.73E+03 6.15E+02 2.98E+04 2.75E+03 O.QQE+00 1.01E+00 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 0.00E+00 2.04E+01 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3.30E+03 O.OOE+00 9.55E+02 9.21E+02 1.88E+03 6.65E+02 4.4SE+04 2.09E+03 O.QOE+00 1.29E+03 N/A N/A N/A N/A BONE LIVER T.BOOY HYROIO KIDNEY LUNG G. I.

SKIN "Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

~""NXINUMVALUES FOR PATHWAYS*>>"

GROUND:

GOAT COM T.B./QRG.

SKIN HILK:

MILK:

MEAT:

VEGTBLE:

0.00E+00 0..0OE+00 4.54E-10 2.12E-10 0.00E+00 2.19E-03 TOTAL INGEST:

INHAL.

2. 19E-03 5.07E+04 PAGE:

4-Z9 OAT

O.D.C.M.

MAXIMUM PATHMAY DOSE FACTORS:

l AOIONVCLIOES OTHER THAN NOBLE GASES*

ir

~

DTOPE: Cs-134

" PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.

SKIN GROUND ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E&9 6.79E+09 6.79E+09 6.79E+09 6.?9E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79&09 6.79E+09 6.?9E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 1.06E+10 2.53E+Io 2.D?E+10 Q.ODE+00 8.19E+09 2.?ZE+09 1.85E+lo 4.35E+10 2.02E+10 0-DOE+00 1.3&E+10 5.2?E+Q9 4.26E+10 6.99E+10 1.47E+lo 0.DOE+00 2.1?E+lo 7-77E+09 2.29E+10 1.28E+ll 1.29E+10 D.DOE+00 3.30E+lo 1.35E+10 6-79E+09 7.92E+09 6.79E+09 7.92E+09 6.79E+09 7.92E+09 6.79E+09 7.92E+09 4.43E+08 N/A 5.41E+QB N/A 3.77E+08 N/A 3.48E+08 NfA COM MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 2.79E+09 6.63E+09 5.42E+09 Q.DOE+00 2.15E+09.7.12E+08 1.16E+08 4.84E+09

1. 14E+)0 5.28E+09 Q.DOE+00'.62E+09 1.38E+09 1.42E+08 1.12E+10 1.83E+10 3.86E+09 Q.DOE&0 5.68E+09 2.04E+09 9.87E+07 1.80E+10 3.35E+10 3.39E+09 D.DDE+DD &-63E+D9 3-54E+09 9.11E+07 3.59E+08 8.54E+08 6.98E+08 Q.DOE+00 2.76E+08 9.1?E+07 1.49E+07 2.85E+08 6.71E+08 3.)ZE+08 Q.DOE+00 2.13E+48 &.ISE+07 8.35E+06 5.03E+OS 8.26E+08 1.74E+08 D.ODE+00 2.56E+08 9.1&E+07 4.45E+06 O.QOE+Oa a.OOE+OO O.OOE+OO O.OOE+OO O.DOE+DO O.OOE+OO O.OOE+OO N/A N/A AN/A N/A N/A N/A N/A N/A VEGTBLE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST.

TEEN CHILD

'NFANT 4.21E+09 1.00E+)0 8.19E+09 D.QDE+Qo 3.24E+09 1.0&E+09 1.75E+08 6.70E+09 1.5BE+10 7.3)E+09 0.DOE+00 5.01E+09 1.91E+09 1.96E+08 1.53E+10 2.52E+10 5.31E+09 O.DOE+00 7.&DE+09'2.80B09 1.36E+08 O.QOE+OO O.OOE+OO O.OOE+OO O.ODE+OO O.OOE+OO D.OOE+QO O.OOE+Oo 1.80E+10 4.28E+)0 3.50E+10 Q.DOE+00 1.39E+10 4.60E+09 7.49E+08 3.03E+10 7. l3E+10 3.31E+10 O.DOE+00 2.27E+10 8.65E+D9 8.87E+08 6.96E+10 1.14E+ll 2.41E+10 Q.OOE+QO 3.54E+)Q 1.27E+10 6 16E+08 4.09E+)0 1.62E+11 1.63E+10 O.DOE+00 4.16E+)0 1.70E+)0 4.39E+08 INHAL.

ADULT 3.73E+0~

8.48E+05 7.28E+05 D.DOE+00 2.87E+05 9.76E+04

).04E+04 TEEN 5.02E+05 1.13E+06 5.49E+QS Q.DOE+00 3.75E+05 1.46E+05 9.76E+03 CHILD 6.5)E+05

).01E+06 2.25E+05 O.DOE+00 3.30E+05 1.21E+05 3.85E+03 INFANT 3.96E+05 7.03E+05 7.45E+04 Q.DOE+00 1.90E+05 7.97E+04

).33E+03 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A BONE LIVER

.BODY HYROID ON LUNG G. l.

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

- "MAX)MUMVALUES FOR PA HMAYS~

GROUND:

GOAT COM TOTAL T.B./ORG.

SKIN MILK:

MILK:

MEAT:

VEGTBLE:

INGEST:

INHAL.

6.79E+09 7.9ZE+09 ).ZBE+ll 3.35E+lo 8.54E+08 2.52E+10 1.62E+II 1.13E+06 PAGE:

4-30

O D.C-M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIOES OTHER THAN NOBLE GASES*

1'OPE:

I-135

'rATHWAY AGE GROUP BONE LIVER T.BODY THYROID'IONEY LUNG SKIN GROUND GOAT NLK COW MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT D.DOE+DO 0.DOE+00 D.DOE+00 Q.DOE+00 O.DOE+00 O.QQE+QO 0.00E+OO D.DDE+00 O.DOE+00 D.DOE+DO D.DOE+00 D.DOE+DO Q.DOE+00 D.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 D.DOE+00 0.DOE+00 0.DOE+00 Q.DOE+00 0.00E+00 D.QQE+OO D.DOE+00 D.DOE+DO D.DOE+00 D.DOE+DO 6.93E+03 1.82E+04 6.70f+03 1.20E+06 2.91E+04 0.DOE+00 2.05E+04 1.23E+04 3.17E+04 1.18E+D4 2.04E+06 5.DIE+04 D.DOE+00 3.51E+04 2.92E+04 5.25E+04 2.@BE+04 4.65E+06 8.05E+04 D.DOE+00 4.DOE+04 5.05E+04 1.21E+05 4.40E+04 1.08E+07 1.34E+05 D.DOE+00 4.37E+04 3.24E+03 8.47f+03 3.13E+03 5.59E+05 1.36E+04 Q.DOE+00 9.57E+03 5.75E+03 1.48E+04 5.48E+03 9.52E+05 2.34E+04 0.DOE+00 1.64E+04 1.36E+04 2.45E+04 1.16E+04 2.17E+06 3.75E+04 0.DOE+00 1.87f+Q4 2.83E+04 5.63E+04 2.05E+04 5.05E+06 6.27E+04 0.DOE+00 2.04E+04 0.DOE+00 0.DOE+00 0.00f+00 Q.DOE+00 0.00f+00 0.DOE+00 0.DOE+00 0.DOE+00 0.00f+00 Q.DOE+00 D.DOE+00 Q.DOE+00 0.DOE+00 0.00f+00 Q.DOE+00 0.00f+00 0.00f+00 Q.DQE+QQ Q.DOE+00 Q.QQE+QQ" Q.DQE+00 0-QDE+QO 0.00f+00 0.DOE+00 Q.DOE+00 0.00f+00 0.DOE+00 D.DOE+00 O.DOE+DO D.DOE+DO Q.DOE+DO D.DOE+00 H/A H/A H/A H/A H/A H/A H/A H/A H/A H/A H/A N/A t

GTBLE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST.

TEEN CHILD INFANT 1.29E+04 3.37E+04 1.24E+04 2.22E+06 5.40E+04 D.DOE+DO 3.8OE+04

l. 16E+04 2.99E+04 1.11E+04 1.92E+06 4.73E+04 D.DOE+DO 3.32E+04 2.06E+04 3.7ZE+04 1.76E+Q4 3.29E+06 5.70E+04 Q.DOE+00 2.83E+04 O.DOE+00 0.00E+00 0.00E+00 Q.DOE+00 D.DOE+00 Q.DOE+00 D.DOE+00 2-30E+04 6.03E+04 2.23E+04 3.98E+06 9.67E+04 0.DOE+00 6.81E+04 2.97E+04 7.64E+04 2.83E+04 4.92E+06 1.21E+05 O.DOE+00 8.47E+04 6.34E+04 1.14E+Q5 5.40f+04 1.01E+07 1.75E+05 Q.DOE+00

-8'70fw04 7.88E+04 1.77E+05 6.45E+04 1.59E+07 1.97E+05 0.DOE+00 6.'40E+0'4 H/A H/A H/A H/A H/A H/A H/A INHAL.

ADULT TEEN CHILD INFANT 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.1IE+04 0.DOE+00 5.25E+03 3.70E+03 9.44E+03 3.49E+03 6.21E+05 1.49E+04 D.DOE+00 6.95E+03 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 Q.DOE+00 4.44E+03 3-86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 0.DOE+00 1.83E+03 H/A H/A H/A N/A BONE LIVER

.BQOY HYROIO KIDNEY LU G

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

"* MAXIMUM VALUES OR PA HWAYS~

GROUND:

GOAT COW T.B./ORG.

SKIN MILK:

MILK:

MEAT:

VEGTBLE:

Q.DOE+00 0.00E+QO 1.08E+07 5.05E+06 Q.DOE+00 3.29E+06 TOTAL INGEST:

IHHAL.

1.59E+07 7.92E+05 PAGE:

4-31

O.D.C.N.

NAXINUN PATHWAY DOSE FACTORS:

RAOIONUCLIOES OTHER THAN NOBLE GASES*

".,JTOPE:

Cs-136 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG

.'G.I.

SKIN GROUND GOAT MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 1.49E+08 1.49E+08 1.'49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1 49E+08 3.57E+08 1.41E+09 1.01E+D9 D.DOE+00 7-84E+08 6.07E+08 2.39E+09 1.61E+09 D.DOE+00 1.30E+09 1.37E+09 3.77E+09 2.44E+Q9 O.DOE+DO 2.Q1E+09 8.93E+08 7.88E+09 2.94E+09 0.DOE+00 3.14E+09 1.49E4$

1-49F+08 1.69E+08 1.49E+08 1.49E+08 1.69E+QS 1.49E+08 1.49E+08 1.69E+DB I;49E+08 1.49E+08 1.69E+08 1.07E+08 1.6OE+08 H/A 2.05E+08 1.9ZE+08 N/A 2.99E+QB 1.3ZE+08 H/A 6.42E+08 1.20E+08 H/A NILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD IHFANT

6. 69E+07 1.14E+08 2.57E+08 5.02E+08 4.DOE+06

3. 12E+06 5.38E+06 0.DOE+00 2.64E+08 1.90E+08 O.DOE+00 1.47E+08 4.48E+08 3.01E+08 Q.DOE+DO 2.44E+08 7.0?E+08 4.58E+08 Q.DOE+00 3.77E+08 1.48E+09 5.52E+08 0.00E+OO 5.&9F+08 1.58E+07 1.14E+07 D.DOE+00 8.7SE+06 1.23E+07 8.24E+06 D.DOE+00 6.68E+06 1.48E+D7 9.57E+06 O.DOE+00 7.87E+06 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 2.02E+07 3.DOE+07 3.85E+07 3.61E+07 5.62E+07 2.4BE+07 1.20E+QS 2.24E+0?

1.20E+06 1.79E+06 1.05E+06 9.87E+05 1.17E+06 5.20E+05 D.DOE+DO O.DOE+00 H/A N/A N/A H/A H/A H/A H/A H/A VEGTBLE ADULT TEEN CHILD INFANT 2.03E+07 8.0)E+07 5.76E+07 D.DOE+DO 4.46E+07 2.43E+07 9.58E+07 6.43E+07 0.DOE+00 5.21E+07 4.96E+07 1.36E+08 B.BZE+07 O.DOE+DO 7.26E+07 0.00E+00 0.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 6.11E+Q6 9. IOE+06 S.ZZE+06 7.7IE+06 1.08E+07 4.79E+06 0.DOE+00 0.00E+00 H/A N/A N/A H/A TOTAL ADULT INGEST.

TEEN

. CHIL9 INFANT 4.4&E+OB l.??E+09 1.27E+09 Q.DOE+DO 9.84E+08

?.49E+08 2.95E+09 1.9BE+09 O.DOE+00 1.60E+Q9 1.68E+09 4.63E+09 2.99E+09 0.DOE+00 2.46E+09 1.40E+09 9.35E+09 3.49E+09 O.DOE+00 3.73E+09 1.35E+08 Z.DIE+08 2.53E+0& Z.3?E+08 3.67E+08 1-:63E+08 7.62E+08 1.42E+08 H/A H/A

'8/A N/A INHAL.

ADULT TEEN CHILD INFANT 3.90E+04 1.46E+05 1.10E+05 D.DOE+00 8.56E+04 5.15E+04 1.94E+05 1.3?E+05 D.DOE+00 1.10E+05 6.51E+04 1.71E+05 1.16E+Q5 O.OOE+Oa 9.55E+04 4.83E+04 1.35E+05 5.29E+04 O.DOE+00 5.64E+04 1.20E+04 1.17E+04 1.7SE+04 1.09E+04 1.45E+04 4.1BE+03 1.1SE+04 1.43f+03 N/A H/A H/A H/A BONE LIVER

'.BODY HYROIO KION LUNG G.l.

SKIN Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

~~*MAXIMUMVALUES FOR PA HWAYS~~*

GOAT COW TOTAL T.B./ORG.

SKIN 1.49E+08 1.69f+08 MILK:

?.BBE+09 MILK

l. 4BE+09 NEAT:.

VEGTBLE:

INGEST:

INHAL.

1.5BE+0?

1.36E+QS 9.35E+09 1.94E+05 V.

DAT PAGE:

4-32

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RAOIONUCLIOES OTHER THAN NOBLE GASES*

t 3PE:

Cs-137 PAfHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G:I.

SKIN GROUND ADULT TEEN CHILD INFANT 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10.1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10

1. 19E+10 1.02E+10 1.19E+10 1,02E+10

1. 19E+10 1.02E+10

1. 19E+10 GOAT NLK COW.

MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 1.42E+10 1.94E+10 1.27E+10 O.OOE+00 6.59E+09 2.19E+09 2.58E+10 3.43E+10'1.19E+10 0.00E+00 1.17E+10 4.53E+09 6.20E+10 5.94E+10 8.77E+09 O.OOE+00 1.94E+10 6.96E+09 3.30E+10 1.16E+ll 8.22E+09 0-OOE+00 3.11E+10 1.26E+10 3.78E+09 5.17E+09 3.39E+09 O.OOE+00 1.76E+09 5.84E+08 6.86E+09 9.12E+09 3.1&E+09 O.OOE+00 3.10E+09 1.21E+09 1.65E+10 1.58E+10 2.33E+09 O.OOE+00 5.15E+09 1.85E+09 2.64E+10 3.09E+10 2.19E+09 O.OOE+00'8.2&E+09 3.35E+09 3.76E+08 4.&BE+08 3.72E+08 3.62E+08 1.00E+08 1.30E+08 9.90E+07 9.65E+07 N/A

'/A N/A N/A N/A N/A N/A N/A ADULT TEEN CHILD INFANT aTBLE AOULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 4.91E+08 6.71E+08 4,40E+08 0.00E+00 2.2&E+08 7.58E+07 4.08E+08 5.42E+08 1.89E+08 0.00E+00 1.85E+08 7.17E+07 7.51E+08 7.19E+08 1.06E+08 O.OOE+00 2.'34E+08 &.42E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 5.76E+09 7.88E+09 5.16E+09 O.OOE+00 2.68E+09 8.89E+08 9.5&E+09 1.27E+10 4.44E+09 O.OOE+00 4-34E+09 1.69E+09 2.29E+10 2.19E+10 3.24E+09 0.00E+00 7.15E+09 2.57E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2.42E+lO 3.3ZE+10 2.17E+10 O.OOE+00 1.13E+10 3.74E+09 4.26E+10 5.67E+10 1.97E+10 O.OOE+00 1.93E+10 7.49E+09 1 02E+ll 9.79E+10 1.44E+10 O.OOE+00 3.19E+10 1.15E+10 5.94E+10 1.47E+ll 1.04E+10 O.OOE+00 3.94E+10 l.60E+10 1.30E+07 7.72E+06 4'.50E+06, O.OOE+00 1.53E+08 1.81E+08 1.37E+08 O.OOE+00 6.42E+08 8.06E+08 6':13E408 4.59E+08 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 1NHAL.

ADULT TEEN CHILD INFANT 4.7&E+05 6.21E+05 4.2&E+05 0.00E+00 2.22E+05 7.52E+04 6.70E+05

&.4&E+05 3.11E+05 O.OOE+00 3.04E+05 1.21E+05 9.07E+05

&.25E+05 1.28E+05 0.00E+00 2.&ZE+05 1.04E+05 5.49E+05 6.12E+05 4.55E+04 O.OOE+00 1.72E+05 7.13E+04 8.40E+03 8.4&E+03 3.62E+03 1.33E+03 N/A N/A H/A H/A BONE LIVER T.BODY HYROID KIDNEY LUNG G.I.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN 1. 02E+10 1. 19E+10

""*HAXINUHVALU S FOR PATHWAYS*~*

GOAT COW MILK:

MILK:

MEAT VEGTBLE:

I. IGE+ll 3.09E+IQ 7.51E+08 2.29E+lO TOTAL INGEST:

INHAL.

1.47E+ll 9.07E+05 jest 4' QAt PAGE:

4-33

Q.D.C.N.

HAXIHUH PATHMAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

QTOPE:

Ba-140 c'ATHWAY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUNG G.I.

SKIN GROUND GOAT MILK ADULT TEEN CHILD INFANT 1.46E+06 1.&3E+03 2.63E+06 3.22E+03 6.35E+06 5.$ 6E+03 l.09E+08 1.31E+04 ADULT 2.03E+07 2.03E+07

.TEEN 2.03E+07 2.03E+07

CHILD,

2. 03E+07 2.03E+07 INFANT 2.03E+07 2.03E+OT 2.03E+07.2.03E+07 2.03E+QT Z.Q3E+07 2.03E+07 2.32E+OZ 2.03E+07 2-03E+07 2.03E+07 2.03E+OZ 2.03E+07 2.32E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.32E+07 2.03E+OT 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.32E&7 9.54E+04 O.OOE+OO 6.22E+02 1.05E+03 3.00E+06 N/A 1.69E+05 O.OOOO 1.09E+03 2'17E&3 4.05E+Q6 N/A 3.TOE+05 O.OOE+OO 1.81E+03 3.31E+03 3.22E+06 N/A 6.73E+05 Q.OOE+00 3.10E+03 8.02f+03 3.21E+06 NJA COM BILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT VEGTBLE ADULT TEEN CHILD INFANT

'OTAL ADULT INGEST.

TEEN CHILD INFANT 6.83E+06 8.S&E+03 4.47E+05 0.00E+00 2.92E+03 4.91E+03 1.41E+07 1.23E+07 1.51E+04 7.94E+QS Q.OOE+00 5.IZE+03 1.02E+04 1.90E+07 2.97E+07 2.61E+04 1.74E+06 Q.QOE+00 8.48E&3 1.55E+04 1.51E+07 6.12E+07 6.12E+04 3.15E+06 0.00E+00 1.45E+04 3.76E+04 1.5OE+07 9.52F+06 1.20E+04 6.24E+05 0.00E+00 4.07E+03 6.85E+Q3 1.96E+07 7.&7E+Q6 9.65E+03 5.0TE+OS O.OOE+00 3.27E+03 6.49E+03 1.21E+07 1.45E+07 1.27E+04 4.4&E+05 O.QOE+Oo 4.14E+03 7.59E+03 T.36E+06 O.OOE+OO O.OOE+OO O.OOE+OO O.OOF+OO O.OOE+OO O'.OOE+OO 0.00E+00 5.9&E+07 7.5)E+Q4 3.92E+06 O.OOE+00 2.55E+04 4.30E+04 1.23E+08 T.SOE+07 9.19E+04 4.83E+06 0.00E+00 3.12E+04 6.18E+04 1.16E+08 1.62E+08 1.42E+05 9.4&E+06 O.QOE+00 4.63E+04 8.48E+04 8.23E+07 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+OO 7.76E+07 9.75E+04 5.08E+06 O.OOE+00 3.31E+04 5.5&E+04 1.60E+08 9.7&E+07 1.20E+05 6.31E+06 0.00E+00 4.QTE+04 8.06E+04 1.51E+08 2.13E+08 1.87E+05 1.24E+07 O.OOE+00 6.08E+04 l.llE+05 J,%BE+08 1.70E+08 7.43E+04 3.83E+06 0.00E+00 1.76E+04 4.56E+Q4 1.&2E+07 N/A H/A N/A N/A H/A H/A N/A N/A H/A H/A H/A N/A N/A H/A ll/A INHAL.

ADULT TEEN CHILD INFANT 3.90E+04 4.90E+01 2.57E+03 0.00E+00 1.67E+Ql 1.27F+06 2.1&E+05 5-47E+04 6.94E+Ql 3.52E+03 0.00E+00 2.2&E+OI 2.03E+06 2.29E+05 7.4OE+04 6.48E+01 4.33E+02 0 OOE+00 2.11E+Ol 1.74E+06 1.QZE+QS 5.60E+04 5.60E+Ol 2.90E+03 0.00E+00 1.34E+Ol 1.60E+06 3.84E+04 N/A N/A H/A N/A BONE LIVER T.BODY HY ROID KION LUNG G. I.

S I "Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN 2.03E+07 2.32E+07

"""HAXIHUHVALUES FOR PATHMAYS~

GOAT COM TOTAL HILK:

HILK:

HEAT:

VEGTBLE:

INGEST:

INHAL.

1.09E+08 6.12E+07 1.96E+07 1.62E+08 2.13E+08 2.03E+06 PAGE:

4-34

Q.D.C.M.

MAXIMUM PATHMAY DOSE FACTORS:

RADIQNUCLIDES OTHER THAN NQBLE GASES*

'I

.TOPE:

La-140 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID 'IDNEY LUNG G. I.

SKIN GROUND GOAT MILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT O.QQE+00 Q.OQE+00 0.00E+00 Q.QQE+00

.Q.QQE+00 Q.OOE+00 Q.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+00 Q.OQE+00 0.00E+00 Q.QOE+00 0.00E+00 0.00E+00 Q.QQE+00 0.00E+00 O.OQE+00 O.OQE+00 Q.QOE+00 Q.OQE+00 Q.OOE+00 Q.QQE+00 2.44E-O1 1.23E-Ol 3.25E-O2 Q.QQE+OO O.OOE+OO O.OOE+OO 4.38E-Ol 2.15E-01 5..72E-02 Q.QOE+Qo Q.OOE+00 0-OOE+00 1.05E+00 3.66E-01 1.23E-01 0.00E+QO O.OOE+00 Q.OOE+Oo 1.82E+01 8.63E-Ol 2.22E-01 O.QOE+00 O.QOE+00 0.00E+00 0.00E+Qo 0.00F+00 0.00E+00 O.OOE+00 O.OQE+00 Q.OQE+00 O.OOE+OO O.QQE+aa 9.02E+03 H/A 1.24E+04 H/A 1.02E+04 N/A 1.01E+04 N/A COM MILK MEAT

.GTBLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 1.14E+OQ 5.73E-Ol 1.51E-01 Q.OQE+00 2.04E+00 1.00E+00 2.67E-Ol Q.QOE+00 4.89E+00 1.7IE+00 5.76E-ol 0.00E+00 1.02E+01 4.03E+00 1.04E+00 Q.OOE+aa 1.22E-02 6.16E-03 1.63E-03 0.00E+00 1.01E-02 4.94E-03 1.32E-03 Q.OQE+QD 1.84E-02 6.44E-03 2.17E-03 Q.QOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Q.QOE+00 O.QOE+00 Q.QQE+00 O.OOE+00 1

Q.QOE+00 O.QQE+DO O.OOE+Oo O.OQE+00 Q.QQE+00 Q.QOE+00 Q.OOE+00 O.QQE+00 0.00E+00 O.QOE+Oo 0.00E+00 0.00E+00 6.53E+02 3.29E+Q2 8.69E+01 O.aOE+aa a.aOE+OO O.aOE+aO 5.96E+02 2.93E+02 7.79E+Ol 0.00E+00 Q.OOE+00 0.00E+00 1.07E+03 3.74E+02 1.26E+02 O.QOE+00 Q.QOE+00 0.00E+QO O.OOE+00 O.OOE+00 0.00E+00 O.OQE+00 O.OQE+00 O.QQE+00 4.21E+04 5.76E+04 4.76E+04 4.73E+04 4.53E+02 2.84E+02 1.79E+02 O.OOE+00 2.4IE+07 1.68E+07 1.04E+07 O.OOE+00 N/A N/A H/A A/A H/A H/A

'N/A H/A H/A N/A N/A H/A TOTAL ADULT INGEST.

TEEN CHILD INFANT 6.54E+02 3.30E+02 8.71E+01 0.00E+00 5.99E+02 2.94E+02 7.83E+01 Q.OQE+00 1.08E+03 3.76E+02 1.27E+02 O.OOE+00 2.85E+01 4.89E+00 1.26E+00 0.00E+00 INHAL.

ADULT 3.44E+02 1.74E+02 4.58E+01 Q.QQE+00 TEEN 4.79E+02 2.36E+02 6.26E+Ol O.OOE+00 CHILD 6.44E+02 2.25E+02 7.55E+01 O.OOE+00 INFANT S.QSE+O2 2.OOE+e2 5.15E+Ol Q.OOE+OO Q.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 a.ooE+oo Q.QOE+00 O.OOE+00 0.00E+00 Q.oof+00 O.OQE+00 O.QOE+00 0.00E+00 1.36E+05 2.14E+05 1.83E+05 1.68E+05 2.42E+07 1.69E+07 1;OS&07 5:74E+04 4.58E+05 4.87E+05 2.26E+05 8.48E+04 H/A N/A H/A N/A H/A H/A N/A N/A BONE LIVER

.BODY THYROID KIDNEY LUNG G.l.

SKIN Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN O.OOE+00 O.OOE+00

"~MAXIMUMVALUES FOR PATHWAYS"~

GOAT COW TOTAL MILK:

MILK:

MEAT:

VEGTB LE:

INGEST:

INHAL.

1.24E+04 5.76E+04 4.53E+02 2.41E+07 2.42E+07 4.87BOS r

OAT PAGE:

4-35

O.D.C.M.

HAXIMUM PATHWAY 00SE FACTORS:

RAOIOHUCLIOES OTHER THAN NOBLE GASES*

?.'OPE:

Ce-141 o~fHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G..I. 'KIN GROUND ADULT TEEN CHILD INFANT 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1-35E+07 1.52E+07 1.USE+07 1.35E+D7 1.35E+D7 1.35E+D7 1.35E+07 1.35E+07 1.52E+07 1.35E+07 1'.35E+07 1.35E+D7 1.35E+07 1.3SE+07 1.35E+07 1.S2E+D7 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.52E+07 ADULT TEEN CHILD INFANT COM ADULT HILK TEEN CHILD INFANT 2.78E+02 5.10E+02 1.26E+03 2.07E+04 l.41E+03 2.58E+03 6.35E+03 1.26E+04 1.88E+02 2.13E+01 O.DOE+00 8.73E+Dl O.DOE+00 7.'9E+05 3.40E+02 3.91E+01 0;00E+00 1.60E+02 0.DOE+00 9.74E+05 6.26E+02 9.30E+01 0.00E+00 2.75E+02 0.DOE+00 7.81E+05 1.52E+03 1.79E+02 0.00E+00 4.68E+02 O.DOE+00 7.84E+05 9.51E+02 1.08E+02 0.00E+00 4.42E+02 0.DOE+00 3.64E+06 1.72E+03 1.98E+02 0.00E+00 8.11E+02 O.DOE+00 4.93E+06 3.17E+03 4.70E+02 0.00E+00 1.39E+03 O.DOE+00 3.95E+06 7.68E+03 9.04E+02 O.OOE+00.2.37E+03 0.DOE+00 3.97E+06 N/A N/A N/A N/A N/A N/A NIA N/A ADULT TEEN CHILD INFANT VEGTBLE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST.

TEEN CHILD INFANT 5.11E+03 4.29E+03 8.08E+03 O.OOE+00 3.46E+03 3.92E+02 0.00E+00 1.61E+03 O.DOE+00 1-32E+07 2.87E+03 3.29E+02 0.00E+00 1.35E+03 O.DOE+00 8.20E+06 4.03E+03 5.99E+02 0.00E+00 1.77E+03 0.DOE+00 5.03E+06 D.OOE+00 0.00E+00 0.00E+00 O.DOE+00 O.DOE+00 O.DOE+00 1.49E+05 1.01E+05 1.14E+04 0.00E+00 4.69E+04 O.DOE+00 3.86E+08 2.38E+QS 1.59E+05 1.83Et04 O.DOE+00 7.49E+04 0.DOE+00 4.55E+08 5.73E+05 2.86E+05 4.25E+04 0.00E+00 1.25E+05 O.DOE+00 3.57E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.DOE+00 0.00E+00 O.DOE+00 1.56E+Q5 1.06E+05 1.20E+04 O.OOE+00 4.90E+04 0.00E+00 4.03E+08 2.46E+05 1.64E+05 1.88E+04 0.,DOE+00 7.72E+04 0.00E+00 4.69E+08 5.89E+05 2.94E+05 4.36E+04 0.00E+00 1.29E+05 0.00E+00 3:67E408 3.33E+04 9.20E+03 1.08E+03 0.00E+00 2.84E+03 O.DOE+00 4.75E+06 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A IHHAL.

ADULT TEEN CHILD

., INFANT 1.99f+04 1.35E+04 1.53E+03 O.OOE+00 6.26E+03 3.62E+05 l.20E+05 2.84E+04 1.90E+04 2.17E+03 0.00E+00 8.88E+03 6.14E+05 1.26E+05 3.92E+04 1.95E+04 2.90E+03 0.00E+00 8.55E+03 5.44E+05 5.66E+04 2.77E+04 1.67E+04 1.99E+03 0.00E+00 5.25E+03 5.17E+05 2.16E+04 N/A N/A N/A N/A BONE LIVER T.BODY HY ID KIDNEY LUNG G.I.

SKIN

~Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

T.B./ORG.

GROUND:

SKIN

"""MAXIMUMVALUES GOAT COM MILK:

MILK:

FOR PA HAYS~~~

MEAT:

VEGTBLE:

TOTAL INGEST:

IHHAL.

1.35E+07 1.52E+07 9.74E+05 4.93E+06 1.32E+07 4.55E+08 4.69E+OB 6.14E+05 A

0AT PAGE:

4-36

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIOHUCLIDES OTHER THAN NOBLE GASES*

APE: Pr-143 w~fHMAY AGE GROUP BONE LIVER T.BODY THYROID.KIDNEY LUNG G..I.

SKIN' GROUND GOAT MILK ADULT TEEN CHILD INFANT 0.00E+00 0.00E+00 O.oof+00 G.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0-OOE+00 O.OOE+00 O.OOE+OO O.OOE+OO O.OOE+00 0.00E+00 O.OOE+00 O.DOE+00 O.OOE+00 ADULT 8.57E+00 3.44E+00 4.25E-01 O.OOE+00 TEEN 1.57f+Ol 6.28E+00 7.83E<<01 0.00E+00 CHILD 3.89E+01 1.17E+Ol 1.93E+00 0.00E+00 INFANT 6.71E+02 3.01E+01 3.99E+00 O.OOE+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.oof+00 0.DOE+00 O.OOE+00 O.OQE+00 O.OOE+00 O.oof+00 Q.OQE+00 O.OOE+00 0.DOE+00 O.OOE+00 0.00E+00 1.98E+00 O.OOE+00 3.75E+04 N/A 3.65E+00 O.DOE+00 5.18E+04 N/A 6.33F+00 O.OOE+00 4.20E+04 N/A 1 12E+01 0 OOE+00 4s25E+04 N/A CON HILK ADULT TEEN CHILD INFANT 4.02E+Ol 1.6IE+01 1.99E+00 0.00E+00 7.39E+Ol 2.95E+Ol 3.68E+00 O.OOE+00 1.83E+02 5.49E+01 9.07E+00 O.oof+00 3.78E+02 1.41E+02 1.87E+Ol O.OOE+00 9.31E+00 O.OOE+00 1.76E+05 1.7IE+01'O.OOE+00 2.43E+05 2.97E+01.0.00E+00 1.97E+05

~

5.26E+Ol O.OOE+00 2.00E+05 N/A N/A

, N/A H/A NEAT ADULT TEEN CHILD INFANT 6.96E+03 2.79E+03 3.45E+02 O.OOE+00 1.6lf+03 5.86E+03 2.34E+03 2.92E+02 O.OOE+00 1.36E+03 1.11E+04 3.33E+03 5.50E+02 O.OOE+00 1.80E+03 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O. OOE+00, 3. 05E+07 O.OOF+00 1.93E+07 O.OOE+00 1.20E+07 O.OOE+00 O.OOE+00 H/A N/A N/A N/A GTBLE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST.

TEEN CHIU)

INFANT 3.04E+04 1.22E+04 1.51E+03 0.00E+00 7.04E+03 4.00E+04 1.60E+04 1.99E+03 O.OOE+00 9.27E+03 8.98E+04 2.69E+04 4.45E+03 O.OOE+00 1.46E+04 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 3.74E+04 1.50F+04 1.86E+03 O.OOE+00 8.67E+03 4.59E+04 1.83E+04 2.28E+03 O.OOE+00 1.07E+04 1 01E+05 3.03E+04 5.01E+03 0.00E+00 1.64E+04 1.05f+03 1.72E+02 2.27E+01 0.00E+00 6.38f+Ol 0.00E+00 1.33E+08 O.OOE+00 1.31E+08 0.00E+00 9.68E+07 O.OOE+00 O.OOE+00 0.00E+00 1.64E+08 O. OOE+00 '1. 51E+08 O.OOE+00 1';09E+08 O.OOE+00 2:42E+05 N/A N/A N/A N/A N/A N/A N/A N/A XNHAL.

ADULT TEEN CHILD INFANT 9.36E+03 3.75E+03 4.64E+02 O.OOE+00 2.16E+03 1.34E+04 5.31E+03 6.62E+02 O.OOE+00 3-09E+03 1.85E+04 5.55E+03 9.14E+02 O.OOE+00 3.00E+03 1.40E+04 5.24f+O3 6.99E+02 O.OOE+00 1.97E+03 2.81E+05 2.00E+05 4.83E+05 2.14E+05 4.33E+05 9.73E+04 4.33E+05 3.72E+04 N/A N/A N/A H/A LIVER

.BODY YOD KIDNEY LUNG G.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN 0.00f+00 G.OOE+00

"**MAXIMUMVALUES FOR PATHWAYS~*"

GOAT COW MILK:

MILK:

HEAT:

VEGTBLE:

5.18E+04 2.43E+05 3.05E+07 1.33E+08 TOTAL INGEST:

IHHAL.

1.64E+08 4.83E+05 PAGE:

4-37

~ OAT

O.D.C.H.

HAXIHUM PATHWAY DOSE FACTORS:

RADIQNUCLIDES OTHER THAN NOBLE GASES*

'3TOPE:

Ce-144 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G-I-SKIN GROUND GOAT HILK ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 6.88E+07 6.88E+07 6.8BE+07 6.88E+07 6.88E+07 6.8BE+07 6.88E+07.6.88E+07 6.88E+07 6.88E+07 6.88E+07 6.8BE+07 6.88E+07 6.88E+07 6.88E+07 6.88E+0?

2.60E+04 1.09E+04 1.39E+03 0.00E+00 4.78E+04 1.98E+04 2.57E+03 O.QQE+00 1.18E+05 3.69E+04 6.2BE+Q3 O.QQE+00 1.41E+06 6.91E+04 9.46E+03 0.00E+00 6.88E+07 6.88E+07 6.88E+07 6.88E+0?

6.88E+07 6.88E+07 6.88E+07 6.8&E+07 6.44E+03 0.00E+00 1.18E+04 O.OOE+00 2.04E+04 0.00E+00 2.79E+04 0.00E+00 8.?BE+06 1.20E+0?

9.63E+06 9.68E+06 N/A N/A N/A N/A 6.88E+07 7.96E+07 6.88E+07 7.96E+07 6.88E+0?

7.96E+07 6.88f+07 7.96E+07 COW MILK ADULT TEEN CHILD INFANT 1.65E+05 6.91E+04 B.BBE+03 0.0QE+00 4.10E+04 O.OOE+00 3.04E+05 1.26E+Q5 1.63E+Q4 O.QQE+00 7.52E+04 0.00E+00

?.5QE+05 2.35E+05 4.00E+04 O.OQE&0 1.30E+05 O.OOE+00 1.07E+06 4.40E+QS 6.02E+04 O.QQE+00 1.78E+05 0 OQE+00 5.59E+07 7.65E+07 6.13E+07 6.17F+07 N/A N/A N/A N/A ADULT,7.55E+05 3.16E+05 4.05E+04 0.00E+00 1.8?E+Q5 O.QQE+00 TEEN 6.36E+QS 2.63E+05 3.42E+04 0.00E+00 1.57E+05 O.OQE+00 CHILD 1.20E+06 3.76E+05 6.40E+04 Q.QQE+00 2.08E+05 O.OQE+00 INFANT Q.OOE+OQ Q.QQE+QQ Q.QQE+00 O.QQE+00 O.OOE+00 O.QQE+00 2.SSE+08 1.60E+08 9.80E+07 O.OQE+OO N/A N/A N/A H/A VEGTBLE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST.

TEEN CHILD

=

'INFANT 2.94E+07 1.23E+07 1.58E+06 O.QQE+00 7.3OE+06 O.OQE+00 4.95E+07 2.05E+07 2.66E+06 O.QOE+00 1.22E+07 Q.OOE+OQ 1.21E+08 3.BQE+07 6.46E+06 0.0QE+00 2.10E+07 Q.OQE+00 0.00E+00 0.00E+OQ O.QQE+00 Q.QQE+OQ O.OQE+00 O.OQE+00 3.04E+02 1.2?E+07 1.63E+06 0.00E+00 7.53E+06 0-DOE+00 S.OSE+02 2.09E+07 2.71E+06 Q.QQE+00 1.25E+07 0.00E+00 1.23E+08 3.86E+07 6.57E+06 O.QQE+00 2.14E+07 O.QQE+00 2.48E+06 S.Q9E+05 6.97E+04 O.QOE+00 2.06E+05 O.QQE+00 9.95E+09 1.24E+10 9.90E+09 O.QQE+00 1.03E+10 1.2?E+10 IDIE+10 7.14E+07 N/A N/A N/A N/A N/A N/A H/A INHAI.

ADULT TEEN CHILD INFANT 3.43E+06 1.43E+06 l.84E+05 Q.QQE+00 8.4BE+05 7.7BE+06 4.89E+06 2.02E+06 2.62E+05 Q.QQE+00 1.21E+06 1.34E+07 6.77E+06 2.12E+Q6 3.6IE+05 Q.QOE+OO 1.17E+06 1.20E+07 3.19E+06 1.21E+06 1.26E+05 Q.OOE+00 5.38E+05 9.84E+06 8.16E+05 8.64E+05 3;89E+05 1.4BE+05 H/A N/A H/A N/A BONE LIVER

.BODY HYROID KIDNEY LUNG G. I.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposi tion pathways:

uni ts are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN 6.88E+Q?

7.96E+Q2

"*NXINUNVALUES FOR PATHWAYS~~

GOAT COW TOTAL MILK:

MILK:

HEAT:

YEGTBLE:

INGEST:

INHAL.

1.2QE+Q7 2.65E+Q2 2.55E+08 1.24E+10 1.27E+10 1.34E+07 rv DAT PAGE:

4-3&

O.D C.M-MAXIMUM PATHMAY DOSE FACTORS:

RADIOHUCLIDES OTHER THAN NOBLE GASES*

fOPE: Pr-144 PATHMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G-I-SKIN GOAT tGLK ADULT TEEN CHILD INFANT GROUND ADULT TEEN CHILD INFANT Q.OOE+00 O.DOE+00 Q.DOE+00 0.DOE+00 O.OQE+00.0.00E+QQ 0.00E+OO O.OQE+00 0.DOE+00 O.QQE+00 0.00E+OO O.OOE+00 O.OOE+00 O.DOE+00 0.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 Q.OOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.00E+00 O.DOE+00 0.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 0.DOE+00 0.00E+00 0.DOE+00 Q.DOE+00 0.DOE+00 0.00E+00 Q.DOE+00 0.DOE+00 D.DOE+00 0.00E+00 Q.DOE+00 O.DOE+00 O.DOE+00 Q.OOE+00 Q.QOE+00 0.00E+00 O.QQE+00 O.DOE+00 0.00E+00 O.DOE+00 O.DOE+00 0 ~ OQE+00 N/A O.DOE+00 N/A 0.DOE+00 N/A 0.00E+00 N/A COM MILK ADULT TEEN CHILD INFANT O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 Q.DOE+00 O.DOE+DO D.DOE+00 O.ODE+DQ O.DOE+00 O.DOE+00 0.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.OOE+QD O.ODE+OD O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+00 N/A N/A N/A N/A MULT TEEN CHILD INFANT ABLE ADULT TEEN CHILD INFANT TOTAL ADULT INGEST.

TEEN CHILD INFANT D.DQE+00 D.DOE+00 0.DOE+00 O.QOE+OQ D.OQE+OQ O.QQE+OO D.DOE+00 0.DOE+00 O.DOE+00 D.DOE+00 0.00E+00 D.DOE+00 Q.DOE+00 0.DOE+00 Q.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Q.DOE+00 O.OQE+QO O.DOE+00 O.DOE+00 O.OQE+OO O.OQE+OO O.OOE+Oo O.OQE+OQ 0;ODF+OO O.OOE+OO O.oof+00 O.DOE+00 0.00E+OQ 0.00E+00 Q.DOE+00 Q.DOE+00 0.00f+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.OOE+OO D.OQE+QQ O.DOE+DO 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.00E+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Q.DOE+00 D.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 D.DOE+00 0.DOE+00 0.DOE+00 0 DOE+00 D.ODE+00 0.DOE+00 0.DOE+00 D.DOE+00 D.DOE+00 0'ROE+00 O.DOE+00 D.DOE+00 O.DOE+DO O.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+DO N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A INHAL.

ADULT TEEH CHILD INFANT 3.01E-02 1.25E-OZ 1.53E-03 O.ODE+QD 7.05E-03 1.02E+03 4.30E-QZ 1.76E-02 2.18E-03 0.DOE+00 1.01E-02 1.75E+03 5.96E-OZ 1.85E-02 3.00E-D3 O.DOE+00 9.77E-03 1.57E+03 4.79E-02 I.&SE-02 2.41E-D3 O.COE+00 6.72E-03 1.61E+03 2.15E-OB 2.35E-04 1.97E+02 4.2&E+03 N/A N/A N/A N/A BONE LIVER T.BOOY THYROID KIDNEY LUNG G.I.

SKIN Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

"""NAXINUNVALUES fOR PATHMAYS*""

GROUND:

GOAT COM TOTAL T.B./ORG.

SKIN MILK:

MILK:

NEAT:

VEGTBLE:

INGEST:

INHAL.

D.DOE+00, O.DOE+DO O.DOE+00 O.DOE+DO D.DOE+DO D.DOE+00 D.DOE+00 4.2&E+03 PAGE:

4-39 OAT

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

"OPE: Nd-147

'..cHMAY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUNG G.. I.

SKIN GROUND GDAT HILK ADULT T)EN CHILD INFANT ADULT TEEN CHILD INFANT 5 09E+00 5 89E+00 3 52E 01 0 sOOE+00 3 44E+00 0 DOE+00 2 83E+04 9.&DE+00 1.07E+01 6.38E-01.O.DOE+00 6.26E+00 D.DOE+00 3.84E+04 2.40E+01 1.95E+01 1.51E+00 O.DDE+00 1.D7E+01 O.ODE+DD 3.09E+04 3.97E+02 4.90E+01 3.DOE+00 0.DOE+00 1.89E+Dl Q.DOE+00 3.10E+04 N/A N/A N/A N/A 8.31E+06 8.31E+06 8.31E+D6 8.31E+06 8.3IE+06 8.31E+06 8.31E+06 9.97E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.3IE+06 8.31E+06 8.31E+06 9.97E+06 8.3IF+06 &.31E+06 &.31E+06 &-31E+06 &.31E+06.&.31E+06 8.31E+06 9.97E+06 8.31E+06 8.31E+06 8.31E+06 8.3IE+06 8.3IE&6 8.31E+06 8.31E+06 9.97E+06 COM HILK ADULT TEEN CHILD

. INFANT AOULT TEEN CHILD INFANT 2.3&E+01 2.75E+01 1.65E+00 0.DOE+00 1.61E+01 0-OOE+OD 1-32E+05 4.5&E+Ol 4.98E+01 2.9&E+00 O.DOE+00 2.93E+01 O.DOE+00 1.80E+05 1.12E+02 9.11E+Ol 7.05E+00 O.DOE+00 5.DOE+01 0.DOE+00 1.44E+05 2.23E+02 2.29E+02 1.40E+Ol O.DOE+00 8.82E+01 D.OOF+00 1.45E+05 2.34E+Q3 2.70E+03 1.62E+02 O.DOE+00 1.5&E+03 O.DOE+00 1.30E+07 2.06E+03 2.24E+03 1.34E+02 0.DOE+00 1.31E+03 O.DOE+00 8.0&E+06 3.86E+03 3.13E+03 2.42E+02 0.DOE+00 1.72E+03 0.DOE+00 4.96E+06 0.00E+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 N/A N/A N/A N/A N/A N/A N/A N/A VEGTBLE ADULT TEEN CHILD INFANT 1.39E+04 1.6lE+04 9.61E+02 0.DOE+00 9.39E+03 O.DDE+00 7.71E+D7 1.72E+04 1.87E+04 1.IZE+Q3 O.DOE+00 1.10E+04 O.DOE+00 6.74E+07 3.65E+04 2.95E+04 2.29E+03 0.DOE+00 1.62E+Q4 0..DOE+00 4.6&E+Q7 0.DOE+00 0.00E+00 D.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 N/A N/A N/A N/A TOTAL ADULT INGEST.

TEEN CHILD INFANT 1.63E+04 1.88E+04 1.12E+03 O.DOE+00 1.93E+04 2. 10E+04 1.26E+03 O.DOE+00 4.05E+04 3.28E+04 2.54E+03 0.00E+00 6.20E+02 2.7&E+02 1.70E+01 Q.DOE+00 1.10E+04 O.DOE+00 9.03E+07 1.23E+04 O.DOE+00 7.57E+07 1.80E+04 O.DOE+00 5;19E+07 1.07E+02 O.DOE+00 1.76E+05 N/A N/A N/A N/A ZNHAL.

ADULT TEEN CHILD INFANT 5.27E+03 6.10E+03 3.65E+02 O.DOE+00 3.56E+03 2.2IE+05 1.73E+05 7.86E+03 8.56E+03 5.13E+02 O.OOE+00 5.02E+03 3.72E+05 1.82E+05 1.08E+04 8.73E+03 6.81E+02 0.DOE+00 4.81E+03 3.2&E+05 8.21E+04 7.94E+03

&.l3E+03 5.DOE+02 0.DOE+00 3.15E+D3 3.22E+05 3.12E+04 N/A N/A N/A N/A BONE LIVER ODY HY ID KI NY LUNG G.I.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec

","MAXIMUM VALUES GROUND:

GROUND:

GOAT CQW T.B./ORG.

SKIN MILK:

MILK:

8.31E+06 9.97E+06 3.84E+04 1.80E+05 FOR PA HAYS***

TOTAL MEAT:

VEGTBLE:

INGEST:

INHAL.

1.30E+07 7.71E+07 9.03E+07 3.72E+05 PAGE:

4-40

O.D.C.M.

MAXIMUM PATHWAY DOSE FACTORS:

RADIONUCLIDES OTHER THAN NOBLE GASES*

9TOPE:

Np-239 I'ATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G-I.

SKIN GROUND GOAT MILK COW MILK

"-GTBLE ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT ADULT TEEN CHILD INFANT 0.00E+00 O.OOE+00 Q.OOE+00 Q.OOE+00 0.00F+Qo 0.00E+00 0.00E+00 O.OOE+00 O.QOE+00 0.'OOE+00 Q.OQE+00 Q.OOE+00 o.ooE+ao o.aoE+ao o.ooE+Qo o.aoE+Qo o.ooE+oo o.ooE+oo O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Q.OOE+00 1.98E-Ol 1.95E-02 1.08E-02 0.00E+00 6.08E-02 O.OOE+00 3.79E-01 3.57E-02 1.98E-02 0.00E+00 1.12E-Ol O.OOE+00 9.32E-01 6.69E-02 4.70E-02 O.OOE+00 1.93E-Ol O.OOE+00 1.64E+Ol 9.96E-02 9.96E-02 0.00E+00 3.5IE-01 0.00E+00 9.26E-Ol 9.10E-02 5.02E-02 0.00E+00 2.84E-Ol Q.OOE+00 1.77E+00 1.67E-01 9.25E-02 0.00E+00 5.23E-Ol O.QOE+00 4.35E+00 3.12E-Q1 2.19E-Q1 0.00E+00 9.02E-01 O.OOE+00 9.19E+00 G.ZZE-01 4.64E-ol O.OOE+00 1.64E+00 O.OOE+OO 8.54E-OZ 8.40E-03 4.63E-03 O.OQE+00 2.62E-O2 0.00E+00 7.47E-OZ 7.04E-03 3.91E-03 O.OOE+00 2.21E-02 O.OOE+00 1.41E-,Ol 1.01E-OZ 7.09E-03 O.OOE+00 2.92E-02 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 4.71E+02 4.63E+Ol 2.55E+Ol O.OOE+00 1.45E+02 O.OOE+00 4.57E+02 4.31E+Ol 2.40E+01 0.00E+00 1.35E+02 O.OOE+00 8.44E+02 6.0GE+Ol 4.26E+01 O.OOE+00 1.75E+Q2 O.OOE+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+aO O.aOE+Oa O.OOE+OO o.aoE+oO a.aoE+oo Q.OOE+00 O.OOE+00 4.00E+03 5.74E+03 4.95E+03 5.09E+03 1.87E+04 2.6&E+04 2.31E+04 2.38E+04 1.72E+03 1.13E+03 7.47E+02 O.OOE+00 9.50E+06 6.94E+06 4.49E+06 Q.OOE+00 o.aaE+ao O.OOE+00 0.00E+00 O.QOE+00 H/A N/A N/A N/A N/A H/A N/A N/A H/A N/A N/A H/A N/A N/A N/A N/A TOTAL ADULT INGEST.

TEEN CHILD

'INFANT 4.72E+OZ 4.64E+01 2.56E+Ol 0.00E+00 1.45E+02 0.00E+00 4.6OE+02 4.33E+01 2.41E+Ol O.OOE+00 1.36E+02 O.OOE+00 8.50E+02 6.10E+Ol 4.29E+Ol O.OOE+00 1.76E+02 O.OOE+00 2.56E+Ol 9.22E-Ol 5.64E-01 O.OOE+00 1.99E+00 O.OOE+00 9.53E+06 6.97E+06 4;52E+06 2.89E+04 N/A H/A N/A N/A INHAL.

ADULT TEEN CHILD INFANT 2.3OE+02 2.26E+01 1.24E+Ol 0.00E+00 7.00E+Ol 3.76E+04 3.38E+02 3.19E+Ol 1.77E+01 O.OOE+00 1.00E+02 6.49E+04 4.66E+02 3.34E+Ol 2.35E+Ol O.OOE+00 9.73E+Ol 5.81E+04 3.71E+02 3.32E+01 1.88E+01 O.OOE+00 6.62E+01 5.95E+04 1.19E+05 1.32E+05 6.40E+04 2.49E+04 N/A N/A N/A N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G. I.

SKIN

Airborne pathways and tritium ingestion:

units are mrem/yr/uCi/m3 Deposition pathways:

units are mrem-m2/yr/uCi/sec GROUND:

GROUND:

T.B./ORG.

SKIN O.OOE+00 O.OOE+00

"*MAXIMUMVAlUES GOAT COW MILK:

MILK:

5.74E+03 2.68E+04 FOR PATHWAYS"**

TOTAL HEAT:

VEGTBLE:

INGEST:

INHAL.

1.72E+03 9.50E+06 9.53E+06 1.32E+05 4-41

5.0 V

U SE DUE TO W.

BO U

S C

C ON 3.11.1.2 - THE DOSE OR DOSE COMMITMENT TO A MEMBER OF THE PUBLIC FRO.

RADIOACTIVE MATERIALS IN LIQUID EFFLUENTS RELEASED FROM EACH REACTOR UNIT TO UNRES

)

AREAS (SEE FIGURE 5.1.3-1)

SHALL BE LIMITED:

a.

DURING ANY CALENDAR QUARTER TO LESS THAN OR EQUAL TO 1.5 MREM TO THE TOTAL BODY AND T LESS THAN OR EQUAL TO 5 MREM TO ANY ORGAN, AND b.

DURING ANY CALENDAR YEAR TO LESS THAN OR EQUAL TO 3 MREM TO THE TOTAL BODY AND TO LES THAN OR EQUAL TO 10 NREM TO ANY ORGAN.

The calculations of dose rec'eived by the hypothetical maximally exposed individual are based on ingestion of fish, drinking water and exposure on the shoreline.

Drinking water is taken from the 'nearest public drinking water intake location (Danville Mater I

Authority).

Shoreline and fish ingestion are associated with the SSES river outfall (edgi of initial mixing zone).

Methodology for calculating dose to the maximum hypothetical offsite individual has been developed (l)(2) for separate (fish, drinking water and shoreline exposure) and c ite liquid effluent pathways.

This methodology incorporates usage, dilution, and trans parameters specific to the SSES site.

(1)

PP8L Calculation EC-ENVR-0501 (2)

PPEL Calculation EC-ENVR-0502 OnT Rev.

1 21

Table 5-la:

Dose Factors for Fish Pathway:

Maximum Hypothetical Adult (Page I of 2)

Dose Factor Units:

mrem-ft /Ci-sec

~

.1.ocation:

Outfall/FIXED DILUTION Ussoe iUsp) )kg/yr:F)SH) ~

Deut)an illMp:F)SH) ~

Trsnsit time itf) bra ~

21 T. Body 1

H-S 2

C-14 0.00o+00 1.ado+ 01 147e44 147e44 3.&Os+00 SA)dot od 147e44 147e44 147~

3.&os+00 3.80etoo SA)dot 00 147e44 S.&oetoo 3

No.24 7.78e42 7.7ae42 7.78e42 7.78s42

'.78e42 7.78e42 7.78e42 4

M2 6'r.sl e

Mn.S4 7

Mse 8

Fe.55 9

FS8 lo c

59 11 Ce40 12 Ni.03 13 Ni-05 14 Cu.04 1S 2n-05 10 2n49 17 Br<3 18 Br%4 19 Br.as 20 Rb-ad 21 Rb.aa 22 Rb.89 23 Sr 89 24 Sr.ae 25 Sr-91 2d Sr-92 27 Y.90 28 Y aim 29 Y-91 30 '82 31 Y-83 B.dos+02 O.doe+00 0.00s+ OO 0.dec+00 3.99e41 d.20o41 O.doe+00 0.dec+00 1.89o+ 0 1 7.91e45 O.ooo+00 1Aooto'l 2.3So-10 0.des+00 0.dec+00 0.00e+00 O.Ms+ 00 O.Me+ 00 O.Me+00 1.32s+01 3.30o+02 3.99o42 1.S7s-04 2.07e44 2.84o-'1 S S.oeo43 240e47 1.7So45 4A)7etol 3.09e+0 1 O.doe+00 7.53e44 2.&So+00 S.ode41 B.oee45 2.70e41 1A3e45 0.43e42 1Aeo+00 6,59s41 Sdee42 1.2~1 1.55o41 3.43o41 14lot00 0.33o41 1.OSo4S 4.09o40 1.SSo43 4.40s+0 1 2.02e+01 4Aao.l 0 3.13e.l 1 0.des+00 1.74e45 O.dos+00 2.14e-l 0 0.00e+00 O.dos+00 5.&Os+01 2.76o+01 0.dec+00 O.Me+00 0.00e+ 00 0.00s+ OO 0.00o+ 00 3.80e41 O.Mot00

&.1 1 o+ 01 O.OOe+ OO

'1.0'l e43 0.00o+ 00 0.77o40 O.Ms+00 7.16e40 0.00o+00 1.10s-le 0.00o+00 1A~

0.00e+00 0.71o49 0.00o+00 4.83e47 0.00e+00 2Al2e 10 OAXhtoo OANe+00 OANst00 OANe+00 O.doe+00 O.Met 00 O.doe+00 0.00o+00 OANe+00, O.dos+00 O.doe+00 OANe+00 O.dos+00 O.Mst00 OANetoo OAXbt00 O.doe+00 0.des+00 O.doe+00 O.doe+00 O.dos+00 0.des+00 O.doe+00 O.doe+00 0.00o+00 O.Met 00 O.dos+ 00 0.dec+00 O.doe+00 OAXbtoo 0.des+00 O.dos+00 OANo+00 '.doe+00 O.ooo+00 O.dos+00 O.dos+00 O.dos+00 O.dos+00 OANo+00 O.doe+00

.O.dos+00 O.doe+00 0.00s+00 0.des+00 O.ooe+00 OANe+00 OANe+00 0.00s+00 1.&de44 O.doe+00 7A)$o41 O.doe+00 O.dos+00 1.02e44 O.Ms+00 0.des+00 OANe too 1.Sie41 OANo+00 OANe too 4Al7e41 O.doe+00 O.dos+00 O.dos+00 O.doe+00

.OANotoo OANo+00 O.doe+00 OANo+00 OANs+00 OANs+00 OANe+00 0.00e+00 O.doe+00 SAQKQ OANe+00 OANe+00 2.98e+01 OANo+00

&A)as+01 1.&ae41 8.12o+00 2.57e43 1.5&e41 4.&do+00 1.dao+00 2.92e+M 2.73o41 2.01e44 142e41 2.&le+01 0.76e-l 1 2.51o46 1.&ae 21 O.doe+00 l.leo+01 O.dos+00 O.dos+ 00 2.12o+00 9.sic+00 1.$0o41 2.&So+00 844e 15 2.7ae+00 4.02o43 S.sso41 32 2r.95 33 Zr.97 34 Nb 95 1.44o44 2.89ioe 2.00~01 1 A8e41 7.94e42 4.02o45 3.13e45 5.83o47 2.07o47 0.00o+ 00 7.26o46 O.Met00,8.80e47 0.00o+00

'lAee41 0.des+ 00 0.dec+00 0.00o+00 1.4eo41

'.81e41 8.97e+02 35 Mo 99 0.00o +00 4.82o42 B. 1 eo43 0.00o+00 1.09o41 O.dos+ 00 1.12o41 5-la(1)

Rev.

1

,Table 5-la:

Dose Factors for Fish Pathway:

Maximum Hypothetical Adult (Page 2 of 2)

Dose Factor Units:

mrem-ft /Ci-sec Locati on:

Outfal l/FIXED DILUTION lsot To 99m 3.03e 07

~ Liver 8.55e-07 1.09e 05 54 icl 0.00eKO 1 30e.05 C.19c 07 01 LLl 5 06e OC Te 101 Ru 103 0.00tt00 2.64e 03 0.00eKXI 0.00eKO 0.00eKS 1.54e-03 0.00eKS O.OOeKN 1.01e 02 0.00eKXI 0.00eKO 0.00eKO 3.08e 01 40 Ru-105 Ru 106 4.52e 06 3.99e 02 0.00eKO.

1.?8e-06 5.05e 03 0.00eKS 0 00etDO ',84e 05 0.00eKO 0 00e+00 0.00eHO 2 T6e 03 2.55eKO 41 42 Ag. 5 50m 5.33e-OC Te 525m 5.54e+00 4.93e 04 5.5?e 05 2.06e 05 0.00eKS C 63e-05 6.2beKO 0 00eHS 0 00eKS 2.0le 01 bot4cKlO CS C7 Te 127 1.00c 02 Te 529Ic 6.54eHS Te 129 i

1.79e.02 Te 53ta "5.64e 01

,"Tc 52?e 3.95cKN 6.71e 03 4 35e-03 2.76e 01 2 30e 01 1.40eKS 4.T6e-01 3.60e-03 2.17e 03 2.4C F00 5.04e+00 9.99e 01 5.59c405

?ARe 03'.08e 02 2.25ee00 2.?3et05 t 3?e 02 7.51e 02 2.80eKS 4.3?e-01 0 00eKO 0 00eKS 0 ORNER 0.00eHO 0.00e+00 5.55~5 ran Ot 3 R9e45 1.35e.02 2.74+45 48 50 51 Te-535 Te-132 5 130 l 131 1.08e 20 1.5?F00 4.05e.03 8.29e-02 4.51e 21 3.Ctc-25 5.20e 02 1.19e Ol 4.72e 03 6.79e-02 T.59e 01 7.12e-01 0 00eKS 0.00e400 1 Ote+00 3 88et05 1.8?e 02 0.00eKO 0.00eKN 2.03 01 8.87e 21 4.73e 20 8.38e-01 7.31eKO 1.53e-21 3.59eKI5 1 03e 02 3.13e 02 52 53 54 55 5-132 l-533 5-134 5-135 2.36e.06 1.35e 02 6.26e.12 7.02e-04 6.32e.06 2.34e-02 1.70e 11 1.84e.03 2.21c-06 7.53e-03 6.08c 12 6.78e 04 2.25e OC 1.0le-05 3.4Ca+00 C.OBe-02 2.94e-10 2.TOe-tt 2.95e 03 1.21e 01 0.00eKO 0 00eKO 0.00e40 0.00e+OO 1 19e 06 2.10e 02 1.C8e 14 2.08e 03 56 57 Cs-534 Ca-536 Cc-537 Cs-538 1.81e+02 1.79~5 2.32 a+OR 1.620 15 7.0?e+05 5.09eKlt 3-5?F02 2.0?eH52 3.20e 15 1.59e 15 4.30e+02 3.51 F02 0.00eKS 0.00eHR 0.00e+00 0.00e+00 5.39eKQ 4.62e+05 93e405 5.39e+00

'1.08eKQ 3.57~5 2.32e~tb 2;3Se-15 7.52ekS 8.03cKS 6.53eKS 1.3?e-20 61 62 Bc 539 B@ 540 Bc 1C1 2.13e.09 1.11e 05 0.00e+OO 1.5R0 12 1.40e.OC 0.00e+00 6.23e-11 7.30e 03 0.00e+00 0.00eKS 0.00e+00 1 42e-52 C.76e 05 0.00eHS 0.00e+00 8.60e 13 8.02e 05 0.00e+00 3.77e 09 2.30e 01 0.00eKS 65 67 69 71 80.1C2 La-140 Lc 142 Oe-141 Ce~543 Ce 1CC Pr-143 Pr-144 II($~ 147 M-587 IIP-239 O.OOc+00 5.90e.OS 8.78e.ll 1.33e-OS 5.42e~0&

7.0?e 04 3.5?c-OC 0.00e+OO 2.54e-OC 8.&8e-02 1.2?e.OS 0.00e+00 2.9?e.OS 3.99e 15 8.99e-06 1 050 03 2.9&e.OC 1.2?e-OC 0.00e+00 2.4?e.OC 7.25e.02 1.25e-06 0.00eKS

?.a 06 9.95e-t2 1.02e-06 1.1&e OF 3.80e.OS 1.57c 05 0,00e+00 1.C8e OS 2.54e.OZ 6.90e.07 0.00e+00 0.00eKO 0.00e+00 0.00e+00 0.00e+00 0.00eKS 0.00e+00 0.00e+00 O.OOe+00 O.OOOO 0.00+HO 0.00eKS 0.00e+M 4.18c 06 4.61e OF 1.75e-04 7.34e-OS O.OOPS 1.45e-OC 0.00eKS 3.90e-O&

0.00cKIO 0.00e+00 0AOe+00 0.00e+OO

0. 00e+00 0.00e+00 0.00et00 0AOe+00 0.00e+00 0.00e+00 0.00e+00 0.00eKN

2. 58eKS 2.92e-07 3.44e-02 3.92e 02 2.39e 01 1.39eKN O.OO~

1.59eKO 2.38et05 2.5?e-01 5-Ia(Z)

DAT~

Table 5-)b Dose Facto t

Location:

le Ussso tUsp) {ks/yrF)SH) a Dose Factors for Fish Pathway:

Haximum Hypothetical Teen (Page r'Units:

mrem-ft'/Ci-sec Outfa11/FIXED DILUTION 1 of 2)

Diction lllMp:FISH) ~

TNw't t)mo g) ~'

15.8 10 Co68 11 'o40 12 C.'14 Ne.24 P-32 Cr 51 0

Mn-54 7

Mse Fe-65 Fo-58 4.18o41 e.39o41 2.80s41 1A9e+00 0.doe+00 5.33o42 O.doe+00 1.5So41 1.See+01 148otoO O.doe+00

'lA)do44 2.07o+Ol 4.13otoo 8.02e42 BA)2e42 8.71e+02 SAoe+Ol O.doe too OA)Ost00 0.00e+00 2.01 e+00 O.ooe+00 BA4eOS 7.7Se44 6.17e41 1.50e4S eA)le42 441e44 O.doe+00 O.doe+00 O.ooetoo 6.70o41 OAOetoo

'1.23e4')

3.50e41 O.doe+00 O.doe+ 00 0.04e41

'.doe+00 T. Body 1ANe04 4.13s+00 4.13otoo BA)2e42 8.02e42 3~tol OA)Oetoo 1.05e4C 4.13o+00 8.02e42 OAX)otoo 1.70o44 7.77e41 1.07e44.

O.ooe+00 OA)Oetoo

'O.doe+00 O.doe+00 O.doe+00 lA)ss41 4.71o41 1.28s41 3.53otoo 0,00e+00 7>4ool 0,00e+00 2.02e+00 O.doe+00 2.20o41 1.00s44 4.13otoo 4.13s+00 BA)2e42 8.02e42 OAOe+00 742etol 1.'1 lo43 OAOe+00

$45etoo O.ooe+00 6.66e43 13 Ni-05 8.55o45 1.09s45 4.$ 8o40 O.doe+00 OA)oetoo O.doe+00 6.$3oo4 11

~4 21 Rb.ss 22 Rb-89 le zn-0$

17

)b 83 18 Br-84 Br-85 20 Rb-sd 0.00otoo 1.03o43 1.27e+01 4.41e+Ol 2.55o 10 4.87e-lo 0.00e+00 0.00s+00 O.ooe+00 0.00e+00 0.00s+00 O.ooe+00 0.00s+OO 0.35e+01 O.OOe+OO O.doe+00 O.OOe+ OO O.OOs+ OO 3Als-11 1.8$ e45 O.ooe+ 00 O.doe+00 220s 10

~

OAXhtoo O.dos+00 0.00o+00 2.8$ s+Ol O.dos+00 0.00e+ 00 '.00e+00 OAIOstoO OA)Oo too 7.05s44 0.00o+00 2.des+01 O.ooo too 4.12e43 2.83s+Ol 3.18s 10 OAXbtoo OAootoo O.ooe+00 OA)dotoo OAX)e+00 0.00e+ 00 OA)dotoo 14do41 O.doe+00 1A)7e+0'l O.doe+00 BJ)7o-10 O.doe+00 O.doe+00 O.dost 00 O.ooe+00 O.doe+00 OAOotoo O.OO +OO 8.39e+OO O.doe+00 O.doe+00 0.00o+00 O.dos+00 23

&.89 1.44s+ 01 O.dos+ OO 4.12o41 O.doe+ 00 0.00o+00 O.doe+00 1.72e+00 24

& SO 25

& 91 2d

& 92 2.70s+02 0.00etoo 4.32o42 0.00s+00 l.dse44 O.OOo+00 1.72o43 0.00o+00 741~

O.OOo+00 dAIlo+01 0.00e+00 O.dos+00 O.dos+00 O.doe+ 00 O.OOo+OO 7.7~tOO O.ooetod l.sdo41 O.doe+00 4.31o43 27 28 Y 90 Y-91m 3.07o.15 O.OOo+00 2.89o44 O.doe+00 7.7$~

1,17e-ld 0.00o+00 0.00e+00 O.ooe+ 00 O.doe+00 0.00e+00 2.39e+00 O.dos+00 1A6e-13 Y.s 1 SA9e43 O.dos+ 00 1.47oOO 0.00e+ 00 0.00s+ 00 0.00e+00 2.26e+00 30 31 Y-92 Y.93 32 Zr.95 33 Zr.97 34 Nb-85 35 Mo.$9 3.11 s40 0.1ss47 2.07s41 1.48s41 O.OOs+00 5.13e42 2.51 o47

~

O.OOs + OO 1.$ 1e45 O.OOst00 1AQMl 4.7os45 8.17s42

$.7$o43 0.00e+ Oo O.doe+ OO 0.00e+OO 5.23s47 O.OOe+ OO O.OOe+ OO 2AI3s47 0.00e+00 O.dos+ OO 0.00o+ OO 0.90e45 922o47 1.44o41 1.17o41 0.00e+ 00 0.88e43 O.OOe+00 6.82o4'l O.OOs+00 1.08s41 0.00s+00 1.00e41 O.doe+00 04tot02 0.00s+00 9.19e42 5-)b())

DAT Rev.

1

Table 5-1c:

Dose Factors for Fish Pathway:

Naximum Hypothetical Child (Page 1 of 2)

Dose Factor Units:

mrem-ft'/Ci-sec

-,'ocation:

Outfall/FIXED DILUTION O<<oge lU<<p) lkg)yr'F)SH) ~

OSution {)lMp:FSH) ~

Trsre)t tine ltf) bro ~

0.00<<+00 0.9 T. 8od)r 8.72<<4S 8.72<<4S

)br<<col 8.72<<45 8.72sO5 8.72sO5 8.72<<46 C14 2.00<<+Ol 541<<too 541<<too Sdl o+00 Sdlo+00

54) <<too 541<<t00 3l No-24 8.72<<42 8.72<<42 8.72<<42 8.72s02 8.72<<42 8.72<<42 8.72<<42 1.12<<t03 0.00<<+00 O.OOe+00 0.00<<+00 SA9<<41 7.76<<41 7.09<<45 1.74<<45 2.91<<41 9.02<<42 1AS<<too 0DS<<41 S>0<<t01 4>3<<t01 0.00<<+00 848<<44'.04<<toOSA3<<41 OA)0<<t00 OA)0<<t00 4.59+04 OA)0<<too

$,72+01 0.00<<+00 9~S 0.00<<+00 OA)0<<too OA)0<<too OA)0<<too OA)0<<t00 3.10<<+01 849s44 4~2 OA)O<<too 1.71<<+00 OA)0<<too 1.11<<42 1.05<<41 549<<42 3A)4sol 1>1<<+00 10 Co.SB 0.00<<+00 0.00<<+00 4.26<<42 1.20<<41 1~<<41 3.72<<41 OA)0<<too OA)O<<too OA)0<<too OA)0<<too 0.00<<+00 2A8<<41 OA)0<<too dAIS<<41 13 14 10 18 21 22 23 24 27 28 30 32 33 Ni.03 Ni45 Zn-05 Br.83 Rb-80 Rb 89 Sr.89 Sr.91 Sr S2 Y-90 Y-Qlm Y 91 Y92 Y.93 2r 95 2 97 Nb.95 2.67<<+01.

1A)9<<44 0.00<<+00 1.30<<+01 3.28<<-10 0.00<<+OO 0.00<<+00 0.00<<+00 0.00<<+ OO 0.00<<+00 0.00<<+00 1.80<<+ 01 2.43<<+ 02 5.55<<42 2.10<<44 3.74<<44 3.92<<.15 7.10<<43 3.21<<47 2AS<<46 1.91<<44 3.95<<40 3.10<<41 147<<too 8.74<<41 1.03e45 0.01<<40 1 AS<<43 9.03s04 3.47<<+01 2.10<<+01 4.74<<.10 448<<-11 3.97<<45 3.54<<45 S.71<<47 3>7<<47 1.23<<41 8.78<<42 0.00<<+00 2A3<<45 0.00<<+00 2.08<<-10 0.00<<+00 0.00<<too 0.16<<+01 3.79<<+0 1 0.00<<+00 0.00<<too 0.00<<+00 0.00<<+00 0.00<<+ 00 522<<41 0.00<<+00 0,17<<tol 0.00<<t00 2.09<<43 0.00<<+OO 8.00<<40 0.00<<+OO 1.00<<45 0.00<<too 1A3<<.10 0.00<<+ 00 1.90<<44 0.00<<t 00 9.20<<49 0.00<<t00 0,72<<47 OA)0<<too OAX)<<+00 0.00<<+00 OA)O<<too

'A)0<<+00 3.01<<43

.0.00<<+00 2.19<<+01 0.00<<+00 2A)8<<-10 0.00<<+00.

0.00<<+00 0.00<<+00 OAX)<<+00 0.00<<+00 0.00<<+00 0.00<<+00 OA)0<<too OAXI<<too OA)0<<too OA)0<<too 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<tOO 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<+00 O.ooo+00 0.00<<too 0.00<<+00 OA)0<<too 0.00<<+00 0.00<<+00 0.00<<+00 5.09<<45 0.00<<+00 8.19<<47 0.00<<+ 00 1.16<<41 0.00<<+00 840<<42 OA)0<<too 120<<43 OA)0<<too 7.01<<42 O.OO +OO 0.1O +OO OAX)<<too 2AI9<<48 OA)0<<t00 O.doe+00 OAO<<too 0.00<<+00 0.00<<+00 0.00<<+00 0.00<<+00 3A)0<<too OA)0<<too 0.00<<+00 0.00<<+00 O.ooe+00 0.00<<+00 7>l<<41 0.00<<+00 3.28<<+00 0.00<<+ 00 1.22<<41 0.00<<+00 4.09<<43 OAX&t00 1.07<<+00 0.00<<+00 7.08<<-12 0.00<<+00 9AS<<41 0.00<<+00 '.29<<43 0.00<<t OO 3.06+01 O.doe+00 4.14<<42 O.OO<<+OO 8.0~2 0.00<<too 227<<t02 Mo99 0.00<<toO 4.88<<42 1.21<<42 0.00<<+00 1.04<<41 0.00<<+00 4.04<<42 5-1c(1)

OAT Rev.

1

Table 5-lb:

Dose Factors for Fish Pathway:

Maximum Hypothetical Teen (Page 2 of 2)

Dose Factor Units:

mrem-ft /Ci-sec Location:

Outfall/FIXED DILUTION lsat 36 Tc-99 3.10e-07

. Liver 8.64e-o?

1.12e 05 Th old O.ooe+00 1.29e-05 L

Ol Ll.l C.Soe.o?

5-65e-04 37 Tc 101 O.ooe+00-,"

O.ooe+00 0.00eKO 0.00eKN '.00eKN 0.~

0.00eKO 38 Ru-103 39 Ru-105 CO Ru 106 41 R

llom 2.??e-03 4.8?e 06 4.33e 02 5.20e 04 0.00eKS 0.00eKS O.ooe+00 4.92e 04, 1.18e 03 1.59e-06 3.00e-04 O.oooo O.ooe+00 0.00eKS O.ooa+00 9.77e 03 6 14e 05 5 35e-02 9.39e 04 O.ooeKN 2.31e-ol 0.00HOO 3.9$e 03 0.08ea00 2.NEO 0.00euR 1.38e-ol 42 Te-125m 1.67e+00 6.03e-ol 2.2Ce 01 4.68e Ol O.aoeeo

. 0.~

C3 Te-127m 4.25e+00 1.51e+00 5.06e 01 1.01 a+00.

1.72et01 O.ooeKS 1.06+%1 44 Te-127 45 Te-129m

1. 10e.02 3.89e 03 7.06e+00 2.62e+00 2.36e 03 1.12e+00 2.28eKN 2.~1 7.56e-03 4.44e-02 O.ooe+00 SA?e-01 0.00eKS 2.65ee01 46 Te 129 1.94e 02 7.24e 03 4.72e-03 1.39e-02 5.15e.02 0.00eKO 1.0be 01 47 Te.131m CS Te 131 49 Te 132 50 1-130 6.06e.ol 1.16e-20 2.91e-ol C.SOe-21 1.24')0 7.84e 01 1.2? e-02 4.210.03 2A3e-01 3.64e-21 7.38e-ol 4.86e-03 4.3?e-ol S.9?e-21 5.2?e 01 9.93e 01 3.03eKS 5JSe 20 7.63eKS 1 55e 02 O.ODDS 2.33e+01 0 00eKO 9.56e-22 0.00+40 2 ASCOT O.ooe+00 9.36e 03 51 1-131 52 1.132 53 l -133 54 1.134 8.88e-02 2.48e-06 1 ASe-02 6.56e-12 1.24e 01 6.48e 06 2A6e.02 1 74e 11 6.68e.02 2.33e-oo 7.51e-03 6.25e-12 3.63et01 2.18e-04 2.90e-lo 2.1Ce 01 1.02e 05 4.32e-o?

2?4e 'll 0.00+40 2A6e 02 O.ooeKO 2.52e 06 0.00e+00' Sbe 02 0.~

2.29e-13 55 l.135 56 Cs-134 1.89e 03 7.36e-04 1.85e+02 C.36e+02 7.02e-04 2.02e+02 1.22e 01 0.00eKO 2.99e 03 1.38e+02 0.00eKS 2.10e 03 5.29')1 SA2eKN 57 Cs-136 1.80@+01 7.08e+01

'4 76e+01 0.00eKS 3,66et01 6.08e+00 5.70eKS 58 Cs-137 59 Cs 138 60 Ba-139 61 Ba 1CO 62 Ba-141 63 Be-142 1.74e-l5 3.34e.l5 2.32e.09 '.64e 12

1. 19e.ol 0.00e+00 1.46e 04 O.ooe+00 O.ooe+00 O.ooe+00 2.48e+02 3.30e+02 1.15e+02

.1.6?e-15 6.7?e-'ll

?.66e 03 O.ooe+00 0.00e+00 O.OOOO 0.06eKS O.ooeKN O.ooe+00 O.ooeKS 0.00e+00 1.12e+02 2A6e-15 1 54e.'l2 O.ooe+00 0 ooe+00 4,36et01 4 69eKIO 2.S7e-lb 1.51e-l8 1.13e-12 2.0?e-08 9.79e 05 1.83e 01 O.ooe+00 O.ooe+00 O.ooe+00 O.ooe+00 64 La-140 65 La-142 66 Ce-141 67 Ce-1C3 6.26e.o5 9.36e.ll 1.4Ce 05 1.54e 06 3.08e 05 C.16e ll 9.6le 06 1.12e.03 8.18e.ob 1.04e-1 1 1.10e-ob 1.25e-o?

O.OOPS O.ooe+00 O.ooeKN O.ooe+00 O.ooe+00 O.ooe+00 4.53e.06 5.02e 07 0.00eKO 1.7?a+00 0.00e+OO 1.2?e-06 O.ooe+00 2.75e-02 O.ooe+00 3.3?e-02 65 Ce-1CC 69 Pr-143

?0 Pr 144 7.68e.04 3.44ei04 3.18e-04 1.37e-OC O.OOMOO O.ooe+00 C.13e.05 1.71e-05 0.00e+00 0.00e+00 0.00eKN O.ooe+OO 1.9oe.04 7.98e.05 O.ooe+00 O.ooe+00 1.93e-03 O.ooe+00 1.13eKN O.ooe+00 O.ooe+00 71 kd-14?

?2 u-18?

?3 kp-239 2.C3e 04 9.3?e-02 1.43e.05 2.64e-OC 7.64e 02 1.35e-06 1.58e-05 2.68e.02

?.510.0?

0.00e+00 O.OOe+OO 0.00e+00 1.55e.04 0 ooe+OO C.24e.06 O.ooe+00 9.54e-ol O.ooe+00 2.0?a+01 0.00+40 2.18e 01 5-]b(2) wC ~

OrT

Table 5-1c:

Dose Factors fol'ish Pathway:

Maximum Hypothetical Child (Page 2 of 2)

Dose Factor Units:

mrem-ft3/Ci-sec Locati on:

Outfall/FIXED DILUTIO>

37 lsat Tc-99m Tc 101 Ru 103 3.72e-07 0.00eKN 3.C3c-03 7.29e 07 0.00eKO O.Ne400'.21e 05 0.00tKN 1.32e-36 T

Id 0.00eKS 0.00eKS 0.00eKO 1.06e-05 0.00eHS 3.70e-OT 0.00eKO 8.62e-03 0.00eKN al-LLt C.15e-OC 0.00eKN 39 40 45 Ru-105 Ru-106 4 -110e Te-125e Tc-127m Te 127 Te-129m Te 129 Tc-131m 6.21e-06 5.57e 02 2.15e+00 5.48et00 1.Cle.02 9.10e+OO 2.500 02 7.72c-01 0.00cKS 0 00eKS 3.98e 04 5.83e 01 1 ASKS 3.50c-03 2.54e+00 6.99c-03 2.67e-01 2,25e 06 6,96e 03 3.19e-04 2.87c 01 6.Sle 01 3.02e 03 1.Cled 5.94e.03 2.84e.01 0.00eKO 0+Net 0.00eKO 6.03e 01 1.31 AN 9.76e-03 2.93eKS 1.79e.02 SA9e 01 SA6e-05 7 53e 02 TA?e-OC 0.00eKO 1 56+%1 4.01e-02 2.67et01 2.She OO 0.00eKN 0.00eKS 0.00eKO 0 00eKO 0.00e+00 0.00eKO 0.00eKO 0.00e+00 0.00eKO 4-06e 03 d.67e-01 4.74e-02 2.07eKS 4A4eKS 5.Slc-01 1.1tet01 1.56eKO 1 08+41 Te-131 1 A9e-20 4.55e 21 4.4Ce-21 t.tCe-20 4.52e-20 0.00eKO 7.85e-20 50 51 55 Tc-132 1 130 1-131 I 132 I 133 l-t34 I 135 1.55eKO 5.15c-03 1.13e-01 3.06c 06 1.84e-02 8.12e-l2 Q.ttc-04 6.84e Ol 1.04e 02 1.13e-01 2.28e 02 1.51e 1'I 1.64e-'03 d.2bc 01 5.3be 03 6A3e 02 2.59c 06 6.94c-l2 T.76c.04 9.96s 01 1.1S+40 3.7CetOt 2.6le-04 3A7e 10 1ASe-Ot 6.35 eke 1.S5e-02 1.6be-01 d.die 06 2.31e 11 2.51e-03 0.00eKS 0.00e+00 0.00e+00 0.00eKS 0.00eHR 0.00eKS O.OOPS 6.85eKS 1.01e-02 6.62e.06 9.18e 03 1.00c-ll 1.25e-03 56 57 Cs-134 Cs-136 2.23c+02

2. 12et01 3.66')2 5.84~1 7.73~t 3.78e+Ot 0.00eo00

'l.t4et02

.0.00eKN

. 3.1 tetOt 4.07~1 4A4eKN 1.97eKN 2.05eKS 58 59 62 67 69 Cs-137 Cs-138 Bs-139 Bs-1CO Bs-1C'I Bs 142 L@ 140 Ls-142 Ce 141 Ce.t43 Cc-144 Pr -143 Pr-144 Nd-t47 M.167 MP-239

3. 12+42 2.20c 15 2.99c-09 1.50c 01 0.00c+00 0.00eKS 7.83c.05 1.15c-10 1.65e.05 1.97c.06 9.90c.04 4.CSc.04 0.00c+00 3.12e.04 1.19e 01 1.84c.05 2.99c+02 3.0be-15 1.59e 12 1.31c-04 0.00c+00 0.00eKR 2.74e-05 3.77c-ll 9.24c 06 1.07c 03 3.10c 04 1.34c OC 0.00eKS 2.53e-04 7.03c 02 1.32c-06 4.41~1 1.94c-l5 d.d5c 11 d.75e-03 0.00eKN 9.23c-06

'I. 1dc-1 1 1.37c-06 1.55c 07 5.29c 05 2.2lc.05 0.00eKO I.Qbc 05 3.lbc 02 9.3 1ci07 0.00eKS 0.00eKO 0.00tKO 0.00eKN 0.00eHS O.OOc+OO O.OOe+00 0.00tKS 0.00c+OO 0.00e+00 0.00e+00 0.00e+OO O.~OO 0.00t+OO 9.74ecOt 2.15e-15 1.39e-12 C.26e-05 0.00e+00 0.00eKS 0.00eKO 0.00etOO 4.05c-06 4.49e-07 1.72e.OC 7.23e 05 O.OOeKN 1.39c 04 0.00e+OO 3.83c.06 3.50+%1 232e-td 9.37e-13 7 83c-05 0.00e+00 0.00eKS 0.00eKO 0.00c+00 0.00c+OO 0.00c+00 0.00eKO 0.00eKO 0.00c+00 0.00c+00 O.OOPS O.OOMOO 1.87e400 1 Cte 15 1.72~7 0 00eKS 0.00eKS 7.63e 01 7.C6c 06 1.15c 02 1 57e 02 8.09e-02 C.dde 01 O.OOc+00 4.00c-Ol 9.55c+00 9.50c.02 5-1c(2)

DA'.2 pe C~

Table 5-Za:

.Dose Factors for potable Uatcr pathway: )lamias Kypothetical Rdwtt (PACE 1 oF 2)

Dose Factor Units:

cree-ft /Ci-sec Location:

Danvi Lle Receiwr/VAR$ N$LE DlLUTTDK Ussoe CUs ) (ky/

TKATER) ~

lsot Bone Liwr T. Body Th id 0$ LLl li 3 C-$4 D.Doe+00 8ASe-02 2.2&e+Oa,',

( 4.56e.01 8.43e 02 4.56e 01 8.43e-02 4 56e 01

&A3e-02 4.56e.01

&A3c 02 4 56e 01

&A3c.02 4.56e.01 Ka 24 1.37e+00 1.37e+00 1.37eKO 1 37e400 1.37c+00 1.37eKO

.5 P 32 Cr-51 1.55e+02 O.Doe+00 9 6CetN 0 Doe+00 O.Doe+00 3.67eKS 5,99eKS 2.14e 03 7.00e 01 0AOe40 1.28c.03 O.Doe+00 O.~-

4.71e-04 1.09c+00 O.aac+00 2.53e.03 O.aae+00 1.74e+01 S37e-0$

1.12e+01 Kn 56 O.DOMOO 9.23e 02 1.64e 02 0.00eKS 1.17ci0$

0.00e4R '.95eKN Fe 55 2.2$ MOO 1.53et00 3.56e 01 0 00eHS 0.00eKS 8.Sle 01

',75e 01 10 Fe 59 Coe55 3.49e+00 8.19eKS O.aae+00 5.98e-al 3.$ 4eKS 1.34e+00 0.00erO)

'.00eKN.

O.Doe+00 O.aaerO) 2.29eKS 0.00eKS 2.73+4$

1.21@41 12 Co-60 Ki-63 O.Doe+00 1.72eroo 7.24 eked 1.04e+02 3.79e+00 0.Doe+00 3.50e+00 O.aaeroo 0.00eKS D.aoeraa 0.00eKS O.Doe+00 3.23')1 1.51 MOO 13 Ki 65 4.24e 0$

5.51e 02 2.51e 02 0.00eKO 0 00e400 D.Doc+00 1 40eKN O.aae+00 6.69c 02 3.14e-az 0 Doe+00 1.69c.al O.aae+00 5.7D AS 15 16 2n-65 Zn-69 3.89e+00

'.24~$

1.5&e-02 5.27e-03 5.59e+00 0 Doe+00 0AOeKN 1.$ 0e-03 8.27e+00 1.03e-az O.aae+00 O.aae+N 7a79cKO 2.3&a 03 17

$8 19 20 2$

Br-83 Br-85 Rb.&8 Rb-89 Sr-89 D.Doe+DO O.Doe+00 O.aae+00 O.aae+00 O.aoe+N O.Dao+00 2.47e+02 D.Doe+00 D.oae+DO O.oae+00 1.69e+01 4.86e 02 3.22e DZ O.Net 3.23e-02 4.1&e 02 1.72e-03 7.59e+OO 2.5&c 02 2.26e 02 7.10e+DO O.No+00 O.aaeKS O.ODORS O.Doc+00 O.Net00 O.Doe+00 O.Doc+Do O.Doc+00 0.00eKS 0.00eKO 0.00eKO O.Net O.Doe+00 0.00eKS O.N+HS 0.00e+00 O.Doe+00 O.Doe+00 O.Doe+00 O.O~N 0.00eKO 4.65e.02 3.28e 07 0.00eKS 3.34+40 6.71e 13 1.87e 15 3.97e+01 24 25 Sr-90 Sr-9$

6.09e+03 4.55e+OO O.Doe+DO a.aac aO

$.49~3

$.54e-a$

0.00~

0.00e+00 0.00eHS O.Doe+DO 0.00&00 1 76e+02 2.17e+01 0.00+40 26 27 2&

29 30 32 33 34 35 Sr-92 Y-90 Y 9$ m Y 91 Y-9Z Y-93 Zr-95 Xr-97 Ko-99 1.73@+DO 7.72e 03 7.3oe.05 1.13e.ol 6.79e-04 2.15e.03 2.44e-oz

$.35e.a3 4.99c.o3 0 Doc+00 0.00' O.oac+OO O.oaeKS O.aae+DO O.oae+OO O.Net 7.83e-03 2.72e-04 2.7&e 03 3A6c+00 7.47e 02 2.07c-04 2.53e 06 3.03e.03 1.9&e-a5 5.94e OS 5.30e 03

$.24c.a4

'$.49e.03 6.5&e al O.Nmo O.Doc+00 O.aae+OO O.aae+N O.aac+00 O.oac+00 O.aae+00 O.aae+DO D.Dacha O.aae+00 O.oae+00 0.00etN O.Nehru O.Doe+00 0.00eKO O.Neraa 1.23c.02 4.11e 04 2.75c.03 7.54e+Oo O.aae+Oa 0 00e+00 O.aac+Oo 0.00et00 O.aae+00 O.Doe+00 O.Doe+DO O.Doc+DO O.aac+OO O.aae+Do 3.42~$

&.19+<1 2.14c.04 6.23+%1

1. $9~$

6.83~$

2.48e401 1.69~$

5.02e+00 5-2a(l)

Table 5.2a-oose Factors for potable llater Pathways llaxtaa Rypotbetfcal adult CPage 2 of 2)

Oose Factor Units:

arce-Ft /Ci-acc Locat ionf Oanvl 1le Receiver/VARIABLE DILIITINI lsot 36 Tc-99m 37 Tc-101 3$

Ru.103 39 Ru-t05 Ca Ru 106 Cl 4

tt0s C2 Te 125a 43 Te 127a 44

'Te-127 CS Te-129a C6 Te 129 Bone 1.9$ o 04 2.04e 04 1.C9e Ol 1.24e 02'.21 et00 1.28e.al 2 tSeKS 5ACeKS 8.83e.OZ 9.23e+00 2.520 02 Liver 5.60e 04 2.94e-04 0.00eKS 0.00eKO 0.00+40 1 19e 01 7 dae 01 1.94eKS 3.17e.aZ 3.44 a+00 9A8o 03 7+14e 03 2.88e 03 6AOe 02 4.8de-03 2.79e 01 2 dde 01 6 62e 01 1 91 ~ 02 1A6eKO 6 tCe 03 Th Id 0.00eKO O.aaeKO O.aae400

~

0 OaeKO O.aaeKS 5A7e-01 6.54e-02 3.17eKO

\\ 94a 02 8.51e 03 5.29e 03 5.67e-af 1 60e-Ot 4.2&eKN 2 3Ce O'I 2.21eKII 3.60e-al 3.55eoOt 1.06e 01 2.75e 04 1 Sae-04 ll 00eKS O.Gaea 0.00eKO 0.00et00 0.00tKO 0.00eKS O.aaeKN 0.00eKO 0.00eKO GliLLI 3.32e 01 8.83a 16 1 73e$ 01 7 5&e$00 1A3e$02 C.85~1 8.5%HOO

.t.82~1 4.65eaat

'1 90e 02 C7 To-131m Cd Te.131 1.39eKN 1.5$ 0 02 6.79e.al 6.61e-03 5.66e 01 4.99e-03 6.8ScKS 1~0$eKN 1.30e 02 6 93e-02 a.ooze O.Gaea 6.75~1 2.2Ce-ls C9 Te 132 50 I 130 51 I 'I31 52 I 132 53 1-133 54 I-13C SS I-135 5&

Cs-134 57 Cs 'I36 5$

C$ 137

~ 59 Cs 13$

60 Ba 139 2 02e+00 6.07e~at 3 34e+00 f.&3e 01 1.14e+OO 8.51e-02 3.5&e Ot 4 99maf 5.23e+00 6.40e+01 4.430 02 7.79$ -02 t.31 AS 1.79e+00 4.78~00 43&e.at 1 95eKS 2 3te 0'I 9.31e-al 1.19e+02 2.06e+Of 8.75~1 d.75e 02 5.55e 05 1.23eKS 7.07e 01 2.74eKO 1 S3e Of 6.05e.al 8.27e-02 3A4e 01 9.72~1 1.49') I 5.73e+Of C.34e-02 2.2$e.a3 t ASSN 1.52eKQ 1.57eK6 1.5Xe<t 2.91 eked 4.01 AS 6.Ne441 0.00eKO 0.00eKS 0,00'Ã 0.00eKO 0.00eKS 1.26e401 2.79e+00

8. 19eKS 6.95e 01 3A6eKS 3.6$ e 01 1 CQeKO 3.85etOI 1.15')t 2.97+41 6.43c-02 5.19e-05 0.00tKS 0.00eKN O.aae+00 0.00e+00 O.aae+00 0.00eKO 1.2$ c at 1.57e+00 9*8$tKO 6.35c-03 3.15$ -05 6 19e$ 0t 1.54eKN 1 26o+00 d.t9e 02 1 78eKO 2.02e 04 1.05 ad%

2.05eKS 2.3C AS 1 69eKN 3.73e 07 1 3$e 01

&l Ba-1CO 1.63e+Of 2.05e 02

'1.07eKS 0.00e400 6.96c 03 1.17e.02 3.36e401

&2 Ba. 'l41 63 Ba ICZ La-1CO 65 La 1C2 66 Ce-141 67 Ce-143 Ce-144

&9 Pr-143 70 Pr 144 7I Kd-147 7Z u-1$ 7

?3 Kp-239 3.78e-aZ 1.7le 02 2.ale.03 1.03e-aC 7.52e.03 1.320-03 3.92e O'I 7.39$ -03 Z.CZe-OS 5.05$.03 8.27e-OZ 9.5&a 04 2.86a 05 1.7&e OS 1.01e 03 4.67e-OS S.ade-03 9.80e-01 1.64e 01 2.96e.03 1.00e-OS 5.84$.03

&.91e.02 9.COe-OS 1.2$ e 03 t.ada-a3 2.67e 04 1.1&e 05 5.77e-04 1.0$ $

OC 2.10e-02 3.66e 04 1.27e 06 3.49e 04 2.42e.a2 5.18e.OS 0.00eKS O.aaa+00 0.00eKN O.aae+00 0.00eKS 0.00e490 O.Gaea O.aaa+00 0.00eKS 0.00eKS O.aae+00 O.Gaea%

2~6&a 05 1A9a-05 a.aac+aa 0.00eKS 2.36e.03 4.31 a-OC 9.72e.02 1.71e 03 5.66e 0&

3A1e 03 0.00e+00 2 93e.04 1 62e-05 9*96e.06 0.00eKO 0 Oaetaa O.aae+00 0.00e+00 O.aae+00 O.aae+00 O.aae+00 0.00eKR 0.00e+Oa 0.00e+Oa 1 78e tf 2.Cte-20 7A3e41 3Ate 01 1.94e$ 01 3.66+41 1.32eKQ 3.2CeoOf 3.Cde 12 2.80etOI 2.2~1 1.93~1 5-2a(2)

I DAT

Table 5-2b:

Oose Factors for Potable lfater patlwayc Haxiaa Nypothetical Teen (page 1 of 2)

Oose Factor Units:

rem.ft~/Ci.sec Location:

Danvi lie Rect'Iver/VhglABLE D)LUTTOM sa e (Us ) (kg/ rtMhTER) a lsot 510 T. 8 Th id L'i 0$

$.Ll H3 C

$4 0.00m+00 2.28e+00, 5.95e 02 4.56e-01 5.95e 02 4.56e-01 5.95e-02 4.56e-01 5.95e-02 4.56e 0'1 5 95e 02 C.56e 01 5.95e-02 C.56e-0$

Na-2C P 32 5

Cr-51

$.29MOO

'.29eKS 1.55e+02 9.59e+00 O.ooe+00 O.OOMOO 1.PPeKS 6.00eKN 2.02e 03 0.00eKN 0.00eHS 1.12e 03 4A3e OC

$.29eRS '.29eKS 1.29eKO 0.00e+00 2.88e 03 1.30e40$

3.39e-01 7

Hn-56 8

F~55 9

Fe-59 10 Co-58 Co-60 Ni-63 13 Ni-65 Cu-64 15 Zn-65 16 Zn 69 17 Br-84 19 Br-85 20 Rb-86 21 Rb-88 22 Rb-89 Sr-89 0.00t+00 0.00cv00 2.12e+00 3.29e+00 0.00e+00 0.00w00 9.93w0$

4.20e.0$

O.OOMOO 3.23e+00 8.250.03 O.OOc+OD O.OOMOO O.ooe+00 0.00e+00 O.ooe+00 O.OOMOO 2.C7e+02 3.31 a+00 8.86e 02

$.50eKS 7.69eKS 5A5e-01 1.58e+00 7.01e+00 5.37e-02 6.45e 02 1.12e+01 1.57e-02 O.ooe+OO O.ooe+00 O.ooeue 1.67e+01 C.78e 02 3.09e.02 O.ooe+00 6.56e 01 1.58e 02 3.51e-o1 2.97e&0 1 26eKÃl 3.55~0 3.37eKN 2.CSe 02 3.0Ce-02 5.23eKS 1.Toe~03 3.22e 02 4.05e-02'.71e 03 7.85e+00 2.55e-02 2.18e 02 7.07eKS 0.00eKO 0.00eKN 0.00eKS 0.00et00 O.~

O.ooeKN 0.00eKS 0.00eKS O.ooe+00 0.00eKS 0.00eKS 0.00eKO 0.00eKS 0 00eKO 0.00eKS 0.00eKS O.ooe+00 0.00eKS 9.87e 0$

1.12e-01 0.00eKO O.ooeKS 0.00+40 0.00eKO 0.00eKS 0.00eKS

$.63e-0$

7

$8eKO 1.03e-02 0.00eKS O.oo AN 0.00eKO 0.0~

O.ooe+00 0.00eKN 0.00eKS 0.00eKO 9.54e 01 2A2eKO 0.00eKS 0.00eKÃ 0.00eKO 0.00eKS O.ooe+00 0.00eKO O.ooe+00 0.00eKN D.ooeKN 0.00eKS 0.~

0.00eKS 0.00eKO O.ooe+00 6.79eKN 5.83eKS 8.5$ e 0$

1.82~$

7.52eKN 2.05m$

1.$ 2eKO 2.9$ eKN 5.00e+00 4.75eKN 2.89e 02 0.00eKS 0.00eKS 0.00eKO 2A7eKN 4.10e 09 4.73e-11 2.9Ceo0$

24 26 27 28 Sr -90 Sr 91 Sr-92 Y 90 Y-9$e 4.66w03 C.53 F00

$.7$ e+00 7.69e.03 7.2Ce.05 O.ooe+00 O.ooe+00 O.ooe+OO O.ooe+00 O.ooe+00

1. $5eK6 1.80e-01 7.29e-02 2.07e OC 2.77e~o6 O.ooe+00 0.00eKS 0.00eKO 0.00eKS O.ooe+00 O.ooe+00 O.ooe+00 O.ooe+00 O.OOPS 0.00eKO O.ooe+00 0.00eKO O.ooe+00 O.ooeKO 0.00eKO 1.3'l e<02 2.05~$

4.36e40$

6 34~$

3A2e-03 29 Y.91 1.13e.0$

O.ooe+00 3.02e 03 O.ooet00 O.ooe+00 0.00eKO 4.62~$

30 31 Y 92 Y.93 6.79e.OC 2 ~ 15e.03 0.00e+00 5.89e-O5 O.ooe+00 '.96e-05 O.ooe+00 O.ooeKN O.ooe+00 0.00eKN O.ooeKN O.ooe+00 1.86+4$

6.56+4$

32 Zr 95 33

,Zr-97 34 Mb.95 35 Ho-99 2.31e.02

$.33L ~ 03 4.61e.03 O.ooe 00 7.29e.03 2.63e.OC 2.560.03 3.38e+00 5.02e-03 1.21e.OC 1.C1e 03 6.45e 0$

0.00~0 O.ooe+00 O.ooe+00 0.00tKO 1.07e.02 3.99e-04 2.CBe 03 7.74e+00 O.ooeKN O.ooe+00 O.ooeKO

. O.ooe+00 1 65m%1

7. $2~$

1.09~$

6.06eKN 5-2b(1)

table 5-2b:

bose Factors for Potable uater Path>cay: ltasi~ Kypothctkcst Taco CPaac'2 of 2)

Dose factorst atcfc ft~lCI scc Locattont Oawlglc Receiver per CRT table 5~2 VI&l~OIMlN lsot Tc %ha 37 Te 101 38 Ru-'!03 39 Ru 105 Ca Ru 106 41 Ay tt0e 42 Te 125a 43 Tc 127e 44 Te 127 45 Te 129a 45 Te 129 47

'Te 13ta l.bbe.OC 2.02c OC 1.C3c 01 1.22e 02 2.20eKO 1.15c 01

2. ISIS 5.42eKO S.bbc 02 9.14eKS 2.5lc 02 1.37eKO

$.19c-04 2.87e OC 0.00e+00 Q.ISeo00 0.00eNO 1.09~1 7.74~1 1.92eKO 3.1Cc 02 3.39 eked 9.37c-03 6.56e 01 6.73c-03 2.52c 03 6.1tc 02 2.7le 01 6.62e 02 2.5Te 01 6.45~1 1.9le 02 t 4%eKO 6.11e 03 5.4Sc 01 Thyroid 0.00tKO 0.00cKS 0.00eKO 0.00eKS 6.~1 1 29eKN 5.04e-at t.~t 4.24cKO 2.~1 O.OOOO 2 20ecat 3 S~t 2 55c 04 1.75e QC 0 00eKO 0.00eNO 0.00eNO 0+aaeKO 0,00oKO 0,00eKS Oi00eKS 0 00e+00 0.00eNO 9.57~1 6.84eKO

- O.aaef00 2 95ef00 3.83ecat 1.05~1 Ol lit 3Atc 01 C.9le 11 1 t~t 9.57eKN 1.05ec02 6.3CeKO 1 DSeKN

'6 54eKS 3s43ec01 1.37~1 5.27etOt CS Te-'l3t 49 Tc 132 50 I-13a S'l I 131 52 I-132 53 1-133 5C I 134 55 I 135 56 Cs-134 57 Cs-136 Sb Cs 13T I.STc.02 1.9beKS S.Tbc Ol 3.2beKO I.STc.al l.13~0 5.19c 02 3A2c.al C.TO~I 6.25 eel 6.45c-03 1.2C AN 1.67eNO 4.59eNS 4.'lac 01 1.9teKN 2.17c-al d.dlc.al I.t1~2 t.~l 5.36+41 4.d9e-03 1.17+40 6.~1 2.47eKO 1.47e 01 5.83e 01 7.80e-02 3.27e 01

5. t3~1 1.27~i 2.9teKl1 1&teKS 1 34eKS 1 38&01 2'67eKk 3.62eKN 5 67e401 0 aacc00 0.00eKO 0.00eKO 6.d4e 02 1.21efat 2.57eKN 7.91eKN 6A~t 3A2c-01 1>>39efaa 3.5teeOt 1 JSeo41 2.54etOI O.OQeKS 0.00et00 0.00e+00 0.00eKS 0.00eKS 0.00eKO 1D4etOt 1.63eNO 1.1 tetOI 3.93~1 1 28eKO 9.09e 01 t.75~1 1.45eKO 2.86e.03 9.76e Ol 1 37eKS 1.53eKO

t. 19eKO 59 Cs-13S 60 Ba 139 C.35c.02 T.bac 02 8.3bc 02 S.C9c 05 C.18c-02 2.2lc 03 0.00eKS i 6.1lc.02 S.tie-OS 0.00eKN 7.1Sc-03 6.~1 61 62 ba 1CO Sa ICl 80 IC2 1.59~1 3.7be-02 1.65c-02 1.95c OZ 2.blc OS 1.65c 05 1.QXa+CO l.2be-03 1.03e 03 0.00cKS 0.00eKO 0 00eKN 6.62c 03 2 61c 05 1.42c-05 1.31e-02 2.46eKlt d.02e-ab 5.15e~tC

~

64 Ls-1CO 65 La. 142 66 Cc lCl 67 Cc-1C3 68 Cc-144 69 Pr-143 70 Pr 144 71 Kd 147 72 u-tbl 1.95e 03 I.OOc 04 T.Cbc 03 1.32c 03 3.90e Ol 7.35c-a3 2.Clc 05 5.2bc-03 5.19c-o2 9.57c-OC 9.59c-04 4.4be.OS 4.95c.03 9.59c OI 1.62c Ol 2.93c-03 9.dlc.ab

,S.nc-03 b.bbe 02 9.3lc 05 2.55'4 l.llc 05 5.72c 04 I O'Fc 04

2. lac 02 1.22c Ob 3.43ci04 234c 02 5 ~ tlceOS 0.00e+00 0.00eKO 0.00eKN 0.00eKN 0.00eKN 0.00eKN 0.00eKO 0.00eKS 0.00eKS 0.00e+00 0.00m+00 0 00et00 2.34e-03 4.3ac 04 9.65c 02 1.7lc.03 5.67c-06 3.36c 03 0.00eNS 2.92c-OC 0.00tKS 0.00eKO 0.00eNO 0.00eKO 0.00eKS 0.00eKS O AORS 0.00eKS 0.00eKS O.OOPS 5.51~1 1.36eKS 1.42eKII 2.5bc+Ot 9.82c 01 2.42+%1 2 bbc 08 t 2.06et01 t.dte401 1.50~1 5-2b(2)

Table 5.2a.

Oooo Footers (or Potable Waar Pathway: Mtttantan Hypothotiaal ChSrI (PRO% 1 OF 2I We~t ~(tv ~

Danvilo Rooahror/VhRABLE OLUTION Usage (UapI (kQIyrNATN n 51Q H3 Q.des+00 1.14o01 T. Body 1.14e01 1.'I4e0'1.

1.14o0'I 1.14e01'.14e01 2

C-14 3

No 14 4

P42 8.79o+00 3.25e+00 4.83o+02 Mtht00 l~t00 1~+00.

l~t00 l~tN LRQt00 345ot00 MQt00 02&t00 32Qt00 2.17o+01

'1.7&a+01 OAIOet00 OAIOst00 OAOot00 l~tN 1M+01 5

Cr 61 0.00o+00 OAOet00 4AIQe03 7.57e04 2.8Se01 8

Fe.66 9

FSQ BASo+00 94&st00 8

Mn-64 0.00o+00 7

Mn Sd 0.00e+N dAXht00 1AXIetN OAIQetN 1 AI&atN OAOetN 1AI7e01 MSe42 OAIOst00 K27o01

OAIQot00, 1.50s+01 7Ads+00 OAOo+00 OAXIet00 4~tN 3A2o+00 1.0de+00 OAOe+00 OAXIst00 1AMetN 2.71e+Ol d~l l,See+01 10 Co.58 0.00o+00 1.01o+00 3.09o+00 O.NotN 0.des+00 OAOet00 5.8&a+ 00 11 Co 60 0.00o+00 2.97o+00 8.76o+00 OAIOot00 O.NotN 0.00o+00 1.84+01 12 Ni.83 3.02s t02 1.82s+ 01 1.03o+01 0.00e+00 OAOetN O.Noted 1.0$e+00 13 NH$5 Ii Cu-84 1.25a+00 0.00o+ 00 1.17e01 1>7s01 8.84o02 8~2 OAIOet00 OAOe+00 OAIQetN OAIQotN 0.00 a+00 342e01 1.44e+01 d.4$e+00 15 Zn46 7.8&a+00 2AISot01 127et01 0.00e+00 1Mt01 OAXIetN ld Zn0$

17 Sr-83 2.4&e02 0.00o+QQ 3.$5e02 3.2&e03

'.00o+00 O.OOe+00 0.des+00 2.16e02 OAXIet00 0.00o+00 Q.QQe+00 2.24e+00 0.00e+00 18 19 Sr<5 0.00o+00 0.00s+ 00 0.des+00 1.11e01 0.00e+00 S.'I 2o03 0.00e+00 OAOe+00 OAOo+00 0.00o+00 0.des+00 O.NetN 0.00e+00 0.des+00 20 Rb Bd 21 Rb.&8 22 Rb-89 0.00o+00 0.00o+00 0.00o+00 3.7&a+01 1.07e01 d.Sde02 Mlet01 7A1o02 5AI3o02 0.00e+00 OAIQetN O.Not00 OAXIst00 OAOst00 OAOotQQ 0.00o+00 OAIQet00 0.00e+00 2AZe+00 S~

5.71o04 7A1o+02 0.00e+00 1.1 le+01 0.00ot00 0.00o+00 0.des+00 2.87e+01 28 Sr 92 24 25 Sr.91 8.54o+ 03 125o+QI 5.07e+ 00 0:QQo+00 0.dec+00 S.Q&e01 0.00o+ 00 2.03e01 0.00e+00 0.00e+00 OAXIet00 0.00o+00 O.Net00 0.00et00 ZA2o+03 OAIOe+00 0.00o+00 OAOet00 14&a+02 2.87e+01 9.6&a+01 27 Y.90 2.31~2 0.00 a+00 8.17e04 0.00e+00 OAXIet00 0.00e+QQ e.Se

+01 29 29 Y.91m Y.91 2.14e04 3.3&o01 0.00o+ 00 7.&Qe0&

Q.QQo+QQ S.03e03 0.00o +00 0.00o+00 Q.dec+00 Q.QQo+00 OAXht00 QAOs+00 4.20e01 4.50e+Ol 3Q Y-92 2.02~3 Q.QQo+00

$.7&eE)$

0.00o+00 0.00o+00 0.00o+00 5.&3o+01 31 32 Y.93 8.400.03 8.51 ~ 02 Q.QQo+00 1.43o02 1.78e04 1.27e02 0.00e+00 0.00e+00 0.00o+00 OAOet00 0.00e+00 2.05e02 9.54+01 1AQe+01 33 Zr.97 34 Nb-95 3.92~3 1.2&e02 5.87~

4.91o03 3>ie04 3.51o03 0.00e+00 4.82o03 0.00e+00 8.13e04 0.00ot00 0.00o+QQ S.S&a+01 Q.Q9o+00 35 O.QQo+00 7.4&at00 '.&So+ 00 0.00e+ 00 1.59e+ 01 0.00st 00 d.lie+00 l

V op; : cubi/Ia-..

5-2c(1)

Table 5 2d!

Oose Factors for Potable Mater Fathwyt suxieaa Synthetical Ififant page 1 of 2)

Oose Factors:

arearft /Ci.sec Location:

OanvIIIe Receiver per CAROL Table 5.2-23/VARIABLKOILIITIOR Usa o (Ua )

lsot (k /

FVATER)

Bone Th id L'I L

GI LLI II 3 0.00et00 1.12e 01 1.12e 01 1.'12e-01 1.12e 01 1.12e-ol 1.12e-ol C 1C Ma-24 P-32 Cr-51 lin-54 7

IIn-56 8.60etOO 3.67e+N 6.17+42 0.00e+OO 0.00etIO 0 Ooe+OO 0.00e+00 7m22IHOO 2 97e-01 5 12e 03 1.64eKN 5.12~

1.84etoo 3.67eKN 3.67eeao 3.63eHOI 2.39ee01 '

84eKO 1 84eKS 1JL4etN 1 SLeKO 3.&7ee00 3A7eKN 3.67~

3.67eKN O.ooeKN 0.00aKO 0.00e+00 MSRKN 3DCe-03 7 3IhHOC 6.50e-03 1A9e 01 0.00eKS 1 60eKS 0.00eKS 2.65eKO 0.00eKS

'2 5~1 0.00et00 2.70eeal 8

Fe-55 Fe-59 Co-58 11 Co 60 12 MI 63

'I3 NI 65 1C Cu-64 15 2n-65 16 Zn-69 17 Br 83 18 Sr-84 5.05+40 1.12e+01 O.ooe+OO 0.00e+OO 2.30e+02 1.7le+OO O.OOe+OO 6.6Se+00 3.39e-02 0.00e4$

0.00e+00 3.26aKO 1.95+%1 1.31 ada 3.92eKO IA2~1 1 93e 01 2.21e 01 2.29~1 6.10e.o2 0 00eKS O.ooe+00 8.71~1 7.70euN 3.26+HO 9.2betM 7.9%HO) 8 78e 02 1.02e 0'I 1.06e+01 4.54e 03 1.32e 01 1.39e 01 0.00eKN O.aaeKO 1 59eKN 4 '14e 01'.00e4R O.aoeKS 5 77e4IOO 9.33eKN 0.00eKS O.aoeKS 0.00e+00 3.26eKO 0.00et00 0.00eKO 0 00eKO 9.33eKO O.IRhHOO O.OO+eO O.~

7.OS Ol 0.00et00 O.ooeKS 0.00eKN 1A7~1 0.00eKS 3.74e 01 0.00eKS 4.54eKS 0.00eKO 1 11eeol

'0 00eKS I,~I 0.00eKN 2.53e 02 0.00e4$

4.97eKO 0.00eKN 0.00eKS 0.00eKS O.ooe+00 0.00eKS '.00eKO O.ooe+00 0.00eKS 19 Sr-SS O.ooe+OO 0.00cKO 7.0Ce-03 0.00eKO O.oaetao 0.00eKO 0.00oKS 20 Rb-86 21 Rb.88 22 Rb 89 Sr-S9 0.age+00 0.00e+OO 0.00e+00 9.11e+02 6.17e+01 1 Sle-Ol 1.04e-ol 0.00eKS 3.05~1 9.91e 02

'7.15e 02 2.61e+OI 0.00et00 0.00etoo 0.00eKO 1.5SeKO 0.~

0.~

1.7&e-O1 0.00eKS 0.00eKS 0.00eKO 3.54e 02 0;00eKS 0.00eKO O.ooe+OO 1.87eIOI 25 26 27 Sr-90 Sr-91 Br-92 Y-90 6.72ek6 1 82e+01 6.97e+OO 3.15e-02 O.ooe4S 0.00e+00 O.ooe+OO 0.00eKS 1 7Ie+03

&.57e 01 2.59e 01 8.4&e 04 0.00eKS 0.00eKS 0.00eKS 8.39etOI O.IOcHIS 0.00eKO 0.00e+00 2.15+<1 O.ooe+00 0.00eKS 0.00eKO 7.51et01 O.aoet00 0.00eKO O.ooe+00 4.36etOI 28 Y-9)m 31 32 Y-93 Zr-95 33 2r-97 35 kb 95 Ilo-99 29 Y-91 30 2.94e 04 C. loe-01 2.78e-03 8.82e-03 7.CSe-02 5.37e-03 1.52e-02 O.OOe+00 O.ooe+00 0.00eKN O.ooe+OO O.ooe+OO 1.82e.02 9.22e 04

&.28e.o3 1.23e+OI I.ooe.05 1.09e-a2 7.80e.05 2AOe 04 1.29e 02 4.21e OC 3.&3e 03 2.41e+00 0.00eKO 0.00eKS 0.00eKS 9.80e 01 O.ooe+00 0.00eKR O.ooe+00 2.94e401 0.~

O.aortae 0.~

5.3~1 0.00eKO O.ooet00 O.OIhHOO 6.97+%1 0.00e+0) 1.96e 02 O.ooeKIO 9.08eKO 0.00eKS 9.29e-oC O.ooe+00 5.58+%1 0.00et00 C.50e-03 O.ooe+OO 5 30etoo O.ooe+00 1 84HOI 0.00eKN C.07e+00 5-2d(1)

Table 5-2ct Dose factors for potable Mater Pathway: Naxbaa Rypotbetioal Dhild (Page 2 of 2)

Dose factors:

mrem-f t~/CI-scc Location:

Danvi1 le Receiver/VlRINLE DILVTION lsot 36 Tc-99m 5.18e 04 Liver 1.02e 03 1.6$ e-02 Th Itl

'KI 1 48e 02 5.16e-04 OI LLI 5.7$ e 01 Cl R

110m C2 Te 125m 43 Tc-12?m 3?

Tc 101 38 Ru.103 39 Ru 105 CO Ru 106

&.OOe-04 4.10e.OI 3.62c.02 6.56eKS 3.02e 01 6.40eKN 1.62e+01

&.2$c 04 0.00eKN 0.00eKN 0 00eKS 2.0Ce-01 1.73et00 4.36e+M

?.9?c-03 1 Sdc O'I 1.31aM 8.19c 01 1.&3c Ol d.53c-01 1 92eKN 0.00e+00 0.00e+00 0-00eKN 0.00eKS 0.00e+00 1 80eKO 3.6$eKS 1.07e 02 1.03eNN 3.18e 01 d.86eKO 3.80e 01 0.00eKN C.&2e401 0.00ea00 0.00iKN 0.00eKO 0.00c+00 0.00e+00 0 00eKN 2 OOe 03

~ 1 06et01 2.%eK)1 1.02e+D2 2A3e41

. 6.1?AN 1.3le41 CC Te 127 45 Tc-129m 2.6Ce-01 7.12e D2 5.67e.02 2.75c+01 7 63@%0 4.24eKS 1.83e 01 8.81 a+00 7 52c 01 8.02~1 0.00eKS 0.00eKS

$.03ef01

" 3.33~1 46 Te-129 7.52e 02 2.10e 02 1.78e-02 5 3&c 02 2 2Dc 01 0.00eHS 4.68eKS 47 Te.131m 4$

Tc 131 1A9eKN 4.04e+OO 1AOe+00 1.C2e 02 1.39e 02 4.66e 02 1.35ct01 3.56e 02 1A1e 01 0.00eKN 0.00eHN 5.67~1 2ASc 01 C9 Te 132 50 1.130 51 I 131 52 I 132 53 I 133 5.67e+OO 1.64e+00 9.65c+OO C.C9e 01 3.32e+DO 2.51e+00 3.31e+00 9.71e+00 8.25e 01 C.lie+DO 3.03eKS 1.71 AS 5.51eNS 3.79e-01 1.55eKO 3.65eKO 3.65~2 3.21et03 3.83e+01 7.63e+02 2.33c+01 4.95 a+00 1.59t+01 1.26e+00 6.84e+00 0.00e+DO 0.00eKO 0.00'Ã 0.00eKS 0.00eKN 2.52~1 1.55eKO 8.64e 01 9.?le 01 1.65eKN 54 1-134 2.350.01 4.3&e.01 2.01e.01 1.00e+01 6.68c 01 0.00e+N 2.89e-01 55 I-135 56 Cg 134 5?

Cg-13&

9 82e 01 1.7?~00 8.36e 01 1.31et02 2.15e+02 4.54e+Ol 3.62e+01 1.32e+OI 2 34~I 1.5?a+02 0.~

0.00e+00 2a?1 a+00 6.68e+01 1.93e+01 0.00eKS 2.40etOI 2.88+40 1.35eK4 1 16eKO 1.2?eKl0 61 62 Be~140 Ba.141 63 Ba 1C2 La ICO 65 La.1C2 58 C$ 13?

'59 Cg-13$

60 Ba.139 1.83e+02 1.2$ e 01 2.32e 01 4.6&e+01 1.12e-01 4'.90e.02 5.&7e.03 2.94e.04 1.76e+02 1.78e.01 1.24e.OC 4.0$ e 02 6.2$ e.05 3.53e.05

'I 9$e.03 9.3?e.05 2.59e+O'I 1.13e-01 6.73e.03 2.72eKS 3.65e 03 2.74e.03 6.6$ e OC 2 93e.05 0.00e+00 0.00eKS 0.00e+00 0.00e+00 0.00eKS 0.00e+00 O.DOe+00 0.000400 5.72c+01 1.25e-01 1.08e 04 1.33e-02 5A4e-05 2.86e 05 0.00e+00 0.00e+00 2.06+41 1.35e 02 7.29e.05 2A3e 02 3.69c-04 2.0$ e-05 0.00eKS 0.00m%0 1.10et00 8.19e-02 1.34+%1 2 36+41 6AOe 02 6.COe.04 5.52~1 1.86+41 67 Co*141 De IC3 2.23e.02 3.92e 03

1. 'Ilc.02 2.13NOO 1.65e 03 3.0$ c.OC 0.00e+00 O.OOe+OO 4.8?e-03 8.92e 04 O.Doe+DO 0.00c+OO 1.39~1 3.11eKN 70 Pr 1CC 71 M6 147 72 M-18?

73 Kp 239 Ce. ICC 69 Pr 1C3

1. I?F00 2.20c.02

?.2Ce-05 1.57c 02 2.41e 01 2.95e.03 3.6&e.OI 6.62e 03 2.24e.05 1.2?e 02 1.42e.01 2.1'le.OC 6.23e.02 1.09e.03 3.64e.D&

9.$ 2e OC

&.CO~.OZ 1.49e~OC 0.00e+00 0.00e+00 0.00e+OO 0.00e+00 O.OOMOO D.DOe+00 2.03c-01 3.58e-03 1.18c-05 6.96c 03 D.OOe+00 6.11e-04 0.00e+OO 0.00c+OO 0.00c+OO 0.00et00 0.00e+OO 0.00et00 9.54ivOI 2.3St401 4.82c-02 2.01+41 2.00~1 1.5?F01 5-2c(2)

I DAT yc.

MREMNZWRKEWRRMRtmlae %%V..'Kama%

K%RmmaKEHRRK%KRME~mm~amr~aPZ.'HARD~

~gg~l~~~l~<~IL Qg>~II+~it I~a

~ ~A.~>~.~<~~

~

K%R555~%%5HRRK.'~%K.'~NHE~REH~R?E~R3K~

K'%RK~RPH55%KK~RK~~~K~~HRKK~

RBNRE~KK~RK~RK~RK~RK~KK~RX~M, REÃNTRZ%%KBHRRKKKRNKVKXEK~MKK~~iRNK!~53K~

~i~~~Q~~~~~~~i~

RKKRKEMW65HRRKP~RK~K3K~KK~KK~RXb~

gg~

~MR~R3KZHRRKE?RKKH~RlKK%NX"~R3C~MZ~

kX%RK~KKCHRKKKE%ÃERHRRE~RKMTRXK.'~KKMM

~ggi~gg++g~~~~a~~~~~~~

~~

RK%RHKI~NKHKTSRKRKRRlKKERKK~MK~R?E~RKM RSEEMRK~KRI~MM~RKE~~~~~R?K~

RXRllK~RXE~83K~KlK~RKHErÃ~~R'?E~

RM~~RKHKRRRHHRRK~QXZ~~~KK~53K~

RRRKEr~RRHKRRK~RMHRRKKHRkK~RK~REHEAR',

RZRREE~RKK~RRXR~RK+~RK.~RKZ~K2M~RK~

RMNK~KRHKiR~KKRR5255%RKRETR~~~R?M~R3E~

KMNK~NKH~RKMMRXHKCRRX~~~~RK~RSME!%,

N%RK~RK~RWKEHRRK~RRK~RKK~MMHRRK~iR'MRK~KEHKRME~RKE5%RPK~REZEKRKK~&R~HR'MK5E~RKEHRRK~REiKCRRK~RKXH%%~2%83K~

KMRK~RKEERNXZ~K~HRRlK~REHKtRMKMERKIK~

RTEE~KKKWRKHKRKK5HRR~~RKHH%NK~~MRK~H%,

RTR~NRXECRR362L5ESRK~RFK~RKHKRKEXEZRREz~

RZRRSL~NKKCR~~~KRRE ~~~R3K~R~~

RERRRXM~KERRKHEHRRRHKRRK~KK~RKK~NXM5%',

NR~R~HRRRHKQRKRKRRK'.~KK~RK~KHZ~

NR~RKRHRRI6BHRRKRKR~~NPM~RK.'~EKE~

NRXMRMKRREMÃRK2KRRM~RKz2K%KK~

mammmaemmammammmam~ammaam~am~

NK~R~~NKH%KR~~RK~RKaKKRKK~RKZ~

RHRKMKK56%REEEZSRIERKRRK~RKHK'%~~WMHK

%5%RK~NKWRRKRKKRRKHKRNK~RKHK%RK'.~%K~~~

KHRER~RKKHHRRKKtRRKZKKRRK~~~RK'.~%KEEK KWREEH~RKHKTSRKHKQ~KER~~KK~RK"~MME RaRR&~RKEHSRKKR~KRWM~RK?KRAK~

Table 5-3 Radioactive Decay Constants 10 12 13 18 21 23 24 2&

21 27 28 29 30 31 32 35 31 H.3 C14 N+24 r 68 Co-58 Ni.13 Itb-88 Sr 89 Sr 91 Sr 92 Y 90 Y.9 1m Y-Ql Y.92 Y.93 Nb 95 Mo 99 Tc.99m Tc 101 Hoff4fo 12.28 6730.

1448 27.704 312.7 2.5785 2.7 44.13 70.8 5.271 100.1 2.52 12.701 244.4 5&.d

, 2.39 31.8 172.

18.ee 17.8 1&A4 50.5&

28.1 9.5 2.71 49.71 58.51 3.54 10.1 14.02 11.9 35.01 41.02 1.02 14.2 Period IS,M.H.D.YI Decoy Constont IHro.ll d.44eO1

~i.d2e42 2.02eO3 1.04o43 9.24eO&

2.10eOl 4.08eO4 1.50eOS 7JRe47 2.7SeOl 5.41eO2 1.18eO4 7.47eO1 2.90eO'I 1> le+00 1A6o+O'I 1.5&eO3 2.33o+00 2.19o+00 5.7 IeO4 2.77eOe 7.30eO2 2.51eO'I 1.08eO2 8.3SeOI 4.91eO4 1.94oOI e.eeeO2 4.51eO4 4.10oO2 8.24eOt 1.0&e02 I.l&oOI 2.92o+ 00

$8 f4-103 39

. Av-'l06 40 lh 101 41 Ay 1lcm 42 Te 125m 43 Te 127m 44 Te.127 46 Te.120m 41 Te 120 47 Te-131m 48 Te.131 48 Te 1$2

&0 l.130 51 l 1$ 1 52 1-132 53 l.l$3

. 54 l.1$4

&5 l.l$6 51 Ce 1$4 67 Ce.131 58 Co-137 59 Ce-138 dO Bo-'139 11 Be.'140 12 Be-141 13 Bo.142 14 Lo-140 4S Le-142 11 Co-141 47 Ce 143 18 Co-144 19 Pr 143 70 Pr 144 71 Nd-147 72 W-187 73 Np-239 Hoff4fe 1A4 10Q.

$3.1 25.

78.2 12ze 62.1 e.dl 13.1d

$0.17 32.2 83.1 12.780 18.27 10.7 40.22 SSA 32.&

281>

13.61 17.28 10.98 23.83 2>55 Period 18.MPl.D.YI D

H Doooy Conotont IHre.ll 7~4 1.&deO1 7$4e46 1.14eO4 4.08eO4 2.1&eO4 7.4leO2 d.eeoO4 2.3le42

'I.dec+ 00

&.dleO2 3.69eO3 3.01eO1 3~2 7.89eOI 1AI&eOl

$.84eO5 2.10eO3 2.12eO1 1.29o+00 4.09eO1 2.21eO3 2.27o+00 3.88o+00 1.72eO2 4.3SeO1 8.8QeO4 2.10eO2

'1.02eO4 2.13o43 2AOot00 Z.d3oO3 2JlleO2 1.23oO2

Table 5-4 (Page 1 of 2)

Dilution Factors and Transit Times for SSES Effluents to Oanville, Pa RIVER DEPTH RIVER DEPTH HEAS.

AT ENV.

LAB HEAS. AT HCR (FEET INCHES RIVER DISCHARGE CFS LEADING EDGE HOURS DILUTION FACTOR 1.5 1.6 1.8 2.2 2.4 2.5*

2.6 2.8 3.2 3.4 3.5*

3.6 3.8 4.2 4.4 4.5*

4.6 4.8 5.2 5.4 5.5>>

5.6 5.8 6.2 6.4 6.5>>

6.6 144 145 148 150 152 155 156*

157 160 162 164 167 168*

169 172 174 176 1?9 180*

181 184 186 188 191 192*

193 196 198 200 2Q3 204*

205 500 530 600 670 730 780 825*

870 930 1000 1200 1400 1500>>

1600 1800 2000 2280 256Q 2?30*

2900 3300 3700 4140 4580 4820*

5060 5580 6100 6?8Q

?460

?890" 8320 68.7 67.8 66.3 64.8 63.3 61.8 61.1*

60.3 5&.8 57.2 52.7 48.2 45.9" 43.5 39.0 35.5 35.2 34.?

34.5*

34.2 33.7 33.0 32.3 31.7 31.4>>

31.0 30.2 29.5 28.5 2?.5 26.9*

26.2 136.4 140.1 147.3 155.5 164.5 D3.9 179.1*

184.5 195.7 208.3 250.6 291.5 280.9*

271.0 250.6 250.6 254.5 259.1 261.4*

263.9 270.3 277.8 284.1 292. 4 297.2*

302.1 312.5 323.6 339.0 354.6 366.3*

3?8.8

Interpolated value

Dilution Table 5-4 (Page 2 of 2)

Factors and Transit Times for SSES Effluents to Danville, Pa RIVER DEPTH MEAS. AT ENV.

LAB (FEET)

RIVER DEPTH RIVER MEAS. AT MCR DISCHARGE INCHES (CFS LEADING EDGE HOURS DILUTION FACTOR 6.8

- 7.5 8.5 9.5 10 10.5 11.5 12 12.5 13 13.5 14 14.5 15 15.5*

16 16.5*

17 17.5*

l&

1&.5*

19.5*

20 20.5*

21 21.5*

22

Interpolated value 208 210 216 222'34

'240 246 252 258 264 270 276

"",'82 288 294 300 306 312*

31&

324*

330 336*

342 348*

354 360*

366 372*

378 384*

390 9360 10400 12500 14900 17500 20700 24000 27000 30100 34570 38730 42530 46490 50630 54940 59430 64090 68930 74030*

79130 84580*

90030 95830*

101630 1077&0*

113930 120430*

126930 133780*

140630 147830*

155030 24.7 23.0 20.0 16.5 15.3 14.7 14.2 13.5 13.0 12.2 11.3 10.7 10.0'0.0 10.0 9.8 9.8 9.8 9.8*

9.8 A &*

9.7 9 7*

9.7 "9 7*

9.7 9.6+

9.5 9.5*

9.5 9 4*

9.3 413.2 456.6 588.2 869.6 980.4 1071.8 1173.7 1285.3 1373.6 1567.4 1795.3 2057.6 2398.1 2597.4 2832.9 3067.5 3311.3.

3558.7 3802.3*

4081.6 4347.8*

4651.2 4926.1*

5235.6 5540.2*

5&82.4 6192.0*

6535.9 6&72.9*-

7246.4 7604.6*

8000.0 5-4(2)

Table 5-5:

Dose factors for Shore Exposure Pathway; All Age Groups (Page I of ?)

Dose Factor Units:

mrem-ft /Ci-sec Location:

Edge of Initial Mixing Zone/FIXED OILUTION Oiiution <1/:SNORE) c Trcnsit tice Cts) hrs c Scdieent

. tice (tb) hrs o 15.9 131400 Vssye

(

)(hri

) ~

lsot T.

B 12 Skin T. B 67 Skin 1C Skin II 3 C-14 Ka 2C P-32 Cr~sl Hn-54 Mn-56 0.00+88 0.00eKO 0 00eKS 0.00eHR O.aae+00 O.NeKN 2.48e-04 2.8le OC 148e 03 O.aac+00 O.aae+00 0.00e+00 1.01e OC 1.19e-OC 5.6Ce OC 3.0lc-02 3.53e-02 1.6be.01 1.Sac-aS 1.77c-aS 8.37~05 6.67e OC 1 18c-04 1.39e-04 1 97e 01

'9 90e 05 3.51e-OZ 4.12e.02 1;75e.as 2.07e 05 0.00e+00 O.aae+00 O.aae+00 0.~

0.~

a.~

1 60e 03 2.89e-OC 3 35e OC 0.00eKO 0.00eKO 0.00et00 Fe 55 0.00et00 0.00eKN 0.00eKO 0.00eKN 0.00eKO 0.00eKO 10 12 Fe-59 Co~58 Co-60 Mi 63 5.92c 03 6.9&e-03 3.31e 02 8.23e-a3 9.64e-03 C.59e 02 4.68c.01 5.50c-al 2.&le+00 0.00+40 O.aae+00 0.00eKO 3.89e 02 6.9'lc 03 5DSe-02 9.60e 03 3.07e+00 5ASe 01 O.aae+00 O.aae+00 6.12e 03 1.12e-02 6A2e-01 0.00eKS Mi~&5 4.90c 06 5,69e 06 2.74e 05 3.15e 05 5 72e-0&

6.64e-a&

14 15 Cu-64 Zn 65 1.25c-as 1A1e-05 6.97e-as 1.62c-02 1.8le-02 9.06e-02 7 9ae 05 1.04e 0'l 1 Cbe 05 1.65e-as 1.89e 02 2.1be-02 Zn-69 O.aaeKO O.aae+00 0.00eKN 0.00eKS O.aac+00 O.aac+00 18 Bri83 Br-84 T.92e 05 1 ~15c-07 4A2e 07 l.20c.ab 1.39c-06 6 67e-06 6AZe-07 9.2Cc-ad 1.34e-07 7 79e 06 1 39e 0&

1.63e.a&

20 Br-65 Rb-86 0.00eKO O.aac+00 0.00eKO 1.95e.04 2.23e.04 1.09c-03 0.00eKN 1.2Ce-03 O.aac+00 O.aae+00 2.60e.04 2.27e-04 21 Rb.dd 6.99c Od 7.99e 05 3.90e-al 4A6e 07 d.16c 08 9.32e 08 22 Rb 69 Sr 89 1.52e-a7 2.18e 07 1.02e 06 C.7ae-07 5 Ase-07 2.62e-06 1.22e-06 3.04e 06 2.12e-07 2.SSe-al 63&c-07 SAbe 07 24 28 29 30 31 Sr.91 Sr-92 Y.90 Y.91e Y 91 Y.92 Y-93 Zr-95 3.22c.06 3.63c.ab l.dac 05 3.72c 06 5.09c.06 2.0de 05 5.31c-a3

&.lbe-03 2.9le-aZ C.34c-05 S.alc-as 2A2e-OC 1.31e 05 1.CSe.aS 7.29c 05 9.65c-ad 1.1Cc-al 5.39c 07 9.47e 07 1.10e.06 5.29c 06 2.33e.aS 2.62e-aS 1 30e 04 2.83e-a4 8.11e-aS 6.37e 07 6.12e-06

'1.C6e 04 2.14c-as 2.84e-as 3A4c-02 5.06c.as 1.52e.as 1.13c.07 1.10e-06 2.72e-05

.T&c.06

.3Ce-06

~20e.03 5.92c.as 1.69e 05 1.33e 07 1.26e 06 3.06c.as 4A6c-06 5.94e-06 7.19e.03 32 33 Zr 97 Nb 95

6. l7e-05 7.15c.05 2.97c.03 3.C9c 03 3.45e-04 l.bbe 02 4.01e 04 1.95c 02

.20c.as

.4&c 03 8.36c 05 4.07c 03 Ho.99 d.59c.as 9.94c 05 4.79c-OC 5.S5c 04

~aac.aC 1.1&e-OC DAT

Table 5-5:

Dose Factors for Shore Exposure

Pathway, A11 Dose Factor Units:

mrem-ft /Ci-sec Location:

Edge of Initial Hixing Zone/FIXED DILUTION Age Groups (Page 2 of 2) lsoto Skin T. B TEEN Skin T. Body Skin 35 Tc-99at 36 Tc-101 37 Ru-103 38 Ru-105 39 Ru 106 CO A

110m 4'l Te-125m C2 Te 12?e C3 Te-127 44 Te-12'5 Te-129 3.5&a.0&

2.3$ e-08 2.3Se S 1.18e 05 9.1'Fe.S 7A?e 02 3.37e-05 1.99e 06 6.0le-08 4.29e.OC 3.1Cc-07 4.08e 0&

1.99e 05 2.65e 08 1 33e Q?

2.7Ce 03 1.31e-02 1.34e-05 6.60e-OS 1.10e 02 5.12e 02 8.71e-02 4.17e 01 4.62e 05 2.35e-06 1.11e-05 6.6le-05 3.35e-07 2,40eeS 3.?2e-0?

1.76e-06 6.14e 02 4.8&e Ol 1.07e 02 1.2$e.02 8 71e 02 1 02e 01 2.Sde-OC 3.93e 05 SB9e-05 1.31e-05 2.32e-06 2.74e-06 3.69e-07 7.01e-08 7.?le-08 2.80e-03 5.01e-04 S.85e-04 2.08e-06 3.6?e-OF 4.3Ce-0'F 2.28e 05 4.16e 06 4.7&e 06 1Ade 07 2?de 0$

3 09e 0$

1.53e-02 2.74e.S 3.20e 03 7Ade-05 1.38e-05 1.56e-05 C6 Te-131'e C7 Te 131 1.70e-OC 1.21e.07 2.0'le 04 9 5le 04 6.74e 07

~

1A3e OC 1.12e S 7.97e-OC 1.99a-OC 2.3Ce-04 1Ala-07 1.6?e-04 48 Te-132 C9 1-130 9.12e.05 1.13e OC 1.0?e-04 1.3?e 04 5.09e-OC 6.32e-04

~

5.99e-04 7.67e 04 1.06e-04 1 32e 04 1.25e OC 1.60e-04 50 1-131 3.?2e.04 4.52e-04 2.08e-S 2.53e 03 4.35e 04 5.28e.04 51 1.132 52 1-133 53 1-134 2.00e.05 5.15e-05 CA2e 06 2.35e.05 1.12e-04 6.2&e.05 2 dde OC 5.25e 06 2.C7e-05 1.31e-04 2.33e-05 4.75e-05 3.50e.04 6.01e-05 7.31e-05 2.93e-05 5.15e-06 6.12e 06 54 1

135 4.94e 05 5 7&a+05 2.7&e-04 3.22e-OC 5.76e 05 6.73e<5 55 Cs 134 5&

Cs-136 Sl Cs-13?

1.49e 01 3.27e-S 2.24e-Ol 1.74e 01 3.? le-S 2.6le Ol 5.32e-01 1.83e-02 1.25eKS 9.70e 01 2.07e-02

'1 A6e400 1.74e-01 2;03e-01 4.32e.03 3.52e-S 2.61e 01 3.05e 01 58 Cs-138 59 Bs-139 60 Ba-1CO 61 Bs-141 62 Bs-142 63 La-140 64 La-142 65 Ce-141 2.15e.06 1.40e-O&

C.45e OC 9.36e-0$

2.02e.0$

4.10e.04 1.0?e 05 2.9?e 04 2A&e 0&

1.S?e-06 5.08e OC 1.07e-07 2.30e.0$

4.65e.04 1.2$e-05 3.3Ce.OC 1.20e-05 7.die 06 2.Cde-03 5.23e 0?

'1.13e-07 2.29e 03 5.9?e 05 1.66e.S 1.3?e-05 8.78e.06 2.84e-03 5.96e-0?

1.28e OF 2.60e.03 7.1?e-05 1.5?e.03 2.5le-0&

1.63e-0&

5 19e 04 1.09e.0?

2.36e.0$

4.79e 04 1.25e-05 3.46e.OC 2.5?e.06 1.84e-06 5.93e 04 1.2Ce.ol 2.68e 0$

S.C2e-04 1.50e 05 3.90eiOC 66 Ce-143 6?

Ce-144 68 Pr-143 4.92e 05 1.51e S 0.00e+00 5.59e 05 1.75e.03 0.00e+00 2.75e-04 8A3e-S

0. 00e+00 3.12e-04 9.75e-03 0.00e+00 5.74c-05 6.52e 05 2.04e 03 1.76c" 03 0.00eKS 0.~0 69 Pr-144

?0 Nd.14?

?1 u-18?

?2 Mp-239 3.62e 09 1.82e-OC 4.9&e-05 3.6?e-05 4.1&e.09 2.15e.04 5.?&e 05 4.25e.05 2.02e-05 1 02e 03 2.??e-OC 2.05e-04 232e.08 1.22e.03 3.22e.04 23?e-04 C.22e.09 2.12e 04 5.?9e.05 4.28e 05 4.85e 09 2.55e 04 6.?3e.05 4.9&a 05 5-5(2) 1

'AT

Table 5-6a:

Composite Dose Factors:

Maximum Hypothetical Adult (Page 1 of 2)

Dose Factor Units:

mrem/Ci Released

~ -'<cation:

Danville (Water Ing.)/Outfall (Fish and Shoreline)/FIXED DILUTION Ussao iUsp) ikglyrRSH) ~

Ussae iUsp) BrriyrAHORQ ~

Oikrt)on lliMp:F)SH) ~

Trsnslt tkno itf) hrs ~

Trsnsit time itp) hrs ~

0.00e+00 3.5$ e45 2'l 26 T. Body 3.5$e45 Ussae iUsp) kka)yrWAT80 ~

oQLrt)on lliMpsHORQ ~

OQMt)on ttiMpWATSR) n Trsnsit time ltor) hrs ~

Transit tkne Bb) hro ~

3.59e45 16%

131IOO 3.58<<05 O.ooe+00 N<<2I P<2 1.70e+00 3.I1<<01 7.0$ o43 7.lao+ 01 7.09o43 IAds+00 3.04o42 2.52o42.

0.00o+00 0.00e+00 OANe+00 23$o41 O.doe+00 7.26<<40 3Ale41 "7.12<<43 2.77e+00 7.72o45 IA)2e42 2.03e40 5.87e43 S.ile41 3.Ile41 7AIQe43 7.09e43 OANo too O.ooe+00 I.07<<05 1.50e45 OANe+00 7.10e42 O.doe+00

$41<<00 OANe+00 OANetoo 3.11e41 7A)as43 o,doe+00 9.0ie46 3Ale41 7.08<<43 8.07e+00 1.71<<02 1.IO<<02 1AI<<02 OANo+00 7>1<<01 O.dos+00 2>1 o4I O.ooe+00 2.58e46 O.dos+00 lAI7o45

'.17o43 1.59o4d.

OANe+00 6.05<<02 1~o41 5.1S<<42 OANe+00 OANe+00 3.72e42 IA3e41 10 Co 58 O.doe+00 I.$7<<03 O.oos+00 1Aie42 1.19e42 7>7e42 OANe+00 OANe+00 O.ooe+00 OANotoo O.ooe+00 1.0 le41 O.ooe+00 2.71e41 B.die4i IA)3o42 12 Ni43 1.72o+00 1.18e41 5.78<<42 OANe+00 O.ooe+00 O.doe+00 2.lae42 OAX4+00 13 Ni46 7~<<od QOSo47 B.0de47 O.doe+00 OANe+00 O.ooe+00

~7e45 S.lle47 17 18

)k 83 Br Bi Br 85 C~OI 16 2rds 15 O.doe+00 1A3o4I 1Ddo+00 IANo+00 2.11o.l 'I 0.00s+ 00 I.03o-l 1 0.00o+00 O.ooo+00 0.00o+00 O.OOo+OO O.OOo+00 OA)I<<05 1A)le+00 2.80e-12 1.57<<40 1AI7o47 O.ooe+OO 0.00e+00 3.01<<OI OANe+00 2.08e+00 O.doe+00 2.02s 11 O.doe+00 OANo+00 O.doe+00 O.doe+00 O.OOo+00 O.doe+00 O.dos+00 1.51o-22

~

O.dos+00 O.ooo+00 OANe+00 1A2e42 OANe+00 2.52e+00 O.odo+00 O.odo-12 O.doe+00 2.2do40 1.27e40 1.07e4 O.ooo+

1.03o48 1DSe47 OANs+00 20 21 Rb 85 Rb 88 0.00s+ 00 0.00o+ 00 5.29o+00 0.00o+00 2.I7e+ Oo 0.27e49 0.dos+00 OANe+00 O.ooo+00 O.doe+00 O.ooe+00 1A)Is+00 O.doe+00 O.ooe+00 2.00<<OS 7.17<<48 23 Sr.89 22 Rb-89 0.00o+00 0.00e+00 1.26o+00 0.00o+00 1.03e48 3.00e42 O.doe+00 O.doe+00 O.dos+00 O.ooetoo O.ooe+00 O.ooe+00 O.ooe+00

~

2.01e41 1.$0e48 I.BQo48 26 Sr.al Sr-82 3.77o43 1.17o46 O.ooo+00 OANot00 3.13o+ 01 O.ooo+ 00 7.dao+00 t.sdo44 1.8'l o45 O.doe+00 O.ooe+00 O.oos+00 O.dos+00 O.dos+00 O.doe+00 O.doe+00 B.OSe41 O.ooe+00 1ANo42 0,00s+00 2.81<<OI OANe+00 I.SSe40 1~o40 27 28 29 31 32 Y 90 Y Qlm Y-91 Y92 Y.83 2.56o45 2.0is-l 0 I.BSo4i 2.18s48 l.d7<<05 l.a7<<os 0.00s+00 O.dos+00 0.00o+00 OANo+00 0.00e+ 00 4.31o44 O.ai<<07 8A9o48 1.5 1e46 2.90<<07 3.80o47 i.8 1 <<OI 0.00o+00 O.doe+00 0.00o+00 0.00e+00 O.OOs+ 00 O.ooe+ 00 O.ooo+00 OANe+00 O.doe+00 O.doe+00 O.dos+00 Q.aoe40 O.ooo+00 2.71o41 O.OOe+OO 7.7I<<1 0 0.00s+00 2.07e41 O.dos+00 3.82e4I

~ O.doe+00 O.dos+00 2.00<<42 1.02o48 9.83o48 2>so40 3A3e47 I.54e47 33

'r-97 Nb.86 3i 3.80o47 7.87o48 2.38<<42 1 43o42 S.S7o45 7>ao43 0.00s+00 1.1$ o47 0.00o+00 1>1 o42 0.00o+00 2AI <<02 0.00o+00 B.oie+Ol 0AIe45 3.13e4i 5-6a(l)

Dr'TE Rev.

1

Table 5-6a:

Composite Dose Factors:

Naximum Hypothetical Adult (Page 2 of 2)

Dose Factor Uni <<:

mrem/Ci Released Location:

Danville (Water Ing.)/Outfall (Fish 8 Shoreline)/FIXED DILUTION lsot Bone Liver T. 8 Th ld Cl LLt Bktn 35 Ho 99 O.OOMOO S.O&e-03 9.7oe 04 0.00c+OO 1.15r02 O.ooe+00 1.17e 02 8.92c 06 39 41 C2

'Tc 99m Tc 101 Ru 1N Ru 105 Ru 106 R.tt0e Te-125a Te-127m 3.00e.08 8.47e-08

'.ooe+OC O.OONOO 2.77e-04 0.00e+00 4 67e.07 O.OOe+00 4.19e-O3 O.OOc OO 8.36c-OS 7.73e 05 1.39e 01 5.02e 02 3.52e 01 1.26e Ol 1AOe-06 O.OOe+00 1.29e-06 4.15e-od 2.14e 09 0.00eKO 0 00eHS 0.00e+00 1.24e-06 1.35e-N 6.74e 03 Oi00e+00 0.00eKN 0.00cKN 6.03e 06 O.ooe+00 d 09r03 0.00eHS 1.52e-OC 0.00et00 1.86e 02 4.17c 02 5.63e 01 0.00eKS 9.00c-02 1A3eKN 0.00+40 4.29e-02 3.30e-OC 0.00eKO 1.06rN 0.00e+00 2.85e OC 2.7te 01 1 20r06 9.57e-04 3.16e.02 T.die-03 5.53e Ol 4.14r06 1.18c+00 2.1'le-07 5.01e-05 3.66e-07 0.00eKO 2 37e 09 3.24e-02 2A6rOC 44 45 Te-127 Te-129m 9.02e.oC 3.24c OC 5.89c ol 2.20e.01 1.95e-OC 933 e-02 6.68c-oC 3.67e-03 2A6eKS 2.02e-ol O.ooe+00 O.ooe+00 7.tRe'-02 5.93r09 2.97e+00 4.50ros 46 Te-129 1.61e.03 6.05e.OC 4.27c-oC 1.23e-N 6.T6e 03 O.ooet00 1.21e-03 4.20e-os 49 Te-131m Te-131 Te-132 5.08e-02 2.49e 02 9.69e 22 4.05e.22 1.06e.ol 6.84e-02 2.0Te.o2 3.94r02 2.52e 01 0.00ecoo 1.08e.od 6.C2e-02 7.97c-22 C.24e 21 0.00et00 T.sse-02 6.58e 01 O.ooet00 2ATe+00 1.37e-22 t~dOr05 1 25e OS 3.23eKS 9.62e 06 50 52 53 54 55 1-130 1-131 1-132 l-133 l -134 l-135 C.OCe.04 1.19e 03 5.95e.13 1.62e.12 6.96e OS 1.82c 04 8.28e-o3 1.18e-02 2.31e.o7 6.18e.07 1.34e.03 2.330.03 4.80e 04 6.82e.03 2.0le-o&

T.16e OC 3.96e 07 7.17e-os t.ole 01 1.86e 03 0.00e4$

2.16c 05 9.85e 07 O.ooe+00 4 07e 03

~ 0 doe+00 3ASe 01 Z.BOc 11 2.57e 12 0.~

0.00eKS 1 2oe-02 2.92e 04 3.68eKS 2.03e 02 O.ooecoo 1.02e 03 1.23c 05 3.t3e N C 06e 05 1.16e 07 2.11e 06 2.10e-N 5.62e-06 1.41e-l5 4 Toe OT 2.06e 04 5.17e.06 56 Cs 134 1.62e+Ol 3.8&c+Ot

3. tset01 0.00c+00 1.25etOt C. 14et00 6.75e-ot 1.56r02 57 Cs-136 1.61 F00 6.35e+00 4.57e+Oo 0 OOe+00 3.53eKN 4.54e 01 T Rle Ol 3 32e 04 58 Cs-137 Z.OBcIot 2.84&01 1.86e+01 O.OOe+00 9.65eKS 3.21 F00 5.50c 01 2.34e-02 59 60 61 Cs-138 Bc.t39 Bc-140 1.4&e-t&

2.87e-l6 2.46e 10 1.75c.13 1.43e.02 l.dOe-oS 1.93e-07 1.2Se-07 9.77c-04 O.OOe+00 O.OOc+OO 0 00e+00 1.64e \\3 6.1'le-06 9.94e-tC 1Neos 2.11e-16 2.09e 17 1.23e-21 2.2le 07 4.36e-to 1Atc 07 4.5&rOS 2.94e OZ 62 Bc-141 Bc-1C2 Lc-tCD O.OOMOO 0.00e+00 O.OOe+00 O.OOe+00 S.&Se-O&

Z.BSc-O&

8.39e-09 t.dte-09 3.7se-os 0.00e+00 0.00eKO 0.00c+Oo O.ooet00 O.Ooe+00 O.ooe+00 O.ooe+00 0.00e+00 O.ooeKN 2.09e 01 4.17e-os O.ooe+00 9.57r09 0.00etoo 2.06e 09 65 Ln-tCZ 8.2&e. 1 2 3.7&e.12 9.60c.o7 O.OOPS O.OOe+OO O.ooeKS 2.74e.od t.tsr06 67 Ce-141 Ce.1C3 3.25e.o&

2.19c 0&

3.42e.07 2.53e 04 2.68e-OS C.44c.06 0.00 F00 O.OOeKN 1.02c-o6 1.11e 07 0.~00 0.~

9A6e.N 5.0le 06 5.39c 03 3.00ros 69 70 Cc.144 Pr-1C3 Pr-1CC 1.73e-oC 3.04e-oS 7.22e OS 1 ~22e.os O.OOe+00 O.OOe+OO 1.45e-oC l.Sic-06 3.24e 10 0.00e+00 O.OOe+00 7.03e 06 O.OOe+OO O.OOe+00 O.ooe+00 0.00eKO C.28e 05 0.00e+00 S.BCe-02 1.33e-ol 0.00eKS 1.57c-04 0 00eKS 3 73e 10 Rd-147 M-t87 wp-239 1.34e-O&

1.31e.07 2.05e-OS 2.37e-05 7.79r03 6.52e-os 1.77c.OS 2.28e.03 3.36e.O&

O.OOe+00 0.00e+OO O.ooeKR 1.39e-oS O.OOe+OO 4.1O.07 0.00e+00 O.OOe+OO O.OOOO 1.14e 01 2.13e+OO 2.69c-02 1 96e 05 5.17e 06 3.81e.o6 5-6a(2)

PAT

Table 5-6b:

Composite Dose Factors:

Maximum Hypothetical Teen (Page 1 of 2)

Dose Factor Units:

mrem/Ci Released

.-~ocation:

Danville (Mater Ing.)/Outfall (Fish and Shoreline)/FIXED DILUTION Ueeao tUep) tka/yr:FISH) n Uoeao lUop) thrIIrrSHOREI >

Ot)rrden llNp:RSH) n Tronett t)mo its hro n Trenott time ttp) bro n 1$

T. Body Ueeao lUep) QrdfyrWATER) a Oikrbon llNpSHORQ ~

Oarrt)on tlNgWATEf0 n Trenelt time lNr) trro n Trenit tine ltb) trre ~

510 25.8 1S1400 O.ooo+00 2.$ 1e45 2.ele45 2.81+05 2A)1e45.

2A)1o05 2.elo45 O.doe+00 2

C14 3

Ne24 P<2 S

CrS1 e

Msi Mn.se 1.86o+00 3.7)F01 7>oe43 740oOS 7.82e+01 4.84e+00 O.doe+00 0.00o+00 O.doe+00 245~1 O.ooo+00 7.59o4d 3.71e41 7A3e4S 3.03o+00 1A1~

$.1 do02 B.sde4d 3.71e41 7~3 O.doe+00 3.~5 OAee+00 O.doe+00 S.7le41 3.71+0) 7~

7~3 OA)de+00 O.ooe+00 1.54e45 7A)oo02 9.$ 1o4$

OA)de+00 3.71e41 O.doe+00 1.77o42 4A)1o41 S.OOe44 S.SSe4e 7~e43 1.44e44 d.S7e+00 O.doe+00 S.aso46 1.18e42 8

Fe55 9

Fsa 10 Co 58 3.8 1e42 2.70e42 6.82o02 1.3$ o41 O.doe+00 4.$3e43 e.SOo43 S.SSe42 1.5So42 O.doe+00 O.doe+ 00 O.doe+ 00 OAOe+00 1.71e02 O.doe+00 'o02 OAX)e+00 O.doe+00 1.17e42 3>1 e41

$.79e42 O.doe+00 3Aae43 4.81e43 11 12 N)43 13 N)46 14 Crr44 O.doe+00 1.44e42 1.78o+ 00 1.28e41 7.77e4$

8.93e47 O.doe+00 1.50e44 1.14e+00 3.ado+00 2.$7o41

$.06o02 2.91~

7.$ 9e45 1.see+ 00 O.doe+00 O.doe+00 O.ooe+00 OA)de+ 00 OA)do+00 OAOe+00 O.ooe+00 OAOe+00 OAXh+00 OA)de+00 O.doe+00 MO+ER OA)de+00 2$ie+00 O.ooe+00 1.87o41 2.76e41 7.08e4$

1.17o42 1.$8e+00 845e43 2A)1e42 O.ooo+00 6~o45, 2.86e4$

1 d Zn49 2.29o-l 1 4.37o-ll 3.0$ e-12 OAOo+00 2.8So-l 1 O.doe+00 S.OSo-l 1 O.doe+00 17 Br 83 18 Br.84 19 Br 85 20 Rb-Sd 21 Rb 88 22 tsr.sa 6 sa O.ooo+ 00 0.00e+ 00 O.doe+00 O.doe+00 O.doe+00 5.70o+00 O.ooo+00 O.doe+00 O.ooe+00 O,doe+00 1.3$ o+00 O.doe+00 O.ooo+00 O.doe+00 1.74o4$

5.99o47 O.ooe+00 2.dao+ 00 3.50o08 9.1 1o08 3.89o42 O.ooo+ 00 O.ooe+ 00 OA)do+00 O.doe+00 0.00e+ 00 O.doe+00 O.oooo 00 0.00o+00 O.doe+00 O.ooe+00 O.ooe+00 OAOo+00 O.doe+00 OA)de+00 O.ooo+00 O.doe+00 O.doe+00 O.doe+00 O.ooo+00 O.ooo+ 00 O.doe+ 00 1.$ 2o41 2.73o47 O.doe+00 5.7eo48 O.ooe+00 d.aso47 O.doe+00 O.ooo+00 8A3o41 O.doe+00 4.00o48 O.ooe+00 1.09e47 24 Snao 26

$ 81 2$

Sr-82 1.Sso45 O.ooe+ 00 2.doe+01 O.doe+00 4.07o43 O.doe+00

$A3e+00 1.8io44 7.12e4$

O.doe+ 00 O.ooo+ 00 OAXIo+00 O.doe+00 O.ooe+00 O.doe+00 O.ooe+00 O.doe+00 O.doe+00 7.3oo41 1.85o42 4.03o44 O.doe+00 2.5ie45 7.27e4$

27 Y-90 28 Y-aim 29 Y91 2.78o45 2.8io-l 6 5.24o44 O.ooo+ 00 O.doe+00 O.doe+00 7.91o47 4,7io47 2.57o45 O.oooo oo O,oooo 00 O.oooo 00 O.doe+00 O.ooe+00 O.ooe+00 O.doe+00 O.doe+00 O.doe+00 2.27o41 134o-14 2.16o41 6.7'I e48 6A9e47 1.31o45 30 Y-a2 31 Y93 2.37e48 O.doe+00 1.81e4$

O.doe+00 1.$ 'Io0$

1.9 Io4$

O.oooo 00 O.ooo+ 00 OAX4+00 O.doe+00 O.doe+00 O.doe+00

$.5Oo44 5.63o42 1.92~

2,56o4$

32 2n$ 6 33 1r.87 34 ttb-96 1.97o45

$.23ood 4.07o47 B.odo48 2AOo41.

1.33o42 2.$ $o4S S.oao46 8.8 1 e43 O.doe+ 00 O.oooo 00 O.ooo +00 1.29o02 O.ooe+00 9.leod O.doe+ 00 1A2e47 O.doe+00 1 A4o42 3.09e43 2.18o41 3.eoe45 S.$ 9o+01

'l.76oos 5-6b(1)

V PAT Rev.

1

Ih l

Table 5-6b:

Composite Dose Factors:

Maximum Hypothetical Teen.(Page 2 of 2)

Dose Factor Units:

mrem/Ci Released Location:

Danville". (Water Ing.)/Outfall (Fish 8 Shoreline)/FIXED DILUTION Isot 36 Tc-99a

., 37 Tc-101 38 Ru-1N 39 Ru 105 0.00e+00 3.05e-08 0.00e+00 2.88e-04 4.98e-07 5.33e-N 8.50e-08 0".00eKS 0.00eKS 0.00eHS T. Bocty lo0&e-N 2.d9e-06 1.19e-08 1.30e.N b.tte 06 TII IcI 0.00eKS 0.00e+00 0.00et00 0.00eKO 0.00et00 1.22e-02 0.00e+00 3.2?c-06 4.?2e.08 0.00eKS 0.00e+00 101eN 0.00ct00 6.28e 06 0.00eHS CI LLI 9.54e N 5.58e.05

'0.00e+00 2AOe~02 4.02e-OC Sktn 4.98e 05 2.04e-06 t.33e-od 1.3?e~N 6.?te 06 CO Ru-106 Cl Ay 110a, 42 Te-125a 43 Te-12?a 44 Te-127 4.50e-03 7.87e-05 1.51e 01 3.83e 01 9.8?e 04 0.00etOO 7ASe-05 SA3e 02 t.3&e 01 3.50e-OC 5.16e.N

'.7Ce-02 2.02e 02 4.55e-02 2.12e-OC 0.00e+00 0.00e+00 4.21e 02 9.11e 02 6.81e-OC 8.6?c-N 1A2e-OC 0.00eKS 0.00e+00 0.00eKS 0.00e+00 1.55eKO 4.00e-03 0 00eKN

'0,00eHS 2.16e 01 5.51eiN 2.09e 02 C.36e 02 4ASe 01 9.5Ce-01 2.31e 05 1;lde 06 7.62e-02 3.31 ~ 05 C5 Te. 1 R9a C6 Te-129 47 Te 131a 48 Te.131 C9 Te.132 SO I 130 51 I 131 6.36e-01 1.75e-03 5 A6e.02 1.05e-21 l.lie.01 4.15e-04 B.doe-03 2.36e 01 6.52e-04 2.62e 02 4.3le-22 7.06e-02 1.20e-N 1.23e.02 1.0le 01 6.23e.04 2.19e.02 6.05e-M 6.65e 02 5.3?e-04 6.80e-N 2.05e-01 1.25e-03 3.94e 02 8.05c-22

?A4e-02 9.80e 02 3.59cKS 7.3Ce-N 2.?3e-OI 4.5?e-21 6.8?e 01 1.85e-N 2.12e-02 0.00eHN 0.00eHS 0.00cHS 0.00cHS 0.00cKO 0.00eKS O.OOHOO 9.24e 04 6.Me 05 2.44e-03 2.26e-04 2 39eHS 2.51e 04 9.56e 03 234e 04 2.10eHN 1.01 ~

OC 8.58e-23

?.15e-05 2.24e+00 5 3?e-05 52 l.132 53 I 133 2.40e.07 1.43e-03 6.29e 07 2.43e-03 1.02e-05 7.68e 04 2.t2e-05 3.40e 01 9.91e-07 0.00+HO C.2?e 03 0.00eKS 2.74e.07 1.18e 05 l.bCe-N 54 I 134 55 I.135 56 Cs 134 57 Cs 136 58 Cs.137 6.22e.13

?.24e-05 1.66e+01 1.62e+00 2.23e+Ot 1.65e

'I2 1.86e 04 3.9lwOI 6.36e+00 2.96e+01 2.21e 06 1.82etOI 4.2?e+00 1.04e+Ot 2.75e-ll 1.20e-02 0.00e+00 0.00e+00 0.00e+00 2.60e 12 0.00et00 0.00e+00 t.24~1 4.?Ce400 5.CSe-01 1.01+%1 3.9teKS R.t?e-tC 2.07e 04 4.86e.0'I 5.12e 01 4.21e O'I 2.63e 06 2.89e 05 8.?O 02 1.86e 03 1.3t~t 59 Cs.138 1.56e.l6 2.99e-16 1.05e 06 0.00e+00 2.21e 16 2.57e 17 1.36e 19 1.23e 06 60 Ba-139 61 Ba.1CO 62 Ba-141 63 Ba-142 64 La.1CO 65 La-142 66 Ce.141 2.64e-10 1.C9e-02 0.00e+00 0.00e+00 5.96e.06 8.77e.12 3.33e.06 I.BSe-t3 1.82e-05 0.00e+00 0.00e+00 2.93e.06 3.59e.12 2.22e.06 7.00e-07 I.lde 03 4.69e~08 1.01e.05 2.06e OC S.36e 0&

I.C9e-04 0.00e+00 0.00eKN 0.00e+00 0.00eKN 0.00e+00 0.00e+00 0.00eKS 1.?Se-13 6.1?e-06 0.00e+00 0.00eHO 0.00et00 0.00eKl0 1.05e-06 1.25e-13 1.22e.05 0.00eKR 0.00eKN 0.00cHS 0.00eKO 0.00e+00 235 e-09 7.~7 0.00e+00 1.68e-01 1.19e-07 6.36e.03 1.15e-08 2.33e-04 6.43e-06 1.6?e-OC 2.29e 02 2.55t44 0 ~ 00e+00 5.34e 08 67 Ce-143 65 Ce-1CC 69 Pr-1C3 3.52e.07 t.?de-04 3.28e.05 2.56e.04 7.35e-05 1.3le 05 2.C7e.05

?.66e-04 1.63e-06 0.00e+00 0.00eKS 0.00e+00 1.15e 07 4.39e-05 7.60e 06 0.00eKS 0.00eKO 0.00~00 7.70e 03 C.C?e-04 1.08e.01 2.80e 05 0.00e400.

70 Pr-144 7I Nd.147

?2 M.187 0.00'0 2.32e.05 8.42e.03 0.00e+00 2.52e 05 6.56e 03 I.dte~09 9.26e-OS 2.43e-03 0.00eKN 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 1.CBe 05 0.00e+00 0.00e+00 9.09e-02 1.86e+00 2.05e 09 1.09e OC 2.89e 05 73 Kp-239 1.C9e'0&

1.COe 07 1.55e 05 0.00eKN C.COe-07 0.00e+00 2.26e-02 2.13e-05 5-6b(2)

Table 5-6c:

Composite Dose Factors:

Maximum Hypothetical Child (page 1 of 2)

Dose Factor. Units:

mrem/Ci Released Location:

Danville (Water Ing.)/Outfall (Fish and Shoreline)/FiXED DELUT10N Uooge IUop) IkgfyrFSH) ~

Uoogo IUop) ihrfyrNORB ~

O$uHon It)Mp&SH) ~

Trono)t tee ItA hre i Trono)t one Itp) hro ~

Q.ooo+00 14 16AI T. Body SAIOe45 Ueege IUop) IbglyrNATER) a Dgubon I1IMpA80RQ ~

NuOort IllMp:WATSRI.a Trono)t time Itw) hro e

~

Treneit time Itb) hro i 510 1bAI 26$

1S1400 Lung OILU Mn 3AIOe4S Saee45 Oaee+00 C.14.

3 No 24 P42 2~+00 B.loe43 4.77e41 8.10e43 1.01e+02 4.72e+00 4.77e41 8.12e43 3.8$o+00 4.77o41 B.loe43 O.ooe+00 4.77o41 8.10e43 Oaoe+00 4.77o41 4.77o41 OAOe+00 8.10e43 B.loo43 S.ole46 Oaoo+00 2.70o+00 Oaeo+00 5

Cr 61 e

M bi Fe.SS 11 Co-50 12 Ni 53 13 Q.ooo+00 Q.ooo+00 Q.ooe+00 5.1~2 7> le42 O.ooe+00 Q.ooe+00 2>9e+00 1A)lo45 O.ego+00 1.84oo'I 5.96e45 2.71e42 1.17e41 4.09o43 1.21e42 1.28e41 0.50e47 1ASe44 8.52e45 5.23e42 3.14o45 8.38e43 5AIVe42 8A7o42 8.12e42 1AIV~

8.70e46 4~5 Q.ooe+00 Oaoo+00 O.ooe+ 00 Oaoe+00 OAOe+00 Oaeo+00 Oaoe+00 Q.ooo+00 Q.ooe+00 1.1Se45 5.17o42 8.41e45 O.coo+00 OAOe+00 Oaoe+00

~ Oaeo+00 Oaeotoo Oaeo+00 3.47e44 7.55e46 iale43 1.26o46 O.ooe+00 1.5~1 3.59o43 Oaoo+00 1.01~

1abo45 1.53e42 6.0'le43 OAOe+00 348o42 141o41 MSrOi O.ooe+00 2~2 1ale43 Oaoo+00 LVSe42 6.76e42 oao +oo B.clue Qao +oo O.oeo+00

'l.1eo44 SAIOo47 OAOe+00 LVSe43 1A8o45 16 Zn45 le Zn49 17 Br.83

'IS Br 94 19 Br-8S 20

~85 21 Rb-88 Q.ooo+00 0.00o+00 Q.ooo+00 6.S3o+00 O.ooe+00 O.ego+00 1.17e+00 S.'12o+00 2.96e-ll Q.ooe+00 0.00o+00 Q.ooo+ 00

~

O.ooe+ 00 1.04o+00 SAHo 12 2.21o45 1.26e47 OAXh+00 SAoo+ 00 741o49 0.00e+00 Oaoo+00 Q.ooo+00 0.00e+00 O.ooo+00 Q.ooo+00 Q.ego+00 1AIVe+00 2$8e 11 O.ooe+00 OANe+00 0.00o+00 O.oooo 00 Oaeeooo SABe41 labe43 O.ooe+00 2.59o40 O.ooe+

O.ooe+00 O.ooe+00 1

O.ooe+00 Oaoo+00 1AOo47 Oaoe+00 Q.ooe+00 OaOe+00 Q.ooe+00 S.bee41 2~6 O.ooe+00 Q.ego+00 845e40 22 Rb-89 2S Sr49 24 Sr.90 26 Sr 91 25 8 $2 2ASo+ 01 0.ego+00 5.5~3 0.00o+00 2.13e45 Q.ooe+00 O.ooo+00 0.00e+00 1.89o+ 00 Q.ooe+ 00

'I.goe48 645o42 5.2le+00 2.14o44 2.22e45 Q.ego+00 Q.ego+00 Oago+00 O.ooe+00 0.00o+00 0.00e+00 Q.ooo+00 O.ooo+00 0.00o+00 O.ooo+00 Q.ooo+00 O.ooo+00 K28e4&

Q.ooe+00 VDOo42 5.71o48 O.ooo+00 3~1 Q.ooo+00 Q.ooo+00 142o42 S>1o45 O.ooe+00 4A)3eoi 1.52e45 27 28 30 31 Y.$0 Y 81m Y-91 Y.92 Y.03 3.84e45 Q.ego+00 3.78o 15 Q.ego+00 7&o44 O.ooo+ 00 3.2io48 0.ego+00 0.ego+00 1.0io45 2.20e46 3.38e47 4.59e47 Q.oooo 00 O.ooe+00 Q.oooo oo O.ooo+00 Q.goo+00 Q.ooo+00 0.00e+00 O.ooe+00 0.00e+00 O.ooo+00 0.00e+00 1.0$o41 1.1$e48 O.ooe+00 7Aoo 13 1.16e47 O.ooo+00 0.72o42

74o45 Q.ooo+00 0.37o44 iaoe47 Q.ooo+00 3.73o42 S>2e47 32 Zr 9S 33 Zr.97 3A2e45 7.51e45 7.34e47 1.05o47 6.5~4 5.62o45 0.geo+00 O.ooe+00 1.08o46 1.52e47 O.ooe+ 00 VANo43 OA6e44 O.ego+00 1.5 1e42 7.51 eoe Si Nb 96 2.83o42 1.10a02 8.I9o43 0.00o+ 00 1.0~2 0.00o+00 2.04o+Q1 3.5~

5-6c(1)

DAT Pev.

1

Table 5-6c:

Composite Dose Factors:

Maximum Hypothetical Child (Page 2 of 2)

Dose Factor Units:

OIrem/Ci Released Location:

Danvi1 le (Mater Ing.)(OLItfall (Fish 8 Shoreline)/FIXED DILUTtOH 36 Isot No 99 Te.%ha Tc-tbt 0.00ehR 5.97'.07e Ob 7.99e 08 0.00eKS 0.00ee00 1A9e 03 1.70e 06 2A9e 09 Th jd 0.~

0.00eKS 0.00eKO 1.27e OR 1

16e 06 0.00eKS 0.00e400 CI LLI 4.94e-03 4.06e-08 C.SSe-05 0.00eKN 0.00eKS Sktn 1.04e 05 C.27e 07 2.77e-09 ku 103 C.20e 04 0.00eKO 0.00eKO

.0.00ee00 1 09e 02 2.87e 04 Ru-105 737ei07 0.00eKO 0.00eKO 0.00eKO 4.81e OC

'IAOe 06 40 41 42 43 45 46 47 48 49 Bu 106 A

1tba Te 125a Te-127a Te0127 Te-12%a Te-129 Te 13ta Te-131 Te 132 6.83e 03 137e 04 1.95~1 4.9~I 1.27e-03 8.24e 01 2.27e-03'.9be 02 t.34e-21 1.40e~01 0.00eKO I.~t 2.30e Ol 6.33e-04 Z.Cled 4.09'2 6: 19~2 I.dtei03 7.89e 03 2.59e 02 5 89e 02 2.73e 04 1;2be 01 5.79e-04 2.57e 02 1.2&e 08 7 Cbee02 0.00eKN 0.00eKS 5.~2

1. 19~1 9.22e 03

'.73~

0.00eKO 1.41eKO 8.82e OC 3.63e.03 Z.6&e 01 2.42e400 1.62e 03 6.63e-03 4.97e 02 2.3Ce-01 1 03e 21 4.06e Rl 5 75e 01 9.01e 02 0 00eKS 0.00eKS 0 00eKS 0.00eKS 0.00tKS 0.00e+N 0.00eKN 0 00eKN 0.00eKS 0.00eKS 1.0&e 01 1.10e OZ I~t 4.02e 01 C.9be 02 1.00eKN 1 Ale-Ot 9.79e-01 7.05e-21 6.23e-01 1.15e-03 9.lie 03 C~

2.~7 6.91e-09 5.25e 05 C.90e 05 2 10e 05 1A9e 05 t.tZ~

50 51 52 55 56

'I30 I.131 I.132 I

133 I

134 I 135 Ca-134 5.69e-OC 1.26e-02 3.27e<7 8.23e 13 1.00e 04 2.Oleic)1 1.26e-OZ 6.0le&7 1.53e 12 3.~t

&.OCe 04 7.21e 03 2.37e-06 4.&Ze-07 9.03e-05 6.96eKS 1.27e Ol 4.15et00 2.79e 05 C.70e 01 3.$ 2e 11 1.59~2 0.00eKS T.n~03 2.07e 02 9.20e 07 2.3Ce-12 2.7~

1.02eeOI 0.00eKN 0.00eKO 0.00e+00 0 00eKN 0.00eKS 0.00eKS 3 A+KM 5.3be OC 1.12e 03 7.08e 07 1.02e 03 1.01e 12 1.37e-04 1.77e 01 t.~

4,73e 05 2A6e 06 6.5$ e-06 SA9e 07 6.03e 0&

1.~2 57.

Ca-136 58

'a-137 1.9te+00 Z.~t S.2S ed%

2~t 3.39e+00 0.00eKS 0.00eKN 2.79eKO C.17e 01 3.15eKS 1.84e 01 t.~t 3.~

~

2.~

59

&I 62 65 67 Ca-138 Be 139 Be-140 Be 141 Be 142 La-140 Le 142 Ce 141 Ce 143 1 9be-16 C.32e-lO 2.57e-OR 0.00eKO 0 00eKN 8.04e 06 1.17e II 7.74e-O&

8.14e-07 2.7Se 16 2.3te-t3 0.00eKO 0.00eNO R.die-06 3.73e 12 3.86e-0&

2.25e&7 1.~7 4 39e-05 1.12e-06 3.16e 05 5.2'Ie-06 0.00et00 0.00eKS 0.00eKO 0.00et00 0.00eKN 0.00e+00 0.00e+00 0.00e+00 0.00e+00 1.93e 16 2 Ole 13 7.3Ce 06 0.00eKN 0.00eKS 0.00eKS 0.00e+00 1.69e 06 1.85e 07 1 3&e 13 1 34e-05 0.00eKN 0.00eKN 0.00eKS 0.00@KM 0.00eKN 0.00eKN 2A9e Ob 1.30e 02 0.00eKO 0.00ehS 7.83e 02 7.3be 07 C.82e-03 6A7e-03 2 Obe 17 1.26e-16 2.57~7."

1.~7 SM~

t.tZ~

2Ale 09 C.~

1.34e 06 3.50e 05 5.85e 06 69 70 71 Ce 144 Pr-143 Pr 144 KO-t47 V-187 Ko 239 4.57e 05 0.00eKO 3.20e 05 1.07e 02 2 ~ 25e-0&

1.37e 05 0.00eKN 2.60e.05 6.33~3 1.&Ze.07 1.80e 04 2.27e-06 3.78e 10 2.10e.05 2.84e-03 3.95e-06 0.00~

0.00e+00 0.00e+00 0.00~

7.19~

7 43e 06 0.00eKS l.CRe 05 0.00e+00 C,&be 07 0.~

0.00eKS 0.00eKS 0.00@AN 0.00eKO 0 00eKS 3.3de-02 C.93e 02 0.00eKN C.lie 02 B.d9e O'I 1.20e.02 t.~

O.OOOO C.3Se 10 Z.~

4ASe.06 5-6c(2}

Table 5-6d:

Water Ingestion Dose Factors:

Haximum Hypothetical Infant (Page 1 of 2)

Dose Factors:

mrem/Ci Released Location:

Danville ReceiverlFIXED OILVTION Use tu

) (k /

NCYRR) ~

troratt t{~ {Mated) hre 330 0llution Ci gMiYRR) ~

321 25 8 cot H 3 2

C1C 3

Ro 24 32 r-St 6

Nn 54 7

Hn-56 e-55 e S9 0.00eNN 2.Coe 03 3.11e 04 1.64e 01 0.00eKS 0.00eKS 0 AORS 1.41e 03 3.07e 03 3.12e-oS

5. 13r04 3.11e-04 9.63c 03 0.00tt00 2.0le-03 8.OTe-ad 9 loc OC 5.37e-03 1

id 3 12e 05 3.12ros 5.13r04 13r04 3 tie 04 3v'lie 04 6.34e 03 O.oocNO 1.39e-06 9.08r07 4.~

0.00eKN 1 39e 08 0+Oaecaa 2,43r04 Q.ooeKO 2.1 te-03 0.~

L at Ll.l 3.t2e 05 '.'t2c 05 3.12e 05 S 13r04 5-13r04 5.13e 04 3.ttr04 3.ttr04 3.1te 04 Q OQeKN 0.00eKN 2.21e 03 1.98r07 1.77e-ob 4.06e-os 4 46r04 0.00eKO T 40r04 0.~

7.33r06 0.00eKN CASe 04 1.16e-o4 0.00e400 1 59e 03 2.S6e 03 10 Co 55 11 Co-60 12 Ni 63 13 RI 65 0.00eKS 0.00eKN 6.43c 02 3.05c.07 3.61e-04 1.09c 03 3.98r03 CA7c 05 9.OtrOC 0.~

Z.s9 03 0.~

2.23e 03 0.00et00 2 03c 05 0 00eKO 0.00eKS 0 00cKO 0.00eKS 0.00eKS 9.00e 04 0.00eKO '.ate-03 0.00eKO 1 98ro4 0.00eKO 3AOe 06 1C Cu-64 15 Zn-ds Q.oaeNO 1.86e-03 1.$ 1c-os 6~35r03 T.OO 06 O.OOeeOO 2 94e 03 O.OQeKO 2.5&ras 0.00eKO 3.10e 04 3.09r03 0 00eKN 5~03 16 Zn 69 17 Rr 83 lb Rr ~84 19 dr 85 C.09c 1C 0 00eKO 0.00eKN 0 00e+00 T.36c 14 0.00tKO 0.00eKS 0.00eKO 5 Ade-15 0 00eKS 2.07rad 0AoeKN 9 19c 20 0 Met00 0.00eKS 3 06e 14 0.00e400 0.00eKO 0 00eKO 0 00eKO 6.00c 1'2 0.00eKS 0.00eKO 0.00e400 0 00et00 0.~

0.00eKO 20 Rb 8&

Q.ooeKS 1.66c QZ d 19e 03 OAOet00 0.00eKO 0 00eKO 4.24e 04 2l Rb 85 22 Rb-80 23 Sr 89 2C Sr-90 25 Sr 01 Zb Sr 92 O.ooeKS O.ooeKS 2.5te&t 7.72e oc Z.&srob 0.00eKO 0.00eKS 0.00eKN 0.00eKO 0.00eKN 0.00eKS 0.00eKO O.aoeeo 7 20r03 0.00eKS O.aocKS a.ooeeoo 4.78 at 0.~

2.79r05 0.~

9ASc 05 0.~

0.~

0.00eKO 0~00eKO 0.00eKO 0 00eNN 0 00eKO 0.00eKO 0.00eKO 0.00eKO 0 00eKO O.~

5 tbr03 0.00eKO

. 2~02 0.00eKO 9~14r04 0.00eKO 2.86e 05 31 Yi03 32 Zr-95 33 Zr 9T 34 Nb-05 35 No.00 2T Y.90 25 Y 9 la 20 Y 01 30 Y-92

&.67c Ob 3.62c-lT 1.13e OC 4.96e 09 C.20c-OT 2.0Te-oS 5.21c OT C.17e-06 O.oorao Q.ooeKN Q.ooeKS 0.00eKO 0.00eKS O.ooeKO 5.03c 06 8.94c 05 1.72c.ob 2.63c.0$

1 79c-07 0.00eKO 1.23c-lb 3.01e 06 0.00eKN 1.40c-la 0.00eKS 1.14rod 0.00eNO 3.5Tc 06 0.00eKS C.odc-od 0.00eHR 0.93c.oT 0.00eKO 0.00e+00 S.13c.OC 0 00eNO 0.00eKN 9.21c 03 0.00eKS 0.00e+00 1.21c-l'3 0.00eKO 0.00eKS 8.11e-03 0.00eKN 0.00eKO 9ATe-05 OAOeKN 0.00eKS 3&le~

5A2c 06 O.tXheKS 2 S'le.ia 9.01c-ad 0.00cKS 5.70r03 1.23e 06 0.00eKS 1 Asc 03 3.93e-03 0.00eKO 8.66c 04 5-6d(l}

Table 5-6d:

Water Ingestion Dose Factors:

Haximttm Hypothetical Infant (Page 2 of 2)

Dose Factors:

nrem/Ci Released Locati on:

Oanv'1 l l e Rece iver(FIXED DILUTION taot fc-99a fe 101 9.98e~09 0.Doe+00 2.0be 08 0.00eNS

f. 8 2.&5e Ol Q.Doe+00 fh td 2.22c 07 0.00eKS 1.08e 08 0:OR+M 5.98e 06 0.00eKO

<<g'38 Ru-103 Ru 't05 1.47e 04 2.4&e.07 0.00eKS 0.0~

8.27c-ob 0.00eeoo 1.8le 06 OAOe+OO 3.07e-04 0.00e400 0.00eKO 1.79c 03 9.7le.05 40 41 C2 43 Ru '106 R

~ 1 toa 1e-125a fe'127a fe 127 2.C4e 03 1.01e.OC 2.33e.03 5.89e 03 1.50e OS D.OOOO 7.35e-05 T.me~DC 1.95e~03 S.OZc-06 3.05c-04 4.8&e 05 3.15e.04 7.13e 04 3.22e-o&

0.00ceoo 0.00et00 7.85e 04 1.70e 03 1.22e 05 2.88e 03 1.05e 04 O.ooceoo 1A5~

3.65e 05 0.00eKO 0.00e+00 0.00eKS 0.00eKO 0.00e+00 3.8te-03 t.tt~

2~

3.15~

45 fe 129a 9.92e*03 3.COe 03 1.53e 03 3.8te 03 2.48e 02 O.ooeeoo CT 50 52 53 55 56 57 58 59 61 65 67 69 71 te-129 fe 13la fe 131 fe 132 I

130 I.131 I.'t32 1.133 l 134 1

135 Cc-134 Ca-136 Cs 137 Cs.138 Bc 139 Be 140 Be 141 Be 142 t ~-'t40 t.e-142 Ce 14'1 Ce-143 Ce-144 Pr 143 Pr-144 Kd 147 u 187 Kp 239 2.82e.QS I

8.49e 04 4'de ZC 1.68e 03 1.C3e OC 3.32e.03 7.07e 08 5.37e-OC 1.27e-13 2.47c~05 3 82e-02 C.COe 03 5.29e.02 1.76e 19 2 26c

'10 1.64e 02 O.~

0.~

1.3le 06 1.C9e 12 T.boe-06 8.73e-QT 3.01e-04 7.80e-od 0.~

5.24e 06 4.32e-05 8.20e-07 9.71e-ob 3.42e-OC t.&5eiZC 8.3lc 04 3.15e 04 3.91e 03 1;44e 07 7.81e-OC ZAOe 13 C.91e 05 7.12e 02 1.~2 6.20e 02 2.86e-19 1.50e 13 1.64e-05 0.00eNN 0.00eKN SAle 07 S.CTe 13 4.76e-ob 5.79e-04 1.23e-04 2.92e.ob 0.00eNN S.38e 06 3.01e.OS 7.34e-ob 6.5be 06 2.82e OC 1.25e-2C

t. 2&e-04 72ee03 5.11e 08 2.29e-04 9.25e 1C 1.79e 05

7. f9~3 4.83e 03 C.39e 03 1.39e l9 6.55e 12 8.43e 04 0.00eKN 0.00eKO 1.39e 07 1 3te-13 5.&oe-ol 6.&le-ob 1.69e 05 3.87e 07 O.Doer 3.30e.ol 1.04e-OS 4.15e-08 2.36e 05 6.93e 04 3.98e-ZC 3;53e-02 1.2SeKS 6.73e 0&

1A2e-ot, 6.06e 12 CAoe 03 0.00eKS 0.00eKO 0.00e+00 0.00eKS 0.~

0.00e+00 0,00eKO O.Doer%

0.00eKS 0.00e+00 O.ooeKO 0 00eKO 0.00eKS 0.00cKS 0.00cKN 0.00eKS 0.00eKS

0. 00e+00 7.01e 05 2.35i 03 1.14e-23 3.46e 04 4.57e 03 1.&oe Ol 9.19c-OC

'.91e 13 5 ATe.05 1.83e-02 5.16e 03 1.&6e 02 1.43e 19 9.02e-tC 3.88e 06 0.00et00 0.00eKS O.ooeKS O.ooeKN 1.47e.06 1.69e-ol C.99e 05 1.08e 06 O.Doe+00 2.08e-06 0.00eKS 1.C6e 07 O.ooeKO 0.00eKS 0.00+AS O.ooetoo O.ooetoo 0.00eKS 0.00eKS 0.00eKS 0.00eKS 7.52ei03 1.05e-03 6.73e.03 2.23e-20 9.09e-14 1.00e 05 0.00e+00 D.Doe@00 0.00ekS 0.00et00 0.Doe+00 0.Doe+00 0.00e+Q)

Q.Doe+00 0.Doe+00 0.Doe+00 0.Doe+00 0.00e+00 2 25~

5.7~

1.80c-22 t.t~7 2.69c 13 t.~

1~

C.5Te 'l9

\\~

O.ooceOO D.oocKO

&~

4.12e~

0.00eKN 3.41e 03 1.77c-03 2.'l2e.03 5-6d(2)

5.1 Fish Pathway Liquid Effluent Dose Calculation Hethodology The following expression is used to calculate the fish ingestion pathway dose contribution for the total release period from all radionuclides released in liquid effluent to unrestricted areas:

ll R g ~

Z~

<< Cg << V~ << k (Eq-lo)

~4pj p

where:

R,)pj Total fish ingestion dose during period to organ j to individuals of age group a from all radi'onuclides i in pathway p (mrem);

i<pl Fish ingestion dose conversion factor to organ 3 of individuals of age group a from all radionuclides i in pathway p (mrem-ft /Ci-sec:

Tables 5-la,b, and c);

c, Average concentration of radionuclide i in undiluted liquid effluent during batch release from radwaste

( uCi, 1e-6 Ci m2 uCi Y,

Total undiluted batch volume released from radwaste (gallons);

Conversion factor (3.785 e3 ml/gallon);

Minimum blowdown flow (ft /sec).

g r 22

5-2 Potable Mater Pathwav Effluent Dose Calculation Hethodology The follow~no exoresscon is used to ca1culate the fish ingestion pathway dose contribution for the total release period from all rad(onuclides releasea in liquia effluent to unrestricted areas:

K~)

~ eXp(-X~t

) + Cq o V,

~ k 4$ D7 f

(Eq 11}

A P

~nere R-Total potable water ingestion dose during period to organ j to individua1s of age group. a from all raaionuc)ides i in pathway p (mrem);

)pj Potab le water ingestion Dose conversion factor to organ j of individuals of age group a from all radionuclides i in path~ay p (mrem-ft /C$ -sec:

Tables 5-2a,b,c, and d);

Radioactive decay constant (hr ~: Table 5-3);

River transit time (hr: Table 5-4);

I OF, Dilution factor (unitless:

Table 5-4);

other factors oescrcbed in Section 5.1.

23

5.3 Shoreline Exposure Pathway The following expression is used to.calculate the shoreline exposure pathway dose contribution for the total, release period from all

.radionuclides released in liquid effluent to unrestricted areas:

where R,-,

J Total shoreline dose during period to organ j (total body or skin) to individuals of age group a from all radionuclides i in pathway p (mrem);

K>

Shoreline dose conversion factor to organ j of individuals of age group a from all radionuclides i in

'athway p (mrem-fthm/Ci-sec: Table 5-5);

other factors described in Section 5.1.

5.4 Projected Dose from l,iquid Effluent The following expression is used to estimate the combined fish, water ingestion and shoreline exposure pathway dose contribution for the F

projected release period and volume from all radionuclides released in liquid effluent to unrestricted areas:

24

R~~p~

E [K~~~ + Cg

+ V~

k]

(Eq 13) where R>

alp)

Total projected dose during peri'od to organ j from fish, water ingestion and shoreline exposure to individuals of age group a from all radionuclides i in pathway p (mrem};

K,fpj Composite dose conversion factor'adult, teen, child} or water

. ingestion dose factor (infant) to organ j of individuals to age group a from all radionuclides i in pathway p (mrem/Ci released:

Tables 5-6a,b,c, and d);

other factors described in Section 5.1.

The projected quarterly dose contribution from batch releases for which radionuclide concentrations are determined by periodic composite sample analysis, as.stated in Table 4. 11.1. 1. 1-1 of the SSES Technical Specification may be approximated by assuming an average concentration based on the previous monthly (rolling 31-day} or quarterly composite analysis.

The calculated dose contributions from these radionuclides shall be base on the actual composite analysis-The cumulative dose comnjtment to the total body or any organ for a quarterly or annual analysis shall be based on the calculated dose contributions from each batch release occurring during that time period.

In actual practice, the LAOTAP II computer code developed by the NRG to implement the liquid dose methodology of Regulatory Guide 1.109 will be used to perform the individual liquid pathway dose calculations for the SSES.

The methods outlined above are consistent with those of the LAOTAP II code.

A discussion of the LADTAP II code as applied to SSES liquid effluent, is given in Section A.3.1 of Appendix A.

26

6.0 INOIV DUAL DOSE OUE TO AI BOR FF UENT 6.1 NOBLE GASCS S

CIFICATION 3.

- THE AIR DOSE OUE TO NOBLE GASES RELEASED IN'ASEOUS EFFLUENTS, FROM EACH REACTOR UNIT, TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-1)

SHALL BE LIMITED TO THE FOLLOWING:

a.

DURING ANY CALENDAR QUARTER:

LESS THAN OR EQUAL TO 5,MRAD FOR GAMMA RADIATION AND LESS THAN. OR EQUAL TO 10 FARAD fOR BETA RADIATION, AND b.

DURING ANY CALENDAR YEAR:

LESS THAN OR EQUAL TO 10 MRAD FOR GAMMA RADIATION AND LESS THAN OR EQUAL TO 20 HRAD FOR BETA RADI ATION.

The air dose in unrestricted areas beyond the site boundary due to noble gases released in airborne effluents from the site shall be determined by the following equation for gamma radiation during any specific time period:

0 3.17 x 10 g

M. (X/Q)v Qi (Eq.

14) and by the following equation for beta radiation during any specified time period:

Ob 3.17 x 10 g

N,. (X/Q)v Q,.v Where:

(Eq.

15)

(X/Q)v the air dose factor due to gamma emissions for each identified noble g~s radionuclide (i)

(mrad/yr per uCi/m

) from Table 2.

the air dose factor due to beta emissions for each identified noble ga~ radionuclide (i)

(mrad/yr per uCi/m ) from Table 2.

the highest calculated annual average relative concentration for any area at or, beyond the site boundary in an u~restricted area from vent release point (v) (sec/m

) such as from Table 3.

the total gamma air dose from gaseous effluents for specified time period (mrad).

27 V

PAT

D r the total beta air dose for gaseous effluents for a

specified time period (mrad).

3.17 x 10 the integrated release of each, identified noble 9as radionuclide (i} in gaseous effluents from all vents (v) for a specified time. period (uCi}.

the inverse of seconds in a year (yr/sec).

A discussion of the method used to calculate the individual dbse from gaseous effluents is given in Section A.3.2 af Appendix A.

Also,. sample calculations for determining gamma and beta air doses from noble gas radionuclides released from the SSES are given.

6.2 0

ONUC ID S 0 THAN 0

G S

SP C

F CAT ON 3.

.3 - THE DOSE TO A MEMBER OF THE PUBLIC FROM IODINE-131, TRITIUM, AND ALL RADIONUCLIDES IN PARTICULATE FORM MITH HALF-LIVES GREATER THAN 8 DAYS IN GASEOUS EFFLUENTS RELEAS'ED, FROM EACH REACTOR UNIT, TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-1)

SHALL BE LIMITED TO THE FOLLOWING:

a.

DURING ANY CALENDAR QUARTER:

LESS THAN OR EQUAL TO 7.5 MREMS TO ANY ORGAN, AND b.

DURING ANY CALENDAR YEAR:

LESS THAN OR EQUAL TO 15 MREMS TO ANY ORGAN.

The critical organ dose to an individual from I-131, tritium, and radioactive materials in particulate form with half-lives greater than 8 days released in airborne effluents from the site to unrestricted areas can be determined by the following equation during any specified time period:

'D 3.17 x 10 Z,.

(R.)

(W) (Qiv) 1 (Eq.

16) 28

where:

P a,

R) w g) e 3.17 x 10 the total dose to a critical orgari from radio-nuclides other than noble gases for a specified time period {mrem).

the dose parameter.for each identified radionucli4e (i) for the inhalation pathway (mrem/yr per uCi/m')

and for food and ground plane pathways (m

mrem/yr per uCi/sec) from Table 4.

the highest annual average'ispersion parameter for estimating the dose to the critical individual; relative concentration (Xg) (sec/m ) for the

'nhalation pathway and relative deposition rate (D/g)

(m

) for the food and ground pathways such as from Table 3.

the integrated release of each identified radio-nuclide other than noble gases (i) in gaseous effluents from all vents (v) for a specified time period (uCi).

the inverse of seconds in a year (yr/sec).

1n actual practice, the GASPAR computer code developed by the NRC to implement the airborne dose methodology of Regulatory Guide 1.109 will be used to perform the individual airborne pathway dose calculations for the SSES.

The methods outlined above are consistent with those of the GASPAR code; site specific dose factors have been computed and are available for implementing the method described above, if required.

A discussion of the GASPAR code is given in Section A.3.2 of Appendix A.

29

7.0 OS N

- THE ANNUAL (CALENDAR YEAR) DOSE OR DOSE COMMITMENT TO ANY MEMBER OF THE PUBLIC, DUE TO RELEASES OF RADIOACTIVITYAND RADIATION, FROM URANIUM FUEL CYCLE SOURCES SHALL BE LIMITED TO LESS THAN.

OR EQUAL TO 25 MREMS TO THE TOTAL BODY'R ANY ORGAN EXCEPT THE THYROID, MHICH SHALL BE LIMITED TO LESS THAN OR EQUAL TO 75 MREMS.

The cumulative dose to any member of the public due to radioactive releases from the SSES site is determined by suaeing the calculated doses to critical organs from the previously discussed effluent sources.

The annual dose to critical organs of a maximally exposed individual for the liquid effluents is determined by using Equations 10, 11, and 12 of Section 5.

The annual dose to critical organs of a real individual for the noble gases released in the gaseous effluents is determined by using Equation 14 modified by replacing Mi with Ki from Table 2 for the whole-body dose and by Equation 15 modified by replacing Ni by [Li+((1.11 Mi)(S,))] from Table 2 for the skin dose of Section 6.0:

D 3.17 x 10 Ki(X/0)(0'I)(SF)

(Eq.

17)

\\

0 3.17 x 10

[L. + ((1.11M )(S,))](X/g) (g', )

(Eq.

18)

The annual dose to critical organs of a real individual for the radionuclides other than noble gases released in the gaseous effluents is determined by using Equation 16 of Section 6.0.

For all dose calculations from airborne effluents, the deposition rate used in the analysis should be at the receptor location of the individual being evaluated, not the highest calculated annual average relative concentration or relative deposition rate for any area at or beyond the site boundary as given in Table 3.

The direct radiation from the site should be determined from the environmental monitoring program's direct radiation (TLD) monitors.

Since all other uranium fuel cycle sources are greater than 20 miles away, only the SSES site need be considered as a

uranium fuel cycle source for meeting the EPA regulations.

In actual practice, the LADTAP and GASPAR computer code developed by the NRC to implement the liquid and gaseous dose methodology of Regulatory Guide 1.109 will be used to perform the total dose calculations for the A

j OAT Rev.

2 30

NRC to implement the liquid and gaseous dose methodology of Regulatory Guide 1.109 will be used to perform the total dose calculations for the SSES.

The methods outlined above are consistent with those of. the LADTAP and GASPAR codes.

A discussion of the methods used to calculate the total dose to critical organs of a maximally exposed individual is given in Section A.4 of Appendix A.

31

8.0 8.1 Y

F SP CIF C ON 3 3 - THE LIQUID RADWASTE TREATMENT SYSTEM, AS DESCRIBED IN THE ODCM, SHALL BE OPERABLE;-

THE APPROPRIATE PORTIONS

'F THE SYSTEM SHALL BE USED TO REDUCE THE RADIOACTIVE MATERIALS IN LIQUID MASTE PRIOR TO THEIR DISCHARGE WHEN THE PROJECTED DOSES DUE TO THE LIQUID EFFLUENT, FROM EACH REACTOR UNIT; TO UNRESTRICTED AREA (SEE FIGURE 5.1.3-1)

MOULD EXCEED 0.06 MREM TO THE TOTAL BODY OR 0.2 MREM TO NY ORGN IN A 31-DAY PERIOD.

The SSES Liquid Rad Waste Management system consists of three processing sub-systems, liquid, chemical and laundry.

Redundant and backup equipment, alternate process

routes, interconnections and spare volumes are designed into the system to provide for operational and unanticipated surge waste volumes due to refueling, abnormal leakage rates, decontamination activities and equipment downtime, maintenance and repair.

The Liquid Rad Maste Management System processes equipment drain and floor drain liquids collected in a common plant drainage system.

The system also processes filter backwash, resin transfer liquids and resin cleaning liquids.

The system has piping connections to allow the installation of vendor-supplied equipment to provide specific treatment of off-normal wastes or to enhance the,.normal treatment capabilities as necessary.

Appropriate vendor-supplied equipment may also be used in place of installed equipment to allow for repair or replacement of components.

Low conductivity liquid wastes are processed in the Liquid Radwaste Treatment Sub-system.

Liquid is collected in three pairs of LRW Collection tanks.

Each pair of tanks has an approximate capacity of 28,000 gallons.

Surge capacity is maintained with two pairs LRW Surge Tanks also with a 28,000 gallon/pair capacity.

DAT Liquids from these tanks are normally processed through two vertical centrifugal discharge precoat filters with 300 ft filter area at a 200 gpm normal flow rate.

Liquid from the filters is then sent to a mixed bed demineralizer with a volume of 140 ft and normal flow rate of 200 gpm.

The demineralizer effluent is collected in three pairs of LRM Sample Tanks.

Each 32 Rev.

2

pair of tanks has an approximate capacity of 28,100 gallons.

The

'ater is isolated in these tanks for analysis prior'to recycle to Unit 1 or discharge to the Susquehanna river.

Off-specification liquids can be recycled back to the Liquid Rad Maste Hanagement System for additional processing.

High conductivity wastes are collected in the Chemical Drain Tank and in specific sumps located in the Turbine and Radwaste Buildings.

Liquid from these sources is collected in a Chemical

Maste Tank of approximately 12,000 gallons capacity.

This liquid can then be sent to any one of two pairs of Chemical Maste Neutralizing Tanks.

Each pair. has a capacit'y of 31,000 gallons.

The liquid is then sent to a vendor-supplied Chemical Waste Processing Sub-system for radionuclide removal.

The effluent from the Chemical Waste Processing Sub-system is routed to the Evaporator Distillate Sample Tank where it can be isolated for analysis prior to discharge.

The capability exists to return the liquid to the Liquid Rad Maste Hanagement System for additional processing if necessary.

The Laundry Waste Sub-system collects water from washdown, laundry and decontamination facilities in one of two Laundry Drain Tanks.

Each tank has a capacity of approximately 820 gallons and has an independent mechanical filter system.

One tank is normally valved to receive waste while the other is valved for processing.

Effluent from these tanks is routed to the Laundry Drain Sample Tank where it can be isolated for analysis prior to discharge.

Non-specification liquid can be returned to the Chemical Maste Processing Sub-system.

A flow diagram of the Liquid Radwaste Management System is shown in Figure l.

DAT Appropriate treatment for liquid effluents from SSES fs defined in ODCN Policy Statement 10.6.

In cases when a batch of liquid waste must be released with treatment less than that specified in Section 10.6, a dose assessment using LADTAP or the methodology 33 6

s Rev.

2

of Section 5.4 shall be performed prior to release to ensure that the limits of Specification 3.11.1.3 are not exceeded."

8;2 S

US A

P C

ICAT ON 3

. - THE GASEOUS RADMASTE TREATMENT SYSTEM SHALL BE IN OPERATION.

~AR I I:

IIEEEEIIER TIIE IAIO CIOOEEEER AIR ERECTOR EEIACEATIOET SYSTEM IS IN OPERATION.

C F

0 5 - THE APPROPRIATE PORTIONS OF THE VENTILATION EXHAUST TREATMENT SYSTEM SHALL BE OPERABLE AND SHALL BE USED TO REDUCE RADIOACTIVE MATERIALS IN GASEOUS MASTE PRIOR TO THEIR DISCHARGE MHEN THE PROJECTEO DOSES DUE TO GASEOUS EFFLUENT RELEASES FROM EACH REACTOR UNIT TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-1)

WHEN AVERAGED OVER 31 DAYS MOULD EXCEED 0.3 MREM TO ANY ORGAN IN A 31-DAY PERIOD.

The SSES off gas treatment system operates with four steam jet air ejectors maintaining condenser vacuum.

Noncondensible gases are passed through one of three recombiners (one for each reactor unit plus a

common recombiner),

reducing the amount of gases to be filtered and released.

Gases pass through a two to nine minute holdup pipe before entering the off gas treatment

system, which consists of one 100 percent capacity system per reactor unit.

Each system consists of precoolers, chillers, reheaters, guard beds, and five charcoal absorbers and an outlet HEPA filter.

Monitored, filtered air then exits to the turbine building vent.

A flow diagram of the off gas and recombiner system is shown in Figure 2.

Filtered exhaust systems serve selected areas of Zone I, II, and III of the SSES reactor building.

The Zone I and Zone II equipment compartment and Zone III filtered exhaust systems each consist of two 100X capacity redundant fans and two 55% capacity filter trains.

Each filter train has, in the direction of air flow, roughing filters, upstream HEPA filters, a charcoal filter

bed, and downstream HEPA filters.

Exhaust fan discharge is then routed to the atmosphere via the reactor building vents, where effluents are continuously sampled and monitored.

I DAT

/E 'ev.

2 34

The turbine building filtered exhaust system draws air from those areas of the building that are most likely to become contaminated.

Two 100X capacity fans serve each system, which contains two 50X capacity filter housings made up of a particulate prefilter, an upstream HEPA filter, a. charcoal filter; and a downstream HEPA filter.

Discharged air is released via the turbine building vent's, which are continuously sampled and monitored.

The radwaste building filtered exhaust system draws potentially contaminated air from selected areas of the radwaste building.

The system contains two 100K capacity fans and.two 50K capacity filter housings, each containing a particulate filter bank and a

HEPA filter.

Filtered air is, discharged via the turbine building vent.

1 In order to minimize the quantities of radioactivity in airborne effluents from the station, the ventilation exhaust treatment (filtered exhaust) systems are normally kept in service at SSES.

As the need arises, these systems are periodically rendered inoperable for maintenance or testing activities. If the most recent 31-day dose projection indicates that dose may exceed 0.3 mRem to any organ when averaged over the projected 31-day period, treatment systems rendered inoperable will be restored to operable status as quickly as is practicable.

The dose projections are performed at least once per 31 days based on the most recently available effluent data.

If it is known prior to performing the dose projection that a treatment system will be out of service, and if data exists which indicates how the lack of treatment will impact effluents, these factors will be considered when performing the dose projection.

V DAT Rev.

2 35

8.3 S

C

- THE SOLID RADWASTE SYSTBI SHALL BE USED IN ACCORDANCE WITH A PROCESS CONTROL PROGlUN, FOR THE PROCESSING AND PACKAGING OF RADIOACTIVE WASTES TO ENSURE HEETING THE REgUIREHENTS OF 10 CFR PART 20, 10 CFR PART 71, AND FEDERAL REGULATIONS COVERING THE DISPOSAL OF THE MASTE.

The SSES solid radwaste system collects all wet wastes produced from the operation of other plant systems.

The'astes are then processed and packaged by a vendo} -supplied system into a waste form that meets all applicable Federal, State and local requirements for transportation, storage and disposal.

The processing methodology and acceptance criteria for the final waste forms are'controlled by the Process Control Program.

Filter material from the Reactor Mater Clean-up Systems and the Fuel Pool Clean-up Systems are collected in Backwash Receiving Tanks.

There is one RWCU tank per unit, each with a capacity pf approximately 2450 gallons and one similar tank for the FPCU System.

Wastes from these tanks are directed to one of two 6300 gallon capacity Phase Separators.

Normally, one Phase Separator is valved to collect waste while the other is isolated to provide time for radioactive decay.

The solid content of the waste is concentrated in the Phase Separator and transferred and processed through a vendor-supplied system and packaged for storage or final disposal.

The supernatant liquid is collected and processed by the Liquid Rad Maste Hanagement System.

The Waste Sludge Phase Separator is a 9500 gallon capacity phase separator tank that accepts input from the Regen Waste Surge Tanks.

The concentrated waste is then transferred and processed through a vendor-supplied system and packaged for storage or final disposal.

The supernatant liquid is collected and processed by the Liquid Rad Waste Management System.

OAV Rev.

2 36

Spent bead resin from the Condensate System and from the Liquid Radwaste Oemineralizer are collected in the Spent Resin Tank.

These are then processed through a vendor-supplied system and packaged for storage or final disposal.

Spent filter material from the Liquid Radwaste Filters are collected in two Waste Mixing Tanks.

The contents of these tanks are processed through a vendor-supplied system and packaged for storage or final disposal.

A flow diagram of the SSES solid radwaste treatment system is shown in Figure 3.

Dry Active Waste (DAW) consists of contaminated plastic,

paper, clothing, metal or other trash and is collected throughout the RCA of SSES.

DAW is processed and packaged for storage or disposal using off-site vendor-supplied super compaction and incineration services.

DAW may also be compacted with an on-site drum compactor into 55-gallon drums.

An automated DAW monitoring system is used to ensure non-radiological waste collected in the RCA is free from radiological contamination prior to release.

A flow diagram of DAW processing at SSES is shown in Figure 4.

Rev.

2

-37

EVAP.

s ZHO STEAN COHDS.

RETURN TANK PHASE SEPARATOAS (DECANTAYE)

AHR SYSTEII AttCU SYSTEN AKhCTOA 1IKLL SEAL LEAK DRAIN AKACYOA SLDO. OAAIHS OAYttKLL DRAINS YLRSINK SLOO.

OAAIHS APOWASYK SLOtt. DRAINS LIOUID AADIIASTE FIGURE LIQUIO RAOY!ASTE SYSTEM Fl.OYl DIAGRAM LIOUID AADWASTE COLLECTION S SUAOE TAHKS OT-302 A THAU F OT-30l A THAU 0 Lloulo IlhDWASTE FILTERS OF-302 A,B LIQUID RAOWASTE DEIIIHERALIZER OF.301 Llaulo RADNASTE SAIIPLK TANKS OT-303 A THAU F CONOKNSATE DKVIN.

AFSIH REOHKRATIHO TANK LAtt COLLECT10k YhkK PstPS OP-301 A,S>C TO WASTE NIXIHO TANKS OT-307 A>B TO SPKNT RKSIII TAHK OT-32'OHOENSATE STORAOK TANKS OT 522 A,B CH'ElllCAL WASTE NEUTRALIIER TANKS 1T-130 A,B 2T-130 A,B CST BEAII WATER SAltPLE STATIONS AUX BOILER BLOWDOWNS RWCU CHENICAL DECOH.

LAB AHD DECOII. DRAINS CHES. lthSYK IfKllTAALIIItt0 TANK PCS IP ~ 130 hsb 2P ~ 130 A,b RAPNASTE EVAPOAATOA OE-302 A,B DISTILLATE SAIIPLE TANK OT.321 g

LRW SANPLE TAIS(

PINPS OP 305 A,B,C TO COOLIH4 TOWBl SL(N DOWN PIPE LAUINAYOAAIHS RKNATKO SHOP NIAINS PERSONAL OKCONTANe INATIOH (OEYSIOBIYS)

CASK CLKNIINS ORAIHS CHEN ICAL WASTE TAHK OT.SIi CHBl WASTE TANK PINPS OP-320 A,b CHENICAL WASTE PROCKSSIHO SUS-SYSTEN (VENDOR SUPPLIED)

EVAPORATOR CONCENTRATE STORAOE TANK OT-322 TD WASTE IIIXIN4 TANKS OT-SOT hgB LAUNDRY DRAIN TANtt OT 814 A,B I

j OAT Rev.'.

'AUNDRY DAAIN TANK PUNPS OP 31S A,B LAUNDRY DRAIN FILTERS OF-513 A,B LAVHIXlYDRAIN SANPLE TANK OT-312 CONCENTRATE STORAOK TANt OISCH. FINP OF.328 LhbNORY DRAIN SANPLE YANK PmtPS OP.310 hsS

MAIRL AUtt SIEAM FROM

<HII I SlfhMÃ1 Atn fJECfOA UHII I I IIIAS b YPASS EL illhl IAACIHG OI IGAS AICOMOIHERSYSIEM I Iunelnf etDG E XIIAUS1 UNIT I AMbtENT TEMPERATURE Ctth'RCOAL OF F GAS SYSTEM UNIT I IF 303 OU LET IIEPA Fll.ff.

IAA OAL AD Abfflbf S

I 1 310 I 1 30S IT.30e 11301 II 300 Ithlh Sf Eh+

COII 014lfl ttnll'<<SIArE

$ 1EAA If1 hlb EIEC 104 CON OEII SEA ll

Ql a I I II OILUflOHSffAM I it I

I I

eh t

)net SIAGa I

I I

IS ITS nfcnMA VFSSEL I

8-i It 131 REcoMe COHO IC 13 ~

MQltVE Slf AM JET r.nHO DELAYtltf IO I'1 30Th IHI.ET IIEPA fttfEA 7

PAE rs<<LI1n ~~ GUhnti M~~

IF3 IA 5 lb.

Ih IF. 3 TA

'1 COMMON OF F GAS AECOMblHEASVST EM Ilhlh STEA COII~

OEA.

SEA ehll f SIEhM JET AIR EJECf04 COHDEHSEA UNII 2 D'ELAYtltf AMblENTTEMtERATURE.CIIAACOAt OFFOASSYSTEM UNIT2 Mhth S AUX STEAV FROM UHIT2 OFFOAS bYPASS OFFOAS AECOMblNER SY5TEM 2 TUAblHE bLDG EXHAUST UNIT 2 FlGURE 2 OFFGAS AND RFCOHBIHER SYSTN FLOM DIAGRAN PAT Rev.

2

FIGURE 3 SOLID Y/ASTE MANAGEMENT SYSTEM FLOII DIAGRAM CONDENSATE DEHIH RESIH STORAOE VESSEL 1T ~ 159 RADWASTE DEIIIHERALI2ER STOAAOE VESSEL OF-301 COHOEHSATE DENIH RESIN STORAOE VESSEL 2T-155 FUEL P001.

F/D SACllhSH RECEIVINO TAHK OT-203 RWCU BACKWASH RECEIVIHO TANK 1T.225 RWCU BACKWASH RECEIVIHO TANK 2T-225 SPENT RESIH TANK OT-324 REaEH WASTE SUROE TANKS 1T-105 A,S REOEH WASTE SURGE TANKS27-105 A,B SPENT RESIN TRANSF ER PUHP OP-320 1P-105 A,B J

REOENERATIOH WASTK 2P-108 A B TRANSFER PUMPS I

I TO VENDOR LIOUID RADWASTE FILTERS OF-502 A)B WASTE SLUDOK DISCHAROK 1IXINO PUHP OP-332 WASTE SLUDOK PHASE SEPARATOR OT 331 RWCU PHASE SEPARATOR OT-318 A RWCU PHASE 5KPARATOll OT $ 18 b WASTE NIXIHO TANKS OT.30T A,S TO VENDOR TO RWSS PUHP EVAPORATOR CONCKNTRATE STORAGE TAHK DISCHARGE PUIS'P-328 EVAPORATOR CONCENTRATE STORAGE TANK OT-322 RWCU SLUDGE DISCHARGE

~

IIININO PUNP OP-33I FROH EVAPORATOR

FIGURE 4

SSES DRY ACTIVE WASTE (DAN)

PROCESSING Non-r adiological Trash from RCA

Paper, Plastic,

Rags, Clothing from RCA Second-Sort DAW Dry Active Waste (DAW)

Monitoring System PP&L Radioactive?

Yes Vendor Services Supercompaction Incineration Drum Compactor 55-gal.

Drums or Boxes No Free Released 41 DAT Rev.

2

9.0 0

OG A

N ROMM 9.1 IIEFFIM Tt N

ONT GP G

Meekly:

Once in each calendar week ht intervals of approximately 7 days, plus or minus 2 days.

Semi-Monthly:

Twice each calendar month at intervals. of approximately 15 days, plus or minus 4 days.

Monthly:

quarterly:

Once each calendar month at intervals of approximately 30 days, plus or minus 6 days.

Once in each three month period.of a calendar year at intervals of approximately 13 weeks, plus or minus 3 weeks.

9.2 0

0 G

0 AN SP 3.

- THE RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM SHALL BE CONDUCTED AS SPECIFIED IN TABLE 3.12.1-1.

Environmental samples shall be collected and analyzed (as a minimum) according to Table 6 at locations shown in Figures 5 and 6.

Analytical techniques used shall ensure that the detection capabilities in Table 7 are achieved.

A dust loading study (RMC-TR-81-01) was conducted to assure that the proper transmission factor was used in calculating gross beta activity of air particulate samples.

This study concluded that the sample collection frequency of once per week was sufficient and that the.use of 1 for the transmission correction factor for gross beta analysis of air.particulate samples is valid.

The charcoal sampler cartridges used in the airborne radioiodine sampling program (Science Applications, Inc., Model CP-100) are designed and tested by the manufacturer to assure a high quality of radioiodine capture.

A certificate from the manufacturer is supplied and retained with each batch of cartridges certifying the percent retention of radioiodine versus air flow rate through the cartridge.

Rev.

2 42

The results of the radiological environmental monitoring program are intended to supplement the results of the radiological effluent monitoring by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and modeling of the environmental exposure pathways.

Thus, the specified environmental monitoring program provides measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides which lead to the. highest potential radiation exposures of individuals resulting from station operation.

Program changes may be proposed based on operational experience.

Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment, and other legitimate reasons.

If specimens are unobtainable due to sampling equipment malfunction, an effort shall be made to complete corrective action prior to the end of the next sampling period.

All deviations from the sampling schedule shall be documented in the next Annual Radioactive Effluent and Waste Disposal report.

Reporting requirements for the radiological environmental surveillance program are given in Appendix B.

~RR PR M

SP C FICAT ON 3. 2.

- A LAND-USE CENSUS SHALL BE CONDUCTED AND SHALL IDENTIFY WITHIN A DISTANCE OF 8 KM (5 MILES) THE LOCATION IN EACH OF THE 16 METEOROLOGICAL SECTORS OF THE NEAREST MILK ANIMAL, THE NEAREST RESIDENCE AND THE NEAREST GARDEN* OF GREATER THAN 50 M2 (500 FT2)

PRODUCING BROAD LEAF VEGETATION.

Broad leaf vegetation sampling of at least three different kinds of vegetation may be performed at the site boundary in each of two direction sectors with the highest predicted 0/9's in lieu of the garden census.

Specifications for broad leaf vegetation sampling in Table 3.12.1-1, item 4C shall be followed, including analysis of control samples.

DAT Rev.

2 43

If a land use census identifies a location(s) with a higher average annual deposition rate (0/Q) than a current indicator location, the following shall apply:

1. If the D/Q is at least 20 percent greater than a previously high D/Q, the new location shall be added to the program within 30 days of documented identification of sampling feasibility.

The indicator location having the lowest D/Q may be dropped from the program after October 31 of the year in which the land use census was conducted.

2. If the 0/Q is not 20 percent greater than the previously highest D/Q, direction, distance, and D/Q will be considered in deciding whethe}

to replace one of the existing sample locations.

If applicable, replacement shall be within 30 days.

Any evaluations of possible location replacement should include the past history of the location, availability of sample, milk production history, and other applicable environmental conditions.

A land use census will be conducted at least once per calendar year by a door-to-door or aerial

survey, by consulting local agricultural authorities, or by any combination of these methods.

9.4 NT R ABO ORY COMPAR SON PROGRAM SPEC F

C TION 3. 1

.3 - ANALYSES SHALL BE PERFORMED ON RADIOACTIVE MATERIALS SUPPLIED AS PART OF AN INTERLABORATORY COMPARISON PROGRAM WHICH HAS BEEN APPROVED BY THE COMMISSION.

The laboratories of the licensee and licensee's contractors which perform analyses shall participate in the Environmental Protection Agency's (EPA's) Environmental Radioactivity Laboratory Intercomparisons Studies (Crosscheck)

Program or an equivalent program which has been approved by the Commission.

This participation shall include some of the determinations (sample medium-radionuclide combination) that are offered by EPA and that are also included in the monitoring program.

The results of the analyses of these crosscheck samples shall be iacluded in the annual report.

'A DAT Rev.

2 44

If the results of analyses performed by the licensee or licensee's contractor in conjunction with the EPA crosscheck program (or equivalent program) are outside the specified control limits, the laboratory shall investigate the cause of. the problem and take steps to correct it.

The results of this investigation and corrective action sha11 be included in the Annual Radiological Environmental Operating Report.

Rev.

2

FIGURE 5 ENVIRONMENTAL MONITORING LOCATIONS WITHIN ONE MILE OF THE SSES 2

~

I GOULD ISI AND I T ]

T i /

(y Tn TT~ ~ gggf iF az aa ~ I a r--"~> "

I t

I I

I t mmeJ I

I I

/

~ y e~ l

/Q~ fan%

C G

~~ ~ m m ~

I p ~ ~ ~ ~ ~ ~ ~ csJ lSQ T ~N gQS i I ae w m m m m eP'ITE BQUNNRY S

0

~SUSQUEIQLNNA RIVER

~lCC 1NR T

DMS~

~:

OAT~

Rev.

2 46

FIGURE 6 ENVIRONMENTALMONITORING LOCATIONS GREATER THAN ONE MILE FROM THE SSES 14 15F1 SUSQ&HIANNA RIVER I

T SHICKSHINNY,gg MOCANAQUA NANTICOKE GLEN LYON

~4K2 POND HILL

~m1 QT BERNICE i2 Q.un MIFFLIN VILLE K

VAPVALLOPEN

~

IRAN T

NESCOPECK gg To~

8 CONYNGHAM

/r HAZLETON qa g}

DRQfKNC %ATIR nm DATF 47

TABLE 6 OPERATlOOL RADIOLOG1CAL ENVIRONKENTAL NNlTiIIN6 PROGRAH Page 1 of 3 Exposure Pathways and or S

le irboIne Radioiodine and Particulates'ree Radi ion NImker of Santplos

~alld oc4ttIgts 1251 0.4 mi VSV - E.O.F. Building 12E1 4.7 mi VSV - Scr>>lck Hospital 7G1 14 mi SE - PPSL Hazleton Complex 1053 0.6 mi SSV - East of Confer's Lane, South of Towers Club 1356 0.4 mi V - Former Laydown Arcs, Vest of Confer's Lane 152 Peristetcr Fence - 0.2 mi N

102 Hocanaqua

- 4.0 mi N

253 Peristcter Fence - 0.2 mi NNK 283 Durabond Corporation - 1.3 mi NNE 2Fl St. Adalbcrts Cemetery - 5.9 mi NNK 354 Perimeter Fence - 0.3 mi NE 3D1 Pond Hill/LilyLake Fire Co. - 3.4 mi KE 3Fl Valanla Residence - 9.1 ml NE 3GS Vilkes-Barre-Parrish St. Substation-18 mi NE'S3 Vest of S5ES APF - 0.2 mi ENE 4E1 Rockies HI11 Road Pole tg) 46422/N35197 - 4.8

@ii EKE 461 Crest>>cod industrial Park-14 mi ENE'S7 Perimeter Fence - 0.3 mi E

5E2 S1oss Farm - 4.5 mi K

654 Pcrimetcr Fence - 0.2 mi ESE 6A4 Rivcrsidc Restaurant - 0.6 mi ESE Smspllng and Continual sampler operation >>lth sample collection weekly.*~

quarterly Type and f Ana Radioiodine Canister:

analyze weekly for 1-131 Particulate Samp1e:

Analyze for gross beta radioactivity less than 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months folio>>ing filter change.

PerforIa isotopic analysis on composite sample (by location) quarterly.

Gasma Dose:

quarterly.

Rev.

Z

Page 2 of 3 Exposure Pathways and or Ntsrker of San@les a~nd acetlons 6E1 St.

James Church - 4.7 mi ESE 659 Perimeter Fence - 0.2 mi ESE 756 Perimeter Fence - 0.2 mi SE 7E1 Harrood Transmission Line Pole l2-4.2 I@i SE 7G1 PPSL Hazleton Complex -

14 ml SE'52 Perimeter Fence - 0.2 ml SSE 882 LaMall Residence - 1.4 mi SSE 803 Harry Residence

- 4.0 ml SSE 952 Security Fence - 0.2 ml 5

904 Country Folk Store - 3.6 mi 5 1051 Post South of Switching Station - 0.4 mi SSV-1001 Ross Rynan Fare - 3.0 mi.SSM 1153 Security Fence - 0.3 ei SV llE1 Ihomas Residence

- 4.7 mi SV 1253 Perimeter fence - 0.4 ml MSM 12E1 Berwick Hospital - 4.7 mi MSV 1ZGl PPLL Bloensbur'9 Service Center - 15 mi VSV'352 Perimeter fence - 0.4 ml V 13E4 Kess1er farm - 4.1 mi V 1455 Beach Grove Rd.

6 Confer 's Lane Intersection 0.5 ml VXV 14E1 Canouse fare - 4.1 mi VtN 15F1 Zawatski Fans - 5.4 ml NV 1555 Perimeter Fence - 0.4 mi HV 1651 Perimeter Fence - 0.3 mi RHM 1652 Perimeter Fence - 0.3 mi RIM 16FI Hldlay Residence - 7.8 HlN Sampling and Co lection F

~

Type and 0

~Va erbo r Surface Orlnking Sediment from Shoreline 6SB river water intake line'57 cooling tower blowdown discharge line 12H2 Oanville 'Mater Co.

tApproximate)y 30 mlles downstream) 7B Bell Bend - 1.2 mi SE Honthly composl te Honthly composl te Honthly composite Semi-annually Gasrsa isotopic.ana1ysis.

Composite trestles analysis at 1east quarterly.

Gross beta and gaama isotopic analyses monthly.

Composite for tr itias analysis at least quarterly.

GasnLs isotopic analysis seal-annually.

DAT Rev.

2

Page 3 of 3 Exposure Pathways Illlk"

'ish and Inver tebrates Food Products Nmker of Samp)es

~and ocatian

~

1293 Young Farm - 2.0 ml MSM IOGI Oavls Farm - Il ml.

SSM'002 Ray Roman Farm - 3.5 ml.

SSM 1001 RCC Roman Farm - 3.0 ml.

SSM Outfall area 2H Falls, PA'Approximately 30 ml NNE) 1101 2ehner Farm - 3.3.

ml SM vegetable 12F1 tupinI Farm - 8.3 ml MSM vegetable Sampling'nd Co ection Semi-month)y when animals are on

pasture, monthly otherwise Semi-annualiy.

One sample'rom each of two reacreatlonally Important species from any of the fol)owing families:

bullhead catfish, sunfish, pikes, or perches.

At time of harvest Gasms Isotopic and 1-131 analysis of each sea@le.

Gamna Isotopic on edlb)e portions.

GasnuL isotopic on edible portions.

4

'The location of samples and equipment were designed using the guidance in the Branch Technical Position.to NRC Rev. Guide 4.8, Rev. 1, Now. 1919, Reg. Guide 48.

1975 and ORP/SID 12-2 Environ>>ntal Radioactivity Surveillance Guide.

Therefore, the airborne san@Ter locations were based upon X/Q and/or 0/Q.

"A dust loading study (RIIC-TR-BI-OI) concluded that the assonptlon of I for the transmission correction factor for gross beta ana)ysls of air partlcu)ate samples Is valid.

AIr particulate samples need not be weighed to determine a transmission correction factor.

"Ifa milk sample Is unavailable for more than two sampling periods from one or mare of the locations, a vegetation sample shall be substituted until a suitab)e milk location Is evaluated.

Such an occurrence will be docmsented ln the REHP annual report.

Control sample Tocatlon.

b Two-week composite if calcu)ated doses due to consumption of water exceed one milllrem per year.

In these cases, 1-131 analyses wI)1 be performed.

c The samp1e co11ector will determine the species based upon availability, which may vary seasonally and yearly.

TABLE 7 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS LoWel'imit of Detection (LLD)

~Anal sis gross beta H-3 Hn-54 Fe-59 Co-58 Zn-65 Water

@Cia 2000 15 30 30 Airborne Particulate or Gas Ci m' x 10 Fish Ci k wet 130 260 130 260 Milk Food Products Sediment fgCi~l fpC~ikq, w~nt gy~Ci k

d~r Zr-95 1-131 Cs-134 Cs-137 Ba-140 La-140 30 Ib 15 18 60 15 7 x 10 5 x 10 6x10 130 150 18 60 15 60 60 150 180 Rev.

2

TABLE 7 (Continued) t The LLD is the smallest concentration of radioactive material in a sample that will be detected with 95 percent probability and with 5 percent probability of falsely concluding that a blank observation represents a

"real" signal.

For a particular measurement system (which may include radiochemical separation):

Ll.D where:

4.66 s, 2.22 EVY exp (-A h t)

LLD is the "a priori" lower limit of detection as defined above (as pCi per unit mass or volume).

sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate

'(as counts per minute)

E is the counting efficiency (as counts per transformation)

V is the sample size (in units of mass or volume) 2.22 is the number of disintegrations per minute per picocurie Y

is the fractional radiochemical yield (when applicable) is the radioactive decay constant'for the particular radionuclide, and is the elapsed time between sample collection (or end of the sample collection period) and time of counting.

In calculating the LLD for a radionuclide determined by gama-ray spectrometry, the background should include the contributions of other radio-nuclides normally present in the samples (e.g.,

potassium-40 milk samples).

Typical values for E, V, Y, and t should be used in the calculations.

It should be recognized that the LLD is defined as an g ~~~r'before the fact) limit representing the capability of a measurement system and not as g tf tt f tttt~<<t t

t bLLD for drinking water.

DAT Rev.

2

10.0 S

SS NT 10.1 Selection f A a u

For determination of compliance with SSES Technical Specification dose limits, effluent totals shall be based only on. activity positively detected at the 95% confidence level.

10.2 ssi nme t o Releases ea r'

s For determination of compliance with SSES radioactive effluent dose limits which are on a "per reactor unit" basis:

a.

Effluents from the Unit 1 Reactor Building vent and the Unit 1

Turbine Building vent shall be included as Unit 1 releases.

b.

Effluents from the Unit 2 Reactor Building vent and the Unit 2 Turbine Building vent shall be included as Unit 2 releases.

c.

Effluents from the Standby Gas Treatment System vent shall be equally divided between Unit 1 and Unit 2 release totals.

d.

Waterborne effluents shall be equally divided between Unit 1

and Unit 2 release totals.

10.3 valuatio and Honi or n ri r'a or f

P thwa Potential unmonitored effluent pathways will be evaluated on a

case-by-case basis.

Periodic sampling and/or realistic evaluation will be performed in order to demonstrate the significance of a potential effluent pathway.

Results of sampling and/or evaluation may be used to classify a potential unmonitored effluent pathway into one of the following categories:

a.

ot an ffl nt Pathw Realistic evaluation (e.g.,

engineering

design, system operation, radionuclide inventory) demonstrates that the pathway has no potential for release of radioactive material (Table 8).

Although not required, periodic DAT Rev.

2 53

sampling may at times be performed to confirm the result of the evaluation.

b.

Evaluation and/or periodic sampling demonstrate that the pathway may contain radioactive effluents,

however, these effluents may not be reasonably expected to exceed 10 percent of the appropriate unrestricted area ffPC value (fractional HPCs sutmed when appropriate) listed in Table II of Appendix 8 to 10 CFR 20 (Table 9).

A release pathway which falls in this category will be sampled periodically.

c. Si

'cant f Pat wa :

Evaluation and/or periodic sampling demonstrate that the pathway may contain radioactive efflue'nts, and these effluents may be reasonably expected to exceed 10 percent of the appropriate unrestricted area HPC value (fractional HPCs sumed when appropriate) listed in Table II of Appendix B to 10 CFR 20.

A release pathway which falls in this category will be sampled continuously.

Analyses of samples will be performed consistent with techniques used for samples of the same types collected from normal effluent pathways.

Any radioactive materials detected in samples collected from either the Insignificant or the Significant Release Pathways will be included in determining compliance with site dose limits.

Additionally, any such occurrences will be reported in the Annual Effluent'nd Waste Disposal Report.

10.4 low from GTS V

w n

tern

'hen the Standby Gas Treatment is not being used, there remains a

small amount of flow from the SGTS vent.

This residual flow is exhaust from the battery rooms in the control structure.

Because there are no identifiable sources of radioactivity in these

rooms, auxiliary particulate and iodine sample and noble gas grab sample at 4-hour intervals are not required from the SGTS vent when the SGTS continuous vent monitor is out of service, ~vied

~t DAT 4

Rev.

2

a.

the Standby Gas Treatment System is not being used, b.

there are proper administrative controls in place to ensure that the required sampling will begin within 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months if the treatment system is operated.

10.5 0

CM Set oi ts are U

e Effluent monitor alarm/trip setpoints calculated in accordance with the ODCH shall be considered upper limit values.

Higher (less conservative) setpoints shall not be used, however lower (more conservative) setpoints may be used as required to maximize the utility of the monitor.

10.6 Defi it'on of "

r ate Trea met"'d stes Technical Specification 3.11.1.3 requires that the appropriate portions of the liquid waste treatment system be operable and be used to reduce radioactivity in liquid wastes prior to their release when projected doses from each reactor unit to unrestricted areas would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31 day period.

o The normal treatment, which is considered appropriate for each subsystem, is as follows:

Filtration is considered appropriate treatment for the Liquid Radwaste Laundry Processing Subsystem, which consists of high conductivity liquid wastes, such as those from equipment washdown and personnel decontamination facilities, or laundry.

The atmospheric demineralizer (a vendor-supplied system which is directed to the Distillate Sample Tank) is considered appropriate for the Liquid Radwaste Chemical Processing Subsystem.

Rev.

2

Demineralization and filtration are considered appropriate treatment for low conductivity/low organic contaminant liquid wastes entering the Liquid Radwaste Processing Subsystem (LRN collection tanks}, except for batches which yield projected doses prior to treatlent of less than or equal to 6.45-04 mrem to the total body and 2.15E-03 mrem to any organ, where filtration alone is appropriate, or o For batches which have no identified gaaea activity above.the Technical'Specification Liquid. Effluent LLD level (Table 4.11.1.1.1-1),

release without. treatment is considered appropriate.

BASES The projected dose threshold values used are derived by dividing the site-total maximum projected doses without treatment (0.12 and 0.4 mrem) by 31 days and by 6, the maximum possible number of batches released per day, to yield per-batch dose action levels.

The two levels of "appropriate" treatment are in place so as not to require application of demineralization for treating low activity, high conductivity water (e.g;, from Circulating or Service Mater leakage).

This would increase the overall efficiency of the solid radwaste program while ensurin9 calculated doses remain at a suitable fraction of 10 CFR 50 design objectives and Technical'Specification 3.11.1.2 limit.~"~ ~

(1)Reference Calculation No.

OT-RKB-92-001:

Calculation of Liquid Isotope Offsite Dose Consequences for Use of Atmospheric Demineralizer System, PLI-70360; 2/4/92.

'Reference Lette~

R.

K.

Barclay to R.

A.

Breslin:

Demineralizer Effluent Results, PLI-70612, 3/4/92.

56 DAT 'ev.

2 Atmospheric

10.7 onitor i e o s o r ct'n order to correct for airborne effluent monitor sample line

loss, the following correction factors shall be applied to monitor data and sample analysis results:

OUTIN FF U

Reactor Building Unit 1

Reactor Building Unit 2 Turbine Building Unit 1

Standby Gas Treatment

'urbine Building Unit 2 1.5 1.6 1.5 1.6 3.2 3.2 3.6 3.9 3.6 POST ACCIOENT VENT NON T S

QN CTO S

TCU S

Turbine Building Unit 1

Standby Gas Treatment Turbine Building Unit 2 1.7 1.6 1.7 4.2 4.3 Each indicated iodine and particulates concentration shall be multiplied by the appropriate correction factor to estimate the actual concentration at the inlet to the sample line.

10.8 Selection of Oata for a

on o ose Rate Com liance Airborne effluent monitor setpoints are maintained in accordance with Section 2.2 to alarm before the dose'rate limits of Specification 3.11.2.1 are exceeded.

Station alarm response procedures contain instructions for investigation and verification of monitor alarms.

Because setpoint calculations must include assumptions about the composition of the monitored effluent, a

monitor high alarm does not necessarily indicate that a dose rate limit has been exceeded.

Rev.

2 57

Valid ten-minute averaged data should be the primary information used to determine 'the compliance status of an incident.

One-minute aver aged data should also be reviewed if available, but they may or may not provide additional information depending on the magnitude of the release due to the manner in which the monitors update values to be stored and associated statistical considerations.

Averages over a longer period should be'used only when data with higher resolution is not aVailable.

Grab sample analyses should be performed whenever possible.to confirm or disprove monitor data, and to provide indication of the nuclide-specific composition of the effluent.

When grab sample data are available which, based on vent monitor data, are indicative of the period of elevated

release, dose rate calculations should be performed using the actual effluent'ix.

The determination of compliance status should not be based on monitor data alone when it is possible to collect and analyze a vent sample which will be representative of the period of elevated release.

10.9 ow-Level Radioactivit in the Sewa e

eat e t P

a t Like all sewage processing facilities, the SSES sewage treatment plant can under certain conditions receive low levels of radioactive materials.

The most notable scenario is when individuals who work on-site have been subjected to the medical administration of radiopharmaceuticals for diagnostic or therapeutic purposes.

In these

cases, normal'biological elimination processes can easily result in levels of radioactivity in sewage treatment plant solutions and suspensions which are within the detection capabilities of the associated sampling and analysis program.

Because disposal of sewage treatment plant sludge by controlled dispersal on specified tracts of land is a common practice, the following guidelines have been established:

a.

All sludge collected in the sludge holding tank should be sampled and analyzed prior to land disposal to quantify any

~:

DAT Rev.

2 58

radioactivity present above natural background levels.

b.

Sludge containing nuclides with short half-lives, for example iodine-131, should be contained on-site to permit decay to less than detectable levels.

c.

When sludge is contaminated with nuclides.which have half-lives sufficiently long to make hold-up for decay impractical, the following options should be coniidered:

1.

Dispose of the sludge as low level radioactive waste.

2.

Obtain a special permit pursuant to the requirements of 10 CFR 20.302.

d.

The sewage treatment plant effluent should be sampled monthly for radioactivity.

This can be accomplished by drawing a

sample from the chlorine contact chamber.

DAT Rev.

2 59

'I

11. 0 ODCH R

V W AND R SION CONTRO The Supervisor-Environmental Services-Nuclear shall ensure that a

total review of the ODCH is performed during each even-numbered year..

Comments shall be documented and revisions initiated as appropriate.

,Each ODCH page shall be numbered and provided with an approval and date box.

The ODCH Table of Contents shall present the current revision date for each page so that any manual holder can check manual completeness based on a current Table of Contents.

All ODCH revisions shall be reviewe'd by PORC before approval by the Manager-Nucle'ar Technology.

PORC review shall be indicated by PORC chairperson or designee signature on ODCH cover.

ODCM copies shall be issued in a controlled fashion by the staff of the Nuclear Department Library.

The distribution list shall be maintained by the Nuclear Department Library Staff.

Any comments on ODCM contents or proposed revisions should be directed to the Supervisor-Environmental Services-Nuclear.

OAT Rev.

2 60

,P

TABLE 8 SYSTEMS CLASSIFIED AS NOT AN EFFLUENT PATHWAY (Page 1 of 2)

Domestic Water SYSTBl DESCRIPTION REFERENCE River Mater Hakeu Intake Com ressed Air Screens and Screenwash Fire Protection Water Fire Protection CO Fire Protection. Halon Turbine Buildin Closed Coolin Water Buildin Drains:

NON RAD Water Pretreatment Condensate and Refuel Water Transfer Low Pressure Air Condensate Demins Lube Oil Transfer Purification Coolin Tower Acid Chlorination Circulatin Water Condenser Tube Cleanin Feedwater Extraction Steam Feedwater Heaters Residual Heat Removal Reactor Core Isolation Coolin Core S ra Hi h Pressure Coolant Injection Standb Li uid Control Control Rod Drives (I)

PPBL Calculation EC-ENVR-1008 DAT A

Rev.

2 61

TABLE 8 SYSTEHS CLASSIFIED AS NOT.AN EFFLUENT PATHWAY (Page 2 of 2)

SYSTBI DESCRIPTION Su ression Pool Primar Containment Vacuum Breakers Su ression Pool Cleanu Reactor Water Cleanu Reactor Pressure Vessel Reactor Recirculation System Radwaste Chilled Water Solid Radwaste Cement Silo LRW Collection Tb and Cond. Outer Area Sum s

LRW Processin Radwaste Eva orator Gaseous Radwaste Recombiner Closed Coolin Water Nitro en Stora e

Hydro en Stora e

Sam lin Stations Post Accident Sam lin S stem By ass Steam Hain Steam Isolation Valves/

Nuclear Steam Su ly S stem Shutoff Automatic De ressurization System HSIV Leaka e Control Hoisture Se arators Turbine Steam, Seals Electrohydraulic Control Stator Coolin Hain Generator Storm Drains REFERENCE (I)

PP8L Calculation EC-ENVR-1008 DAI'ev. 2 62

0

TABLE 9 SYSTENS CLASSIFIED AS INSIGNIFICANT EFFLUENT PATHWAY H

Seal Oil SYSTEN DESCRIPTION REFERENCE Condensate Stora e Tank Hain Turbine/RFPT Lube Oil Instrument Air Service Air Tem orary Laundry Facilit Second Sort (DAW Volume Reduction Facilit Low Level Radwaste Handlin Facility (1)

PP8L Calculation EC-ENVR-1008 (2)

Safety Evaluation NL-90-029:

Temporary Laundry Facility (3)

Safety Evaluation NL-89-002:

Dry Active Waste Volume Reduction System (4)

Safety Evaluation NL-92-007:

Operation of LLRWHF at SSES DAT Rev.

2 63

APPENDIX A SAMPLE CALCULATIONS OF ODCM PA A.I

~SPOINTS A.l.I waterborne Effluent Monitors A.l. 1.1 Li uid Radwaste Oischar e Line Monitor For an unidentified mixture with an assumed MPC of IE-7 uCi/ml, an actual activity concentration of If-5 uCi/ml, and a blowdown flow setpoint of 5000 gpm, the high radiation setpoint concentration, c,

can be determined from c x(A). If x 3,

then the actual high radiation setpoint concentration is:

c 3 (A) 3 (IE-5) c 3E-5 uCi/ml The Alert radiation setpoint is 0.8 times the high radiation

setpoint, or 1.6 times the actual activity concentration.

The setpoint value for the liquid effluent monitors is then determined by Equation 3 in the ODCM.

For the above release conditions, the setpoint value, assuming a typical calibration factor of 1.3 x 10 uCi/ml per cpm, would be:

Setpoint cpm-Cal. Factor

+ Background (cpm)

B k

"B 1.3 x 10 Setpoint cpm - 2.3E3 + Background The LRM discharge Row setpoint is then determined as fo11ows:

A-1

F+f Y(A).

f MPC F

where Y is made equal to 10.

5000+f 10 (1E-5)

~ f 1E-7 f ~ 5 gpm For an identified mixture 'with an actual HPC of 7.22E-7 uCi/ml and the same activity concentration, blowdown flow and X and Y values as above, the LRW discharge monitor setpoint value and LRW discharge flow setpoint become:

High radiation setpoint concentration (c) 3E-5 uCi/ml High radiation setpoint value 2.3E3 cpm + Background LRW discharge flow setpoint (f) 36 gpm A.l.1.2 Service Water Monitor

Background

300 cps Calibration.Factor 1.5E-8 uCi/ml per cps Activity concentration - 2E-5 uCi/ml (2E-5)/Cal. Factor 1333 cps Because 300 cps is less than 1333 cps:

HI RAD Setpoint

0.5 Background

+ (2E-5)/Cal. Factor

- 0.5 (300 cps)

+ (2E-5)/(1.5E-8)

- 150 cps + 1333 cps 1483 cps DOWNSCALE Setpoint - 0.5 Background (0.5)(300 cps) 150 cps 14 0

Calibration Factor 1.5E-B uCi/ml per cps (2E-5)/Cal. Factor 1333 cps Because 1400 cps is greater than 1333 cps:

HI RAD Setpoint Background + (0;5)(2E-5)/Cal.

Factor 1400 cps + (IE-5)/(1.5E-B) 2067 cps A-2

OOMNSCALE Setpoint

= Background - 0.5 (ZE-5)/Cal.

Factor

= 1400 cps - 0.5 (ZE-5)/1.5E-8)

= 1400 cps - 667 cps -"'33 cps A. 1. 1.3 RHR Service Mater Monitor

~61 0

6:

0 ill 6

= l60*

, Calibration Factor 3.9E-9 uCi/ml per cpm (2E-5)/Cal. Factor

~ 5128 cpm Because 160 cpm is less than 5128 cpm:

HI RAO Setpoint

= 0.5 Background

+ (2E-5)/Cal. Factor

= Q.5 (16Q cpm) + (ZE-5)/(3.9E-9)

= 80 cpm + 5128 cpm

~ 5208 cpm LOW RAO Setpoint

= 0.5 Background

= 0.5 (160 cpm)

= 80 cpm ALERT Setpoint

= 0.8 HI RAD Setpoint

~ 4166 cpm 0000 Calibration Factor

= 3.9E-9 uCi/ml

-per cpm (ZE-5)/Cal. Factor ~'128 cpm Because 6000 cpm is greater than 5128 cpm:

HI RAD Setpoint

Background

+ (0.5)(2E-5)/Cal. Factor 6000 cpm + ( lE-5)/(3.9E-9)

- 6000 cpm + 2564 cpm 8564 cpm LOM RAG Setpoint Background - 0.5 (2E-5)/Cal. Factor

~ 6000 cpm - 0.5 (ZE-5)/(3.9E-'9) 6000 cpm - 2564 cpm = 3436 cpm ALERT Setpoint - 0.8 HI RAD Setpoint 6851 cpm Gaseous Effluent Honitors A.1.2.1 Noble Gas Honitor To determine the release rate limit for noble gases, an isotopic mixture representative of plant effluents is selected.

For example, the following mixture from A-3 DEC g j 1989

0

Argon-41 Krypton-83m Krypton-85m Krypton-85 Krypton-87 Krypton-88 Xenon-131m Xenon-133m Xenon-133 Xenon-135m Xenon-135

~Xe on-38 Total 25 Ci/yr per reactor 4

1,700 270 32 660 71 14 12,500 220 590

~0 16,376 Ci/yr per reactor The above annual release quantities are entered into GASPAR with the following annual average dispersion estimates

(

Reference:

1982 SSES Meteorology Report):

Relative Concentration Decayed Relative Concentration Decayed Depleted Relative Concentration Deposition Rate 4.1E-5 sec/m 3 4.1E-5 sec/m 3.8E-5 sec/m 3 4.2E-B m

This set of annual average meteorological parameters is the most conservative over the period 1973-1982.

The total body dose via the plume pathway which results is 18.3 mrem.

Equation 5 of the ODCM is then used to calculate the limiting release rate from each of the five plant release points:

Limiting Release Rate 32 752 Ci (36.6 mrem) 500 mrem r

8.95E4 Ci/yr per vent (5 vents)

A-4 DAT

This limiting release rate is then converted to limiting.(setpoint) concentrations using Equation 6 of the ODCN and high limit vent flow rates.

Sample High Limit Vent Flow Rates:

Unit 1 Reactor Building Vent Unit 2 Reactor Bu)lding Vent Standby Gas Treatment System Vent Unit 1 Turbine Building Vent Unit 2 Turbine Building Vent 4.77E9 cc/min 4.77E9 cc/min 5.05E8 cc/min 8.64E9 cc/min 6.52E9 cc/min Limiting Vent Concentration 8.95 4 Ci r vent 1E6 uCi Ci 3.57E-5 uCi/cc (5.26E5 min/yr)

(4.77E9 cc/min) for Reactor Buildings 182 Substituting the other vent flow rates into Equation 6

as above, the following noble gas high radiation set-point concentrations are calculated for the remaining vents:

Standby Gas Treatment System Unit 1 Turbine Building Unit 2 Turbine Building 3.37E-4 uCi/cc 1.97E-5 uCi/cc 2.61E-5 uCi/cc A.1.2.2 1odine -131 Monitor When the FES expected annual release quantity for I-131 (2.40E-l curies) is entered into GASPAR with the dispersion estimates of A. 1.2.1, the maximum calculated organ dose via the inhalation pathway is 4.88 mrem to the child thyroid.

Using Equation 5 of the ODCN, the limiting 1-131 release rate is calcu-lated as follows:

A-5

Limiting Release Rate

. 24 Ci 1500 mrem r

1.48El Ci/yr/ven (4.88 mrem)

(5 vents)

Using Equation 6 of the ODCM, the limiting (setpoint) 1-131 concentrations can be calculated for each of the five plant vents.

Limiting Vent Concentration 14.8 Ci r vent 1

6 uC Ci 5.90E-9 uCi/cc for.

(5.26E5 min/yr)

(4.77E9 cc/min)

Reactor Buildings 152 Substituting the other vent flow rates into Equation 6

of the ODCH above, the high ra'diation setpoints for the remaining plant vents are calculated to be the following:

Standby Gas Treatment System Unit 1 Turbine Building Unit 2 Turbine Building 5.57E-8 uCi/cc 3.26E-9 uCi/cc 4.32E-9 uCi/cc A. 1.2.3 Particulate Monitor Following are the SSES Final Environmental Statement (FES) expected annual release quantities for particu-late radionuclides:

A-6

Cr-51 Hn-54 Fe-59 Co-58 Co-60 Zn-65 Sr-89 Sr-90 Zr-95 Sb-124 Cs-134 Cs-136 Cs-137 Ba-140 Ce-141 Total 1.2E-4 Ci/yr per reactor 3.6E-4

1. 6E-4 5.8E-5 1.1E-3 5.5E-5 1.8E-S 3.1E-6 8.7E-6 5.1E-6 1.3E-4 1.3E-3 2.1E-4 4.2E-5

~2.9 -5 3.6E-3 Ci/yr per reactor When the above annual release quantities are entered into GASPAR with the annual average dispersion esti-mates of A. 1.2.1, the maximum calculated organ dose via the inhalation pathway is 1.33E-2 mrem to the teen lung.

Using Equation 5 of the OOCH, the limiting release rate of particulates can be calculated:

Limiting Release Rate 7.2E-3 Ci 500 mrem r

(2.66'-Z mrem)

(5 vents)

Using Equation 6 of the OOCM, the limiting (setpoint) particulate concentrations can be calculated for each of the five plant vents.

Limiting Vent Concentration 8.12El Ci r vent 1 6 uCi Ci 3.24E-8 uCi/cc for (5.26ES min/yr)

(4.77E9 cc/min)

Reactor Buildings 152 A-7

When the vent flow rates for the.remaini'ng five plant vents are substituted into Equation '6 as above, the following high radiation setpoint concentrations result.

Standby Gas Treatment System Unit 1 Turbine Building Unit 2 Turbine Building 3.06E-.7 uCi/cc 1.79E-8 uCi/cc

'.37E-8 uCi/cc A.2 AIRBORNE EFFLUENT DOSE RATE CALCULATIONS A.2.1 Noble Gases To evaluate the annual whole-body or skin dose from noble gas release

rates, the highest calculated annual average relative concentration for any sector is selected from Table 3.

For the SSES site, the critical downwind sector is the West sector with an annual dispersion factor of 2.6 x 10 sec/m The expected release rate of the principal noble gas radionuclide, xenon-133, is 396 uCi/sec.

To calculate the annual whole-body dose due to the release of any noble gas in the gaseous

effluent, Equation 7 in the ODCN should be used.

The whole-body dose factor (K.)

1 from Table 2 for xenon-133 is 2.94 x 10 mrem/yr per uCi/m Substituting these values in Equation 7, 3

the whole-body dose contribution from xenon-133 releases from the SSES would be 3.0 mrem/yr:

Dwb (K.)(X/9) (g')

(Equation 7)

Deb (2.94 x 10

~mrem r) 2 uCi/m X (396 uCi/sec)

(2.6 x 10 sec) 3 3.0 mrem/year To calculate the annual skin dose due to release of any noble gas in the gaseous effluent, Equation 8 in A-8

the OOCH should be used-The skin dose factor (Li) from Table 2 for xenon-133 is 3.06 x 10 mrem/yr 2

per uCi/m.

The air dose factor (Mi) from Table 2 for xenon-133 is 3.53 x 1Q mrad/yp per uCi/m.

Substituting these values and the previous values for release rate and annual dispersion factor in Equation 8, the skin dose contribution from xenon-133 from the SSES would be 7.1 mrem/yr:

D (Li + 1.1 M ) (X/Q)(Q'.)

0 (3.06 l02

~mr em r' uCi/m (Equation 8)

+ 1.1 (3.53 x 102 tt'ra ~r)) (2.6 x 10

)

uCi/m.3 m

x (396 uCi/sec}

7.1 mrem/year

A.2.2 Rad onuc de Other Tha Nob e Gas To evaluate the annual critical organ dose from radionuclides other than noble gases, th'e highest annual average dispersion parameter for estimating the dose to the critical receptor is selected from Table 3.

The highest annual dispersion factor is

-5 3

~

2.6 x 10 sec/m in the Mest sector.

The expected release rate of iodine-131 is 3e8 x 10 uCi/sec.

The expected release rate of cesium-137 is 6.66 x 10 uCi/sec.

To calculate the annual critical organ dose due to the release of radionuclides other than noble gases in the gaseous effluent, Equation 9 in the ODCM should be used.

The inhalation pathway parameter (R ) from Table 4 for iodine-131 is 1.62 x 10 mrem/yr per 3

uCi/m.

Substituting these values in Equation 9, the maximum thyroid dose contribution from iodine-131 would be 1.6 mrem/yr from the inhalation pathway.

o, - (R;)

(Mv) (0';v)

(Equation 9) 0 (1.62 x 10 m~rem r) (2.6 x 10 sec) uCi/m

~

3 m

X (3.8 x 10 uCi/sec) 1.6 mrem/year INHALATION PATHl)tAY, I-131 DAT A-10

0 0

0

A.3 ~tt L

0 A.3.1 Waterborne ff uents The liquid effluent dose calculations are performed using the Liquid Annual Dose To All. Persons (LADTAP.II) computer program.

This program may be used to calculate the quarterly (or. any other time period) doses to the maximum individual. The computer code LADTAP II, which was developed by the NRC to perform dose calculations in accordance with Regulatory Guide 1.109, is used.

The User's Manual for the LADTAP II program contains details of.

the calculational procedures.

The total number of curies released for each radionuclide during the time period being evaluated must be supplied from the SSES radiation monitoring program.

A.3.2 Airborne Effluents The airborne effluent dose calculations are performed using the GASPAR computer program.

This program may be used to calculate the maximum individual and population doses due to radionuclides released in gaseous effluents from the SSES.

The code implements the semi-infinite cloud model and the dose calculational models of Regulatory Guide 1.109 and is used to calculate all maximum individual and population doses and maximum individual organ doses from the SSES.

A more detailed description of the GASPAR code can be found in the GASPAR dose code manuals dated October 17,

1975, and February 20, )976.

The total number of curies released for each radionuclide during the time period being evaluated must be supplied from the SSES radiation monitoring program.

The meteorological parameters must be provided from the SSES meteorology program.

rl 0

To evaluate the air dose from noble gas release

rates, the highest calculated annual average relative concentration for any sector is selected from Table 3.

This critical downwind sector is the West sector with an annual dispersion factor of.2.6 x

.5 10 sec/m The expected release rate of the principal noble gas radionuclide, xenon-133, is 396 uCi/sec.

The total release in a calendar quarter would be 7.9 x 10 seconds times 6

396 uCi/sec or 3.13 x 10 uCi.

To calculate the quarterly gamma 9

air dose due to the Xenon-133 release in the gaseous effluent, Equation 12 in /he GDCH should be used.

The gamma air dose factor (H.) from Table 2for xenon-133 is 3.53 x 10 mrad/yr 2

per uCi/m Substituting these values in Equation 12, the quarterly gamma air dose contribution from xenon-133 releases from the SSES would be 0.9 mrad:

0

= 3.17 x 10 gr H,. (X/g)9i-(Equation 14) sec 0

- (3.17 x 10

~r)(3.53 x 10 prad~r)(2.6 x 10 sec) sec uCi/m3 m

X (3.13 x 10 uCi/qtr)

=.9 mrad/quarter To calculate the quarterly beta air dose due to the xenon-133 release in the gaseous effluent, Equation 13 in the ODCH should be used.

The beta air dose factor (N,.) from Table 2 for xenon-133 is 1.05 x 10 mrad/yr per uCi/m.

Substituting these values 3

3'n Equation 13, the quarterly beta air dose contribution from xenon-133 releases from the SSFS would be 2.7 mrad:

Db 3.17 x 10 Zr N. (X/g) (l'Equation 15)

Db - (3.17 x 10 Zr )(1.05 x 10'ec X (3.13 x 10 uCi/qtr)

~mrad r)(2.6 s )0 sec) uCi/m3 m

2.7 mrad/quarter

Since the beta air dose is greater than the gamma air dose by a factor of 3 for xenon-'33 and the dose limits are only a factor of 2 greater for beta than gamma radiation, the beta air dose would be controlling for xenon-133 releases.

A.E

~TA AL 4

The total cumulative annual dose to any member of. the public from.

operations at the SSES should be determined 'by summing the critical organ doses to real individuals from all three sources of radiation.

Only the maximum dose or dose commitment to a real individual needs to be evaluated.

A.4.1 Li uid Effluents The cumulative dose to any member of the public due to liquid effluents from the SSES should be determined from the LADTAP II program used for evaluating the individual doses as stated in Section A.3. 1 of this Appendix.

A.4.2 Gaseous Effluents The cumulative dose to any member of the public due to gaseous effluents from the SSES should be determined from the GASPAR program used for evaluating the individual doses as stated in Section A.3.2 of this Appendix.

A.4.3 Direct Radiation The direct radiation to any member of the public due to operations at the SSES should be determined from the environmental monitoring program results.

A-13

APPENDIX B REPORTING RE UIREMEHTS B. 1 ANNUAL ENVIRONMENTAL OPERATING REPORT, PART B, RADIOLOGICAL A repor t on the radiological environmental surveillance program for the previous calendar year shall be submitted to the Director of the HRC Regional Office (with a copy to the Director, Office of Nuclear Reactor Regulation) as a separate document by Hay of each year.

The period of the first report shall begin with the date of initial criticality.

The.

repor ts shall include a suaeary (format of Table 8-1.), interpretations, and an analysis of tr ends from the results of the radiological environmental surveillance activities for the. report period, including a comparison with operational controls, preoperational, studies (as" appropriate),

and previous environmental surveillance reports and an-assessment of the-observed impacts of. the station operation on the-environment.

lm the event that some results are not available, the report shall be submitted noting and explaining the reasons for the missing results; The missing data shall be submitted as soon as possible in a supplementary report.

B.2

.NONROUTINE RAOIOI OGICAL ENVIRONMENTAL OPERAT NG REPORTS When the level of radioact'ivity in an. environmental sampling medium averaged over 'any quarterly sampling period exceeds the reporting level given in Table B-2, a written report shall be submitted to the Director of the NRC Regional Office (with a copy to the Director, Office of Nuclear Reactor Regulation) within 30 days.

If it can be demonstrated that the level is not a result of station effluents (i.e.,

by comparison with control station or preoperational data) a report need not be submitted, but an explanation shall be given in the Annual Radiological Environmental Operating Report.

When more than one of the radionuclides in Table B-2 are detected in the I

medium, the reporting level will have been exceeded if:

concentration I

+

concentration 2

+...

1 reporting level (1) reporting level (2)

If radionuclides other than those in Table B-2 are detected and are due from station effluents, a reporting level is exceeded if the potential annual dose to an individual is equal to or greater than the design objective doses of 10 CFR Part 50, Appendix I.

This report shall include an evaluation of any release conditions, environmental factor, or other aspects necessary to explain the anomalous result.

7" ai a'v..~

L(/,

.$2 B-2

TABLE B-I SAMPLE ENVIRONMENTAL RADIOLOGICAL HOHITORIHG PROGRAH ANNUAL

SUMMARY

Reporting Period:

1/1/79 - 12/31/79 Hedium or Pathway Sampled (Unit of Heasurement Type and Total Humber of Analyses Performed All Indicator l.ower Limit Locations of Detection Hean

Name, Distance 8

Direction Hean Ran e

Location with Highest Annual Hean Control Locations Number of Honroutine Reported Mean Ran e

Heasurements Air Particulates

( 10 pCi/m

)

Gross Beta 336 26.6(234/234) 102 (7.7-71) 3.7 mi H

29.9(52/52) 28.2(102/102)

(11-71)

(9.8-64)

CO I4J Air Iodine (10 pCi/m )

Gaaea 28 Be-7 Cs-137 1-131 160 0.6 1.5 81(20/20)

(37-130) 1.6(4/20)

(1.1-1.8)

- (0/109) 3D1 82(4/4) 3.2 mi HE (54-130)

H/A H/A 1D2 5.7(2/4) 3.7 mi HE (2.3-9.0) 85(8/8)

(51-140) 2.7(1/8)

(2.7)

-(0/51) 0 0

o e; e examp e

a a are provided for illustrative purposes only.

~

1 J98g

t

TABLE B-2 REPORTlNG LEVELS FOR NOHRouTIHE OPERATING REPORTS

~Anal sls Mn-54 Fe-59 Co-58 Co-60 2n-65 Zr-Hb-95 1-131 Cs-134 Gs-137 Ba-La-140 Mater QCi~l 2 x 104(')

1 x 10 4 x 10 1x10 3

3 x 10 3 x 10 4

102(

)

2 30 50 2 x 102(b)

Airborne Particulate of Gases Ci/m'.9 10 20 Fish Ci k

, wet 3 x 10 1x10 3 x 10 4

1x10 4

2 x 10 4

1x10 2 x 10 3 Nilk Q)~Ci (~l 3

60 70 3 x 102(b)

Broad Leaf Vegetation Ci/k wet 1x10 1x10 2 x 10 a

a For drinking water samples.

This is 40 CFR Part 141 value.

Total for parent and daughter.

APPENDIX C SITE SPECIFIC INFORMATION USED BY'ASPAR CODE 1)

The distance from the facility to the NE corner of the U.S.

(Maine} in miles 590 miles.

2)

Fraction of year leafy vegetables are grown 0'.33 3)

Fraction of year cows are oh 'pasture Oe60 (April-Nov.)

4)

Fraction of crop from garden 0.76 5}

Fraction of daily intake of cows derived from pasture while on pasture.

0. 42 6}

Absolute humidity over growing season

~9.0

/m-Relative humidity is 67.6% if T is supplied.

7)

Average temperature over growing season 60.2'F 8}

Fraction of year goats are on pasture 0.60 g)

Fraction of daily intake of goat from past.ure while on pasture 0.75 10)

Fraction of year beef cattle are on pasture 0.60 11}

Fraction of daily intake of beef cattle derived from pasture while on.

pasture O.55

APPENDIX D SITE SPECIFIC INFORNATION USED B

LAD AP I CODE 1)

Total discharge per unit:

11 cubic feet per

second, or specific to release period.

2) 'Total Annual Blowdown Volume:

6.94ES cubic feet 3)

Dose to Maximum Hypothetical Individual Shorewidth Factor:

0.2 Sediment exposure time:

131,400 hr.

USAGE FACTORS PATHWAY Fish k

r Potable Water liter yr Shoreline hr yr INFANT 330 CHILD 6.9 510 14 TEEN 16 510 67 ADULT 21 730 12 DILUTION FACTORS (DF)

Fish PATHWAY Potable Water Shoreline LOCATION Outfall Danville Outfall DF 15.9 321*

15.9

For estimating purposes.

Actual dilution factors at Danville, Pa., for various river levels located in Table 5-4.

TRANSIT TINES (Tp)

Fish PATHWAY Potable Water Shoreline LOCATION Outfall Danville Outfall T

hr 25**

25.8*

For estimating purposes.

Actual river transit times at Danville, Pa., for various river levels located in Table 5-4.

- Includes one hour transit from outfall plus 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months to consumption.

A DAT i> O'ev.

1 D-1

k 0:

ML17164A589

Text

1.0 INTRODUCTION

0.5 Background

Background

Background

0.5 Background

Background

Reference:

SUMMARY

Navigation menu

Search